Sentence,class,file
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>.,Non-OADS,/arxiv_data1/oa_pdf/39/8d/S2048679013000025a.PMC4153088.pdf
http://globocan.iarc.fr (accessed August 2012).,Non-OADS,/arxiv_data1/oa_pdf/39/8d/S2048679013000025a.PMC4153088.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>.,Non-OADS,/arxiv_data1/oa_pdf/9c/a0/S2048679012000274a.PMC4153089.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>.,Non-OADS,/arxiv_data1/oa_pdf/34/f9/S2048679013000013a.PMC4153090.pdf
http://www.statistikbanken.dk/statbank 5a/default.asp?w=1920 13.,Non-OADS,/arxiv_data1/oa_pdf/34/f9/S2048679013000013a.PMC4153090.pdf
7.01. http://www.foodcomp.dk/v7/fvdb_search.asp 16.,Non-OADS,/arxiv_data1/oa_pdf/34/f9/S2048679013000013a.PMC4153090.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>.,Non-OADS,/arxiv_data1/oa_pdf/11/f7/S2048679012000158a.PMC4153093.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>.,Non-OADS,/arxiv_data1/oa_pdf/bf/99/S2048679012000031a.PMC4153094.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>.,Non-OADS,/arxiv_data1/oa_pdf/14/d1/S2048679013000207a.PMC4153096.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>.,Non-OADS,/arxiv_data1/oa_pdf/e7/04/S204867901200016Xa.PMC4153098.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>.,Non-OADS,/arxiv_data1/oa_pdf/64/72/S2048679012000146a.PMC4153101.pdf
"The Ministry of Health, Labour and Welfare in Japan (2010) The Results of National Health and Nutrition Examination Survey in 2008. http://www.mhlw.go.jp/bunya/kenkou/eiyou09/01.html (In Japanese).",Non-OADS,/arxiv_data1/oa_pdf/64/72/S2048679012000146a.PMC4153101.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/> .,Non-OADS,/arxiv_data1/oa_pdf/4b/89/S2048679012000067a.PMC4153103.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>.,Non-OADS,/arxiv_data1/oa_pdf/9e/19/S2048679012000286a.PMC4153124.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>.,Non-OADS,/arxiv_data1/oa_pdf/22/56/S2048679012000122a.PMC4153281.pdf
The sequences of the speciﬁc primers used in the Power SYBR Green PCR Master Mix protocol are listed in Supplementary Table S1 (available online at http://journals.cambridge.org/JNS).,OADS,/arxiv_data1/oa_pdf/22/56/S2048679012000122a.PMC4153281.pdf
Supplementary material The supplementary material for this article can be found athttp://journals.cambridge.org/JNS References 1.,Non-OADS,/arxiv_data1/oa_pdf/22/56/S2048679012000122a.PMC4153281.pdf
"Therefore, in collabor- ation with the publishers of the BJN, Cambridge University Press, the Society has launched a new journal, Journal of Nutritional Science (JNS) (http://www.nutritionsociety.org/ journal-nutritional-science).",Non-OADS,/arxiv_data1/oa_pdf/2b/87/S2048679011000012a.PMC4153284.pdf
Articles may be submitted to JNS at http://jnutsci.msubmit.net/cgi-bin/main.,OADS,/arxiv_data1/oa_pdf/2b/87/S2048679011000012a.PMC4153284.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>.,Non-OADS,/arxiv_data1/oa_pdf/2b/87/S2048679011000012a.PMC4153284.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>.,Non-OADS,/arxiv_data1/oa_pdf/29/36/S2048679012000201a.PMC4153285.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>.,Non-OADS,/arxiv_data1/oa_pdf/fe/42/S2048679012000080a.PMC4153286.pdf
http://www.ibt.ku.dk/jesper/FoodCalc/Default.htm (accessed October 2005).,Non-OADS,/arxiv_data1/oa_pdf/fe/42/S2048679012000080a.PMC4153286.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>.,Non-OADS,/arxiv_data1/oa_pdf/c8/41/S2048679013000086a.PMC4153288.pdf
http://www.iuna.net/?p=27 15.,Non-OADS,/arxiv_data1/oa_pdf/c8/41/S2048679013000086a.PMC4153288.pdf
http://www.food.gov.uk/multimedia/pdfs/publication/eatwellplate0907.pdf 8journals.cambridge.org/jns,Non-OADS,/arxiv_data1/oa_pdf/c8/41/S2048679013000086a.PMC4153288.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>.,Non-OADS,/arxiv_data1/oa_pdf/89/6d/S2048679012000298a.PMC4153289.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>.,Non-OADS,/arxiv_data1/oa_pdf/61/a7/S2048679012000110a.PMC4153304.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>.,Non-OADS,/arxiv_data1/oa_pdf/d0/74/S2048679012000304a.PMC4153306.pdf
"All compu-tational tasks were performed using the R Programming Language and Environment for Statistical Computing (R ver- sion 2.13.0, http://cran.r-project.org/ ).",OADS,/arxiv_data1/oa_pdf/d0/74/S2048679012000304a.PMC4153306.pdf
http://www.epa.gov/iris/rfd.htm 15.,OADS,/arxiv_data1/oa_pdf/d0/74/S2048679012000304a.PMC4153306.pdf
http://www.foodstandards.gov.au/_src ﬁles/CYANOGENIC_ GLYCOSIDES_IN_CASSAVA_CHIPS_Feb_2008.pdf 43.,Non-OADS,/arxiv_data1/oa_pdf/d0/74/S2048679012000304a.PMC4153306.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>.,Non-OADS,/arxiv_data1/oa_pdf/ff/da/S2048679013000037a.PMC4153309.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>.,Non-OADS,/arxiv_data1/oa_pdf/7f/a7/S2048679013000062a.PMC4153310.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>.,Non-OADS,/arxiv_data1/oa_pdf/7f/a7/S2048679013000062a.PMC4153310.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>.,Non-OADS,/arxiv_data1/oa_pdf/97/e9/S2048679013000219a.PMC4153321.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>.,Non-OADS,/arxiv_data1/oa_pdf/92/53/S2048679012000043a.PMC4153322.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>.,Non-OADS,/arxiv_data1/oa_pdf/b6/d5/S2048679012000171a.PMC4153323.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>.,Non-OADS,/arxiv_data1/oa_pdf/4e/56/S2048679013000177a.PMC4153324.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>.,Non-OADS,/arxiv_data1/oa_pdf/fe/21/S2048679013000153a.PMC4153325.pdf
The Let ’s Prevent Diabetes study is registered with ISRCTN ( http://www.controlled-trials.com/ ); reference no.,Non-OADS,/arxiv_data1/oa_pdf/fe/21/S2048679013000153a.PMC4153325.pdf
http://www.com- munities.gov.uk/documents/communities/pdf/576659.pdf (accessed June 2010).,Non-OADS,/arxiv_data1/oa_pdf/fe/21/S2048679013000153a.PMC4153325.pdf
http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/fe/21/S2048679013000153a.PMC4153325.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>.,Non-OADS,/arxiv_data1/oa_pdf/9f/34/S2048679013000074a.PMC4153327.pdf
"Methods Protocol and registration The protocol for this review was peer reviewed by the Joanna-Briggs Institute (JBI), and is registered in the JBI library of systematic review protocols ( http://www.joannab- riggs.edu.au/Search.aspx ).",OADS,/arxiv_data1/oa_pdf/9f/34/S2048679013000074a.PMC4153327.pdf
http://www.who.int/nutrition/publications/en/ida_assessment_ prevention_control.pdf 6.,Non-OADS,/arxiv_data1/oa_pdf/9f/34/S2048679013000074a.PMC4153327.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>.,Non-OADS,/arxiv_data1/oa_pdf/33/0e/S2048679012000237a.PMC4153328.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>.,Non-OADS,/arxiv_data1/oa_pdf/bd/a2/S2048679012000134a.PMC4153331.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>.,Non-OADS,/arxiv_data1/oa_pdf/6b/3c/S2048679013000050a.PMC4153341.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>.,Non-OADS,/arxiv_data1/oa_pdf/6b/3c/S2048679013000050a.PMC4153341.pdf
"The PD map is accessible at http://minerva.uni.lu/pd_map .Keywords Parkinson ’s disease .Molecular neuropathology .Knowledge repository .Bioinformatics Introduction Parkinson ’s disease (PD) is a major neurodegenerative dis- ease, characterized clinically by a range of symptoms, in particular, impaired motor behaviour.",Non-OADS,/arxiv_data1/oa_pdf/bc/7a/12035_2013_Article_8489.PMC4153395.pdf
"The PD map is accessible under http://minerva.uni.lu/pd_map (Online resource 1), as a SBML file (Online resource 2), and Payao, a community platform for pathway model curation [264].",OADS,/arxiv_data1/oa_pdf/bc/7a/12035_2013_Article_8489.PMC4153395.pdf
Detailed contents of the PD map are accessible at http://minerva.uni.lu/MapViewer/map?id=pdmap (Online resource 1) as an SBML file (Online resource 2) and in Payao [264].,OADS,/arxiv_data1/oa_pdf/bc/7a/12035_2013_Article_8489.PMC4153395.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: S.T.,Non-OADS,/arxiv_data1/oa_pdf/6d/55/ncomms5702.PMC4153407.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Tasoglu, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/6d/55/ncomms5702.PMC4153407.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5702 ARTICLE NATURE COMMUNICATIONS | 5:4702 | DOI: 10.1038/ncomms5702 | www.nature.com/naturecommunications 11 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/6d/55/ncomms5702.PMC4153407.pdf
"Patients were diagnosed  with KC if the Schimpff flow-based elevation map showed  posterior corneal elevation within the central 5 mm ≥+20 µm,  inferior-superior dioptric asymmetry (I-S value) >1.2 diop - ters (D), and the steepest keratometry >47 D. Patients were Molecular Vision  2014; 20:1203-1208 <http://www.molvis.org/molvis/v 20/1203 > Received 28 April 2014 | Accepted 27 August 2014 | Published 27 August 2014© 2014 Molecular Vision 1203Keratoconus is associated with increased copy number of  mitochondrial DNA Khaled.",Non-OADS,/arxiv_data1/oa_pdf/65/37/mv-v20-1203.PMC4153421.pdf
Molecular Vision  2014; 20:1203-1208 <http://www.molvis.org/molvis/v 20/1203 > © 2014 Molecular Vision  1204considered sporadic cases after immediate family members  were examined and the patient was identified as an isolated  case of KC.,Non-OADS,/arxiv_data1/oa_pdf/65/37/mv-v20-1203.PMC4153421.pdf
"Molecular Vision  2014; 20:1203-1208 <http://www.molvis.org/molvis/v 20/1203 > © 2014 Molecular Vision  1205To assess the risk of disease, the levels of mtDNA content  among the control and patient subjects were initially dichoto - mized (uncategorized) at the 50th percentile (or median)  value.",Non-OADS,/arxiv_data1/oa_pdf/65/37/mv-v20-1203.PMC4153421.pdf
"Molecular Vision  2014; 20:1203-1208 <http://www.molvis.org/molvis/v 20/1203 > © 2014 Molecular Vision  1206category (0.817–1.259; inter-quartile) did not show significant  association; however, individuals in the highest category  (>1.259) were at an increased risk of the disease (OR = 2.62,  95% CI = 1.40 to 4.89; p = 0.0025; Table 2).",Non-OADS,/arxiv_data1/oa_pdf/65/37/mv-v20-1203.PMC4153421.pdf
"Molecular Vision  2014; 20:1203-1208 <http://www.molvis.org/molvis/v 20/1203 > © 2014 Molecular Vision  1207group of patients from a restricted ethnic population, and this  type of evaluation must be repeated at other centers.",Non-OADS,/arxiv_data1/oa_pdf/65/37/mv-v20-1203.PMC4153421.pdf
Molecular Vision  2014; 20:1203-1208 <http://www.molvis.org/molvis/v 20/1203 > © 2014 Molecular Vision  120825.,Non-OADS,/arxiv_data1/oa_pdf/65/37/mv-v20-1203.PMC4153421.pdf
"Proteomics  has expanded the opportunities to identify disease-specific  proteins involved in many diseases, including ophthalmic  diseases such as dry eye [ 14,15], cataract [ 16,17], keratoconus  [18], myopia [ 19], and pterygia [ 20].Molecular Vision  2014; 20:1192-1202 <http://www.molvis.org/molvis/v 20/1192 > Received 13 March 2014 | Accepted 27 August 2014 | Published 27 August 2014© 2014 Molecular Vision 1192Proteomic analysis in pterygium; upregulated protein expression  of ALDH3A1, PDIA3, and PRDX2 Sun Woong Kim,1 Jonghoon Lee,2 Boram Lee,2 Taiyoun Rhim2 1Department of Ophthalmology, Hando Hospital, Ansan, Korea; 2Department of Bioengineering and Institute for Bioengineering  and Biopharmaceutical Research, Hanyang University, Seoul, Korea Purpose:  To identify differentially expressed proteins in the pterygium compared to healthy conjunctiva using a pro - teomic analysis.",Non-OADS,/arxiv_data1/oa_pdf/20/1e/mv-v20-1192.PMC4153422.pdf
"Molecular Vision  2014; 20:1192-1202 <http://www.molvis.org/molvis/v 20/1192 > © 2014 Molecular Vision  1193As in previous studies, hundreds of protein molecules  were newly identified as candidate biomarkers of pterygia.",Non-OADS,/arxiv_data1/oa_pdf/20/1e/mv-v20-1192.PMC4153422.pdf
"Molecular Vision  2014; 20:1192-1202 <http://www.molvis.org/molvis/v 20/1192 > © 2014 Molecular Vision  1194Samples were then washed twice, and final incubation was  performed for 30 min using streptavidin-peroxidase.",Non-OADS,/arxiv_data1/oa_pdf/20/1e/mv-v20-1192.PMC4153422.pdf
Molecular Vision  2014; 20:1192-1202 <http://www.molvis.org/molvis/v 20/1192 > © 2014 Molecular Vision  1195were up- or downregulated in pterygia tissues were classified.,Non-OADS,/arxiv_data1/oa_pdf/20/1e/mv-v20-1192.PMC4153422.pdf
"Molecular Vision  2014; 20:1192-1202 <http://www.molvis.org/molvis/v 20/1192 > © 2014 Molecular Vision  1196Table  2. p roTeIns IDenTIfIeD by lc-ms/ms a nalys Is In normal  conjunc TIVa, prImary  anD recurren T pTeryg Ium TIssue.",Non-OADS,/arxiv_data1/oa_pdf/20/1e/mv-v20-1192.PMC4153422.pdf
Molecular Vision  2014; 20:1192-1202 <http://www.molvis.org/molvis/v 20/1192 > © 2014 Molecular Vision  1197Identified Proteins Accession numberPeptide Hits Normal conjunctiva Primary pterygiumRecur - rent Pterygium PSMA2 Proteasome subunit alpha type-2 IPI00219622 150 117 58 RPL22 60S ribosomal protein L22 IPI00219153 4 3 0 RPL30 60S ribosomal protein L30 IPI00219156 4 3 0 STOM Erythrocyte band 7 integral membrane protein IPI00219682 5 4 0 TAGLN Transgelin IPI00216138 14 8 3 TTN Isoform 7 of Titin IPI00179357 18 3 0,Non-OADS,/arxiv_data1/oa_pdf/20/1e/mv-v20-1192.PMC4153422.pdf
"Molecular Vision  2014; 20:1192-1202 <http://www.molvis.org/molvis/v 20/1192 > © 2014 Molecular Vision  1198Western blot analysis and immunohistochemistry:  To vali - date the proteomic analysis data, we performed a western  blot analysis of homogenates from normal conjunctiva and  pterygium (100 μg of protein/lane).",Non-OADS,/arxiv_data1/oa_pdf/20/1e/mv-v20-1192.PMC4153422.pdf
"Molecular Vision  2014; 20:1192-1202 <http://www.molvis.org/molvis/v 20/1192 > © 2014 Molecular Vision  1199through the production of NADPH, 4) maintaining corneal  refractive and transparent properties as a corneal crystal - line, 5) chaperon-like activity, and 6) cell cycle regulation  [25-28].",Non-OADS,/arxiv_data1/oa_pdf/20/1e/mv-v20-1192.PMC4153422.pdf
"Molecular Vision  2014; 20:1192-1202 <http://www.molvis.org/molvis/v 20/1192 > © 2014 Molecular Vision  1200from peroxide-induced apoptosis and necrosis, while down - regulation of this enzyme promotes injurious effects of oxida - tive stress in cardiomyocytes [ 40].",Non-OADS,/arxiv_data1/oa_pdf/20/1e/mv-v20-1192.PMC4153422.pdf
Molecular Vision  2014; 20:1192-1202 <http://www.molvis.org/molvis/v 20/1192 > © 2014 Molecular Vision  1201and pterygium.,Non-OADS,/arxiv_data1/oa_pdf/20/1e/mv-v20-1192.PMC4153422.pdf
Molecular Vision  2014; 20:1192-1202 <http://www.molvis.org/molvis/v 20/1192 > © 2014 Molecular Vision  1202HPV-16 dysplastic and neoplastic tissues.,Non-OADS,/arxiv_data1/oa_pdf/20/1e/mv-v20-1192.PMC4153422.pdf
"Molecular Vision  2014; 20:1174-1181 <http://www.molvis.org/molvis/v 20/1174 > Received 12 June 2013 | Accepted 27 August 2014 | Published 29 August 2014© 2014 Molecular Vision 1174Osteogenesis imperfecta and primary open angle glaucoma:  Genotypic analysis of a new phenotypic association Dana J. Wallace,1 Felix Y. Chau,1 Cecilia Santiago-Turla,1 Michael Hauser,1,2 Pratap Challa,1 Paul P. Lee,1  Leon W. Herndon,1 R. Rand Allingham1,2 1Department of Ophthalmology, Duke Eye Center, Durham, NC; 2Duke University Center for Human Genetics, Durham, NC Purpose:  Osteogenesis imperfecta (OI) is a group of inherited disorders characterized by bone fragility.",Non-OADS,/arxiv_data1/oa_pdf/c8/ba/mv-v20-1174.PMC4153423.pdf
"Molecular Vision  2014; 20:1174-1181 <http://www.molvis.org/molvis/v 20/1174 > © 2014 Molecular Vision  1175Type I collagen genes ( COL1A1  and COL1A2,  OMIM  120160 ) were sequenced.",OADS,/arxiv_data1/oa_pdf/c8/ba/mv-v20-1174.PMC4153423.pdf
Molecular Vision  2014; 20:1174-1181 <http://www.molvis.org/molvis/v 20/1174 > © 2014 Molecular Vision  1176performed OU.,Non-OADS,/arxiv_data1/oa_pdf/c8/ba/mv-v20-1174.PMC4153423.pdf
"Molecular Vision  2014; 20:1174-1181 <http://www.molvis.org/molvis/v 20/1174 > © 2014 Molecular Vision  1177rigidity, low IOP (range: 10–14 mmHg), and high facility of  outflow.",Non-OADS,/arxiv_data1/oa_pdf/c8/ba/mv-v20-1174.PMC4153423.pdf
Molecular Vision  2014; 20:1174-1181 <http://www.molvis.org/molvis/v 20/1174 > © 2014 Molecular Vision  1178 Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/c8/ba/mv-v20-1174.PMC4153423.pdf
Molecular Vision  2014; 20:1174-1181 <http://www.molvis.org/molvis/v 20/1174 > © 2014 Molecular Vision  1179the optic nerve head and lamina cribrosa could render the  optic nerve more susceptible to damage from elevated IOP.,Non-OADS,/arxiv_data1/oa_pdf/c8/ba/mv-v20-1174.PMC4153423.pdf
Molecular Vision  2014; 20:1174-1181 <http://www.molvis.org/molvis/v 20/1174 > © 2014 Molecular Vision  1180associated with the development of glaucoma in these indi - viduals.,Non-OADS,/arxiv_data1/oa_pdf/c8/ba/mv-v20-1174.PMC4153423.pdf
Molecular Vision  2014; 20:1174-1181 <http://www.molvis.org/molvis/v 20/1174 > © 2014 Molecular Vision  11816.,Non-OADS,/arxiv_data1/oa_pdf/c8/ba/mv-v20-1174.PMC4153423.pdf
"In this study, using liquid chromatography followed by  tandem mass spectrometry (LC-MS/MS), we sought to iden - tify the proteomic profile of a clinical isolate of P. aeruginosa  Molecular Vision  2014; 20:1182-1191 <http://www.molvis.org/molvis/v 20/1182 > Received 15 September 2013 | Accepted 27 August 2014 | Published 29 August 2014© 2014 Molecular Vision 1182Proteomic analysis of keratitis-associated Pseudomonas aeruginosa Abby Sewell, Jeffrey Dunmire, Michael Wehmann, Theresa Rowe, Rachida Bouhenni Summa Health System, Akron, OH Purpose:  To compare the proteomic profile of a clinical isolate of Pseudomonas aeruginosa  (P. aeruginosa ) obtained  from an infected cornea of a contact lens wearer and the laboratory strain P. aeruginosa  ATCC 10145.",Non-OADS,/arxiv_data1/oa_pdf/93/d6/mv-v20-1182.PMC4153424.pdf
Molecular Vision  2014; 20:1182-1191 <http://www.molvis.org/molvis/v 20/1182 > © 2014 Molecular Vision  1183obtained from an active human ulcerative keratitis and  compared it to the non-clinical laboratory strain ATCC 10145  [23].,Non-OADS,/arxiv_data1/oa_pdf/93/d6/mv-v20-1182.PMC4153424.pdf
"Molecular Vision  2014; 20:1182-1191 <http://www.molvis.org/molvis/v 20/1182 > © 2014 Molecular Vision  1184prepared for in-gel digest by mixing 150 μg of protein with  100 µl acrylamide/bis (30%T/2.67%C), 10 µl of 10% sodium  hydroxide (NaOH), 10 µl of 10% ammonium persulfate, and  5 µl of N,N,N′,N′-Tetramethylethylenediamine (TEMED) in  the lid of a microcentrifuge tube.",Non-OADS,/arxiv_data1/oa_pdf/93/d6/mv-v20-1182.PMC4153424.pdf
Molecular Vision  2014; 20:1182-1191 <http://www.molvis.org/molvis/v 20/1182 > © 2014 Molecular Vision  1185 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/93/d6/mv-v20-1182.PMC4153424.pdf
Molecular Vision  2014; 20:1182-1191 <http://www.molvis.org/molvis/v 20/1182 > © 2014 Molecular Vision  1186non-ribosomal peptide synthetases (NRPSs) the most abun - dant (NCBI reference sequences # 218891724  and 386058801 ).,Non-OADS,/arxiv_data1/oa_pdf/93/d6/mv-v20-1182.PMC4153424.pdf
Molecular Vision  2014; 20:1182-1191 <http://www.molvis.org/molvis/v 20/1182 > © 2014 Molecular Vision  1187Table  1.,Non-OADS,/arxiv_data1/oa_pdf/93/d6/mv-v20-1182.PMC4153424.pdf
Molecular Vision  2014; 20:1182-1191 <http://www.molvis.org/molvis/v 20/1182 > © 2014 Molecular Vision  1188such as the Clustered Regularly Interspaced Short Palin - dromic Repeats (CRSPR)/Cas domain that belongs to the  CRISPR/Cas system-associated Repair Associated Myste - rious Proteins (RAMP) superfamily protein (hypothetical  protein PA14_33310).,Non-OADS,/arxiv_data1/oa_pdf/93/d6/mv-v20-1182.PMC4153424.pdf
Molecular Vision  2014; 20:1182-1191 <http://www.molvis.org/molvis/v 20/1182 > © 2014 Molecular Vision  1189adaptation to its niche.,Non-OADS,/arxiv_data1/oa_pdf/93/d6/mv-v20-1182.PMC4153424.pdf
Molecular Vision  2014; 20:1182-1191 <http://www.molvis.org/molvis/v 20/1182 > © 2014 Molecular Vision  119022.,Non-OADS,/arxiv_data1/oa_pdf/93/d6/mv-v20-1182.PMC4153424.pdf
Molecular Vision  2014; 20:1182-1191 <http://www.molvis.org/molvis/v 20/1182 > © 2014 Molecular Vision  119151.,Non-OADS,/arxiv_data1/oa_pdf/93/d6/mv-v20-1182.PMC4153424.pdf
<http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/ucm064982.htm>.,Non-OADS,/arxiv_data1/oa_pdf/75/6c/clpt201470a.PMC4153445.pdf
<http://www.ema.europa.eu/docs/en_GB/document_ library/Scientific_guideline/2012/07/WC500129606.pdf> (2012).,Non-OADS,/arxiv_data1/oa_pdf/75/6c/clpt201470a.PMC4153445.pdf
"ISSX Online Abstracts (http://www.issx.org), Supplement 6, No.",Non-OADS,/arxiv_data1/oa_pdf/75/6c/clpt201470a.PMC4153445.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ ClInIC al Pharma Cology & ThEraPEuTICS  | VOLUME 96 NUMBER 2 | AUGUST  2014  213",Non-OADS,/arxiv_data1/oa_pdf/75/6c/clpt201470a.PMC4153445.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/13/ca/mjiri-28-40.PMC4153476.pdf
28.40.7 June2014http://mjiri.iums.ac.irdata were excluded from the study.,Non-OADS,/arxiv_data1/oa_pdf/13/ca/mjiri-28-40.PMC4153476.pdf
"28.40.7 June2014 http://mjiri.iums.ac.irleft sided lesions (3,5).",Non-OADS,/arxiv_data1/oa_pdf/13/ca/mjiri-28-40.PMC4153476.pdf
28.40.7 June2014http://mjiri.iums.ac.irjority of patients with perinata l HN are asymptomatic and detected incidentally.,Non-OADS,/arxiv_data1/oa_pdf/13/ca/mjiri-28-40.PMC4153476.pdf
"Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________ _______________________________________________________ _______ 1.MSc of Epidemiology, Department of Epidemiology, Shiraz University of Medical Sciences, Shiraz, Iran.",Non-OADS,/arxiv_data1/oa_pdf/59/f9/mjiri-28-13.PMC4153495.pdf
2 8.13.23Feb2014http://mjiri.iums.ac.irbut not always with a good quality of life (QOL) (3).,Non-OADS,/arxiv_data1/oa_pdf/59/f9/mjiri-28-13.PMC4153495.pdf
"2 8.13.23Feb2014 http://mjiri.iums.ac.irwhich is a 36 -item self administered or i n- terviewer -administered instrument with eight scales: physical functioning, role lim i- tations caused by physical health problems, pain, general health perceptions, emotional well-being, role limitation caused by em o- tional problems, social functioning, and e n- ergy/fatigue.",Non-OADS,/arxiv_data1/oa_pdf/59/f9/mjiri-28-13.PMC4153495.pdf
2 8.13.23Feb2014http://mjiri.iums.ac.irdistance between the house and the service providing center ( p>0.05).,Non-OADS,/arxiv_data1/oa_pdf/59/f9/mjiri-28-13.PMC4153495.pdf
"2 8.13.23Feb2014 http://mjiri.iums.ac.irrelationships, those who infected by intrav e- nous drug abuse had a lower QOL.",Non-OADS,/arxiv_data1/oa_pdf/59/f9/mjiri-28-13.PMC4153495.pdf
2 8.13.23Feb2014http://mjiri.iums.ac.irin black patients and white patients with acute chest pain.,Non-OADS,/arxiv_data1/oa_pdf/59/f9/mjiri-28-13.PMC4153495.pdf
"The integrity of the coding  sequence was purified and sequenced by Sanger dideoxy se - quencing (http://www.ncbi.nlm.nih.gov/genbank) (Sanger  et al., 1977).",OADS,/arxiv_data1/oa_pdf/3c/4f/NRR-9-481.PMC4153500.pdf
DebateArticle http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/c7/3c/mjiri-28-34.PMC4153516.pdf
2 8.34.19 May2014http://mjiri.iums.ac.irpurpose and none is agreed upon as the best method or gold standard for all setting s (5).,Non-OADS,/arxiv_data1/oa_pdf/c7/3c/mjiri-28-34.PMC4153516.pdf
2 8.34.19 May2014 http://mjiri.iums.ac.irbased concept with a norm -referenced one (13).,Non-OADS,/arxiv_data1/oa_pdf/c7/3c/mjiri-28-34.PMC4153516.pdf
"2 8.34.19 May2014http://mjiri.iums.ac.irholders, that may or may not be different from the judges, should decide on students’ performance levels including number of categories, their labels, and a behavioral descriptor for each category (13 -15).",Non-OADS,/arxiv_data1/oa_pdf/c7/3c/mjiri-28-34.PMC4153516.pdf
2 8.34.19 May2014 http://mjiri.iums.ac.irabove-mentioned approaches do not prove the validity of the standard itself (i.e.,Non-OADS,/arxiv_data1/oa_pdf/c7/3c/mjiri-28-34.PMC4153516.pdf
2 8.34.19 May2014http://mjiri.iums.ac.irthe Nedelsky and Angoff cutting score procedures using generalisability theory.,Non-OADS,/arxiv_data1/oa_pdf/c7/3c/mjiri-28-34.PMC4153516.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/e0/36/mjiri-28-37.PMC4153517.pdf
2 8.37.24 May2014http://mjiri.iums.ac.irbeen recorded in Eastern Mediterranean and African region in the world.,Non-OADS,/arxiv_data1/oa_pdf/e0/36/mjiri-28-37.PMC4153517.pdf
2 8.37.24 May2014 http://mjiri.iums.ac.irtory crash helmet law was performed by traffic police.,Non-OADS,/arxiv_data1/oa_pdf/e0/36/mjiri-28-37.PMC4153517.pdf
"2 8.37.24 May2014http://mjiri.iums.ac.irthe Fars province, the highest mortality rate was revealed in Niriz city (NSC) (254/100,000 motorcycles) and the least reported from Eghlid city (SC) (122/100,000 motorcycles ).",Non-OADS,/arxiv_data1/oa_pdf/e0/36/mjiri-28-37.PMC4153517.pdf
2 8.37.24 May2014 http://mjiri.iums.ac.ircommunity practicing cities and the odds for hearing blockage was 0.65(CI:0.4-1.0) in safe community non practicing cities a f- ter age adjustment (Table7).,Non-OADS,/arxiv_data1/oa_pdf/e0/36/mjiri-28-37.PMC4153517.pdf
2 8.37.24 May2014http://mjiri.iums.ac.irdisciplinary members of the committee and determining the duties of each members based on the instructions 3.Holding sessions in order to design o p- erational plans for prevention of injuries in the city area.,Non-OADS,/arxiv_data1/oa_pdf/e0/36/mjiri-28-37.PMC4153517.pdf
2 8.37.24 May2014 http://mjiri.iums.ac.irties to the motorc yclists' death was positive in these two cities in comparison to other cities of the province in which the safe community model was not practicing.,Non-OADS,/arxiv_data1/oa_pdf/e0/36/mjiri-28-37.PMC4153517.pdf
"2 8.37.24 May2014http://mjiri.iums.ac.irsimilar findings may say common senten c- es that motorcyclists' safety was not the main priority of the community in safe community settings, but as a subsidiary outcome to the main activities of road tra f- fic safety (8,10).Factors related to the ind i- vidual level, remain by far the main dete r- minants in injury severity.",Non-OADS,/arxiv_data1/oa_pdf/e0/36/mjiri-28-37.PMC4153517.pdf
2 8.37.24 May2014 http://mjiri.iums.ac.ir(Accessed on February 18 2008) .,Non-OADS,/arxiv_data1/oa_pdf/e0/36/mjiri-28-37.PMC4153517.pdf
Available from http://www.who.int/healthinfo/bodestimates/en/.,Non-OADS,/arxiv_data1/oa_pdf/e0/36/mjiri-28-37.PMC4153517.pdf
"WH O, Geneva .2009. http://www.who.int/world -health-day/2009/ inf o- materials/world_report/en/ .",Non-OADS,/arxiv_data1/oa_pdf/e0/36/mjiri-28-37.PMC4153517.pdf
"35.http://www.safecommunities.ca/images/Doc uments/Uploads/Manifesto.pdf , accessible on 15/01/2013 .",Non-OADS,/arxiv_data1/oa_pdf/e0/36/mjiri-28-37.PMC4153517.pdf
"36.http://www.phs.k i.se/csp/who_safe_commun ities_network_en.htm , accessible on 15/01/2013 .",Non-OADS,/arxiv_data1/oa_pdf/e0/36/mjiri-28-37.PMC4153517.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences __________________________________________________________________________________ __________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/df/87/mjiri-28-29.PMC4153518.pdf
"2 8.29.7 May2014http://mjiri.iums.ac.irConsidering the evidence on the role of folic acid to reduce the occurre nce of Ne u- ral Tube Defects (NTDs) and also available experiences on fortification with folic acid and Based on the World Health Organiz a- tion recommendations, through a national law, named Mandatory wheat f lour fortif i- cationwith   folic acid (1.5 ppm: 150 Micro gram per 100 g flour.)",Non-OADS,/arxiv_data1/oa_pdf/df/87/mjiri-28-29.PMC4153518.pdf
"2 8.29.7 May2014 http://mjiri.iums.ac.irIndeed, the preventive fraction rate of oral cleftingafter fortification period in compa r- ison with before fortification period was 49.8% [OR=0.502, 95% CI 0.26 -0.97, p=0.036] (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/df/87/mjiri-28-29.PMC4153518.pdf
2 8.29.7 May2014http://mjiri.iums.ac.irfortification in the United States is assoc i- ated with a significant decline (6%) in the prevalence of orofacial clefts.,Non-OADS,/arxiv_data1/oa_pdf/df/87/mjiri-28-29.PMC4153518.pdf
2 8.29.7 May2014 http://mjiri.iums.ac.ir40(5):481 -5.,Non-OADS,/arxiv_data1/oa_pdf/df/87/mjiri-28-29.PMC4153518.pdf
"Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.MD, Professor of Infectious Diseases, Departm ent of Community Medicine, Tehran University of Medical Sciences, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/6f/0c/mjiri-28-31.PMC4153519.pdf
"2 8.31.10 May2014http://mjiri.iums.ac.irproximately, 100,000 Iranian pilgrims have participated in hajj rituals each year in re- cent years ( 8).",Non-OADS,/arxiv_data1/oa_pdf/6f/0c/mjiri-28-31.PMC4153519.pdf
2 8.31.10 May2014 http://mjiri.iums.ac.irHajj pilgrims in 2 studies (15 -16).,Non-OADS,/arxiv_data1/oa_pdf/6f/0c/mjiri-28-31.PMC4153519.pdf
2 8.31.10 May2014http://mjiri.iums.ac.irInterleukin 4: No statistically signif i- cant difference was observed.,OADS,/arxiv_data1/oa_pdf/6f/0c/mjiri-28-31.PMC4153519.pdf
2 8.31.10 May2014 http://mjiri.iums.ac.irpointssuggest that the pilgrims' respiratory problems had mostly infectiousorigin.,Non-OADS,/arxiv_data1/oa_pdf/6f/0c/mjiri-28-31.PMC4153519.pdf
"2 8.31.10 May2014http://mjiri.iums.ac.irSome experiences Ourexperiences of dealing with patients withrespiratory diseases during Hajj period for 10 years are summarized in following suggested statements: In most cases, affliction with severe respiratory infections occurs during or after Tashriqdaysand it seems that the disease spread point is Masharolharam (the holly place for Muslims inMecca,SaudiArabia).",Non-OADS,/arxiv_data1/oa_pdf/6f/0c/mjiri-28-31.PMC4153519.pdf
2 8.31.10 May2014 http://mjiri.iums.ac.irAvoid eating spicy foods.,Non-OADS,/arxiv_data1/oa_pdf/6f/0c/mjiri-28-31.PMC4153519.pdf
"2 8.31.10 May2014http://mjiri.iums.ac.irdition to conservative treatment, one ofthe following drugs can be administered : Amoxicillin, 500 to 875 mg per 12 hours Co-amoxiclav, 875 to 2000 mg per 12 hours Cefpodoxime Proxetil, 200 mg per 12 hours Cefdinir, 600 mg per 24 hour s Cefprozil, 500 mg per 12 hour s Azithromycin 500 mg for 3 days Clarithromycin 500 mg per 12 hours till 14 days Levofloxacin 500 mg every day moxifloxacin 400 mg every day Unfortunately, some of these medicines are not in the Hajj drug lists.",Non-OADS,/arxiv_data1/oa_pdf/6f/0c/mjiri-28-31.PMC4153519.pdf
"2 8.31.10 May2014 http://mjiri.iums.ac.ireases.Therefore, it is suggested to prevent all the factors which can lead to such co n- ditions.",Non-OADS,/arxiv_data1/oa_pdf/6f/0c/mjiri-28-31.PMC4153519.pdf
"2 8.31.10 May2014http://mjiri.iums.ac.irtors of respiratory diseases among Iranian Hajj pilgrims and suggested some applied points for prevention, treatment, and co r- rection of common malpractices in the treatment of respiratory diseases of the pi l- grims.",Non-OADS,/arxiv_data1/oa_pdf/6f/0c/mjiri-28-31.PMC4153519.pdf
"Available frome:http://sph.bu.edu/otlt/lamorte/EP713/Web_Pa ges/EP713_Surveillance/EP713_Surveillance4.html 10.Razavi SM, Sabouri -Kashani A, Ziaee - Ardakani H, Tabatabaei AR, Karbakhsh M, Sadeghipour HR, et al.",OADS,/arxiv_data1/oa_pdf/6f/0c/mjiri-28-31.PMC4153519.pdf
"2 8.31.10 May2014 http://mjiri.iums.ac.irHajj pilgrims returning to Shiraz, Fars province, Iran.Influenza Other Respi Viruses.",Non-OADS,/arxiv_data1/oa_pdf/6f/0c/mjiri-28-31.PMC4153519.pdf
"Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________________________________________________________________________ 1.Assistant Professor of Orthopedic Surgery, Shohada Hospital, Tabriz University of Medical Sciences, Tabriz, Iran.",Non-OADS,/arxiv_data1/oa_pdf/8c/db/mjiri-28-7.PMC4153520.pdf
Case Report http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/3a/a7/mjiri-28-39.PMC4153521.pdf
Case Report http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/5e/4c/mjiri-28-11.PMC4153522.pdf
"Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________________________________________________________________________ 1.MSc in Epidemiology, Kurdistan Research Center for Social Determinants of Health (KRSDH), Kurdistan University of Medical Sciences, Sanandaj, Iran.",Non-OADS,/arxiv_data1/oa_pdf/ba/8e/mjiri-28-17.PMC4153523.pdf
2 8.17.1 Mar2014http://mjiri.iums.ac.irical thinking ( 3) and Coleman’s exposition of “family social capital” (4) are three di s- tinct schools of thought which currently well known in the publish ed literature.,Non-OADS,/arxiv_data1/oa_pdf/ba/8e/mjiri-28-17.PMC4153523.pdf
2 8.17.1 Mar2014 http://mjiri.iums.ac.irwhich indicated a significant but not redu n- dant contribution from each item.,Non-OADS,/arxiv_data1/oa_pdf/ba/8e/mjiri-28-17.PMC4153523.pdf
"2 8.17.1 Mar2014http://mjiri.iums.ac.ir(yes, definitely or yes, frequently) (15).",Non-OADS,/arxiv_data1/oa_pdf/ba/8e/mjiri-28-17.PMC4153523.pdf
"2 8.17.1 Mar2014 http://mjiri.iums.ac.irences students in Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/ba/8e/mjiri-28-17.PMC4153523.pdf
2 8.17.1 Mar2014http://mjiri.iums.ac.irExploratory Factor Analysis was pe r- formed to evaluate the factor structure of the P-SCQ.,OADS,/arxiv_data1/oa_pdf/ba/8e/mjiri-28-17.PMC4153523.pdf
2 8.17.1 Mar2014 http://mjiri.iums.ac.ir(22).,Non-OADS,/arxiv_data1/oa_pdf/ba/8e/mjiri-28-17.PMC4153523.pdf
2 8.17.1 Mar2014http://mjiri.iums.ac.irThese dissimilarities b etween different studies discussed in another expert panel to decide if the new bundles of items can be interpreted like the original title or a new oneswas needed.,Non-OADS,/arxiv_data1/oa_pdf/ba/8e/mjiri-28-17.PMC4153523.pdf
2 8.17.1 Mar2014 http://mjiri.iums.ac.irterpretation of a factor.,Non-OADS,/arxiv_data1/oa_pdf/ba/8e/mjiri-28-17.PMC4153523.pdf
2 8.17.1 Mar2014http://mjiri.iums.ac.irferences were found.,OADS,/arxiv_data1/oa_pdf/ba/8e/mjiri-28-17.PMC4153523.pdf
2 8.17.1 Mar2014 http://mjiri.iums.ac.irmay be difficult and could cause variations in results of different studies.,Non-OADS,/arxiv_data1/oa_pdf/ba/8e/mjiri-28-17.PMC4153523.pdf
2 8.17.1 Mar2014http://mjiri.iums.ac.ir161-180.,Non-OADS,/arxiv_data1/oa_pdf/ba/8e/mjiri-28-17.PMC4153523.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/9c/01/mjiri-28-20.PMC4153524.pdf
2 8.20.3Mar2014http://mjiri.iums.ac.irinstead of soft tissue detachment (9).,Non-OADS,/arxiv_data1/oa_pdf/9c/01/mjiri-28-20.PMC4153524.pdf
2 8.20.3Mar2014 http://mjiri.iums.ac.irinferior portion of healthy glenoid contour fit the shape of true circle  so that the su r- face could be calculated meticulously (10).,Non-OADS,/arxiv_data1/oa_pdf/9c/01/mjiri-28-20.PMC4153524.pdf
"2 8.20.3Mar2014http://mjiri.iums.ac.irwith the mean age of 32.7±6.3 (23 to 41 years), In which 17 (89%) had glenoid l e- sion; 8 (42%) bony Bankart lesion while 9 patients (47%) counted to have erosion without bone fragment, and 8 (42%) had Hill-Sachs lesion (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/9c/01/mjiri-28-20.PMC4153524.pdf
2 8.20.3Mar2014 http://mjiri.iums.ac.iranterior shoulder dislocation including er o- sion and/or bony Bankart lesions.,Non-OADS,/arxiv_data1/oa_pdf/9c/01/mjiri-28-20.PMC4153524.pdf
"Brief Communication http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.MD of Hematology and Oncology, Genetic Researcher Center in Non -Communicable Disease, Zahedan University of Medical Sciences, Zaheedan ,Iran, naderifactorxiii@yahoo.com 2.",Non-OADS,/arxiv_data1/oa_pdf/9a/d7/mjiri-28-27.PMC4153525.pdf
2 8.27.7 May2014http://mjiri.iums.ac.irmajority of them were Fars (63.3%) and a minority w asBaluch(36.8%).,Non-OADS,/arxiv_data1/oa_pdf/9a/d7/mjiri-28-27.PMC4153525.pdf
2 8.27.7 May2014 http://mjiri.iums.ac.irAcknowledgment s This research has been supported by Tehran University of Medical Sciences  &health Services grant 25341 .,Non-OADS,/arxiv_data1/oa_pdf/9a/d7/mjiri-28-27.PMC4153525.pdf
"Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________________________________________________________________________ 1.MD., State University of New York, Downstate Medical Center, Department of Neurology, Brooklyn, NY 11203, USA.",Non-OADS,/arxiv_data1/oa_pdf/7c/cc/mjiri-28-18.PMC4153526.pdf
"2 8.18.1 Mar2014http://mjiri.iums.ac.irniqueis a bilateral deep brain stimulation (DBS) by implanting electrodes in the Gl o- bus Pallidus Internus (GPi) which is partic u- larly recommended for pa tients with DYT1 - positive dystonia (4,7).",Non-OADS,/arxiv_data1/oa_pdf/7c/cc/mjiri-28-18.PMC4153526.pdf
28.18.1 Mar2014 http://mjiri.iums.ac.irResults Demographic characteristics of the p a- tients are shown in Table 1.,Non-OADS,/arxiv_data1/oa_pdf/7c/cc/mjiri-28-18.PMC4153526.pdf
2 8.18.1 Mar2014http://mjiri.iums.ac.iralso reported in the st udy(15).,Non-OADS,/arxiv_data1/oa_pdf/7c/cc/mjiri-28-18.PMC4153526.pdf
28.18.1 Mar2014 http://mjiri.iums.ac.irwere also observed in another study (15).,Non-OADS,/arxiv_data1/oa_pdf/7c/cc/mjiri-28-18.PMC4153526.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/12/bd/mjiri-28-25.PMC4153527.pdf
"2 8.25.3 May2014http://mjiri.iums.ac.irguage, visual -spatial, calculation, jud g- ment, and problem -solving at risk of da m- age in patients with dementia (2).",Non-OADS,/arxiv_data1/oa_pdf/12/bd/mjiri-28-25.PMC4153527.pdf
"2 8.25.3 May2014 http://mjiri.iums.ac.irwell as lack of valid and reliable IADL scales for Iranian population, the need for IADL assessment is essential.",Non-OADS,/arxiv_data1/oa_pdf/12/bd/mjiri-28-25.PMC4153527.pdf
2 8.25.3 May2014http://mjiri.iums.ac.irselected.,Non-OADS,/arxiv_data1/oa_pdf/12/bd/mjiri-28-25.PMC4153527.pdf
"2 8.25.3 May2014 http://mjiri.iums.ac.irAs the figures in Table 2 indicates, the experts stated that 1 item was excellent (medication management), 5 items were good or very good (use of telephone, meal preparation, laundry, mode of transport a- tion and money management), and 2 items (shopping and housekeeping) were above the average.",Non-OADS,/arxiv_data1/oa_pdf/12/bd/mjiri-28-25.PMC4153527.pdf
"2 8.25.3 May2014http://mjiri.iums.ac.irDiscussion In this study, the validity and reliability of 8-item scale of the Lawton Instrumental Activities of Daily Living Scale were e x- amined.",OADS,/arxiv_data1/oa_pdf/12/bd/mjiri-28-25.PMC4153527.pdf
"2 8.25.3 May2014 http://mjiri.iums.ac.irthat as the dementia progresses, patient’s IADL abilities reduce and s/he becomes more and more dependent on others t o per- form those functions.",Non-OADS,/arxiv_data1/oa_pdf/12/bd/mjiri-28-25.PMC4153527.pdf
2 8.25.3 May2014http://mjiri.iums.ac.irAcknowledgements The authors express their appreciation of the efforts of the Department of Occup a- tional Therapy of Iran University of Med i- cal Sciences and Health Services.,Non-OADS,/arxiv_data1/oa_pdf/12/bd/mjiri-28-25.PMC4153527.pdf
World Health Organization website (2013) http://www.who.int/mental_health/publications/dem entia_report_2012 [20 June 2013].,Non-OADS,/arxiv_data1/oa_pdf/12/bd/mjiri-28-25.PMC4153527.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/e8/ec/mjiri-28-15.PMC4153528.pdf
2 8.15.23 Feb2014http://mjiri.iums.ac.irpairment measure the quality of life and rehabilitation based on their individual pe r- formance and pay less attention to other aspects of quality of life of these people (5).,Non-OADS,/arxiv_data1/oa_pdf/e8/ec/mjiri-28-15.PMC4153528.pdf
2 8.15.23 Feb2014http://mjiri.iums.ac.ircant.,Non-OADS,/arxiv_data1/oa_pdf/e8/ec/mjiri-28-15.PMC4153528.pdf
2 8.15.23 Feb2014http://mjiri.iums.ac.irparticipants was 42 years and the percen t- age of female patients was higher (48%).,Non-OADS,/arxiv_data1/oa_pdf/e8/ec/mjiri-28-15.PMC4153528.pdf
"Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________________________________________________________________________ 1.Medical student, Iran University of Medical Sciences, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/44/06/mjiri-28-9.PMC4153529.pdf
"Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran(MJIRI) Iran University of Medical Sciences _______________________________________________________________________________________________________ 1.MSc of audiology, Department of Audiology, Faculty of Rehabilitation, Iran University of Medical Sciences, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/1c/08/mjiri-28-14.PMC4153530.pdf
2 8.14.23Feb2014http://mjiri.iums.ac.irconcept (3) and can be classified based on the type of task (2).,OADS,/arxiv_data1/oa_pdf/1c/08/mjiri-28-14.PMC4153530.pdf
"2 8.14.23Feb2014 http://mjiri.iums.ac.irWechsler Intelligence Scale for Children Revised (WISC -R), right hand superiority in single-handed exercises according to the Edinburgh Handedness Inventory, and were native monolinguals of Persian language thatselected from student of elementary schools located in the 6thregion of Teh ran province.",Non-OADS,/arxiv_data1/oa_pdf/1c/08/mjiri-28-14.PMC4153530.pdf
2 8.14.23Feb2014http://mjiri.iums.ac.irfamiliar and understandable for children under 6 years of age (list A) followed by an intervening word list (list B).,Non-OADS,/arxiv_data1/oa_pdf/1c/08/mjiri-28-14.PMC4153530.pdf
2 8.14.23Feb2014 http://mjiri.iums.ac.irTable 3 shows the acquired ICC quant i- ties for evaluating the repeatability of the SAACT.,OADS,/arxiv_data1/oa_pdf/1c/08/mjiri-28-14.PMC4153530.pdf
2 8.14.23Feb2014http://mjiri.iums.ac.irchildren with normal hearing from these two other groups (20).,Non-OADS,/arxiv_data1/oa_pdf/1c/08/mjiri-28-14.PMC4153530.pdf
"2 8.14.23Feb2014 http://mjiri.iums.ac.irror) in 12 children with ADHD.To check the reliability, they performed the test three times on the se children with an interval of seven days.",Non-OADS,/arxiv_data1/oa_pdf/1c/08/mjiri-28-14.PMC4153530.pdf
2 8.14.23Feb2014http://mjiri.iums.ac.irder (with hyperactivity).,Non-OADS,/arxiv_data1/oa_pdf/1c/08/mjiri-28-14.PMC4153530.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/mjiri-28-30.PMC4153531.pdf
2 8.30.7 May2014http://mjiri.iums.ac.irPresumptive diagnosis of GERD can be done by typical history of heartburn and/or regurgitation.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/mjiri-28-30.PMC4153531.pdf
"2 8.30.7 May2014 http://mjiri.iums.ac.ircontrols were 47.5±5.6 years and 46.8± 5 years, respectively.",OADS,/arxiv_data1/oa_pdf/5c/59/mjiri-28-30.PMC4153531.pdf
2 8.30.7 May2014http://mjiri.iums.ac.ircians.Ann Intern Med.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/mjiri-28-30.PMC4153531.pdf
Case Report http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/f8/2f/mjiri-28-21.PMC4153532.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/.0/),whichpermitsnon-commercialre-use,distribution,andreproductioninanymedium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/84/6d/ihu018.PMC4153746.pdf
Commitments Summary: 29 September 2010. http://www.who.int/pmnch/events/ 2010/commitments_summary092910.pdf [accessed 4 August 2013].,Non-OADS,/arxiv_data1/oa_pdf/84/6d/ihu018.PMC4153746.pdf
Aggregate Indicators of Governance 1996– 2010. http://www.govindicators.org/ [accessed 10 March 2012].,Non-OADS,/arxiv_data1/oa_pdf/84/6d/ihu018.PMC4153746.pdf
http://sowf.moi.gov.tw/stat/year/elist.htm [accessed 29 June 2013].,OADS,/arxiv_data1/oa_pdf/84/6d/ihu018.PMC4153746.pdf
http://www.ggdc.net/pwt [accessed 7 July 2013].,Non-OADS,/arxiv_data1/oa_pdf/84/6d/ihu018.PMC4153746.pdf
http://www.mohw.gov.tw/cht/DOS/Statistic.aspx?f_list_no=312&fod_ list_no=1717 [accessed 13 January 2013].,OADS,/arxiv_data1/oa_pdf/84/6d/ihu018.PMC4153746.pdf
http://www.wra.gov.tw/ct.,Non-OADS,/arxiv_data1/oa_pdf/84/6d/ihu018.PMC4153746.pdf
Social Indicators 2011. http://ebook.dgbas.gov.tw/public/ Data/331311353471.pdf [accessed 29 June 2013].,Non-OADS,/arxiv_data1/oa_pdf/84/6d/ihu018.PMC4153746.pdf
http://taqm.epa.gov.tw/taqm/en/default.,OADS,/arxiv_data1/oa_pdf/84/6d/ihu018.PMC4153746.pdf
Geneva: World Health Organization; 2012. http://www.who.int/tb/Review4bAacceptabilityHousehold_ CommunityScreening.pdf [accessed 20 June 2014].,Non-OADS,/arxiv_data1/oa_pdf/c3/cc/ihu055.PMC4153747.pdf
"Communicative & Integrative Biology 2014; 7:e29410; http://dx.doi.org/10.4161/cib.29410 Commentary to: Tong  X, Ao Y, Faas  GC,  Nwaobi  SE, Xu J, Haustein  MD, Anderson   MA, Mody  I, Olsen  ML, Sofroniew  MV,  et al.",Non-OADS,/arxiv_data1/oa_pdf/9c/bd/cib-7-e29410.PMC4153761.pdf
Nat  Neurosci  2014 ; 17:694-703; PMID:24686787 ;  http://dx.doi.org/10.1038/nn.3691,Non-OADS,/arxiv_data1/oa_pdf/9c/bd/cib-7-e29410.PMC4153761.pdf
Nat Rev Neurol 2014; 10:204-16; PMID:24614516 ;  http://dx.doi.org/10.1038/nrneurol.2014.24 2.,OADS,/arxiv_data1/oa_pdf/9c/bd/cib-7-e29410.PMC4153761.pdf
Semin Neurol  2007; 27:143-50;  PMID:17390259 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/bd/cib-7-e29410.PMC4153761.pdf
Mov Disord 2012; 27:1083-91;   PMID:22692795 ; http://dx.doi.org/10.1002/ mds.25075 5.,OADS,/arxiv_data1/oa_pdf/9c/bd/cib-7-e29410.PMC4153761.pdf
Nat Clin Pract Neurol 2006; 2:679-89;   PMID:17117171 ; http://dx.doi.org/10.1038/ ncpneuro0355 6.,Non-OADS,/arxiv_data1/oa_pdf/9c/bd/cib-7-e29410.PMC4153761.pdf
Commun Integr Biol 2012;  5:301-3;  PMID:23060947 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/bd/cib-7-e29410.PMC4153761.pdf
Commun Integr Biol 2012; 5:405- 7; PMID :23181153 ; http://dx.doi.org/10.4161/ cib.22571 8.,OADS,/arxiv_data1/oa_pdf/9c/bd/cib-7-e29410.PMC4153761.pdf
Mol Cell 2004 ; 15:853-65;  PMID:15383276 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/bd/cib-7-e29410.PMC4153761.pdf
J Cell Biol 2005; 171:1001-12;  PMID:16365166 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/bd/cib-7-e29410.PMC4153761.pdf
Hum Mol Genet  2010; 19:3053-67;  PMID:20494921 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/bd/cib-7-e29410.PMC4153761.pdf
Commun Integr Biol  2014; 7:e28424;  PMID:24748914 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/bd/cib-7-e29410.PMC4153761.pdf
Nat Neurosci 2014; 17:694-703;   PMID:24686787 ; http://dx.doi.org/10.1038/nn.3691 13.,Non-OADS,/arxiv_data1/oa_pdf/9c/bd/cib-7-e29410.PMC4153761.pdf
Glia 2000; 30:362-72; PMID:10797616 ;  http://dx.doi.org/10.1002/(SICI)1098-1136(200006)30:4<362::AID-GLIA50>3.0.CO;2-4 15.,Non-OADS,/arxiv_data1/oa_pdf/9c/bd/cib-7-e29410.PMC4153761.pdf
Neuron 1990; 5:527-44; PMID:1698397 ;  http://dx.doi.org/10.1016/0896-6273(90)90091-S 16.,OADS,/arxiv_data1/oa_pdf/9c/bd/cib-7-e29410.PMC4153761.pdf
N Engl J Med 2009; 360:1960-70; PMID:19420365 ;  http://dx.doi.org/10.1056/NEJMoa0810276 17.,Non-OADS,/arxiv_data1/oa_pdf/9c/bd/cib-7-e29410.PMC4153761.pdf
Nature 1996; 383:634-7;   PMID:8857541 ; http://dx.doi.org/10.1038/383634a0 18.,Non-OADS,/arxiv_data1/oa_pdf/9c/bd/cib-7-e29410.PMC4153761.pdf
Prog Neurobiol 2001; 65:1-105;  PMID:11369436 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/bd/cib-7-e29410.PMC4153761.pdf
Neuron 2014; 82:279-93; PMID:24742457 ;  http://dx.doi.org/10.1016/j.neuron.2014.03.030 20.,OADS,/arxiv_data1/oa_pdf/9c/bd/cib-7-e29410.PMC4153761.pdf
Neuroscience 2009; 159:1055-69;  PMID:19356689 ;  http://dx.doi.org/10.1016/j.neuroscience.2009.01.023,OADS,/arxiv_data1/oa_pdf/9c/bd/cib-7-e29410.PMC4153761.pdf
Cancer Biol ther 2014 ; 15:236 - 44; PM id:24316664 ; http://dx.doi.org/10.4161/ cbt.27222 Molecular characterization of H. pylori type IV  secretion system component CagX the gram-negative bacteria Helicobacter  pylori  are found in almost half of the world`s  population and can cause gastric ulcer and  duodenal cancer.,Non-OADS,/arxiv_data1/oa_pdf/d1/93/gmic-5-273.PMC4153762.pdf
Virulence  2014 ; 5:1-5; PM id:24153016 ;  http://dx.doi.org/10.4161/viru.27864 Effectiveness of Hepatitis A vaccination Hepatits a is an acute infectious disease  of the liver caused by the hepatitis a v irus  (HaV).,Non-OADS,/arxiv_data1/oa_pdf/d1/93/gmic-5-273.PMC4153762.pdf
Hum Vaccin immun other  2014 ;  10:1-4; PM id:24503599 ; http://dx.doi.org/10.4161/ hv.27775,Non-OADS,/arxiv_data1/oa_pdf/d1/93/gmic-5-273.PMC4153762.pdf
"RT-PCR analyses revealed 5-fold higher levels of Nod2 mRNA in Lgr5-positive intestinal stem cells compared with the adjacent Paneth cells, and high level Nod2 expres - sion was independently confirmed by other methods.Muramyl dipeptide Not just another brick in the wall VK Viswanathan School of Animal & Comparative Biomedical Sciences; University of Arizona; Tucson, AZ USA Keywords:  muramyl dipeptide,  organoids, Nod2, Lgr5, stem cells Correspondence to: VK Viswanathan;   Email: vkv@email.arizona.edu Submitted: 06/20/2014   Accepted: 06/20/2014   Published Online: 07/28/2014 http://dx.doi.org/10.4161/gmic.28932",Non-OADS,/arxiv_data1/oa_pdf/2c/2b/gmic-5-275.PMC4153763.pdf
Am J Philol 2004; 125:563-601; http://dx.doi.org/10.1353/ajp.2005.0009 2 .,Non-OADS,/arxiv_data1/oa_pdf/2c/2b/gmic-5-275.PMC4153763.pdf
Tissue Barriers 2013; 1:e24965;   PMID:24665395 ; http://dx.doi.org/10.4161/ tisb.24965 3 .,Non-OADS,/arxiv_data1/oa_pdf/2c/2b/gmic-5-275.PMC4153763.pdf
Cell Host Microbe 2014 ; 15:792-8 ;  PMID:24882705 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/2b/gmic-5-275.PMC4153763.pdf
Nature 2011; 469:415-8 ;  PMID:21113151 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/2b/gmic-5-275.PMC4153763.pdf
J Exp Med 2013; 210:2465-76; PMID:24062413 ; http://dx.doi.org/10.1084/ jem.20122490 8 .,Non-OADS,/arxiv_data1/oa_pdf/2c/2b/gmic-5-275.PMC4153763.pdf
Nat Rev Immunol 2014; 14:9-23;  PMID:24336102 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2c/2b/gmic-5-275.PMC4153763.pdf
"This structure  is then modified by core transferases, which serve to elongate *Correspondence to: P Ronan O’Connell; Email: ronan.oconnell@ucd.ie Submitted: 14/03/2014; Revised: 04/04/2014; Accepted: 04/04/2014;Published Online: 08/04/2014 http://dx.doi.org/10.4161/gmic.28793Influences of the colonic microbiome   on the mucous gel layer in ulcerative colitis Gráinne Lennon1,2, Áine Balfe1,2, Helen earley1,2, Liam a Devane1,2, aonghus Lavelle1,2, Desmond C Winter1,2, J Calvin Coffey3,  and P ronan O’Connell1,2,* 1School of Medicine and Medical Sciences; University College Dublin; Dublin, Ireland; 2Centre for Colorectal Disease; St Vincent’s University Hospital; elm Par k, Ireland;  3Graduate entry M edical School; University Hospital Limerick; University of Limerick; Limerick, Ireland Keywords:  colon, mucus gel layer, bacteria, mucins, ulcerative colitis Abbreviations:  MGL, mucus gel layer; UC, ulcerative colitis; ER, endoplasmic reticulum; FISH, fluorescent in situ hybridization;  MDB, mucus degrading bacteria; MUP, mucus-binding protein; SRB, sulfate reducing bacteria The colonic mucus gel layer (MGL) is a critical component  of the innate immune system acting as a physical barrier to  microbes, luminal insults, and toxins.",Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
PLoS Biol 2008; 6:e280;  PMID:19018661 ;  http://dx.doi.org/10.1371/journal.pbio.0060280 2.,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Annu Rev Nutr 2002; 22:283-307;  PMID:12055347 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Lancet 2003; 361:512-9;  PMID:12583961 ;  http://dx.doi.org/10.1016/S0140-6736(03)12489-0 4.,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Nat Rev Immunol 2010; 10:159-69;   PMID:20182457 ; http://dx.doi.org/10.1038/nri2710 5 .,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Proc Natl Acad Sci U S A 2008; 105:15064-9; PMID:18806221 ; http://dx.doi.org/10.1073/ pnas.0803124105 6 .,OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Proc Natl Acad Sci U S A 2004; 101:1981-6; PMID:14766966 ; http://dx.doi.org/10.1073/ pnas.0307317101 7 .,OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Nat Immunol 2001; 2:361-7;   PMID:11276208 ; http://dx.doi.org/10.1038/86373 8 .,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Gut 1987; 28:976-80;  PMID:3666566 ;  http://dx.doi.org/10.1136/gut.28.8.976 9 .,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Immunity 2009; 31:401-11; PMID:19766083 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Gut 2001; 48:132-5; PMID:11115835 ; http://dx.doi.org/10.1136/ gut.48.1.132 11 .,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Nat Rev Immunol 2009; 9:313-23;   PMID:19343057 ; http://dx.doi.org/10.1038/nri2515 12 .,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Inflamm Bowel Dis 2013; 19:2227-37;  PMID:23669404 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Curr Opin Colloid Interface Sci 2006; 11:164-70; http://dx.doi.org/10.1016/j.cocis.2005.11.001 15 .,OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Glycobiology 2012; 22:1128-39;  PMID:22581805 ;  http://dx.doi.org/10.1093/glycob/cws083 17 .,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
PLoS One 2011; 6:e24447; PMID:21931721 ;  http://dx.doi.org/10.1371/journal.pone.0024447 18 .,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Colorectal Dis 2013;  PMID:24345279 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
J Clin Pathol 1990; 43:143-6;  PMID:2318990 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Gut 1994; 35:353-9; PMID:8150346 ; http://dx.doi.org/10.1136/ gut.35.3.353 22 .,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Gut 1994; 35:961-8;  PMID:8063225 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Br Med J 1973; 2:645-6; PMID:4714849 ; http://dx.doi.org/10.1136/ bmj.2.5867.645 24 .,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Gut 1993; 34:926-32; PMID:8344580 ; http://dx.doi.org/10.1136/ gut.34.7.926 26 .,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
"Gastroenterology 2010; 139:1844-U105, e1; PMID:20816835 ; http://dx.doi.org/10.1053/j.",Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
J Exp Med 2007; 204:1417-29; PMID:17517967 ; http://dx.doi.org/10.1084/ jem.20061929 28 .,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Mol Cell Biol 2009; 29:3770-82; PMID:19349303 ; http://dx.doi.org/10.1128/ MCB.00204-0929 .,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
J Clin Invest 2011; 121:1657-66;  PMID:21383503 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
FEMS Microbiol Ecol 1991; 86:103-11; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Dis Colon Rectum 2010; 53:1530-6; PMID:20940602 ;  http://dx.doi.org/10.1007/DCR.0b013e3181f1e620 33 .,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Gastroenterology 2006; 131:117-29;   PMID :16831596 ; http://dx.doi.org/10.1053/j.,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Science 2002; 295:1726-9;  PMID:11872843 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
PLoS Med 2008; 5:e54;  PMID:18318598 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Ultrastruct Pathol 2004; 28:23-7;  PMID:14967595 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Inflamm Bowel Dis 2007; 13:963-70; PMID:17455202 ; http://dx.doi.org/10.1002/ ibd.20163 41 .,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
PLoS One 2012; 7:e39743;  PMID:22761885 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Chem Biodivers 2010; 7:1065-75;  PMID:20491064 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Appl Environ Microbiol 2002; 68:3401-7; PMID:12089021 ; http://dx.doi.org/10.1128/ A EM.68.7.3401-3407.2002 46 .,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Science 2005; 308:1635-8;  PMID :15831718 ;  http://dx.doi.org/10.1126/science.1110591 47 .,OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
ISME J 2011; 5:627-38; PMID:20981114 ; http://dx.doi.org/10.1038/ ismej.2010.161 48 .,OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Environ Microbiol 2011; 13:2667-80;  PMID:21883787 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Br J Surg 2009; 96:151-8; PMID:19160346 ; http://dx.doi.org/10.1002/ bjs.6454 50 .,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Int J Clin Pract 2008; 62:762-9;  PMID:18194279 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
BMC Microbiol 2011; 11:7;  PMID:21219646 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Am J Gastroenterol 2010; 105:2420-8; PMID:20648002 ; http://dx.doi.org/10.1038/ ajg.2010.281 55 .,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Acta Paediatr Scand 1985; 74:207-12;  PMID:3922199 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Gut 1993; 34:437-9; PMID:8491386 ; http://dx.doi.org/10.1136/ gut.34.4.437 59 .,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Microbiology 2006; 152:273-80;  PMID:16385136 ;  http://dx.doi.org/10.1099/mic.0.28415-0 61 .,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
J Bacteriol 2005; 187:6128-36;  PMID:16109954 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Proc Natl Acad Sci U S A 2009; 106:17193-8; PMID :19805152 ; http://dx.doi.org/10.1073/ pnas.0908876106 63 .,OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Infect Immun 2006; 74:425-34;  PMID:16368998 ;  http://dx.doi.org/10.1128/IAI.74.1.425-434.2006 64 .,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Proc Natl Acad Sci U S A 2011; 108:11217-22; PMID:21690406 ; http://dx.doi.org/10.1073/ pnas.1105380108 65 .,OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Anaerobe 2011; 17:137-41;  PMID:21664470 ;  http://dx.doi.org/10.1016/j.anaerobe.2011.05.01767 .,OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
J Clin Invest 1985; 75:944-53;  PMID:3920248 ;  http://dx.doi.org/10.1172/JCI111795 69 .,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
J Clin Invest 1981; 67:163-72;  PMID:6161136 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Microb Ecol Health Dis 1992; 5:193-207; http://dx.doi.org/10.3109/08910609209141586 71 .,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Anaerobe 1996; 2:117-22; http://dx.doi.org/10.1006/anae.1996.0015 75 .,OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
J Pediatr Gastroenterol Nutr 1994; 18:321-6;  PMID :8057215 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Cell Host Microbe 2009; 5:200-11; PMID:19218090 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Science 2005; 307:1955-9; PMID:15790854 ;  http://dx.doi.org/10.1126/science.1109051 79.,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Gut Microbes 2011; 2:183-9;  PMID:21804355 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Nature 2013; 502:96-9;   PMID:23995682 ; http://dx.doi.org/10.1038/ nature12503 81 .,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Proc Natl Acad Sci U S A 2011; 108:7194-9; PMID:21482772 ; http://dx.doi.org/10.1073/ pnas.1014125108 82 .,OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Glycobiology 2013; 23:1038-46; PMID:23720460 ; http://dx.doi.org/10.1093/ glycob/cwt040 84 .,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
PLoS Biol 2007; 5:e156; PMID:17579514 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Lett Appl Microbiol 1991; 13:97-101; http://dx.doi.org/10.1111/j.1472-765X.1991.,OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
BMC Biol 2013; 11:61;  PMID:23692866 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Inflamm Bowel Dis 2009; 15:1183-9;  PMID:19235886 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Gut 1991; 32:766-73; PMID:1855683 ; http://dx.doi.org/10.1136/ gut.32.7.766 91 .,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Dis Colon Rectum 2002; 45:384-8; PMID:12068199 ; http://dx.doi.org/10.1007/ s10350-004-6187-z 92 .,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Int J Syst Evol Microbiol 2004; 54:1469-76;  PMID :15388697 ;  http://dx.doi.org/10.1099/ijs.0.02873-0 94 .,OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Appl Environ Microbiol 2012; 78:7720-32;  PMID:22923411 ;  http://dx.doi.org/10.1128/AEM.01350-1295 .,OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
J Biol Chem 1997; 272:7932-9;  PMID:9065462 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Science 2003; 299:2074-6; PMID:12663928 ;  http://dx.doi.org/10.1126/science.1080029 97 .,OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
FEMS Microbiol Lett 1991; 61:289-93;  PMID:1903753 ;  http://dx.doi.org/10.1111/j.1574-6968.1991.tb04363.x 98 .,OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Curr Microbiol 1992; 24:55-9; http://dx.doi.org/10.1007/ BF01570100 99 .,OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
Emerg Infect Dis 2000; 6:171-4;  PMID :10756151 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/d8/gmic-5-277.PMC4153764.pdf
"Defects associated with the mucus layer or its components disrupt the relationship  *Correspondence to: Lijun Xia; Email: lijun-xia@omrf.org; Daniel A Peterson; Email: daniel.peterson@jhmi.edu, Submitted: 18/12/2013; Revised: 13/03/2014; Accepted: 21/03/2014; Published Online: 24/03/2014  http://dx.doi.org/10.4161/gmic.28622Discordance between changes   in the gut microbiota and pathogenicity   in a mouse model of spontaneous colitis Maria elisa Perez-Muñoz1,4,†, Kirk Bergstrom2,†, Vincent Peng2, robert Schmaltz1, roberto Jimenez-Cardona1,   Nathan Marsteller1, Sam McGee2, Thomas Clavel3, ruth Ley5, Jianxin Fu2, Lijun Xia2,*, and Daniel a Peterson1,4,* 1Department of Food Science and Technology; University of Nebraska; Lincoln, N e USa; 2Oklahoma Medical resea rch Foundation; Oklahoma City, OK US a; 3Junior research  Group Intestinal Microbiome; ZI eL-resea rch Center for Nutrition and Food Sciences; Technische Universität München; Munich, Germany; 4Department of Pathology;   Johns Hopkins University School of Medicine; Baltimore, MD US a; 5Department of Microbiology; Cornell University; Ithaca, N y USa †These authors contributed equally to this work Keywords:  gut microbiota, pyrosequencing, core 1 O-glycans deficient mice, dysbiosis, spontaneous colitis, Bacteroides  thetaiotaomicron , Lactobacillus johnsonii , Bacteroides sartorii , Clostridium , Akkermasia muciniphila Abbreviations:  IBD, inflammatory bowel diseases; UC, ulcerative colitis; CD, Crohn disease; C1GALT1, core 1 β1,3- galactosyltransferase enzyme (also known as T-synthase) which exclusively controls the formation of the core 1 structure in the  mucins that form the mucus layer; IEC C1galt1-/-, mice that lack the C1GALT1 enzyme specifically in the intestinal epithelial  cells; HLA-B27, human leukocyte antigen B27; TM, tamoxifen; TM-IEC C1galt1-/- mice, Tamoxifen-induced deficiency of the  C1GALT1 enzyme specifically in the intestinal epithelial cells, thus mice are deficient in core 1-derived O-glycans; GF, germ-free;  WT, wild type mice; FISH, flourescence in-situ hybridization; AB, Alcian Blue staining; H&E, Hematoxylin and Eosin staining;  RDP, Ribosomal Database Project; QIIME, Quantitative Insights into Microbial Ecology; PCA, Principal Component Analysis;  OTU, operational taxonomic unit; LP, lamina propria Under conventional conditions, mice deficient in core 1-derived O-glycans (TM-I eC C1galt1-/-), which have a  defective mucus layer, experienced spontaneous inflammation of the colon.",Non-OADS,/arxiv_data1/oa_pdf/94/99/gmic-5-286.PMC4153765.pdf
"S2A and B ).Sequences were analyzed using the Ribosomal Database  Project (RDP) Classifier (http://rdp.cme.msu.edu).14,15 The total  of sequences per taxa per sample was summarized at different taxonomic levels, and proportions were calculated.",OADS,/arxiv_data1/oa_pdf/94/99/gmic-5-286.PMC4153765.pdf
H&E and AB were applied as established in the Core Imaging Facility of the Oklahoma Medical Research Foundation (OMRF) (http://imaging.omrf.org/wp-content/uploads/2011/08/hande.pdf.,OADS,/arxiv_data1/oa_pdf/94/99/gmic-5-286.PMC4153765.pdf
Taxonomic-based analysis was performed using the Classifier 13 program of the Ribosomal Database Project  (RDP) version 9 (http://rdp.cme.msu.edu/)14 to assign taxonomic  status to each sequence.,OADS,/arxiv_data1/oa_pdf/94/99/gmic-5-286.PMC4153765.pdf
Prog Mol Biol Transl Sci 2012; 105:263- 320; PMID:22137435 ; http://dx.doi.org/10.1016/ B978-0-12-394596-9.00009-3 2.,OADS,/arxiv_data1/oa_pdf/94/99/gmic-5-286.PMC4153765.pdf
Differentiation  2009 ; 77:84- 94; PMID:19281767 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/94/99/gmic-5-286.PMC4153765.pdf
Inflamm Bowel Dis   2009 ; 15:100-13; PMID:18623167 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/99/gmic-5-286.PMC4153765.pdf
Inflamm Bowel Dis  2011 ;  17:2299 -307; PMID:21290483 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/99/gmic-5-286.PMC4153765.pdf
Int J Clin Pract  2008 ;  62:762-9; PMID:18194279 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/99/gmic-5-286.PMC4153765.pdf
Am J Gastroenterol 2010 ; 105:2420 - 8; PMID:20648002 ; http://dx.doi.org/10.1038/ ajg.2010.281 7 .,Non-OADS,/arxiv_data1/oa_pdf/94/99/gmic-5-286.PMC4153765.pdf
J Clin Invest  2011 ; 121:1657 -66; PMID:21383503 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/99/gmic-5-286.PMC4153765.pdf
Cell Host Microbe  2007 ; 2:328- 39; PMID:18005754 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/94/99/gmic-5-286.PMC4153765.pdf
Gastroenterology  2008 ; 134:577- 94; PMID:18242222 ; http://dx.doi.org/10.1053/j.,Non-OADS,/arxiv_data1/oa_pdf/94/99/gmic-5-286.PMC4153765.pdf
Sci Transl Med  2010 ;  2:43ps39 ; PMID:20686177 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/99/gmic-5-286.PMC4153765.pdf
Am J Physiol  Gastrointest Liver Physiol  2011 ; 300:G327 -33;  PMID:21109593 ; http://dx.doi.org/10.1152/ ajpgi.00422.2010 12.,Non-OADS,/arxiv_data1/oa_pdf/94/99/gmic-5-286.PMC4153765.pdf
Eur J Immunol   1984 ; 14:1127 -30; PMID:6083871 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/99/gmic-5-286.PMC4153765.pdf
BMC  Bioinformatics  2006 ; 7:371; PMID:16893466 ;  http://dx.doi.org/10.1186/1471-2105-7-371 14 .,OADS,/arxiv_data1/oa_pdf/94/99/gmic-5-286.PMC4153765.pdf
Appl Environ Microbiol  2007 ; 73:5261 -7;  PMID:17586664 ; http://dx.doi.org/10.1128/ AEM.00062-07 15 .,OADS,/arxiv_data1/oa_pdf/94/99/gmic-5-286.PMC4153765.pdf
Nucleic Acids  Res 2009 ; 37:D141 -5; http://dx.doi.org/10.1093/ nar/gkn879 ; PMID:1900487216 .,OADS,/arxiv_data1/oa_pdf/94/99/gmic-5-286.PMC4153765.pdf
Cell  Host Microbe  2011 ; 9:390-403; PMID:21575910 ;  http://dx.doi.org/10.1016/j.chom.2011.04.009 17 .,OADS,/arxiv_data1/oa_pdf/94/99/gmic-5-286.PMC4153765.pdf
PLoS One  2012 ;  7:e42645 ; PMID:22880065 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/99/gmic-5-286.PMC4153765.pdf
Science  2005 ; 307:1955 -9;  PMID:15790854 ; http://dx.doi.org/10.1126/ science.1109051 19.,Non-OADS,/arxiv_data1/oa_pdf/94/99/gmic-5-286.PMC4153765.pdf
Sci Rep 2013 ; 3:1110 ;  PMID:23346367 ; http://dx.doi.org/10.1038/ srep01110 20 .,OADS,/arxiv_data1/oa_pdf/94/99/gmic-5-286.PMC4153765.pdf
ISME J  2010 ; 4:377-87; PMID :19924154 ;  http://dx.doi.org/10.1038/ismej.2009.123 22.,OADS,/arxiv_data1/oa_pdf/94/99/gmic-5-286.PMC4153765.pdf
PLoS One  2013 ; 8:e70783 ; PMID:23951007 ;  http://dx.doi.org/10.1371/journal.pone.0070783,Non-OADS,/arxiv_data1/oa_pdf/94/99/gmic-5-286.PMC4153765.pdf
Gut 1971 ; 12:230-5; PMID:4928173 ;  http://dx.doi.org/10.1136/gut.12.3.230 24.,Non-OADS,/arxiv_data1/oa_pdf/94/99/gmic-5-286.PMC4153765.pdf
Microbiology  2010 ; 156:3368 -78; PMID:20847011 ;  http://dx.doi.org/10.1099/mic.0.043265-0 25 .,Non-OADS,/arxiv_data1/oa_pdf/94/99/gmic-5-286.PMC4153765.pdf
Am J Pathol  2002 ; 160:2253 - 7; PMID:12057927 ; http://dx.doi.org/10.1016/ S0002-9440(10)61172-8 26 .,OADS,/arxiv_data1/oa_pdf/94/99/gmic-5-286.PMC4153765.pdf
J Biol Chem  2011 ;  286:25973 -82; PMID:21507958 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/99/gmic-5-286.PMC4153765.pdf
Nat Immunol  2004 ; 5:104-12;  PMID:14691478 ; http://dx.doi.org/10.1038/ni1018 28 .,Non-OADS,/arxiv_data1/oa_pdf/94/99/gmic-5-286.PMC4153765.pdf
"Gastroenterology  2010 ; 139:1844 ,  e1; PMID:20816835 ; http://dx.doi.org/10.1053/j.",Non-OADS,/arxiv_data1/oa_pdf/94/99/gmic-5-286.PMC4153765.pdf
Inflamm Bowel Dis 2005 ; 11:481-7;  PMID:15867588 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/94/99/gmic-5-286.PMC4153765.pdf
Am J  Gastroenterol  2013 ; 108:1620 -30; PMID:24060759 ;  http://dx.doi.org/10.1038/ajg.2013.257 32 .,Non-OADS,/arxiv_data1/oa_pdf/94/99/gmic-5-286.PMC4153765.pdf
Science  1996 ; 273:1380 - 3; PMID:8703071 ; http://dx.doi.org/10.1126/ science.273.5280.1380 33 .,Non-OADS,/arxiv_data1/oa_pdf/94/99/gmic-5-286.PMC4153765.pdf
Appl Environ Microbiol   2009 ; 75:4175 -84; PMID:19411417 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/99/gmic-5-286.PMC4153765.pdf
"In the small intestine, bile acids are modified by bacterial enzymes promoting secondary bile acids through deconjugation,  *Correspondence to: Tine R Licht; Email: trli@food.dtu.dk Submitted: 17/02/2014; Revised: 18/03/2014; Accepted: 07/04/2014; Published Online: 09/04/2014 http://dx.doi.org/10.4161/gmic.28806Lactobacillus acidophilus  NCFM affects   vitamin E acetate metabolism and intestinal bile  acid signature in monocolonized mice Henrik M roager1,†, Karolina Sulek2,3,†, Kasper Skov1, Henrik L Frandsen1, Jørn Smedsgaard1, andrea Wilcks4, Thomas H Skov5,  Silas G Villas-Boas3, and Tine r Licht1,* 1National Food Institute; Technical University of Denmark; Søborg, Denmark; 2Liggins Institute; University of auckland; auckland, New Zealand; 3School of Biological Sciences;  University of auckland; auckland, New Zealand; 4Faculty of Health and Medical Sciences; University of Copenhagen; København, Denmark; 5Department of Food Science;  Faculty of Science; University of Copenhagen; København, Denmark †These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
Proc Natl Acad Sci U S A 2011; 108(Suppl 1):4523-30; http://dx.doi.org/10.1073/ pnas.1006734107 ; PMID:20837534 3 .,OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
J Lipid Res 2010; 51:1101-12; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
Cell Metab 2013; 17:225-35; http://dx.doi.org/10.1016/j.cmet.2013.01.003 ;  PMID:23395169 6 .,OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
Proc Natl Acad Sci U S A 2009; 106:5859-64; http://dx.doi.org/10.1073/ pnas.0901529106 ; PMID:19321416 8 .,OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
Front Microbiol 2011; 2:166;   PMID:21904534 ; http://dx.doi.org/10.3389/ fmicb.2011.00166 9 .,OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
Proc Natl Acad Sci U S A 2002; 99:15451-5; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
J Dairy Sci 2001; 84:319-31; http://dx.doi.org/10.3168/jds.S0022- 0302(01)74481-5 ; PMID:11233016 11 .,OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
Int Dairy J 1998; 8:545; http://dx.doi.org/10.1016/ S0958-6946(98)00081-8 12 .,OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
Br J Nutr 2009; 101:367-75; http://dx.doi.org/10.1017/ S0007114508003097 ; PMID:18634707 13 .,Non-OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
FEMS Microbiol Ecol 2011; 75:482-96; http://dx.doi.org/10.1111/j.1574-6941.2010.01024.x ;  PMID:21204871 14 .,OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
Br J  Nutr 2010; 104:1831-8; http://dx.doi.org/10.1017/ S0007114510002874 ; PMID:20815975 15 .,Non-OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
Proc Natl Acad Sci  U S A 2008; 105:19474-9; http://dx.doi.org/10.1073/ pnas.0810305105 ; PMID:19047644 17 .,OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
Proc Natl Acad Sci U S A 2005; 102:3906-12; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
J Lipid Res 2006; 47:241-59; http://dx.doi.org/10.1194/jlr.R500013-JLR200 ; PMID:16299351 19 .,OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
J Bacteriol 2007; 189:4624-34; http://dx.doi.org/10.1128/JB.00337- 07; PMID:17449631 21 .,Non-OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
Proc Natl Acad Sci U S A 2011; 108:17785-90; http://dx.doi.org/10.1073/ pnas.1114152108 ; PMID:2200631822 .,OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
Metabolomics 2012; 8:244-52; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
Ther Drug Monit 2005; 27:747-51;   PMID:16404815 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
Nucleic Acids Res 2007; 35:W606-12; http://dx.doi.org/10.1093/ nar/gkm324 ; PMID:17584797 26 .,OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
Appl Environ Microbiol 2001; 67:1935-9; http://dx.doi.org/10.1128/AEM.67.4.1935-1939.2001 ;  PMID:11282651 27 .,Non-OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
J Proteome Res 2007; 6:1471-81; http://dx.doi.org/10.1021/pr060596a ;  PMID:17316039 28 .,OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
Proc Natl Acad Sci U S A 2009; 106:3698-703; http://dx.doi.org/10.1073/ pnas.0812874106 ; PMID:19234110 29 .,OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
J Lipid  Res 2009; 50:1955-66; http://dx.doi.org/10.1194/jlr.R900010-JLR200 ; PMID:19346330 30 .,Non-OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
J Lipid Res 2009; 50:1509-20; http://dx.doi.org/10.1194/jlr.R900007-JLR200 ; PMID:19346331 31 .,Non-OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
Mol Cell Endocrinol 2013; 368:17-29; http://dx.doi.org/10.1016/j.mce.2012.05.004 ; PMID:22609541 32 .,OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
Proc Natl Acad Sci U S A 2003; 100:8957-62; http://dx.doi.org/10.1073/ pnas.1332765100 ; PMID:12847288 34 .,OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
"Rigotti A. Absorption, transport, and tissue delivery  of vitamin E. Mol Aspects Med 2007; 28:423-36; http://dx.doi.org/10.1016/j.mam.2007.01.002 ;  PMID:17320165 35 .",OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
Br J Nutr 2005; 94:92-9; PMID:16115338 ; http://dx.doi.org/10.1079/ BJN20051434 36 .,OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
Nutr Rev 2013; 71:319-31; http://dx.doi.org/10.1111/nure.12026 ;  PMID:2373144337 .,Non-OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
Biopharm Drug Dispos 2012; 33:246-56; http://dx.doi.org/10.1002/bdd.1790 ; PMID:22528033 38 .,OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
Biochim Biophys Acta 1980; 611:147-55; http://dx.doi.org/10.1016/0005-2744(80)90050-9 ; PMID:7350913 40 .,OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
Nature 2012; 489:242-9; http://dx.doi.org/10.1038/ nature11552 ; PMID:22972297 41 .,OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
Br J Nutr 2004; 91:539-50; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
J Nutr Biochem 2001; 12:219-24;  http://dx.doi.org/10.1016/S0955-2863(00)00156-X ;  PMID:11287217 45 .,OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
J Lipid  Res 2002; 43:2017-30; http://dx.doi.org/10.1194/jlr.,OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
Mol  Aspects Med 2007; 28:437-52; http://dx.doi.org/10.1016/j.mam.2006.12.007 ; PMID:17306359 48.,OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
Food and nutrition sciences 2011; 2:1088; http://dx.doi.org/10.4236/fns.2011.210146 49 .,Non-OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
J Am Diet Assoc 2004; 104:567-75; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
Mol Nutr Food Res 2013; 57:1237-45; http://dx.doi.org/10.1002/ mnfr.201200720 ; PMID:23520193 51 .,Non-OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
Anal Chem 2006; 78:779-87; http://dx.doi.org/10.1021/ac051437y ;  PMID:16448051,OADS,/arxiv_data1/oa_pdf/2c/47/gmic-5-296.PMC4153766.pdf
"Keywords:  Clostridia, Treg, gut  microbiota *Correspondence to: Kenya Honda;   Email: kenya@rcai.riken.jp Submitted: 28/01/2014; Accepted: 17/03/2014;   Published Online: 18/03/2014 http://dx.doi.org/10.4161/gmic.28572 Addendum to: Atarashi K, Tanoue T, Oshima K,  Suda W, Nagano Y, Nishikawa H, Fukuda S, Saito T, Narushima S, Hase K, et al.",Non-OADS,/arxiv_data1/oa_pdf/19/43/gmic-5-333.PMC4153770.pdf
Nature 2013; 500:232-6; PMID:23842501; http://dx.doi.org/10.1038/nature12331,OADS,/arxiv_data1/oa_pdf/19/43/gmic-5-333.PMC4153770.pdf
Annu Rev Immunol  2012; 30:759-95;  PMID:22224764 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/19/43/gmic-5-333.PMC4153770.pdf
Cell Host Microbe 2012 ;  12:496-508; PMID:23084918 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/19/43/gmic-5-333.PMC4153770.pdf
Cell 2009 ; 139:485- 98; PMID:19836068 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/19/43/gmic-5-333.PMC4153770.pdf
Science  2011 ; 331:337- 41; PMID:21205640 ; http://dx.doi.org/10.1126/ science.1198469 5.,Non-OADS,/arxiv_data1/oa_pdf/19/43/gmic-5-333.PMC4153770.pdf
Int J Syst Bacteriol  1994 ; 44:812-26; PMID:7981107 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/19/43/gmic-5-333.PMC4153770.pdf
Lab Anim  1985 ; 19:111-8; PMID:3889493 ;  http://dx.doi.org/10.1258/002367785780942589 8 .,OADS,/arxiv_data1/oa_pdf/19/43/gmic-5-333.PMC4153770.pdf
Infect Immun 2012 ; 80:3786 -94; PMID:22890996 ;  http://dx.doi.org/10.1128/IAI.00647-12 9 .,Non-OADS,/arxiv_data1/oa_pdf/19/43/gmic-5-333.PMC4153770.pdf
Gut Microbes   2011 ; 2:99-104; PMID:21694499 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/19/43/gmic-5-333.PMC4153770.pdf
Antimicrob Agents Chemother  2005 ; 49:77-81;  PMID :15616278 ; http://dx.doi.org/10.1128/ AAC.49.1.77-81.2005 12 .,Non-OADS,/arxiv_data1/oa_pdf/19/43/gmic-5-333.PMC4153770.pdf
FEMS Microbiol Lett   2002 ; 217:133-9; PMID:12480096 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/19/43/gmic-5-333.PMC4153770.pdf
Immunity 2014 ; 40:128-39; PMID:24412617 ;  http://dx.doi.org/10.1016/j.immuni.2013.12.007decreases in the prevalence of Clostridia  have been associated with increased risk of airway hypersensitivity and atopic dermatitis.,Non-OADS,/arxiv_data1/oa_pdf/19/43/gmic-5-333.PMC4153770.pdf
Science   2013 ; 341:569-73; PMID:23828891 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/19/43/gmic-5-333.PMC4153770.pdf
Nature  2013 ; 504:446-50; PMID:24226770 ;  http://dx.doi.org/10.1038/nature12721 17.,Non-OADS,/arxiv_data1/oa_pdf/19/43/gmic-5-333.PMC4153770.pdf
Proc Natl Acad Sci U S A  2012 ; 109:1293 -8;  PMID:22232681 ; http://dx.doi.org/10.1073/ pnas.1119658109 18 .,OADS,/arxiv_data1/oa_pdf/19/43/gmic-5-333.PMC4153770.pdf
FEMS Microbiol Lett   2009 ; 294:1-8; PMID:19222573 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/19/43/gmic-5-333.PMC4153770.pdf
PLoS One   2013 ; 8:e80604 ; PMID:24278294 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/19/43/gmic-5-333.PMC4153770.pdf
Gut 2006 ; 55:205-11; PMID:16188921 ;  http://dx.doi.org/10.1136/gut.2005.073817 21 .,Non-OADS,/arxiv_data1/oa_pdf/19/43/gmic-5-333.PMC4153770.pdf
EMBO Rep  2012 ; 13:440- 7; PMID:22422004 ; http://dx.doi.org/10.1038/ embor.2012.32 23.,Non-OADS,/arxiv_data1/oa_pdf/19/43/gmic-5-333.PMC4153770.pdf
BMC Microbiol   2012 ; 12:95; PMID:22672413 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/19/43/gmic-5-333.PMC4153770.pdf
Cell  2007 ; 131:33-45; PMID:17923086 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/19/43/gmic-5-333.PMC4153770.pdf
N  Engl J Med 2013 ; 368:407-15; PMID:23323867 ;  http://dx.doi.org/10.1056/NEJMoa1205037 26.,OADS,/arxiv_data1/oa_pdf/19/43/gmic-5-333.PMC4153770.pdf
Gastroenterology  2013 ; 145:946- 53; PMID:24018052 ; http://dx.doi.org/10.1053/j.,Non-OADS,/arxiv_data1/oa_pdf/19/43/gmic-5-333.PMC4153770.pdf
J Chromatogr   1987 ; 421:33-41; PMID:3429573 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/19/43/gmic-5-333.PMC4153770.pdf
"Alexander V Tyakht1,*, Dmitry G Alexeev1,2, Anna S Popenko1, Elena S Kostryukova1,3, and Vadim M Govorun1,2,4 1Research Institute of Physico-Chemical Medicine; Moscow, Russia; 2Moscow Institute of Physics and Technology; Dolgoprudny, Russia; 3Kazan’ (Volga Region)  Federal University; Kazan’, Russia; 4Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Moscow, Russia Keywords:  gut microbiota, intestinal  microbiome, metagenomics, Russian metagenome, markers of healthy microbiota, fecal mass transplantation, stool donor matching Abbreviations:  ANOSIM, analysis of  similarities; ASW, average silhouette  width; FMT, fecal mass transplantation; HGC, high gene count; SRB, sulfate-reducing bacteria *Correspondence to: Alexander V Tyakht;   Email: at@niifhm.ru Submitted: 01/28/2014; Revised:  03/21/2014; Accepted: 03/27/2014; Published Online: 04/01/2014  http://dx.doi.org/10.4161/gmic.28685 Addendum to: Tyakht AV, Kostryukova ES,  Popenko AS, Belenikin MS, Pavlenko AV, Larin AK, Karpova IY, Selezneva OV, Semashko TA, Ospanova EA, et al.",Non-OADS,/arxiv_data1/oa_pdf/cb/2c/gmic-5-351.PMC4153773.pdf
Nat Commun 2013; 4:2469; PMID:24036685; http://dx.doi.org/10.1038/ncomms3469,OADS,/arxiv_data1/oa_pdf/cb/2c/gmic-5-351.PMC4153773.pdf
N Engl J Med 2013; 368:407-15;   PMID:23323867 ; http://dx.doi.org/10.1056/ NEJMoa1205037 2 .,OADS,/arxiv_data1/oa_pdf/cb/2c/gmic-5-351.PMC4153773.pdf
Gastroenterology  2013 ;  145:946-53; PMID:24018052 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cb/2c/gmic-5-351.PMC4153773.pdf
Nat Commun  2012 ; 3:1245 ;  PMID:23212374 ; http://dx.doi.org/10.1038/ ncomms2266 4 .,OADS,/arxiv_data1/oa_pdf/cb/2c/gmic-5-351.PMC4153773.pdf
Genome  Biol 2012 ; 13:R79; PMID :23013615 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cb/2c/gmic-5-351.PMC4153773.pdf
Nature  2013 ; 500:541-6; PMID:23985870 ;  http://dx.doi.org/10.1038/nature12506 7 .,Non-OADS,/arxiv_data1/oa_pdf/cb/2c/gmic-5-351.PMC4153773.pdf
Nature  2012 ; 486:207-14;  PMID:22699609 ; http://dx.doi.org/10.1038/ nature11234 9 .,Non-OADS,/arxiv_data1/oa_pdf/cb/2c/gmic-5-351.PMC4153773.pdf
Proc Natl Acad Sci U S A   2010 ; 107:14691 -6; PMID:20679230 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cb/2c/gmic-5-351.PMC4153773.pdf
Nature  2010 ; 464:59- 65; PMID:20203603 ; http://dx.doi.org/10.1038/ nature08821 11 .,Non-OADS,/arxiv_data1/oa_pdf/cb/2c/gmic-5-351.PMC4153773.pdf
Nat Commun  2013 ; 4:2469 ;  PMID:24036685 ; http://dx.doi.org/10.1038/ ncomms3469 12 .,OADS,/arxiv_data1/oa_pdf/cb/2c/gmic-5-351.PMC4153773.pdf
Nat Methods  2012 ; 9:811- 4; PMID:22688413 ; http://dx.doi.org/10.1038/ nmeth.2066 13 .,OADS,/arxiv_data1/oa_pdf/cb/2c/gmic-5-351.PMC4153773.pdf
Austral Ecol  1993 ; 18:117-43; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cb/2c/gmic-5-351.PMC4153773.pdf
Nature  2011 ; 473:174- 80; PMID :21508958 ; http://dx.doi.org/10.1038/ nature09944 15.,Non-OADS,/arxiv_data1/oa_pdf/cb/2c/gmic-5-351.PMC4153773.pdf
PLoS One  2013 ; 8:e56612 ;  PMID:23437186 ; http://dx.doi.org/10.1371/ journal.pone.0056612 16 .,Non-OADS,/arxiv_data1/oa_pdf/cb/2c/gmic-5-351.PMC4153773.pdf
BMC Genomics   2012 ; 13:514; PMID:23020652 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cb/2c/gmic-5-351.PMC4153773.pdf
Benef Microbes   2013 ; 4:319-28; PMID:24311315 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cb/2c/gmic-5-351.PMC4153773.pdf
Carcinogenesis   2004 ; 25:1477 -84; PMID:14742316 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cb/2c/gmic-5-351.PMC4153773.pdf
Bioinformatics  2006 ; 22:1540 -2; PMID:16595560 ;  http://dx.doi.org/10.1093/bioinformatics/btl117 22.,OADS,/arxiv_data1/oa_pdf/cb/2c/gmic-5-351.PMC4153773.pdf
Nature   2013 ; 498:99-103; PMID:23719380 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cb/2c/gmic-5-351.PMC4153773.pdf
Nat Rev Gastroenterol Hepatol   2014 ; 11:79-80; PMID:24296579 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cb/2c/gmic-5-351.PMC4153773.pdf
World J  Gastroenterol  2013 ; 19:7213 -6; PMID:24222969 ;  http://dx.doi.org/10.3748/wjg.v19.i41.7213 27.,Non-OADS,/arxiv_data1/oa_pdf/cb/2c/gmic-5-351.PMC4153773.pdf
Am J Clin Nutr  2013 ; 98:111-20; PMID:23719549 ;  http://dx.doi.org/10.3945/ajcn.112.056689 28 .,Non-OADS,/arxiv_data1/oa_pdf/cb/2c/gmic-5-351.PMC4153773.pdf
Microbiome   2013 ; 1:3; PMID:24467987 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cb/2c/gmic-5-351.PMC4153773.pdf
Genome Res  2013 ; 23:1163 -9;  PMID:23568836 ; http://dx.doi.org/10.1101/ gr.155465.11330.,OADS,/arxiv_data1/oa_pdf/cb/2c/gmic-5-351.PMC4153773.pdf
Proc Natl Acad Sci U S A  2014 ;  111:1455 -60; PMID:24474772 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cb/2c/gmic-5-351.PMC4153773.pdf
Science  2014 ; 343:241- 3; PMID:24436401 ; http://dx.doi.org/10.1126/ science.343.6168.241,OADS,/arxiv_data1/oa_pdf/cb/2c/gmic-5-351.PMC4153773.pdf
"There is growing recognition that bacteria and yeasts, for  *Correspondence to: Mark Lyte; Email: mark.lyte@ttuhsc.edu Submitted: 11/08/2013; Revised: 28/02/2014; Accepted: 27/03/2014; Published Online: 01/04/2014 http://dx.doi.org/10.4161/gmic.28682Microbial endocrinology Host-microbiota neuroendocrine interactions   influencing brain and behavior Mark Lyte Department of Immunotherapeutics and Biotechnology; School of Pharmacy; Texas Tech University Health Sciences Center; abile ne, TX US a Keywords:  hormones, neuroendocrine, enteric nervous system, signaling, behavior, microbial endocrinology The ability of microorganisms, whether present as  commensals within the microbiota or introduced as part  of a therapeutic regimen, to influence behavior has been demonstrated by numerous laboratories over the last few years.",Non-OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Pharmacol Res 2013; 69:52-60;  PMID:23147033 ;  http://dx.doi.org/10.1016/j.phrs.2012.10.020 2.,Non-OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Nat Rev Neurosci 2012; 13:701-12; PMID :22968153 ; http://dx.doi.org/10.1038/ nrn3346 4 .,Non-OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Annu Rev Pathol 2012; 7:99-122; PMID:21910623 ; http://dx.doi.org/10.1146/ annurev-pathol-011811-1324215 .,Non-OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Nat Rev Gastroenterol Hepatol 2012; 9:312-22;  PMID:22450307 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Cell 2013; 152:39-50; PMID:23332745 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Trends Microbiol 2004; 12:14-20;  PMID:14700547 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Proc Jpn Acad Ser B Phys Biol Sci 2013; 89:139-56; PMID:23574805 ; http://dx.doi.org/10.2183/ pjab.89.139 10 .,OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
J Neuroimmunol 2008; 205:44-50;   PMID:18954912 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Am J Physiol Gastrointest Liver Physiol 2012; 303:G1288-95; PMID:23064760 ; http://dx.doi.org/10.1152/ ajpgi.00341.2012 15 .,Non-OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
J Clin Pathol 1989; 42:516-22;  PMID:2499609 ;  http://dx.doi.org/10.1136/jcp.42.5.516 17 .,Non-OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
J Parasitol  1993; 79:17-22;  PMID:8437056 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Neurosci Biobehav Rev 2012; 36:502-19;  PMID:21893093 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
J Appl Microbiol  2001; 90:158-62;  PMID:11168717 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Trends Genet 2004; 20:292-9;  PMID:15219393 ;  http://dx.doi.org/10.1016/j.tig.2004.05.007 22 .,OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
PLoS Comput Biol 2013; 9:e1003107;  PMID:23840181 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Med Hypotheses 2010; 74:634-8;  PMID:19900764 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Trends Biochem Sci 1992; 17:147-50; PMID:1585458 ;  http://dx.doi.org/10.1016/0968-0004(92)90323-2 25.,OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Sci Rep 2012; 2:233; PMID:22724057 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Mol Syst Biol 2007; 3:112;  PMID :17515922 ; http://dx.doi.org/10.1038/ msb4100153 27 .,OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Histochem Cell Biol 2012; 138:13-24;  PMID:22527698 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Proc Soc Exp Biol Med 1981; 167:301-3;  PMID:7019921 ;  http://dx.doi.org/10.3181/00379727-167-41169 30 .,Non-OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Neurochem Res 1990; 15:1237-8; PMID:1965858 ; http://dx.doi.org/10.1007/ BF01208585 32 .,Non-OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Experientia 1986; 42:782-8;  PMID :3015665 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
N Engl J Med 1982; 306:523-7; PMID:6120460 ; http://dx.doi.org/10.1056/ NEJM198203043060907 35 .,OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Med Hypotheses 1992; 37:255-8;  PMID:1625603 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Life Sci 1992; 50:203-12;  PMID:1731173 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Microbes Infect 2008; 10:807-16; PMID:18554972 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Appl Microbiol Biotechnol 2009; 84:763-76;  PMID:19517106 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Microbiology 2008; 154:2581-8;  PMID:18757792 ;  http://dx.doi.org/10.1099/mic.0.2008/020230-0 42.,Non-OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Microb Pathog 2011; 51:1-8; PMID:21419838 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Arch Biochem Biophys 1959; 85:487-90;  PMID:13840159 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
J Biol Chem 2003; 278:43373-83; PMID:12900412 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Comp Gen Pharmacol 1971; 2:347-71;  PMID:4353991 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Gen Comp  Endocrinol 1990; 80:257-63; PMID:2074003 ;  http://dx.doi.org/10.1016/0016-6480(90)90170-Q 48.,OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Infect Immun 2010; 78:914-26;  PMID:20028809 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Int J Med Microbiol 2008; 298:429-39; PMID:17888732 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Appl Environ Microbiol 2002; 68:4788-94;  PMID:12324321 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
J Bacteriol 2008; 190:3940-7;  PMID:18390651 ; http://dx.doi.org/10.1128/ JB.00086-08 52.,Non-OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Lancet 2003; 361:130-5;  PMID :12531580 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Infect Immun 2004; 72:5446-51;   PMID:15322043 ; http://dx.doi.org/10.1128/ IAI.72.9.5446-5451.2004 59 .,Non-OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Infect Immun 2010; 78:1509-19;  PMID:20145094 ;  http://dx.doi.org/10.1128/IAI.00862-09 60 .,Non-OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Process Biochem 2013; 48:559-68; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Proc Natl Acad Sci U S A 2011; 108:16050-5;  PMID :21876150 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Handb Clin Neurol 2012; 106:211-25; PMID:22608623 ; http://dx.doi.org/10.1016/ B978-0-444-52002-9.00012-7 63 .,Non-OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Biol Rev Camb Philos Soc 1971; 46:201-41;  PMID:4942955 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
J Plant Growth Regul 1995; 14:91-7; http://dx.doi.org/10.1007/BF00203119 65 .,Non-OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Int J Food Sci Nutr  1996; 47:263-72;  PMID:8735780 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Physiol Behav 2009; 96:557-67; PMID:19135464 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Nat Rev Gastroenterol Hepatol 2012; 9:286-94;  PMID:22392290 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Gastroenterology 2004; 127:635-57; PMID :15300595 ; http://dx.doi.org/10.1053/j.,Non-OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Future Microbiol 2008; 3:563-78;  PMID:18811240 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
Nat Rev Microbiol 2009; 7:526-36; PMID:19528959 ; http://dx.doi.org/10.1038/ nrmicro2164 71 .,Non-OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
J Bacteriol 2013; 195:411-6; PMID:23144247 ; http://dx.doi.org/10.1128/ JB.01384-12,Non-OADS,/arxiv_data1/oa_pdf/e0/d9/gmic-5-381.PMC4153777.pdf
"Specific pathogen-free (SPF) mice with extremely *Correspondence to: Kathy D McCoy; Email: mccoy@dkf.unibe.ch Submitted: 10/19/2013; Revised: 05/15/2014; Accepted: 05/22/2014; Published Online: 06/12/2014http://dx.doi.org/10.4161/gmic.29330The interplay between the gut microbiota   and the immune system Markus B Geuking, yasmi n Köller, Sandra rupp, a nd Kathy D McCoy* Mucosal Immunology Lab; Department of Clinical resea rch; University of Bern; Bern, Switzerland Keywords:  microbiota, homeostasis, regulatory T cells, microbial conditioning, IgA, innate lymphoid cells, autoimmunity, allergies Abbreviations:  IBD, Inflammatory bowel diseases; Treg, regulatory T cells; Th, T helper cells; ILC, innate lymphoid cells;   T1D, Type 1 Diabetes; EAE, Experimental Autoimmune Encephalomyelitis; RA, retinoic acid (RA); SFB, segmented filamentous  bacteria; ASF, Altered Schaedler Flora; DC, dendritic cell; NK, natural killer cell; PRR, pattern recognition receptor; AHR, aryl  hydrocarbon receptor; SCFA, short chain fatty acids; IL, interleukin; TGF β, tumor growth factor β; TNF, tumor necrosis factor;  INFγ, interferon- γ; TSLP, thymic stromal lymphopoietin; RALDH, Retinaldehyde dehydrogenases; BAFF, B cell activating factor;  APRIL, A proliferation-inducing ligand The impact of the gut microbiota on immune homeostasis  within the gut and, importantly, also at systemic sites has  gained tremendous research interest over the last few years.",Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Proc Natl Acad Sci U S A 2010; 107:11971-5;   PMID:20566857 ; http://dx.doi.org/10.1073/ pnas.1002601107 2.,OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Clin Perinatol 2011; 38:321-31;  PMID:21645799 ;  http://dx.doi.org/10.1016/j.clp.2011.03.008 3.,OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Microbiol Immunol 1984; 28:975-86;  PMID:6513816 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
"J Allergy Clin Immunol 2011; 128:948, e1-3;  PMID :21872915 ; http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Sci Transl Med 2009; 1:ra14;   PMID:20368178 ; http://dx.doi.org/10.1126/ scitranslmed.3000322 9 .,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Nature 2012; 488:621-6; PMID:22914093 ; http://dx.doi.org/10.1038/ nature11400 10 .,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Cell 2013; 152:39-50; PMID:23332745 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Nature 2007; 449:804-10;  PMID:17943116 ;  http://dx.doi.org/10.1038/nature0624412 .,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
J Exp Med 2012; 209:1445-56;  PMID:22826298 ;  http://dx.doi.org/10.1084/jem.20120504 13 .,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Sci Transl Med 2014; 6:20ra11;   PMID:24452263 ; http://dx.doi.org/10.1126/ scitranslmed.3008051 15 .,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Science 2013; 341:1241214;  PMID:24009397 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Nature 2006; 444:1027-31;  PMID:17183312 ;  http://dx.doi.org/10.1038/nature05414 18.,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Proc Natl Acad Sci U S A 2004; 101:4596-601;  PMID:15070763 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Nat Rev Microbiol 2013; 11:615-26; PMID:23893105 ; http://dx.doi.org/10.1038/ nrmicro3074 20 .,OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Proc Natl Acad Sci U S A 2008; 105:15064-9; PMID:18806221 ; http://dx.doi.org/10.1073/ pnas.0803124105 21 .,OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Gastroenterology 2006; 131:117-29;   PMID :16831596 ; http://dx.doi.org/10.1053/j.,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Nat Rev Immunol 2012; 12:503-16;  PMID:22728527 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
J Biol Chem 2000; 275:40478-82; PMID:11010975 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Science 2006; 313:1126-30; PMID:16931762 ; http://dx.doi.org/10.1126/ science.1127119 25 .,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Nat Immunol 2003; 4:269-73;  PMID:12548285 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Proc Natl Acad Sci U S A 2008; 105:20858-63;  PMID:19075245 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Science 2011; 334:255-8;  PMID:21998396 ;  http://dx.doi.org/10.1126/science.1209791 28 .,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Nat Rev Immunol 2014; 14:141-53; PMID:24566914 ;  http://dx.doi.org/10.1038/nri3608 29 .,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Int Immunol 2011; 23:159-63;   PMID:21393631 ; http://dx.doi.org/10.1093/ intimm/dxr001 30.,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Nat Rev Immunol 2012; 12:821-32; PMID:23103985 ; http://dx.doi.org/10.1038/ nri3322 33 .,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Science 2010; 328:1705-9; PMID:20576892 ; http://dx.doi.org/10.1126/ science.1188454 34 .,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Nat Immunol 2011; 12:264-70;   PMID:21258321 ; http://dx.doi.org/10.1038/ni.1991 36 .,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Immunol Rev 2013; 252:164-82;  PMID:23405904 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Science 2011; 331:337-41; PMID:21205640 ; http://dx.doi.org/10.1126/ science.1198469 38 .,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Immunity 2011; 34:794-806; PMID:21596591 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Proc Natl Acad Sci U S A 2010; 107:12204-9;  PMID:20566854 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Immunity 2009; 31:677-89; PMID:19833089 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Cell 2009; 139:485-98; PMID:19836068 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Am J Gastroenterol 2013; 108:860-1; PMID:23644973 ; http://dx.doi.org/10.1038/ ajg.2013.61 44 .,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
J Immunol 2005; 174:3237-46; PMID :15749854 ;  http://dx.doi.org/10.4049/jimmunol.174.6.323745 .,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Am J Respir Crit Care Med 2009; 179:186-93;   PMID:19029003 ; http://dx.doi.org/10.1164/ rccm.200806-951OC 46 .,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Nature 2008; 453:620-5;  PMID:18509436 ;  http://dx.doi.org/10.1038/nature07008 47 .,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Science 2013; 341:569-73;  PMID:23828891 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Nature 2013; 504:446-50;  PMID:24226770 ;  http://dx.doi.org/10.1038/nature12721 49 .,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Nature 2013; 504:451-5;  PMID:24226773 ;  http://dx.doi.org/10.1038/nature12726 50 .,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Nat Rev Immunol 2013; 13:145-9;  PMID:23348417 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Immunity 2008; 29:958-70; PMID:19084435 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Annu Rev Immunol 2012; 30:647-75; PMID:22224763 ; http://dx.doi.org/10.1146/ annurev-immunol-020711-075053 53 .,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Nat Immunol 2011; 12:21-7;   PMID:21113163 ; http://dx.doi.org/10.1038/ni.1962 54 .,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Nat Immunol 2009; 10:83-91;  PMID:19029903 ;  http://dx.doi.org/10.1038/ni.1684 55 .,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Science 2010; 330:665-9; PMID:20929731 ; http://dx.doi.org/10.1126/ science.1194597 56 .,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Nat Immunol 2011; 12:320-6; PMID:21336274 ; http://dx.doi.org/10.1038/ ni.2002 57 .,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Immunity 2010; 33:736-51;   PMID:21093318 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Immunity 2010; 33:752-64; PMID:21055975 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Immunity 2012; 36:276-87;   PMID:22306017 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Science 2012; 336:489-93;  PMID:22442383 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Nat Rev Immunol 2013; 13:101-17;  PMID:23334244 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Immunol Rev 2012; 245:239-49;  PMID:22168424 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Proc Natl Acad Sci U S A 2012; 109:8334-9;   PMID:22566627 ; http://dx.doi.org/10.1073/ pnas.1205624109 70 .,OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Science 2013; 339:1084-8;  PMID:23328391 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Nature 2011; 474:327-36; PMID:21677749 ; http://dx.doi.org/10.1038/ nature10213 72 .,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Pediatr Res 2007; 61:37-41;  PMID:17211138 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Immunity 1998; 9:229-37; PMID:9729043 ; http://dx.doi.org/10.1016/ S1074-7613(00)80605-6 77 .,OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Autophagy 2011; 7:235-7;  PMID:21160278 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Cell Biochem Funct 2009; 27:48-55;  PMID:19107872 ;  http://dx.doi.org/10.1002/cbf.1533 80 .,OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Clin Sci (Lond) 2009; 117:331-8; PMID:19335337 ;  http://dx.doi.org/10.1042/CS20080642 81 .,OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Nat Commun 2013; 4:1829;   PMID:23652017 ; http://dx.doi.org/10.1038/ ncomms2852 82 .,OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Proc Natl Acad Sci U S A 2006; 103:10011-6; PMID:16782812 ; http://dx.doi.org/10.1073/ pnas.0602187103 83 .,OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Immunity 2011; 35:13-22;  PMID:21777796 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Immunity 2004; 21:527-38; PMID:15485630 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
J Exp Med 2007; 204:1775-85;  PMID:17620362 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
J Exp Med 2007; 204:1757-64;  PMID:17620361 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Immunity 2011; 34:435-47; PMID:21419664 ;  http://dx.doi.org/10.1016/j.immuni.2011.03.003 90 .,OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Science 2014; 343:432-7; PMID:24458645 ; http://dx.doi.org/10.1126/ science.1247606 91 .,OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Nature 2014; 508:123-7; PMID:24670648 ; http://dx.doi.org/10.1038/ nature13158 92 .,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Pharmacol Rev 2013; 65:1148-61;  PMID:23908379 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Science 2011; 334:1561-5; PMID:22033518 ; http://dx.doi.org/10.1126/ science.1214914 94 .,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Nat Immunol 2012; 13:144-51;   PMID:22101730 ; http://dx.doi.org/10.1038/ni.2187 95 .,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Immunity 2012; 36:92-104; PMID:22177117 ;  http://dx.doi.org/10.1016/j.immuni.2011.11.011 96 .,OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Front Immunol 2012; 3:124;  PMID:22666222 ; http://dx.doi.org/10.3389/ fimmu.2012.00124 97 .,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
Nature 2008; 455:808-12; PMID:18716618 ; http://dx.doi.org/10.1038/ nature07240,Non-OADS,/arxiv_data1/oa_pdf/25/1c/gmic-5-411.PMC4153781.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c8/e6/bht117.PMC4153805.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/47/85/bht121.PMC4153806.pdf
Supplementary Material Supplementary material can be found at: http://www.cercor.,Non-OADS,/arxiv_data1/oa_pdf/47/85/bht121.PMC4153806.pdf
"111Review http://dx.doi.org/10.9758/cpn.2014.12.2.111 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2014;12(2):111-123 Copyrightⓒ 2014, Korean College of Neuropsychopharmacology                       Received:  February 17, 2014/ Revised:  March 25, 2014 Accepted:  April 7, 2014 Address for correspondence: Anekal C. Amaresha, MSW, MPhil Department of Psychiatric Social Work, First Floor, Dr. M.V.",Non-OADS,/arxiv_data1/oa_pdf/5d/10/cpn-12-111.PMC4153857.pdf
"124Original Article http://dx.doi.org/10.9758/cpn.2014.12.2.124 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2014;12(2):124-127 Copyrightⓒ 2014, Korean College of Neuropsychopharmacology                       Received:  December 24, 2013/ Revised:  February 1, 2014 Accepted:  February 14, 2014 Address for correspondence: Kenji Hashimoto, PhD Division of Clinical Neuroscience, Chiba University Center for  Forensic Mental Health, 1-8-1 Inohara, Chiba 260-8670, Japan Tel: +81-43-226-2517, Fax: +81-43-226-2561E-mail: hashimoto@faculty.chiba-u.jp  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Antidepressant Effects of Ketamine on Depression-like Behavior in Juvenile  Mice after Neonatal Dexamethasone Exposure Su-Xia Li1,2, Ji-Chun Zhang1, Jin Wu1, Kenji Hashimoto1 1Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan, 2National Institute on Drug  Dependence, Peking University, Beijing, P.R.",Non-OADS,/arxiv_data1/oa_pdf/e3/9e/cpn-12-124.PMC4153858.pdf
"128Original Article http://dx.doi.org/10.9758/cpn.2014.12.2.128 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2014;12(2):128-136 Copyrightⓒ 2014, Korean College of Neuropsychopharmacology                       Received:  December 12, 2013/ Revised:  February 19, 2014 Accepted:  March 10, 2014 Address for correspondence: Chul-Eung Kim, MD, PhD  Department and Research Instutitute of Psychiatry, Inha Univers ity  College of Medicine, 366 Seohae-daero, Jung-gu, Incheon 400-103, KoreaTel: +82-32-890-3475, Fax: +82-32-890-3558E-mail: kce320@inha.ac.kr  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Prescription Patterns for Patients with  Schizophrenia in Korea: A Focus on  Antipsychotic Polypharmacy Hee-Yun Kim, Hee-Won Lee, Seung-Ho Jung, Min-Hee Kang, Jae-Nam Bae, Jeong-Seop Lee, Chul-Eung Kim Department of Psychiatry, Inha University Hospital, Incheon, Ko rea Objective: This study investigated the prescription patterns for Korean pa tients with schizophrenia with a particular focus on  antipsychotic polypharmacy.",Non-OADS,/arxiv_data1/oa_pdf/8c/34/cpn-12-128.PMC4153859.pdf
"137Original Article http://dx.doi.org/10.9758/cpn.2014.12.2.137 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2014;12(2):137-141 Copyrightⓒ 2014, Korean College of Neuropsychopharmacology                       Received:  July 26, 2013/ Revised:  February 5, 2014 Accepted:  March 10, 2014 Address for correspondence: Tjhin Wiguna, MD, MIMH, PhD Child and Adolescent Psychiatry Division, Department of  Psychiatry, University of Indonesia, Jl.",Non-OADS,/arxiv_data1/oa_pdf/48/24/cpn-12-137.PMC4153860.pdf
"142Original Article http://dx.doi.org/10.9758/cpn.2014.12.2.142 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2014;12(2):142-148 Copyrightⓒ 2014, Korean College of Neuropsychopharmacology                       Received:  January 22, 2014/ Revised:  March 10, 2014 Accepted:  April 15, 2014 Address for correspondence: Claudio Terranova, MD School of Medicine, Forensic Toxicology and Antidoping, Univers ity  Hospital of Padova, via Gabriele Falloppio n.50, Padova 35121, Italy Tel: +39-0498272230, Fax: +39-0498213146E-mail: claudio.terranova@sanita.padova.it  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.GABA Receptors Genes Polymorphisms and Alcohol Dependence: No  Evidence of an Association in an Italian Male Population Claudio Terranova, Marianna Tucci, Laura Di Pietra, Santo David e Ferrara School of Medicine, Forensic Toxicology and Antidoping, Univers ity Hospital of Padova, Padova, Italy Objective: The genes encoding for gamma-aminobutyric acid (GABA) A and B r eceptors may be considered as candidates  for alcoholism; genetic alterations at this level may produce s tructural and functional diversity and thus play a role in the response  to alcohol addiction treatment.",Non-OADS,/arxiv_data1/oa_pdf/e7/a3/cpn-12-142.PMC4153861.pdf
"SNP Selection and Genotyping SNPs were selected from the dbSNP database of  National Center for Biotechnology Information, United  States (NCBI; http://www.ncbi.nlm.nih.gov) and from lit- erature findings for DNA re gions encoding for GABA A  receptor, alpha-1 subunit (G ABRA1 gene) and GABA B  receptor, subunit 1 (GABBR1 gene) and subunit 2  (GABBR2 gene).",OADS,/arxiv_data1/oa_pdf/e7/a3/cpn-12-142.PMC4153861.pdf
"GABBR1, gamma-aminobutyric acid B receptor, subunit 1; AD, alco - hol dependent.Statistical Analysis To evaluate study feasibility, a power analysis was per- formed with software available at http://pngu.mgh.harvard.edu/~purcell/gpc/.",OADS,/arxiv_data1/oa_pdf/e7/a3/cpn-12-142.PMC4153861.pdf
"149Original Article http://dx.doi.org/10.9758/cpn.2014.12.2.149 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2014;12(2):149-156 Copyrightⓒ 2014, Korean College of Neuropsychopharmacology                       Received:  January 16, 2014/ Revised:  March 17, 2014 Accepted:  April 23, 2014 Address for correspondence: Sung-Man Bae, PhD Department of Psychiatry, Ilsan Paik Hospital, Inje University  College of Medicine, 170 Juhwa-ro, Ilsanseo-gu, Goyang 411-706,   KoreaTel: +82-31-910-7873, Fax: +82-31-910-7267E-mail: spirit73@hanmail.net  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Validation of the Korean Version of the Ch ildren’s Revised Impact of Event Scale  Eun A Oh, Eun Jin Park, Seung-Hwan Lee, Sung-Man Bae Department of Psychiatry, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea Objective: This study examined the psychometric properties of the Korean v ersion of the Children ’s Revised Impact of Event  Scale (CRIES) and its validity as a screening instrument for th e post-traumatic stress disorder (PTSD).",Non-OADS,/arxiv_data1/oa_pdf/93/9a/cpn-12-149.PMC4153862.pdf
"Translation of the Children ’s Revised Impact of Event  Scale First, approval for using CRIES for research and a sam- ple scale of the English version of CRIES were obtained  from the Children and War Foundation (http://www.chil-drenandwar.org/measures/).",Non-OADS,/arxiv_data1/oa_pdf/93/9a/cpn-12-149.PMC4153862.pdf
Available from http://www.child- renandwar.org/measures/ 15.,Non-OADS,/arxiv_data1/oa_pdf/93/9a/cpn-12-149.PMC4153862.pdf
"157Case Report http://dx.doi.org/10.9758/cpn.2014.12.2.157 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2014;12(2):157-159 Copyrightⓒ 2014, Korean College of Neuropsychopharmacology                       Received:  September 26, 2013/ Revised:  January 3, 2014 Accepted:  January 6, 2014 Address for correspondence: Ather Muneer, MD Department of Psychiatry, Islamic International Medical College ,  Pakistan Railway Teaching Hospital, Rawalpindi, PakistanTel: +92-51-4433097, Fax: +92-51-512-5170E-mail: muneerather2@gmail.com  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Aripiprazole in the Treatment of Refractory Mood Disorders: A Case Series Ather Muneer Department of Psychiatry, Islamic International Medical College , Pakistan Railway Teaching Hospital, Rawalpindi, Pakistan Major depressive disorder and bipolar disorders are among the c ommonest neuropsychiatric conditions, affecting persons of  both sexes which belong to all age groups.",Non-OADS,/arxiv_data1/oa_pdf/98/67/cpn-12-157.PMC4153863.pdf
"160Case Report http://dx.doi.org/10.9758/cpn.2014.12.2.160 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2014;12(2):160-162 Copyrightⓒ 2014, Korean College of Neuropsychopharmacology                       Received:  February 11, 2014/ Revised:  February 24, 2014 Accepted:  February 25, 2014 Address for correspondence: Yuta Yoshino, MD Department of Neuropsychiatry, Ehime University Graduate School   of Medicine, Shitsukawa, Toon, Ehime 791-0295, JapanTel: +81-89-960-5315, Fax: +81-89-960-5317E-mail: whisperoftheheart2@yahoo.co.jp  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Combined Clozapine and Electroconvulsive Therapy in a Japanese Schizophrenia  Patient: A Case Report Yuta Yoshino1, Yuki Ozaki2, Koichiro Kawasoe1, Shinichiro Ochi1, Takanori Niiya1, Naomi Sonobe1, Teruhisa Matsumoto1,  Shu-ichi Ueno1 1Department of Neuropsychiatry, Ehime University Graduate School  of Medicine, 2Department of Postgraduate Clinical Training Center,  Ehime University Hospital, Shitsukawa, Japan Clozapine is well-known for successful use in schizophrenic pat ients treatment resistant to other antipsychotics.",Non-OADS,/arxiv_data1/oa_pdf/12/97/cpn-12-160.PMC4153864.pdf
"163Case Report http://dx.doi.org/10.9758/cpn.2014.12.2.163 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2014;12(2):163-165 Copyrightⓒ 2014, Korean College of Neuropsychopharmacology                       Received:  January 24, 2014/ Revised:  March 6, 2014 Accepted:  March 19, 2014 Address for correspondence: Chien-Han Lai, MD Department of Psychiatry, Cheng Hsin General Hospital, No.45,  Cheng Hsin St., Pai-Tou Destrict, Taipei City, TaiwanTel: +886-2-28264400 ext 3502, Fax: +886-2-28264570E-mail: stephenlai99@gmail.com  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Late-onset Quetiapine-related Tardive D yskinesia Side Effects in a Patient with  Psychotic Depression Yi-Cheng Hou1, Chien-Han Lai2 1Department of Nutrition, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, 2Department of Psychiatry, Cheng  Hsin General Hospital, Taipei City, Taiwan The atypical antipsychotics were believed to induce less extrap yramidal syndrome, including tardive dyskinesia (TD).",Non-OADS,/arxiv_data1/oa_pdf/8d/4f/cpn-12-163.PMC4153865.pdf
"166Case Report http://dx.doi.org/10.9758/cpn.2014.12.2.166 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2014;12(2):166-168 Copyrightⓒ 2014, Korean College of Neuropsychopharmacology                       Received:  June 12, 2014/ Revised:  July 18, 2014 Accepted:  July 22, 2014 Address for correspondence: Hyo-Deog Rim, MD, PhD Department of Psychiatry, Kyungpook National University School of  Medicine, 130 Dongdeok-ro, Jung-gu, Daegu 700-721, KoreaTel: +82-53-420-5755, Fax: +82-53-426-5361E-mail: hdrim@knu.ac.kr  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Acamprosate-induced Extrapyramidal Symptoms in an Elderly Patient with  Alcohol Dependence Jungmin Woo1, Hyo-Deog Rim2 1Department of Psychiatry, Catholic University of Daegu School o f Medicine, 2Department of Psychiatry, Kyungpook National University  School of Medicine, Daegu, Korea Acamprosate reduces the craving for alcohol by decreasing gluta mate activity and increasing gamma-aminobutyric acid (GABA)  action in patients with alcohol dependence.",Non-OADS,/arxiv_data1/oa_pdf/39/c6/cpn-12-166.PMC4153866.pdf
"75Review http://dx.doi.org/10.9758/cpn.2014.12.2.75 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2014;12(2):75-82 Copyrightⓒ 2014, Korean College of Neuropsychopharmacology                       Received:  February 4, 2014/ Revised:  February 23, 2014 Accepted:  March 31, 2014 Address for correspondence: Kiyofumi Yamada, PhD Department of Neuropsychopharmacology and Hospital Pharmacy,  Graduate School of Medicine, Nagoya University, 65 Tsuruma-cho,Showa-ku, Nagoya 466-8560, JapanTel: +81-52-744-2674, Fax: +81-52-744-2876E-mail: kyamada@med.nagoya-u.ac.jpYasushi Ohizumi, PhDKansei Fukushi Research Institute, Tohoku Fukushi University, 6-149-1 Kunimigaoka, Aoba-ku, Sendai 989-3201, JapanTel: +81-22-728-6009E-mail: ohizumi@tfu-mail.tfu.ac.jp  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Anti-dementia Activity of Nobiletin, a Citrus Flavonoid: A Review of Animal  Studies Akira Nakajima1, Yasushi Ohizumi2,3,4,5, Kiyofumi Yamada1 1Department of Neuropsychopharmacology and Hospital Pharmacy, Gr aduate School of Medicine, Nagoya University, Nagoya, 2Department  of Molecular Toxicology, School of Pharmaceutical Sciences, Uni versity of Shizuoka, Shizuoka, 3Department of Anti-Dementia Functional  Food Development, Research Center of Supercritical Fluid Techno logy, Graduate School of Engineering, Tohoku University, Sendai ,  4Laboratory of Kampo Medicines, Yokohama College of Pharmacy, Yo kohama, 5Kansei Fukushi Research Institute, Tohoku Fukushi  University, Sendai, Japan Alzheimer ’s disease (AD), the most common form of dementia among the elde rly, is characterized by the progressive decline  of cognitive function and has a detrimental impact worldwide.",Non-OADS,/arxiv_data1/oa_pdf/b6/ca/cpn-12-75.PMC4153867.pdf
"83Review http://dx.doi.org/10.9758/cpn.2014.12.2.83 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2014;12(2):83-93 Copyrightⓒ 2014, Korean College of Neuropsychopharmacology                       Received:  March 9, 2014/ Accepted:  March 24, 2014 Address for correspondence: Aparna Shah, PhD Department of Pharmacology, University of Texas Health Science  Center, 7703 Floyd Curl Drive, Mail Code 7764, San Antonio, TX 78229-3900, USATel: +1-210-567-4170, Fax: +1-210-567-4300E-mail: shahap@uthscsa.edu  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Therapeutic Modalities for Treatment Resistant Depression: Focus on Vagal  Nerve Stimulation and Ketamine Aparna Shah1, Flavia Regina Carreno1, Alan Frazer1,2 1Department of Pharmacology and Center for Biomedical Neuroscien ce, University of Texas Health Science Center, 2South Texas Veterans  Health Care System (STVHCS), Audie L. Murphy Division, San Anto nio, TX, USA Treatment resistant depression (TRD) is a global health concern  affecting a large proportion of depressed patients who then  require novel therapeutic options.",Non-OADS,/arxiv_data1/oa_pdf/a7/5b/cpn-12-83.PMC4153868.pdf
"94Review http://dx.doi.org/10.9758/cpn.2014.12.2.94 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2014;12(2):94-110 Copyrightⓒ 2014, Korean College of Neuropsychopharmacology                       Received:  January 14, 2014/ Revised:  March 26, 2014 Accepted:  April 6, 2014 Address for correspondence: Brian Dean, HND Appl Biol, MSc, PhD, FSB, CBiol Molecular Psychiatry Laboratory, The Florey Institute of Neuroscience and Mental Health, Kenneth Myer Building, The University of Melbourne, Victoria 3010, AustraliaTel: +613-8344-3786, Fax: +613-9348-1707E-mail: anddali@unimelb.edu.au  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Potential Molecular and Cellular Mechanism of Psychotropic Drugs Myoung Suk Seo1, Elizabeth Scarr1,2, Chi-Yu Lai1,3, Brian Dean1,2 1Molecular Psychiatry Laboratory, The Florey Institute of Neuros cience and Mental Health, 2Department of Psychiatry, The University of  Melbourne, Parkville, Victoria, Australia, 3Institute of Epidemiology and Preventive Medicine, College of P ublic Health, National Taiwan  University, Taipei, Taiwan Psychiatric disorders are among the most debilitating of all me dical illnesses.",Non-OADS,/arxiv_data1/oa_pdf/e7/eb/cpn-12-94.PMC4153869.pdf
"The full prescribing information for rasburicase states that‘the incidence of anaphylaxis, hemolysis, and methemoglobi-nemia was <1% of the 887 rasburicase-treated patients entered on these clinical trials’ (see http://products.sanoﬁ.us/ elitek/elitek.html#section-9).",Non-OADS,/arxiv_data1/oa_pdf/22/3d/bjh0164-0469.PMC4153881.pdf
"Large scale centrifugation performance based on its clariﬁcation ef ﬁciency can be evaluated at the bench scale through the use of the Stheory, which allows for comparison between centrifuges of different sizes and, using appropriate calibration factors, different centrifuge types (Ambler, 1959).This is an open access article under the terms of the Creative Commons Attribution- NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modiﬁcations or adaptations are made.Correspondence to: M. HoareContract grant sponsor: The authors are pleased to acknowledge ﬁnancial support of Alex Chatel by EPSRC IDTC and by GSK Received 12 August 2013; Revision received 19 November 2013; Accepted 19November 2013Accepted manuscript online 27 November 2013; Article ﬁrst published online 28 December 2013 in Wiley Online Library (http://onlinelibrary.wiley.com/doi/10.1002/bit.25164/abstract).DOI 10.1002/bit.25164ARTICLE /C2232013 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/dc/e1/bit0111-0913.PMC4153950.pdf
Avail- able from: http://psoriasis.org/document.doc?id=193 (last accessed 28 October 2013).,Non-OADS,/arxiv_data1/oa_pdf/5f/8b/bjd0170-0705.PMC4153951.pdf
"Between November 2008 and Janu- ary 2011, patients were recruited into the study from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate, which was established to study predic-tors of treatment response to biologic drugs (for a list ofmembers, see Supplementary Appendix A, available in the online version of this article at http://onlinelibrary.wiley.",Non-OADS,/arxiv_data1/oa_pdf/b0/ff/acr0066-0861.PMC4153952.pdf
The DAS28 was calculated using established methods (online at http://www.das-score.nl/).,OADS,/arxiv_data1/oa_pdf/b0/ff/acr0066-0861.PMC4153952.pdf
"We identiﬁed and approachedBackCare (http://www.backcare.org.uk/), the National As- sociation for Patient Participation (http://www.napp.",Non-OADS,/arxiv_data1/oa_pdf/b3/a9/acr0066-0925.PMC4153953.pdf
"org.uk/), the Expert Patients Programme Community Inter-est Company, and the Expert Patient Programmes (EPP;http://www.expertpatients.co.uk/).",Non-OADS,/arxiv_data1/oa_pdf/b3/a9/acr0066-0925.PMC4153953.pdf
URL: http://ipdas.ohri.ca/resources.html.,OADS,/arxiv_data1/oa_pdf/b3/a9/acr0066-0925.PMC4153953.pdf
"All applications are administered by a national Clearing House (http://www.leeds.ac.uk/chpccp), using a single application for up to four courses across the United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/71/6b/bjc0053-0194.PMC4153958.pdf
"USDepartment of Health and Human Services; Food and Drug Administration, 2006. http://www.fda.gov/OHRMS/DOCKETS/ 98fr/06d-0344-gdl0001.pdf .",Non-OADS,/arxiv_data1/oa_pdf/d0/ea/40268_2014_Article_53.PMC4153963.pdf
http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020496s027lbl.pdf .,Non-OADS,/arxiv_data1/oa_pdf/06/6a/40268_2014_Article_54.PMC4153964.pdf
World Medical Association; 2008.http://www.wma.net/en/30publicat ions/10policie s/b3/17c.pdf .,Non-OADS,/arxiv_data1/oa_pdf/06/6a/40268_2014_Article_54.PMC4153964.pdf
ICH Har- monised Tripartite Guideline; 1996. http://www.ich.org/ ﬁleadmin/Public_Web_Site/ICH_P roducts/Guidelines/Efﬁcacy/ E6_R1/Step4/E6_R1__Guideline.pdf .,Non-OADS,/arxiv_data1/oa_pdf/06/6a/40268_2014_Article_54.PMC4153964.pdf
"US Department of Health and Human Services,Food and Drug Administration, Center for Drug Evaluation and Research (CDER); 2012. http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM292362.pdf .",OADS,/arxiv_data1/oa_pdf/06/6a/40268_2014_Article_54.PMC4153964.pdf
US Department of Health and Human Services; 2011. http://www.cdc.gov/diabetes/pubs/pdf/ ndfs_2011.pdf .,Non-OADS,/arxiv_data1/oa_pdf/06/6a/40268_2014_Article_54.PMC4153964.pdf
http://www.health.kr/images/ insert_pdf/IN_A11AGGGGA5812_00.pdf .,Non-OADS,/arxiv_data1/oa_pdf/06/6a/40268_2014_Article_54.PMC4153964.pdf
Available from: http://www.samhsa.gov/data/2k13/dawn073/ sr073-add-adhd-medications.htm .,Non-OADS,/arxiv_data1/oa_pdf/c4/11/40268_2014_Article_58.PMC4153965.pdf
Oxford Centre for Evidence-based Medicine—Levels of Evidence 1; 2009. http://www.cebm.net/index.aspx?o=1025 .,Non-OADS,/arxiv_data1/oa_pdf/86/a6/40273_2014_Article_169.PMC4153967.pdf
The Oxford Levels of Evidence 2; 2013. http://www.cebm.net/index.aspx?o= 5653 .,Non-OADS,/arxiv_data1/oa_pdf/86/a6/40273_2014_Article_169.PMC4153967.pdf
SEER Stat Fact Sheets: oral cavity and pharynx cancer; 2013. http://seer.cancer.gov/statfacts/html/oralcav.html .,OADS,/arxiv_data1/oa_pdf/86/a6/40273_2014_Article_169.PMC4153967.pdf
ERBITUX /C210(cetuximab) website; 2013. http://www.erbitux.com/ main.aspx .,OADS,/arxiv_data1/oa_pdf/86/a6/40273_2014_Article_169.PMC4153967.pdf
Statistics Sweden (2009) Utbildningsnivå efter kommun och kön 2011. http://www.scb.se/Pages/ ProductTables____9575.aspx .,OADS,/arxiv_data1/oa_pdf/ca/82/520_2014_Article_2279.PMC4153973.pdf
Available from: http://www.cancer.org/Cancer/BreastCancer/ DetailedGuide/breast‑cancer‑keystatistics [Last accessed on 2013  Oct 14].,Non-OADS,/arxiv_data1/oa_pdf/19/ef/JMP-39-169.PMC4154185.pdf
"Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________________________________________________________________________ 1.MScin Rehabilitation Management, Rehabilitation Management Department, School of Rehabilitation Sciences, Iran University of Med ical Sciences, Tehran, Iran .azamsharifi.2000@gmail.com 2.",Non-OADS,/arxiv_data1/oa_pdf/b1/4d/mjiri-28-16.PMC4154271.pdf
2 8.16.26Feb2014http://mjiri.iums.ac.irwanted and hence look after their essential needs.,Non-OADS,/arxiv_data1/oa_pdf/b1/4d/mjiri-28-16.PMC4154271.pdf
"2 8.16.26Feb2014 http://mjiri.iums.ac.irquestions and selected topics .After each interview, the researcher converted the re c- orded remarks to the written texts as sen- tences,phrasesand quotations, so i t could beused to evaluate people’s experiences and level of understanding various phe- nomenons .Inthe next step, theresearcher usedimportant phrases toclassify the meanings which lead to achieving the sub- themes.Thesubthemes also were used for writingwhat participants had experienced in thethemecover.Finally, themes were placed in a cover of wider range asdomain.",Non-OADS,/arxiv_data1/oa_pdf/b1/4d/mjiri-28-16.PMC4154271.pdf
"2 8.16.26Feb2014http://mjiri.iums.ac.irkindness and love is different, brother is different, sister is different but this disabil- ityaffected us morally, because they have already been limitedtochoose a partner ...",Non-OADS,/arxiv_data1/oa_pdf/b1/4d/mjiri-28-16.PMC4154271.pdf
2 8.16.26Feb2014 http://mjiri.iums.ac.irreally feel lack of emotional behavior.,Non-OADS,/arxiv_data1/oa_pdf/b1/4d/mjiri-28-16.PMC4154271.pdf
"2 8.16.26Feb2014http://mjiri.iums.ac.irceptance, access to urban facilities , labor, education andsupportive organization that constitute major and important dimensions of these people lives ,wereplacedin do- main ofsocial needs .Thesupportandac- companying by others theme has been r e- ported by some researchers .",Non-OADS,/arxiv_data1/oa_pdf/b1/4d/mjiri-28-16.PMC4154271.pdf
"2 8.16.26Feb2014 http://mjiri.iums.ac.irgrams and services that might focus on achieving positive outcomes for people with disabilities, such as increasing ind e- pendency, employment opportunities and integration within the comm unity (30) .",Non-OADS,/arxiv_data1/oa_pdf/b1/4d/mjiri-28-16.PMC4154271.pdf
2 8.16.26Feb2014http://mjiri.iums.ac.irwithsufficient incomes.Somealsopointed to theneed for employment at home.,Non-OADS,/arxiv_data1/oa_pdf/b1/4d/mjiri-28-16.PMC4154271.pdf
"2 8.16.26Feb2014 http://mjiri.iums.ac.ir7.OriadiZanjani,M.Cerebral palsy from the standpoint of, speech and language pathology.",Non-OADS,/arxiv_data1/oa_pdf/b1/4d/mjiri-28-16.PMC4154271.pdf
2 8.16.26Feb2014http://mjiri.iums.ac.iratrics.,Non-OADS,/arxiv_data1/oa_pdf/b1/4d/mjiri-28-16.PMC4154271.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences __________________________________________________________________________________________ ______________ ____________ 1.,Non-OADS,/arxiv_data1/oa_pdf/af/6e/mjiri-28-4.PMC4154272.pdf
"2 8.4.16Feb2014http://mjiri.tums.ac.irly one-half of all US health care costs for asthma (4, 5).",Non-OADS,/arxiv_data1/oa_pdf/af/6e/mjiri-28-4.PMC4154272.pdf
"2 8.4.16Feb2014 http://mjiri.tums.ac.iradministration of corticosteroids, short ac t- ing beta-agonist and corticosteroid sprays and in cases of patients that were not r e- sponding, Aminophiline.",Non-OADS,/arxiv_data1/oa_pdf/af/6e/mjiri-28-4.PMC4154272.pdf
2 8.4.16Feb2014http://mjiri.tums.ac.ir(32.7%) male and 37 (67.3%) female p a- tients with a mean age of 54.96 (SD=17.54) years.,OADS,/arxiv_data1/oa_pdf/af/6e/mjiri-28-4.PMC4154272.pdf
"2 8.4.16Feb2014 http://mjiri.tums.ac.irDiscussion Many studies have evaluated factors rela t- ed to survival and mortality of asthmaticpatients, but this is one of a few studies to assess factors affecting duration of hospital stay among patients.",Non-OADS,/arxiv_data1/oa_pdf/af/6e/mjiri-28-4.PMC4154272.pdf
2 8.4.16Feb2014http://mjiri.tums.ac.ira recently published cohort multi -center study on 183 adult asthmatic patients showed that female gender is a risk factor for asthma -related hospitalization (18).,Non-OADS,/arxiv_data1/oa_pdf/af/6e/mjiri-28-4.PMC4154272.pdf
2 8.4.16Feb2014 http://mjiri.tums.ac.ir1659–1664.,Non-OADS,/arxiv_data1/oa_pdf/af/6e/mjiri-28-4.PMC4154272.pdf
Review Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/c2/10/mjiri-28-24.PMC4154273.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _____________________________________________________________________________________________________ _____________ __ 1.,Non-OADS,/arxiv_data1/oa_pdf/a1/51/mjiri-28-38.PMC4154274.pdf
2 8.38.1 June2014http://mjiri.iums.ac.irwhich requires laparotomy (7-9).,Non-OADS,/arxiv_data1/oa_pdf/a1/51/mjiri-28-38.PMC4154274.pdf
2 8.38.1 June2014 http://mjiri.iums.ac.irStatistical Analysis All data were analyzed using statistical program SPSS Ver.,OADS,/arxiv_data1/oa_pdf/a1/51/mjiri-28-38.PMC4154274.pdf
2 8.38.1 June2014http://mjiri.iums.ac.irand 60th day of follow up.,Non-OADS,/arxiv_data1/oa_pdf/a1/51/mjiri-28-38.PMC4154274.pdf
2 8.38.1 June2014 http://mjiri.iums.ac.ircies in patients on long -termambulatory peritoneal dialysis .,Non-OADS,/arxiv_data1/oa_pdf/a1/51/mjiri-28-38.PMC4154274.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/52/a9/mjiri-28-1.PMC4154275.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences __________________________ _____________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/0b/38/mjiri-28-36.PMC4154276.pdf
"2 8.36.21May2014http://mjiri.iums.ac.irIran(1,4).The prevalence of hypertension, diabetes, obesity and overweight in big ci t- ies in Iran was 14%, 13%, 27% and 2 0% respectively (1).",Non-OADS,/arxiv_data1/oa_pdf/0b/38/mjiri-28-36.PMC4154276.pdf
2 8.36.21May2014 http://mjiri.iums.ac.irdeaths.,Non-OADS,/arxiv_data1/oa_pdf/0b/38/mjiri-28-36.PMC4154276.pdf
2 8.36.21May2014http://mjiri.iums.ac.ires.,Non-OADS,/arxiv_data1/oa_pdf/0b/38/mjiri-28-36.PMC4154276.pdf
2 8.36.21May2014 http://mjiri.iums.ac.ir40.5% of samples had a normal BMI.,Non-OADS,/arxiv_data1/oa_pdf/0b/38/mjiri-28-36.PMC4154276.pdf
"2 8.36.21May2014http://mjiri.iums.ac.irhis/her colleagues’ study showed that the mean of BMI (SE) was 27.81 (0.22), 27.87 (0.16) and 27.99 (0.13) in 1999 -2000, 2001-2002 and 2003 -2004 respectively based on NHNES database (11).",OADS,/arxiv_data1/oa_pdf/0b/38/mjiri-28-36.PMC4154276.pdf
"2 8.36.21May2014 http://mjiri.iums.ac.ir(18)Singh and his/her colleagues’ study indicated that the prevalence of female and male prehypertension and hypertension in five Indian cities was 27.2%, 27.2%, 30.0 and 30.6% respectively (22).Ishikawa and his/her colleagues’ study s howed that the prevalence of the prevalence of normote n- sion, prehypertension and hypertension was 32.7%, 33.0% (34.8% in males and 31.8% in females), 34.3% (36.8% in males and 32.7% in females) respectively (23).",Non-OADS,/arxiv_data1/oa_pdf/0b/38/mjiri-28-36.PMC4154276.pdf
"2 8.36.21May2014http://mjiri.iums.ac.irConclusion Despite the low prevalence of hyperte n- sion in our samples, the high prevalence of prehypertension and overweight needs great attention.",Non-OADS,/arxiv_data1/oa_pdf/0b/38/mjiri-28-36.PMC4154276.pdf
"2 8.36.21May2014 http://mjiri.iums.ac.irGhosh S, De AK, et al.",Non-OADS,/arxiv_data1/oa_pdf/0b/38/mjiri-28-36.PMC4154276.pdf
"Case Report http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________________________________________________________________________ 1.Medical student, Iranian Center Of Neurological Research, Tehran University of Medical Sciences, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/c5/9a/mjiri-28-12.PMC4154277.pdf
"Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________________________________________________________________________ 1.Assistant Professor of Sports and Exercise Medicine,  Department of Sports Medicine,  Rasoul Akram Hospital, Iran University of Medical Science, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/b8/40/mjiri-28-26.PMC4154278.pdf
2 8.26.3May2014http://mjiri.iums.ac.irprevalence of poor posture and resultant neck pain.,Non-OADS,/arxiv_data1/oa_pdf/b8/40/mjiri-28-26.PMC4154278.pdf
2 8.26.3 May2014 http://mjiri.iums.ac.irof C7 and T7.,Non-OADS,/arxiv_data1/oa_pdf/b8/40/mjiri-28-26.PMC4154278.pdf
"2 8.26.3May2014http://mjiri.iums.ac.irDiscussion The results of the present study show that among 203 office workers who was wor k- ing with computers, the prevalence of neck and shoulder pain was 36.7 % and 9.3 % respectively.",Non-OADS,/arxiv_data1/oa_pdf/b8/40/mjiri-28-26.PMC4154278.pdf
2 8.26.3 May2014 http://mjiri.iums.ac.irnificant difference compared to Ariens's work.,Non-OADS,/arxiv_data1/oa_pdf/b8/40/mjiri-28-26.PMC4154278.pdf
"2 8.26.3May2014http://mjiri.iums.ac.irReferences 1.Fejer R, Kyvik KO, Hartvigsen J.",OADS,/arxiv_data1/oa_pdf/b8/40/mjiri-28-26.PMC4154278.pdf
2 8.26.3 May2014 http://mjiri.iums.ac.irneck pain.,Non-OADS,/arxiv_data1/oa_pdf/b8/40/mjiri-28-26.PMC4154278.pdf
"Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________________________________________________________________________ 1.PhD Student of Exercise Physiology, Exercise Physiology Department, Mazandaran University, Mazandaran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/69/99/mjiri-28-6.PMC4154279.pdf
2 8.6.17 Feb2014http://mjiri.iums.ac.irhand omega -6 fatty acids consumption can lead to tissue damage and susceptibility for inflammatory disease.,Non-OADS,/arxiv_data1/oa_pdf/69/99/mjiri-28-6.PMC4154279.pdf
2 8.6.17 Feb2014 http://mjiri.iums.ac.irand pellet chow containing of calcium and phosphorus.,Non-OADS,/arxiv_data1/oa_pdf/69/99/mjiri-28-6.PMC4154279.pdf
"2 8.6.17 Feb2014http://mjiri.iums.ac.ir(138±0.65pg/ml), and the minimum level belonged to the fourth sampling of the su p- plement group (76±0.65pg/ml; Fig .1.a).",OADS,/arxiv_data1/oa_pdf/69/99/mjiri-28-6.PMC4154279.pdf
"2 8.6.17 Feb2014 http://mjiri.iums.ac.irDiscussion The results of the present study show that fish oil supplement consumption accomp a- nied with incremental aerobic exercise si g- nificantly modulate inflammatory responseby suppressing IL -17, CRP and CK  that are usually increased following intensive exercise(16).",Non-OADS,/arxiv_data1/oa_pdf/69/99/mjiri-28-6.PMC4154279.pdf
"2 8.6.17 Feb2014http://mjiri.iums.ac.irry cytokines production is necessary for immune defence, but over production of these cytokines may lead to inf lammation and subsequently causing skeletal muscle damage, weakness and increased risk of infection (11).",Non-OADS,/arxiv_data1/oa_pdf/69/99/mjiri-28-6.PMC4154279.pdf
2 8.6.17 Feb2014 http://mjiri.iums.ac.irEightweeks of incremental aerobic trai n- ing in our training group increased the CRP level.,Non-OADS,/arxiv_data1/oa_pdf/69/99/mjiri-28-6.PMC4154279.pdf
"2 8.6.17 Feb2014http://mjiri.iums.ac.irsyndrome, and risk of coronary heart disease in women an d men  Atherosclerosis.",Non-OADS,/arxiv_data1/oa_pdf/69/99/mjiri-28-6.PMC4154279.pdf
Case Report http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________________________________________________________________________ 1-1.,Non-OADS,/arxiv_data1/oa_pdf/88/07/mjiri-28-10.PMC4154280.pdf
"Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________________________________________________________________________ 1.Associate Professor of Occupational Medicine, Iran University of Medical Sciences ,Department of Occupational Medicine and Occupational Medicine Rese arch Center (OMRC), Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/80/56/mjiri-28-3.PMC4154281.pdf
"2 8.3.12 Feb2014http://mjiri.tums.ac.irpharmaceutical and agricultural production plants, printing industries and laundries, and also as a result of their con tinual con- tact with paints, adhesives and detergents.",Non-OADS,/arxiv_data1/oa_pdf/80/56/mjiri-28-3.PMC4154281.pdf
2 8.3.12 Feb2014 http://mjiri.tums.ac.irWe studied 510 cases.,Non-OADS,/arxiv_data1/oa_pdf/80/56/mjiri-28-3.PMC4154281.pdf
"2 8.3.12 Feb2014http://mjiri.tums.ac.irAccording to this questionnaire, if it co n- tained 4 positive answers or more for the workers younger than 28 -year old and 6 positive answers or more for the 28 -year old workers or older, then the respondent was supposed to be suffering from neur o- behavioral disorders (8).",Non-OADS,/arxiv_data1/oa_pdf/80/56/mjiri-28-3.PMC4154281.pdf
"2 8.3.12 Feb2014 http://mjiri.tums.ac.irand non-exposed groups for some questions of the questionnaire including amnesia in others’ opinions, feeling of chest pressure, note-taking due to paramnesia, frequent review, and once a week headaches.",Non-OADS,/arxiv_data1/oa_pdf/80/56/mjiri-28-3.PMC4154281.pdf
"2 8.3.12 Feb2014http://mjiri.tums.ac.irdepends on the duration and the severity of exposure to the solvents and also to the time past from the last exposure (13, 14, 15).",Non-OADS,/arxiv_data1/oa_pdf/80/56/mjiri-28-3.PMC4154281.pdf
2 8.3.12 Feb2014 http://mjiri.tums.ac.irtudinal study to explore chronic neuropsychologic effects on solvent exposed workers.,Non-OADS,/arxiv_data1/oa_pdf/80/56/mjiri-28-3.PMC4154281.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/3e/2a/mjiri-28-5.PMC4154282.pdf
2 8.5.16Feb2014http://mjiri.tums.ac.irdiscussed in the groups.,Non-OADS,/arxiv_data1/oa_pdf/3e/2a/mjiri-28-5.PMC4154282.pdf
2 8.5.16Feb2014 http://mjiri.tums.ac.irsession that was pertinent to the eight next sessions.,Non-OADS,/arxiv_data1/oa_pdf/3e/2a/mjiri-28-5.PMC4154282.pdf
"2 8.5.16Feb2014http://mjiri.tums.ac.irResults The average of student scores after 8 teaching sessions by conventional lectures was 11.99 (SD=1.44, Min=10.0, Max=15.5) out of 20.",Non-OADS,/arxiv_data1/oa_pdf/3e/2a/mjiri-28-5.PMC4154282.pdf
"2 8.5.16Feb2014 http://mjiri.tums.ac.irtions, and it was 0.921(p< 0.001).",OADS,/arxiv_data1/oa_pdf/3e/2a/mjiri-28-5.PMC4154282.pdf
2 8.5.16Feb2014http://mjiri.tums.ac.irof this scale were selected among the bene- fits that were discussed for active learning in literature (Appendix 1).,Non-OADS,/arxiv_data1/oa_pdf/3e/2a/mjiri-28-5.PMC4154282.pdf
"2 8.5.16Feb2014 http://mjiri.tums.ac.irabove 80 percent is appropriate and accept able and confirms the content validity of the self-assessment scale (14,15).Another important characteristic of the each que s- tionnaire is its reliability.",Non-OADS,/arxiv_data1/oa_pdf/3e/2a/mjiri-28-5.PMC4154282.pdf
"2 8.5.16Feb2014http://mjiri.tums.ac.ir2008, 28 (3): 165 -71.",Non-OADS,/arxiv_data1/oa_pdf/3e/2a/mjiri-28-5.PMC4154282.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/78/9a/mjiri-28-19.PMC4154283.pdf
"2 8.19.9Mar2014http://mjiri.iums.ac.irbe visualized but without capability of any diagnostic or therapeutic interventions (2, 3); also, there are several studies suggesting the low sensitivity of capsule endosco py in finding solitary and/or mass lesions (4, 5).",Non-OADS,/arxiv_data1/oa_pdf/78/9a/mjiri-28-19.PMC4154283.pdf
2 8.19.9Mar2014 http://mjiri.iums.ac.irgression analysis was used to identify pr e- dictors of final diagnosis.,OADS,/arxiv_data1/oa_pdf/78/9a/mjiri-28-19.PMC4154283.pdf
"2 8.19.9Mar2014http://mjiri.iums.ac.irin 12 cases (46.2%), followed by polyps in 5 (19.2%), stenosis in 4 (15.4%), mass in 3 (11.5%), and telangiect asia and divertic u- lum in 1 case (3.8%) each.",Non-OADS,/arxiv_data1/oa_pdf/78/9a/mjiri-28-19.PMC4154283.pdf
2 8.19.9Mar2014 http://mjiri.iums.ac.irno significant difference regarding t he la- boratory and imaging results between these centers before DBE procedure.,Non-OADS,/arxiv_data1/oa_pdf/78/9a/mjiri-28-19.PMC4154283.pdf
2 8.19.9Mar2014http://mjiri.iums.ac.irnical details and early experience in 6 U.S. tertiary care centers.,Non-OADS,/arxiv_data1/oa_pdf/78/9a/mjiri-28-19.PMC4154283.pdf
Case Report http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/49/09/mjiri-28-22.PMC4154284.pdf
"Case Report http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________________________________________________________________________ 1.Assistant Professor, Lung Transplantation Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRI TLD), Sh a- hid Beheshti University of Medical Sciences, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/29/28/mjiri-28-23.PMC4154285.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/9a/db/mjiri-28-8.PMC4154286.pdf
"Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.Community and Preventive Medicine Specialist, Center for Academic and Health Policy, Tehran University of Medical Sciences, T ehran, Iran.lalehghadirian@yahoo.com 2.",Non-OADS,/arxiv_data1/oa_pdf/60/f5/mjiri-28-32.PMC4154287.pdf
"2 8.32.10 May2014http://mjiri.iums.ac.irand educational system and it is clear that they are not independent from each other and the community as a whole, thus a m u- tual relationship should be considered (5).",Non-OADS,/arxiv_data1/oa_pdf/60/f5/mjiri-28-32.PMC4154287.pdf
"2 8.32.10 May2014 http://mjiri.iums.ac.irmary abo ut the necessity of the project for interviewees, obtaining permission to re c- ord the interview with the emphasis on pr i- vacy, emphasis on the fact that the inte r- viewees are able to reject the interview in any step, and final results would be sent to the interviewees, if they want.",Non-OADS,/arxiv_data1/oa_pdf/60/f5/mjiri-28-32.PMC4154287.pdf
"2 8.32.10 May2014http://mjiri.iums.ac.irskills"" and ""lack of communication knowledge and skills.""",Non-OADS,/arxiv_data1/oa_pdf/60/f5/mjiri-28-32.PMC4154287.pdf
2 8.32.10 May2014 http://mjiri.iums.ac.irfor students was another challenge me n- tioned by most participants.,Non-OADS,/arxiv_data1/oa_pdf/60/f5/mjiri-28-32.PMC4154287.pdf
2 8.32.10 May2014http://mjiri.iums.ac.irResearch deputy No.,Non-OADS,/arxiv_data1/oa_pdf/60/f5/mjiri-28-32.PMC4154287.pdf
2 8.32.10 May2014 http://mjiri.iums.ac.irvision quali ty and students' skills develo p- ment(17).,Non-OADS,/arxiv_data1/oa_pdf/60/f5/mjiri-28-32.PMC4154287.pdf
2 8.32.10 May2014http://mjiri.iums.ac.irUnavailability of the supervisor due to having executive position or involvement in multiple activities was another problem.,Non-OADS,/arxiv_data1/oa_pdf/60/f5/mjiri-28-32.PMC4154287.pdf
2 8.32.10 May2014 http://mjiri.iums.ac.irran University of Medical Sciences & health Services grant (number 91 -03-74- 18682).,Non-OADS,/arxiv_data1/oa_pdf/60/f5/mjiri-28-32.PMC4154287.pdf
Available from: URL:http://www.jcu.,Non-OADS,/arxiv_data1/oa_pdf/60/f5/mjiri-28-32.PMC4154287.pdf
Available from: URL: http://hca.ltsn.ac.uk/assets/York /documents/ourwork /research/surveys/pres/PR ES Executive Summary.,OADS,/arxiv_data1/oa_pdf/60/f5/mjiri-28-32.PMC4154287.pdf
Available from: URL : http://auqa.edu.au/auqf/ 2004/proceedings/AUQF 2 004_Proceedings.pdf .,OADS,/arxiv_data1/oa_pdf/60/f5/mjiri-28-32.PMC4154287.pdf
URLhttp://ijme.mui.ac.ir/browse.php?a_code=A - 175-1-10&slc_lang=fa&sid= 1.,OADS,/arxiv_data1/oa_pdf/60/f5/mjiri-28-32.PMC4154287.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/1b/4d/mjiri-28-2.PMC4154288.pdf
"2 8.2.12 Feb2014http://mjiri.iums.ac.irhealth, and social research repertoire has practically used social well -being in lieu of social health (2).According to the defin i- tion presented by World Health Organiz a- tion (WHO), “health” is a state of complete physical, mental, and social well -being and not merely the absence of disease or infi r- mity(3).",Non-OADS,/arxiv_data1/oa_pdf/1b/4d/mjiri-28-2.PMC4154288.pdf
"2 8.2.12 Feb2014 http://mjiri.iums.ac.irstudies, has developed scales for measuring social health in an individual level within our county.",Non-OADS,/arxiv_data1/oa_pdf/1b/4d/mjiri-28-2.PMC4154288.pdf
2 8.2.12 Feb2014http://mjiri.iums.ac.irrate as 0.15; error type one as 5%; error type 2 as 20%; response rate as 80%; and study design effect as 1.5.,OADS,/arxiv_data1/oa_pdf/1b/4d/mjiri-28-2.PMC4154288.pdf
"2 8.2.12 Feb2014 http://mjiri.iums.ac.irIn the quantitative stage, there was a sa m- pling population with 778 samples (i.e.",Non-OADS,/arxiv_data1/oa_pdf/1b/4d/mjiri-28-2.PMC4154288.pdf
2 8.2.12 Feb2014http://mjiri.iums.ac.irject assessed the remained questions and confirmed that content validity would be met with little changes.,Non-OADS,/arxiv_data1/oa_pdf/1b/4d/mjiri-28-2.PMC4154288.pdf
"2 8.2.12 Feb2014 http://mjiri.iums.ac.irDiscussion In this study, a new social health que s- tionnaire was developed that was consisted of three main factors, including family, friends and relatives, and community, each has 6, 8 and 19 questions, respectively.",Non-OADS,/arxiv_data1/oa_pdf/1b/4d/mjiri-28-2.PMC4154288.pdf
"2 8.2.12 Feb2014http://mjiri.iums.ac.irproaches are almost self -administered; however, a limited number of the a p- proaches are fulfilled using an interv iew and interviewer’s judgment.",Non-OADS,/arxiv_data1/oa_pdf/1b/4d/mjiri-28-2.PMC4154288.pdf
"2 8.2.12 Feb2014 http://mjiri.iums.ac.irtal Health Statistics Improvement Program Co n- sumer Survey (MHSIP), Community Ment Health J, 2010; 47(4):454 –462.",Non-OADS,/arxiv_data1/oa_pdf/1b/4d/mjiri-28-2.PMC4154288.pdf
Available from: http://www.who.int/ about/definition/en/print.html (12.19.2012).,Non-OADS,/arxiv_data1/oa_pdf/1b/4d/mjiri-28-2.PMC4154288.pdf
Available on: http://ir.uiowa.edu/etd/730.,Non-OADS,/arxiv_data1/oa_pdf/1b/4d/mjiri-28-2.PMC4154288.pdf
"Case Report http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________________________________________________________________________ 1.MD, Assistant Professor of Neurology, Department of Neurology, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran.",Non-OADS,/arxiv_data1/oa_pdf/fa/fd/mjiri-28-33.PMC4154289.pdf
Available from:http://www.neurologyindia.com/text.asp?199 9/47/1/78/1650 .,Non-OADS,/arxiv_data1/oa_pdf/fa/fd/mjiri-28-33.PMC4154289.pdf
Case Report http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/6f/8a/mjiri-28-35.PMC4154290.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4f/59/nihms616557.PMC4154351.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, seven figures, four tables, and three movies and can be  found with this article online at http://dx.doi.org/10.1016/j.celrep.2014.07.024 .",OADS,/arxiv_data1/oa_pdf/4f/59/nihms616557.PMC4154351.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a8/79/ldu021.PMC4154397.pdf
"More details on these databases can be found here http://www.crd.york.ac.uk/ CRDWeb/AboutPage.asp (5 August 2014, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/a8/79/ldu021.PMC4154397.pdf
2003. http://www.fda.gov/medicaldevices/safety/alertsandnotices/ucm197339.htm.,Non-OADS,/arxiv_data1/oa_pdf/82/df/e2014.00202.PMC4154403.pdf
2006. http://www.figo.org/publications/staging classifications /H11001.,Non-OADS,/arxiv_data1/oa_pdf/99/85/e2014.00215.PMC4154407.pdf
"2011. http://www.R-project.org.January 17 th, 2013.",Non-OADS,/arxiv_data1/oa_pdf/99/85/e2014.00215.PMC4154407.pdf
Available at: http://www.cdc.gov/nchs/nhds/nhds_tables.htm#detailed.,OADS,/arxiv_data1/oa_pdf/0d/85/e2014.00231.PMC4154410.pdf
Available at:http://www.2cog.org/CREOG.,Non-OADS,/arxiv_data1/oa_pdf/0d/85/e2014.00231.PMC4154410.pdf
Available at: http://www.apgo.org/faculty/scholars-program/surgical-scholars-electrosurgery/313.html.,Non-OADS,/arxiv_data1/oa_pdf/da/98/e2014.00293.PMC4154422.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 The joint service manual of the Law of Armed Con ﬂict.,Non-OADS,/arxiv_data1/oa_pdf/17/cf/jramc-2013-000177.PMC4154587.pdf
"Information on the candidate genes at qSH3 was obtained from RAP-DB (IRGSP-1.0, Rice Annotation Project, http://rapdb.dna.affrc.go.jp/) (Sakai et al.",OADS,/arxiv_data1/oa_pdf/4f/c5/64_199.PMC4154608.pdf
"DNA was extracted according to the experimental protocols of the Rice Genome Project (RGP) (http://rgp.dna.affrc.go.jp/E/rgp/protocols/index.html, written in Japanese) with some modifications.",OADS,/arxiv_data1/oa_pdf/1b/e2/64_222.PMC4154611.pdf
"2010,  http://www.shigen.nig.ac.jp/rice/oryzabaseV4/blast/search) and two Indica cultivars, ‘93-11’ and ‘PA64’, in the Rice In-formation System (Zhao et al.",Non-OADS,/arxiv_data1/oa_pdf/1b/e2/64_222.PMC4154611.pdf
"2004, http://rise2.genomics.org.cn/page/rice/index.jsp).",OADS,/arxiv_data1/oa_pdf/1b/e2/64_222.PMC4154611.pdf
URL: http://mapdisto.free.fr/.,Non-OADS,/arxiv_data1/oa_pdf/1b/e2/64_222.PMC4154611.pdf
http://statgen.ncsu.edu/qtlcart/WQTLCart.htm.,OADS,/arxiv_data1/oa_pdf/b6/6e/64_231.PMC4154612.pdf
"The global com-mercial apple production was more than 75 Mt in 2011 (FAOSTAT, http://faostat.fao.org).",Non-OADS,/arxiv_data1/oa_pdf/05/15/64_240.PMC4154613.pdf
"In Japan, apple is also a major crop, with gross production  exceeded only by those of rice, tomato, orange, strawberry, cucumber, and welsh onion (Ministry of Agriculture, Forest-ry and Fisheries, http://www.maff.go.jp/j/tokei/index.html).",Non-OADS,/arxiv_data1/oa_pdf/05/15/64_240.PMC4154613.pdf
These statistical analyses were carried out us- ing the PASW software (http://www.spss.com.hk/statistics/)  or the R software (http://www.r-project.org/).,OADS,/arxiv_data1/oa_pdf/05/15/64_240.PMC4154613.pdf
"(2002) MDAJ, U50187SSR http://www.hidras.unimi.it/index.php MEST Moriya et al.",OADS,/arxiv_data1/oa_pdf/05/15/64_240.PMC4154613.pdf
"2008), M. truncatula  (release 3.5 version 4:  http://www.medicago.org/genome/), and Glycine max   (Glyma1; Schmutz et al.",OADS,/arxiv_data1/oa_pdf/e5/0e/64_252.PMC4154614.pdf
The EST contigs and sin­ glets were classified into KOG categories according to the results of BLASTX searches with an E-value cutoff of 1e-10 against amino acid sequences in the KOG database (http://www.ncbi.nlm.nih.gov/COG/) (Tatusov et al.,OADS,/arxiv_data1/oa_pdf/e5/0e/64_252.PMC4154614.pdf
"In the former case, the data were analyzed using Polyans software (http://www.polyans.kazusa.or.jp).",OADS,/arxiv_data1/oa_pdf/e5/0e/64_252.PMC4154614.pdf
The identi ­ fied syntenic regions were plotted using the Cicros program (http://circos.ca).,OADS,/arxiv_data1/oa_pdf/e5/0e/64_252.PMC4154614.pdf
"The details of the designed faba bean EST­SSR primers, along with the corresponding SSR motif,  product size, and primer sequence, are available at http://marker.kazusa.or.jp/Faba_bean.",OADS,/arxiv_data1/oa_pdf/e5/0e/64_252.PMC4154614.pdf
"TAIR for Arabidopsis thaliana  (http://Breeding Science 64: 264–271 (2014)   doi:10.1270/jsbbs.64.264 Note Kazusa Marker DataBase: a database for genomics, genetics, and molecular  breeding in plants Kenta Shirasawa, Sachiko Isobe, Satoshi Tabata and Hideki Hirakawa* Department of Plant Genome Research, Kazusa DNA Research Institute , Kisarazu, Chiba 292-0818, Japan In order to provide useful genomic information for agronomical plants, we have established a database, the  Kazusa Marker DataBase (http://marker.kazusa.or.jp).",OADS,/arxiv_data1/oa_pdf/da/d0/64_264.PMC4154615.pdf
"In addition, there are also data - bases integrating the information for several plant species,  such as the Gramene database for cereal plant species (http://www.gramene.org), the Sol Genomics Network (SGN) for the Solanaceae family (http://solgenomics.net), and VegMarks for seven species of vegetables analyzed in the NARO Institute of Vegetable and Tea Sciences (http://vegmarks.nivot.affrc.go.jp).",OADS,/arxiv_data1/oa_pdf/da/d0/64_264.PMC4154615.pdf
"In this paper, we introduce the Kazusa Marker DataBase (http://marker.kazusa.or.jp), which provides information on DNA markers, genetic linkage and physical maps developed in the Kazusa DNA Research Institute, for crops and other plant species to enrich the available molecular genetic infor - mation on agronomical plants.",OADS,/arxiv_data1/oa_pdf/da/d0/64_264.PMC4154615.pdf
"The MySQL (http://dev.mysql.com) system, which is a relational database management system, was employed for management of the database contents.",OADS,/arxiv_data1/oa_pdf/da/d0/64_264.PMC4154615.pdf
"Most of the contents of this database were written using html text format and Ruby on Rails (RoR), the open-source web frame-work (http://rubyonrails.org).",OADS,/arxiv_data1/oa_pdf/da/d0/64_264.PMC4154615.pdf
"The SSR markers, 7,599 EST-SSR (TES) and 13,501 genome-   SSR (TGS) designed from EST and BAC-end sequences available from a public database (http://solgenomics.net), respectively, were developed to construct an interspecific high-density genetic linkage map (Shirasawa et al.",OADS,/arxiv_data1/oa_pdf/da/d0/64_264.PMC4154615.pdf
"In addition, we have established a portal website for to- mato genomics, KatomicsDB (Shirasawa and Hirakawa 2013: http://www.kazusa.or.jp/tomato/), because our group provides not only information on the DNA markers and ge-netic maps as described above but also inferences of SNP effects on gene functions and sequence data of gene-rich re-gions in the tomato genome.",OADS,/arxiv_data1/oa_pdf/da/d0/64_264.PMC4154615.pdf
2013a: http://plant1.kazusa.,OADS,/arxiv_data1/oa_pdf/da/d0/64_264.PMC4154615.pdf
"or.jp/tomato/), and a database for genome sequences of se-lected BAC clone mixtures in gene-rich regions (http://www.kazusa.or.jp/tomato_sbm/).",OADS,/arxiv_data1/oa_pdf/da/d0/64_264.PMC4154615.pdf
"A total of 5,751 CaES markers were designed from the 118,060 EST sequences for Capsicum annuum obtained  from a public DNA database, GenBank (http://www.ncbi.nlm.nih.gov).",OADS,/arxiv_data1/oa_pdf/da/d0/64_264.PMC4154615.pdf
2008: http://www.kazusa.or.jp/lotus/).,Non-OADS,/arxiv_data1/oa_pdf/da/d0/64_264.PMC4154615.pdf
"A total of 6,920 EST-SSR markers were developed from 63,676 publicly available non-redundant soybean ESTs from public databases (Dana-Farber Center Institute; http://compbio.dfci.harvard.edu/tgi/).",OADS,/arxiv_data1/oa_pdf/da/d0/64_264.PMC4154615.pdf
2011: http://www.kazusa.or.jp/ eucaly/).,Non-OADS,/arxiv_data1/oa_pdf/da/d0/64_264.PMC4154615.pdf
"2011) among the plant species registered in  the Kazusa Marker DataBase at the time of writing, genome sequences for the other species would be determined in near future with the cooperation of the NGSs as summarized in Genomes OnLine Database (http://www.genomesonline.org).",OADS,/arxiv_data1/oa_pdf/da/d0/64_264.PMC4154615.pdf
"To overcome the prob-lem, an integrated database of the plant genome-related information, i.e., PGDBj (http://pgdbj.jp), has been estab-lished (Asamizu et al.",OADS,/arxiv_data1/oa_pdf/da/d0/64_264.PMC4154615.pdf
http://www.uic.edu/classes/pmpr/pmp r652/final/bressler/painmang.hmtl#1  3.,Non-OADS,/arxiv_data1/oa_pdf/50/87/pharmpract-05-099.PMC4154742.pdf
"Available  at: http://www.ACPE_Revised_PharmD_Standards _Adopted_Jan152006.pdf (accessed on March 10, 2006).",Non-OADS,/arxiv_data1/oa_pdf/e7/36/pharmpract-05-109.PMC4154744.pdf
"Available at:  http://www.who.int/mediacentre (accessed Sep 28,2006).",Non-OADS,/arxiv_data1/oa_pdf/ef/25/pharmpract-05-125.PMC4154746.pdf
"https://www.hpsc.ie/hpsc/A-Z/ Gastroenteric/ViralGastroenteritis/Publications/File,1194,en.pdf2004.",Non-OADS,/arxiv_data1/oa_pdf/64/49/coidi-27-437.PMC4154788.pdf
Available at: http://www.myhealthywaist.org/cmrejournal/articles/vol2/v2i1a5.,Non-OADS,/arxiv_data1/oa_pdf/39/96/coedo-21-345.PMC4154790.pdf
"Such docu - ments are pivotal in obtaining accurate in - formation, data pooling and/or comparisons  across countries (http://www.mapi-research.",Non-OADS,/arxiv_data1/oa_pdf/63/6e/MEJDD-2-84.PMC4154829.pdf
Available  at: http://www.mapi-research.fr/i_02_meth.htm.,OADS,/arxiv_data1/oa_pdf/63/6e/MEJDD-2-84.PMC4154829.pdf
"*Source:  Iran national population and housing census, 2006,  http://www.sci.org.ir/portal/faces/public/sci_en , reproduced from Merat et al.29     Subjects   Samples  Percent  Percent  Meanage±S d  interviewed  randomly    male    rural          (years)       selected Tehran 2561 789 (55.4%) 39.7% 2.7% 35.3±13.3 Golestan 2035 634 (44.6%) 34.4% 37.1% 4.1±12.8 Total 4596 1423 (100%) 37.3% 18.0% 37.9±13.4table 2:  Characteristics of study participants.",OADS,/arxiv_data1/oa_pdf/2e/b6/MEJDD-2-97.PMC4154831.pdf
For the ADNI investigators data used in the preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging Ini- tiative (ADNI) database (http://www.loni.ucla.edu \ADNI).,OADS,/arxiv_data1/oa_pdf/92/20/wad-27-168.PMC4154837.pdf
A full list of ADNI investigators is available at: http://adni.loni.ucla.edu/wp-content/ uploads/how_to_apply/ADNI_Authorship_List.pdf.,Non-OADS,/arxiv_data1/oa_pdf/92/20/wad-27-168.PMC4154837.pdf
Private sector contributions to ADNI arefacilitated by the Foundation for the National Institutes of Health (http://www.fnih.org).,Non-OADS,/arxiv_data1/oa_pdf/92/20/wad-27-168.PMC4154837.pdf
"Details are available at http://www.adni-info.org.Written informed consent was obtained, as approved by theInstitutional Review Board, at each of the participating centers.",Non-OADS,/arxiv_data1/oa_pdf/92/20/wad-27-168.PMC4154837.pdf
ADNI inclusion and exclusion criteria are detailed elsewhere (http://adni.loni.ucla.edu/wp-content/uploads/2010/09/ADNI_GeneralProceduresManual.pdf).,Non-OADS,/arxiv_data1/oa_pdf/92/20/wad-27-168.PMC4154837.pdf
"Subjects were included in the current study if theyhad 1.5 T scans available at the baseline and 12 months (n = 335), which were downloaded from the LONI website (http://www.loni.ucla.edu/ADNI).",Non-OADS,/arxiv_data1/oa_pdf/92/20/wad-27-168.PMC4154837.pdf
MRI Acquisition Details can be found elsewhere (http://adni.loni.ucla.,Non-OADS,/arxiv_data1/oa_pdf/92/20/wad-27-168.PMC4154837.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/89/f0/bctt-6-145.PMC4154879.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pBreast Cancer: Targets and Therapy 2014:6 145–150Breast Cancer: Targets and Therapy Correspondence: Potchavit Aphinives   Department of Surgery, Faculty of  Medicine, Khon Kaen University, 123  Moo 16, Mittraphap Road, Tambon Muang,  Khon Kaen 40002, Thailand   Email potchavit@gmail.co mDove press submit your manuscript | www.dovepress.co m Dove press  145ORiginAl RESEARChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S6755 3Effects of switching from anastrozole   to letrozole, due to reimbursement policy,   on the outcome of breast cancer therapy Potchavit Aphinives Damnern Vachirodom Chaiyut Thanapaisal Dhanes Rangsrikajee Ongart Somintara Department of Surgery, Faculty of  Medicine, Khon Kaen University,   ThailandBackground:  Endocrine therapy is one of the standard treatments for estrogen-receptor-positive  breast cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/89/f0/bctt-6-145.PMC4154879.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast-cancer---targets-and-therapy-journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/89/f0/bctt-6-145.PMC4154879.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e2/40/dddt-8-1161.PMC4154880.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 1161–1167Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1161Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/DDDT .S6623 6effect of administration of water enriched in O2  by injection or electrolysis on transcutaneous  oxygen pressure in anesthetized pigs antoine charton1  François Péronnet2 stephane Doutreleau3 evelyne lonsdorfer3  alexis Klein4  liliana Jimenez4 Bernard geny3 Pierre Diemunsch1 ruddy richard5 1Department of anesthesia and  critical care, and ea 3072, hôpital de  hautepierre; University of strasbourg,   strasbourg, France; 2Department of  Kinesiology, Université de Montréal,   Montreal, Qc , canada; 3chr U of  strasbourg, Physiology and Functional  explorations Department, new civil  hospital, strasbourg, France and  University of strasbourg, Faculty of  Medicine, Physiology Department,   strasbourg, France; 4Danone research,   Palaiseau, France; 5Department  of sport Medicine and Functional  explorations, chU clermont-Ferrand  and inra UM r 1019, crnh- auvergne, clermont-Ferrand, France correspondence: antoine charton   service d’anesthésie-réanimation,  hôpital de hautepierre, 1 avenue  Molière, cP 67000, strasbourg, France   Tel +33 388 127 076   Fax +33 388 127 074   email antoine.charton@chru-strasbourg.f rBackground:  Oral administration of oxygenated water has been shown to improve blood  oxygenation and could be an alternate way for oxygen (O2) supply.",Non-OADS,/arxiv_data1/oa_pdf/e2/40/dddt-8-1161.PMC4154880.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/e2/40/dddt-8-1161.PMC4154880.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e2/40/dddt-8-1161.PMC4154880.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b9/9c/dmso-7-391.PMC4154881.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014:7 391–400Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  391Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S4889 8Treating the elderly diabetic patient:   special considerations Louise Kezerle Leah Shalev Leonid Barski Department of internal Medicine F ,   Soroka University Medical Center,   Beer-Sheva, israel Correspondence: Leonid Barski   Department of internal Medicine F,  Soroka University Medical Center,  PO Box  151, Beer-Sheva  84101, israel   Tel +972 8 640 3431  Fax +972 8 640 0097  email lbarski@bgu.ac.i lAbstract:  The prevalence of diabetes is rising in the .65 year-old group.",Non-OADS,/arxiv_data1/oa_pdf/b9/9c/dmso-7-391.PMC4154881.pdf
"Available from: http://www.cdc.gov/diabetes/pubs/pdf/ ndfs_2011.pd f. Accessed January 20, 2014.",Non-OADS,/arxiv_data1/oa_pdf/b9/9c/dmso-7-391.PMC4154881.pdf
"Available from: http://www.fda.gov/Drugs/ DrugSafety/ ucm376389.ht m. Assessed May  10, 2014.",Non-OADS,/arxiv_data1/oa_pdf/b9/9c/dmso-7-391.PMC4154881.pdf
"Available from: http://www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements/ucm345848.ht m. Accessed May  22, 2014.",Non-OADS,/arxiv_data1/oa_pdf/b9/9c/dmso-7-391.PMC4154881.pdf
"Available from: http://www.fda.gov/NewsEvents/ Newsroom /PressAnnouncements/ucm380829.ht m. Accessed May  22,   2014.",Non-OADS,/arxiv_data1/oa_pdf/b9/9c/dmso-7-391.PMC4154881.pdf
Available from: http://www.fda.gov/Drugs/ DrugSafety/ P ostmarketDrugSafetyInformationforPatientsandProviders/ucm124713.,Non-OADS,/arxiv_data1/oa_pdf/b9/9c/dmso-7-391.PMC4154881.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/b9/9c/dmso-7-391.PMC4154881.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b9/9c/dmso-7-391.PMC4154881.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ef/69/opth-8-1595.PMC4154882.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1595–1602Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1595Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OPTH.S6913 3a survey of potential and previous cataract-surgery  patients: what the ophthalmologist should know Bonnie an henderson1 Kerry solomon2 samuel Masket3 richard Potvin4 edward J holland5 robert Cionni6 helga sandoval2 1Ophthalmic Consultants of Boston,   Boston, M a, 2Carolina eyecare  research institute, Carolina eyecare  Physicians, Mount Pleasant, sC,   3advanced Vision Care, los angeles,   Ca, 4science in Vision, akron, nY,   5Cincinnati eye institute, Cincinnati,   Oh, 6eye institute of Utah, salt lake  City, UT, Usa Correspondence: Kerry solomon   Carolina eyecare research institute,  Carolina eyecare Physicians,   1101 Clarity rd., suite 100,   Mount Pleasant, sC 29464, Usa   Tel +1 843 881 3937   Fax +1 843 375 1487   email kerry.solomon@carolinaeyecare.co mJournal name: Clinical Ophthalmology Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Henderson et al Running head recto: Vision and cataract surgery: a patient perspective DOI: http://dx.doi.org/10.2147/OPTH.S69133 Objective:  This study utilized a phone survey to characterize patient perceptions of cataract  surgery and the manner in which the ophthalmologist contributes to the patient’s understanding  in electing cataract surgery.",Non-OADS,/arxiv_data1/oa_pdf/ef/69/opth-8-1595.PMC4154882.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/ef/69/opth-8-1595.PMC4154882.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1602henderson et al have been accepted or published.,Non-OADS,/arxiv_data1/oa_pdf/ef/69/opth-8-1595.PMC4154882.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/21/66/dddt-8-1175.PMC4154883.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 1175–1181Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1175Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6871 5remote ischemic conditioning improves   coronary microcirculation in healthy subjects   and patients with heart failure Yasushi Kono1 shota Fukuda1 akihisa hanatani2 Koki nakanishi2 Kenichiro Otsuka2 haruyuki Taguchi1 Kenei shimada2 1Department of Medicine, Osaka  ekisaikai hospital, Osaka, Japan;   2Department of internal Medicine and  cardiology, Osaka city University  school of Medicine, Osaka, Japan correspondence: shota Fukuda   Department of Medicine, Osaka ekisaikai  hospital,  2-1-10 honden, nishi-ku,   Osaka 550-0022, Japan   Tel +81 6 6581 2881  Fax +81 6 6584 1807  email h-syouta@mve.biglobe.ne.j pBackground:  Remote ischemic conditioning (RIC) is a treatment modality that suppresses  inflammation and improves endothelial function, which are factors involved in the pathogen - esis of heart failure (HF) with reduced left ventricular ejection fraction.",Non-OADS,/arxiv_data1/oa_pdf/21/66/dddt-8-1175.PMC4154883.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/21/66/dddt-8-1175.PMC4154883.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/21/66/dddt-8-1175.PMC4154883.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/17/fa/cia-9-1425.PMC4154884.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 1425–1436Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1425OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S6538 1Kaycee M sink1 Mark A espeland2 Julia rushing2 Cynthia M Castro3 Timothy s Church4 ronald Cohen5 Thomas M gill6 leora henkin2 Janine M Jennings7 Diana r Kerwin8 T odd M Manini5 Valerie Myers9 Marco Pahor5 Kieran F reid10 nancy Woolard1 stephen r rapp11 Jeff D Williamson1 On behalf of lIFe Investigators 1Department of Internal Medicine, section on  gerontology and geriatric Medicine, sticht  Center on Aging, Wake Forest school of Medicine,   Winston-salem, nC, UsA; 2Department   of Biostatistical sciences, Wake Forest school   of Medicine, Winston-salem, nC, UsA; 3stanford  Prevention research Center, stanford University  school of Medicine, stanford, CA, UsA;   4Pennington Biomedical, louisiana state University,   Baton rouge, lA, UsA; 5Institute on Aging and  Department of Aging and geriatric research,   University of Florida, gainesville, Fl, UsA; 6Yale  school of Medicine, Department of Internal  Medicine, new haven, CT, UsA; 7Department   of Psychology, Wake Forest University, Winston- salem, nC, UsA; 8T exas Alzheimer’s and Memory  Disorders, Texas health Presbyterian hospital  Dallas, TX, UsA; 9Klein Buendel, Inc., golden,   CO, UsA; 10nutrition, exercise Physiology and  sarcopenia laboratory, Jean Mayer United states  Department of Agriculture human nutrition  research Center on Aging, T ufts University,    Boston, MA, UsA; 11Department of Psychiatry   and Behavioral Medicine, Wake Forest school   of Medicine, Winston-salem, nC, UsA Correspondence: Kaycee M sink   sticht Center on Aging, Wake Forest  school of Medicine, One Medical Center  Blvd, Winston salem, nC 27157, UsA   T el +1 336 713 8560   email kmsink@wakehealth.eduThe lIFe Cognition study: design and baseline  characteristics Abstract:  Observational studies have shown beneficial relationships between exercise and cog - nitive function.",Non-OADS,/arxiv_data1/oa_pdf/17/fa/cia-9-1425.PMC4154884.pdf
"In human and animal studies, exercise has been shown to have  beneficial effects on growth factors such as brain-derived neurotrophic factor, neu - rogenesis, resistance to brain insult, perfusion, connectivity, the promotion of gene  expression fostering brain plasticity,1–5 and brain volume.6–9 Exercise has also been  shown to decrease beta-amyloid plaques in transgenic Alzheimer’s mice.10 In addi - tion to biologic data, there are considerable epidemiologic data to support a beneficial  relationship between exercise and cognition.11–13 For example, Y affe et al found that  among 5,925 community-dwelling older women, those who reported higher baseline  physical activity (PA) (blocks walked per week) had significantly less cognitive  decline over the next 8 years.11 Several small randomized controlled trials (RCTs)  have demonstrated improvements in executive function and memory in response to Journal name: Clinical Interventions in Aging Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Sink et al Running head recto: The LIFE Cognition Study DOI: http://dx.doi.org/10.2147/CIA.S65381",Non-OADS,/arxiv_data1/oa_pdf/17/fa/cia-9-1425.PMC4154884.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lDove pres s Clinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/17/fa/cia-9-1425.PMC4154884.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/17/fa/cia-9-1425.PMC4154884.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b4/56/opth-8-1591.PMC4154885.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1591–1594Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1591Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OPTH.S6803 7retinal breaks due to intravitreal ocriplasmin ruwan a silva Darius M Moshfeghi Theodore Leng Byers eye institute at stanford,   stanford University school of  Medicine, Palo alto, C a, Usa Correspondence: Theodore Leng   Byers eye institute at stanford, stanford  University school of Medicine, 2452  Watson Ct, Palo alto, Ca 94303, Usa   Tel +1 650 498 4264   Fax +1 888 565 2640   email tedleng@stanford.ed uJournal name: Clinical Ophthalmology Journal Designation: Case Series Y ear: 2014 Volume: 8 Running head verso: Silva et al Running head recto: Retinal breaks due to intravitreal ocriplasmin DOI: http://dx.doi.org/10.2147/OPTH.S68037 Abstract:  Ocriplasmin represents a new treatment option for numerous vitreoretinopathies  involving an abnormal vitreomacular interface.",Non-OADS,/arxiv_data1/oa_pdf/b4/56/opth-8-1591.PMC4154885.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/b4/56/opth-8-1591.PMC4154885.pdf
"Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1594silva et al to inducing vitreous liquefaction, ocriplasmin produces  complete separation of the vitreous cortex from the internal  limiting membrane.10 This has, in fact, previously been cited  as one of the advantages of ocriplasmin’s use over surgical  PVD induction, which was deemed less favorable in yielding  incomplete cortical removal from the retinal surface with  the consequent potential for fibrocellular proliferation and  vitreoretinal traction.11,12 Anomalous PVD formation has,  however, previously been implied in ocriplasmin-treated eyes  which eventually underwent vitrectomy as surgeons report - edly encountered intraoperative vitreoschisis and continued  vitreoretinal adhesion in these eyes.2 While it is not surprising  that an anomalous PVD occurs in ocriplasmin treated eyes  which suffer treatment failure, our cases are notable in that  the vitreomacular traction was successfully relieved, yet both  patients still suffered an anomalous PVD, and consequently,  retinal breaks.",Non-OADS,/arxiv_data1/oa_pdf/b4/56/opth-8-1591.PMC4154885.pdf
"JETREA (ocriplasmin): US prescribing information   http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/  125422s000lbl.pd f. Accessed May 1, 2014.",Non-OADS,/arxiv_data1/oa_pdf/b4/56/opth-8-1591.PMC4154885.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3e/8e/cia-9-1437.PMC4154886.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 1437–1452Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1437RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/CIA.S6669 0Stephen Martinkovich* Darshan Shah* Sonia Lobo Planey John A Arnott Department of Basic Sciences, The  Commonwealth Medical College,   Scranton, PA, USA *These authors contributed equally  to this work Correspondence: John A Arnott   Department of Basic Sciences, The  Commonwealth Medical College,   525 Pine Street, Scranton, PA 18509 USA   T el +1 570 504 9675   Fax +1 570 504 9660   email jarnott@tcmedc.or gSelective estrogen receptor modulators: tissue  specificity and clinical utilityJournal name: Clinical Interventions in Aging Journal Designation: Review Y ear: 2014 Volume: 9 Running head verso: Martinkovich et al Running head recto: SERM s: tissue specificity and clinical utility DOI: http://dx.doi.org/10.2147/CIA.S66690 Abstract:  Selective estrogen receptor modulators (SERMs) are a diverse group of  nonsteroidal  compounds that function as agonists or antagonists for estrogen receptors (ERs) in a target  gene-specific and tissue-specific fashion.",Non-OADS,/arxiv_data1/oa_pdf/3e/8e/cia-9-1437.PMC4154886.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lDove pres s Clinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/3e/8e/cia-9-1437.PMC4154886.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/3e/8e/cia-9-1437.PMC4154886.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3c/ed/ijgm-7-425.PMC4154887.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of General Medicine 2014:7 425–432International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  425OrIGInal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJGM.S5516 9cerebral responses to innocuous somatic pressure   stimulation following aerobic exercise rehabilitation   in chronic pain patients: a functional magnetic   resonance imaging study Peter s Micalos1 Mayuresh s Korgaonkar2 eric J Drinkwater3 Jack cannon3 Frank e Marino3 1school of Biomedical sciences,  charles sturt University, Bathurst,   2Brain Dynamics centre, Westmead  Millennium Institute, University  of sydney Medical school, sydney,   3school of human Movement studies,  charles sturt University, Bathurst,  nsW, australia correspondence: Peter s Micalos   school of Biomedical sciences, charles   sturt University, Panorama avenue,   Bathurst, nsW  2795, australia   Tel +61 2 6338 4505  Fax +61 2 6338 4993  email pmicalos@csu.edu.a uObjective:  The purpose of this research was to assess the functional brain activity and percep - tual rating of innocuous somatic pressure stimulation before and after exercise rehabilitation  in patients with chronic pain.",Non-OADS,/arxiv_data1/oa_pdf/3c/ed/ijgm-7-425.PMC4154887.pdf
Available  from: http://www.csep.ca/english/view.asp?x=69 8.,Non-OADS,/arxiv_data1/oa_pdf/3c/ed/ijgm-7-425.PMC4154887.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/3c/ed/ijgm-7-425.PMC4154887.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3c/ed/ijgm-7-425.PMC4154887.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5f/dc/copd-9-871.PMC4154888.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 871–888International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  871RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S4962 1epidemiology and clinical impact of major  comorbidities in patients with COPD Miranda Caroline Smith1 Jeremy P wrobel2 1Respiratory Medicine, Royal Perth  Hospital, Perth, wA, Australia;   2Advanced Lung Disease Unit, Royal  Perth Hospital, Perth, wA, Australia Correspondence: Jeremy P wrobel   Advanced Lung Disease Unit,   Royal Perth Hospital, wellington   Street Campus, Perth 6000,   wA, Australia   Tel +61 8 9224 8793   Fax +61 8 9224 3866   email jeremy.wrobel@health.wa.gov.a uAbstract:  Comorbidities are frequent in chronic obstructive pulmonary disease (COPD) and  significantly impact on patients’ quality of life, exacerbation frequency, and survival.",Non-OADS,/arxiv_data1/oa_pdf/5f/dc/copd-9-871.PMC4154888.pdf
Available from: http://www.goldcopd.org /.,Non-OADS,/arxiv_data1/oa_pdf/5f/dc/copd-9-871.PMC4154888.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/5f/dc/copd-9-871.PMC4154888.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5f/dc/copd-9-871.PMC4154888.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/84/bb/ppa-8-1135.PMC4154889.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 1135–1142Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1135Short rePortopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/ 10.2147/PPA.S6545 6Physicians’ interpersonal relationships  and professional standing seen through the eyes  of the general public in Croatia Marko Ćurković1 Milan Milošević2 Ana Borovečki3 Jadranka Mustajbegović2 1University Psychiatric hospital  Vrapče, Zagreb, Croatia; 2Department  of environmental and occupational  Health, School of Public Health  “Andrija Štampar,” University of  Zagreb, School of Medicine, Zagreb,   Croatia; 3Department of Social  Medicine and organization of health  Care, School of Public Health “Andrija  Štampar,” University of Zagreb, School  of Medicine, Zagreb, Croatia Correspondence: Marko Ćurković   University Psychiatric Hospital Vrapče,  Bolnička cesta 32, 10000 Zagreb, Croatia   tel +385 1 378 0666   Fax +385 1 348 3660   email markocurak@gmail.co m Journal name: Patient Preference and Adherence Journal Designation: Short Report Y ear: 2014 Volume: 8 Running head verso: C ´urkovi c´ et al Running head recto: Physicians’ professional standing in Croatia DOI: http://dx.doi.org/10.2147/PPA.S65456 Purpose:  Medical professionalism, as a cornerstone of medicine’s social contract with society,  demands physicians adhere to high professional standards while placing public interest ahead  of self-interest.",Non-OADS,/arxiv_data1/oa_pdf/84/bb/ppa-8-1135.PMC4154889.pdf
Available from: http://www.dzs.hr/Hrv_Eng/ publication/2012/14-01-03_01_2012.htm.,Non-OADS,/arxiv_data1/oa_pdf/84/bb/ppa-8-1135.PMC4154889.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/84/bb/ppa-8-1135.PMC4154889.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/37/fc/opth-8-1573.PMC4154890.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1573–1578Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1573Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S6616 0evaluation of cardiovascular biomarkers in patients  with age-related wet macular degeneration sadullah Keles1 Orhan ates1 Baki Kartal2  hamit hakan alp3  Metin ekinci4 erdinc Ceylan2  Osman Ondas5  eren arpali2  semih Dogan6  Kenan Yildirim7  Mevlut sait Keles8 1Department of Ophthalmology,   school of Medicine, ataturk  University, erzurum, T urkey;   2Department of Ophthalmology,   regional Training and research  hospital, erzurum, T urkey;   3Department of Biochemistry, school  of Medicine, Yuzuncu Yil University,   Van, T urkey; 4Department of  Ophthalmology, school of Medicine,   Kafkas University, Kars, T urkey;   5Department of Ophthalmology, erbaa  government hospital, T okat, T urkey;   6Department of Ophthalmology,   Kolan hospital, istanbul, T urkey;   7Department of Ophthalmology, Igdır  Government Hospital, Igdır, T urkey;   8Department of Biochemistry, school  of Medicine, ataturk University,   erzurum, T urkey Correspondence: sadullah Keles   Ophthalmology Department, Faculty   of Medicine, ataturk University,   25240, erzurum, Turkey   Tel +90 442 231 79 83   Fax +90 442 236 13 01   email opdr_sadullah@yahoo.co mJournal name: Clinical Ophthalmology Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Keles et al Running head recto: Pathogenesis of AMD is still unknown DOI: http://dx.doi.org/10.2147/OPTH.S66160 Aim:  To evaluate levels of homocysteine, asymmetric dimethylarginine (ADMA), and nitric  oxide (NO), as well as activity of endothelial NO synthase (eNOS), in patients with age-related  macular degeneration (AMD).",Non-OADS,/arxiv_data1/oa_pdf/37/fc/opth-8-1573.PMC4154890.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/37/fc/opth-8-1573.PMC4154890.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1578Keles et al  43.,Non-OADS,/arxiv_data1/oa_pdf/37/fc/opth-8-1573.PMC4154890.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/98/27/nsa-7-073.PMC4154891.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pNanotechnology, Science and Applications 2014:7 73–83Nanotechnology, Science and Applications Dove press submit your manuscript | www.dovepress.co m Dove press  73Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NSA.S5110 1Prevention of bacterial foodborne disease   using nanobiotechnology Craig Billington J Andrew Hudson elaine D’Sa Food Safety Programme, eSR,    ilam, Christchurch, New Zealand Correspondence: J Andrew Hudson   Food Safety Programme,   eSR, PO Box 29-181, ilam,   Christchurch 8540, New Zealand   Tel +64 3 351 0099   Fax +64 3 351 0010   email andrew.hudson@esr.cri.n zAbstract:  Foodborne disease is an important source of expense, morbidity, and mortality for  society.",Non-OADS,/arxiv_data1/oa_pdf/98/27/nsa-7-073.PMC4154891.pdf
An example of this is a   “performance-tested method” by AOAC Research Institute   (http://goo.gl/413U6 y).,Non-OADS,/arxiv_data1/oa_pdf/98/27/nsa-7-073.PMC4154891.pdf
"Nanotechnology, Science and Applications Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/nanotechnology-science-and-applications-journa lNanotechnology, Science and Applications is an international, peer- reviewed, open access journal that focuses on the science of nanotech - nology in a wide range of industrial and academic applications.",Non-OADS,/arxiv_data1/oa_pdf/98/27/nsa-7-073.PMC4154891.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e8/ae/ott-7-1487.PMC4154892.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 1487–1496OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1487Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OTT .S6549 6The involvement of Kras gene  3′-UTr   polymorphisms in risk of cancer and influence   on patient response to anti-egFr therapy in  metastatic colorectal cancer: a meta-analysis hou-Qun Ying1,2 Feng Wang2 Bang-shun he2 Yu-Qin Pan2 Tian-Yi gao2 Ye-Qiong Xu2 rui li2 Qi-Wen Deng2 hui-lin sun2 shu-Kui Wang2 1Medical college, southeast  University, nanjing, Jiangsu, People’s  republic of china;  2central  laboratory, nanjing First hospital,   nanjing Medical University, nanjing,   Jiangsu, People’s republic of china correspondence: shu-Kui Wang   central laboratory, nanjing First  hospital, nanjing Medical University,   68 changle rd,  210006, nanjing,   People’s republic of china   Tel/fax +86 25 5288 7003  email shukuiwang@163.co mBackground:  Genetic variation of the Kras oncogene is a candidate factor for increasing suscepti - bility to carcinoma and modulating response of metastatic colorectal cancer (mCRC) patients treated  with anti-epidermal growth factor receptor monoclonal antibody (anti-EGFR).",Non-OADS,/arxiv_data1/oa_pdf/e8/ae/ott-7-1487.PMC4154892.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e8/ae/ott-7-1487.PMC4154892.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/ae/ott-7-1487.PMC4154892.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3c/19/opth-8-1579.PMC4154893.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1579–1590Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1579Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OPTH.S7116 2effect of dorzolamide/timolol combination  on the visual field in glaucoma sakurako Takeda1,2 Tatsuya Mimura1 Masao Matsubara1,2 1Department of Ophthalmology,   Tokyo Women’s Medical University  Medical Center east, T okyo, Japan;   2Department of Ophthalmology,   nippori Clinic, Medical Center east,   T okyo Women’s Medical University,   T okyo, JapanPurpose:  To evaluate the effect of treatment for 3 years with a dorzolamide/timolol (1%/0.5%)  fixed combination (DTFC) on visual field progression in patients with open-angle glaucoma.",Non-OADS,/arxiv_data1/oa_pdf/3c/19/opth-8-1579.PMC4154893.pdf
"Combination therapy is expected to improve compliance and convenience for  patients because it achieves fewer doses, lower costs, and fewer adverse effects because Correspondence: Tatsuya Mimura  Department of Ophthalmology,   Tokyo Women’s Medical University  Medical Center east, Tokyo, Japan,  2-1-10, nishiogu, arakawa-ku,   Tokyo 116-8567, Japan  Tel +81 3 3810 1111, extension 7765   Fax +81 3 3894 0282   email mimurat-tky@umin.ac.j p Journal name: Clinical Ophthalmology Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Takeda et al Running head recto: Visual fields in glaucoma after switching to dorzolamide/timolol DOI: http://dx.doi.org/10.2147/OPTH.S71162",Non-OADS,/arxiv_data1/oa_pdf/3c/19/opth-8-1579.PMC4154893.pdf
Available  from: http://www.eugs.org/eng/EGS_guidelines.asp.,Non-OADS,/arxiv_data1/oa_pdf/3c/19/opth-8-1579.PMC4154893.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journalClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/3c/19/opth-8-1579.PMC4154893.pdf
Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1590Takeda et al  21.,Non-OADS,/arxiv_data1/oa_pdf/3c/19/opth-8-1579.PMC4154893.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/aa/1b/copd-9-889.PMC4154894.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 889–905International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  889OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S6275 0Management of COPD in the UK primary-care  setting: an analysis of real-life prescribing patterns David Price1 Daniel West2 guy Brusselle3–5 Kevin gruffydd-Jones6 rupert Jones7 Marc Miravitlles8 andrea rossi9 Catherine hutton2 Valerie l ashton2 rebecca stewart2 Katsiaryna Bichel2 1Centre of academic Primary Care,   University of aberdeen, aberdeen, UK;   2research in real-life ltd, Cambridge,   UK; 3Department of respiratory  Medicine, ghent University hospital,   ghent, Belgium;  4Department of  epidemiology,  5Department of  respiratory Medicine, erasmus  Medical Center, rotterdam, the  netherlands;  6Box surgery, Wiltshire,   UK; 7Centre for Clinical Trials and  health research – Translational  and stratified Medicine, Plymouth  University Peninsula schools of  Medicine and Dentistry, Plymouth  UK; 8Department of Pneumology,   hospital Universitari Vall d’hebron,   Ciber de enfermedades respiratorias  (CIBeres), Barcelona, spain;   9Pulmonary Unit, Cardiovascular and  Thoracic Department, University and  general hospital, Verona, Italy Correspondence: David Price   Centre of academic Primary Care,   University of aberdeen, Polwarth   Building, Foresterhill, aberdeen   aB25  2ZD, UK   Tel +44 208 123 3923  Fax +44 808 280 0792  email david@rirl.or gBackground:  Despite the availability of national and international guidelines, evidence suggests  that chronic obstructive pulmonary disease (COPD) treatment is not always prescribed accord - ing to recommendations.",Non-OADS,/arxiv_data1/oa_pdf/aa/1b/copd-9-889.PMC4154894.pdf
Available from:  http://www.goldcopd.or g/uploads/users/files/GOLD_Report_2014.pdf.,OADS,/arxiv_data1/oa_pdf/aa/1b/copd-9-889.PMC4154894.pdf
Available from: http://www.nice.org.uk/ guidance/CG10 1.,Non-OADS,/arxiv_data1/oa_pdf/aa/1b/copd-9-889.PMC4154894.pdf
Available from: http://www.goldcopd.or g/uploads/users/files/ GOLDReport07_0108.pdf.,Non-OADS,/arxiv_data1/oa_pdf/aa/1b/copd-9-889.PMC4154894.pdf
"Available from: http://bma.org.uk/practical- support-at-work/contracts/independent-contractors/qof-guidanc e.  Accessed June  18, 2014.",Non-OADS,/arxiv_data1/oa_pdf/aa/1b/copd-9-889.PMC4154894.pdf
Available from:  http://www.goldcopd.or g/uploads/users/files/GOLD_Report_2013_ Feb20.pdf.,OADS,/arxiv_data1/oa_pdf/aa/1b/copd-9-889.PMC4154894.pdf
Available from: http://www.mult-sclerosis.org/news/May2001/ HarrisPollPwMSundertreated .html.,Non-OADS,/arxiv_data1/oa_pdf/aa/1b/copd-9-889.PMC4154894.pdf
"available from http://www.goldcopd.or g.1 Abbreviations: CaT,  COPD assessment Test; COPD, chronic obstructive pulmonary disease; FeV1, forced expiratory volume in  1 second; gOlD, global Initiative for  Chronic Obstructive Lung Disease; mMRC, modified Medical Research Council.",Non-OADS,/arxiv_data1/oa_pdf/aa/1b/copd-9-889.PMC4154894.pdf
"available from http://www.goldcopd.or g.1 Abbreviation: mMrC,  modified Medical Research Council.",Non-OADS,/arxiv_data1/oa_pdf/aa/1b/copd-9-889.PMC4154894.pdf
Available from:  http://www.goldcopd.or g/uploads/users/files/GOLD_Report_2014.pdf.,OADS,/arxiv_data1/oa_pdf/aa/1b/copd-9-889.PMC4154894.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/aa/1b/copd-9-889.PMC4154894.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/aa/1b/copd-9-889.PMC4154894.pdf
"*Source: Iran national population and housing census, 2006,  http://www.sci.org.ir/portal/faces/public/sci_en, reproduced from Merat et al.11  Participants interviewed Number valid Samples collected Percent male Percent rural Mean age±SD (yr) Tehran  2561 2561 2290 41.5% 5.1% 35.6 ± 13.6 Hormozgan 1987 1745 1403 44.6% 0% 33.4 ± 11.9 Golestan 2035 1896 1896 32.0% 48.2% 38.8 ± 12.9 Total 6583 6202 5589 39.3% 18.4% 36.1 ± 13.1Table 2:  Demographic data of the study population.NASH in Iran",OADS,/arxiv_data1/oa_pdf/b9/21/MEJDD-2-14.PMC4154901.pdf
"Elattar I. Website of the National Cancer Institute, Egypt:  http://www.nci.edu.eg.",Non-OADS,/arxiv_data1/oa_pdf/8f/f9/MEJDD-2-31.PMC4154905.pdf
Available from: http://www.iranica.com; Accessed  31.1.2010.,Non-OADS,/arxiv_data1/oa_pdf/05/53/MEJDD-2-51.PMC4154910.pdf
REFERENCES 1. http://www.who.int/healthinfo/global_burden_disease/ GBD_report_2004update_part2.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/bd/c5/MEJDD-3-103.PMC4154912.pdf
http://www.apregistry.com/forms/apr_report_106.pdf.,OADS,/arxiv_data1/oa_pdf/e3/0f/MEJDD-3-92.PMC4154922.pdf
"AGA core curriculum 2007 revision, http://www.gastro.",Non-OADS,/arxiv_data1/oa_pdf/73/50/MEJDD-3-35.PMC4154927.pdf
"The Adult Gastroenterology and Hepatology Curriculum,  Ministry of Health and Medical Education, Islamic Re - public of Iran, http://cgme.behdasht.gov.ir, 2008 version 13.",Non-OADS,/arxiv_data1/oa_pdf/73/50/MEJDD-3-35.PMC4154927.pdf
[Available at: <http://www.gastro.org/wmspage.cfm?,Non-OADS,/arxiv_data1/oa_pdf/ad/cc/MEJDD-3-44.PMC4154928.pdf
(Source: http://en.wikipedia.org) Fig.,Non-OADS,/arxiv_data1/oa_pdf/83/51/MEJDD-3-74.PMC4154935.pdf
"PBCs can therefore be cultured directly after being obtained from Regeneration through autologous hypoxia preconditioned plasma Ektoras Hadjipanayi1,2 and Arndt F Schilling1,3,* 1Experimental Plastic Surgery; Clinic for Plastic and Hand Surgery; Klinikum Rechts der Isar, Technische Universität München; Munich, Germany;   2Department of Plastic, Reconstructive, Hand and Burn Surgery; Bogenhausen Hospital; Munich, Germany; 3Center for Applied New Technologies in  Engineering for Regenerative Medicine (Canter); Munich, Germany Keywords:  hypoxia, blood, plasma,  preconditioning, factors, angiogenesis, wound, ischaemia, therapy, regeneration Abbreviations:  VEGF, vascular  endothelial growth factor; MMPs,  matrix metalloproteinases; PF-4, platelet factor 4; TSP-1, thrombospondin 1; FGF, fibroblast growth factor; IL-8, interleukin-8 Correspondence to: AF Schilling;   Email: a.schilling@tum.de Submitted: 03/23/2014Accepted: 05/12/2014Published Online: 05/15/2014http://dx.doi.org/10.4161/org.29208 Comment on: Hadjipanayi E, Bauer AT, Moog  P , Salgin B, Kuekrek H, Fersch B, Hopfner U, Meissner T, Schlüter A, Ninkovic M, et al.",Non-OADS,/arxiv_data1/oa_pdf/3d/00/org-10-164.PMC4154949.pdf
J Control Release 2013; 169:91-102; PMID:23603614; http://dx.doi.org/10.1016/j.jconrel.2013.04.008,OADS,/arxiv_data1/oa_pdf/3d/00/org-10-164.PMC4154949.pdf
Organogenesis 2013; 9:261-72; PMID:23974216 ;  http://dx.doi.org/10.4161/org.25970 2.,Non-OADS,/arxiv_data1/oa_pdf/3d/00/org-10-164.PMC4154949.pdf
J Control Release   2010 ; 146:309-17; PMID:20538024 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3d/00/org-10-164.PMC4154949.pdf
Tissue Eng Part  A 2012 ; 18:2138 -47; PMID:22559333 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3d/00/org-10-164.PMC4154949.pdf
J Control Release   2012 ; 161:852-60; PMID:22634070 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3d/00/org-10-164.PMC4154949.pdf
Coron Artery Dis   1999 ; 10:427-30; PMID:10474795 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3d/00/org-10-164.PMC4154949.pdf
Respiration  2008 ;  75:328-38; PMID:18073453 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3d/00/org-10-164.PMC4154949.pdf
Arterioscler Thromb Vasc Biol   2007 ; 27:1426 -32; PMID:17363691 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3d/00/org-10-164.PMC4154949.pdf
Am J Pathol 2003 ; 163:1233 -43; PMID:14507633 ;  http://dx.doi.org/10.1016/S0002-9440(10)63483-9 11.,Non-OADS,/arxiv_data1/oa_pdf/3d/00/org-10-164.PMC4154949.pdf
J Transl  Med 2003 ; 1:6; PMID:14585103 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3d/00/org-10-164.PMC4154949.pdf
Clin Orthop Relat Res   2011 ; 469:3118 -26; PMID:21409457 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3d/00/org-10-164.PMC4154949.pdf
Immunobiology  2011 ; 216:832- 9; PMID:21281980 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/3d/00/org-10-164.PMC4154949.pdf
Basic Res Cardiol   2011 ; 106:1283 -97; PMID:21952733 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3d/00/org-10-164.PMC4154949.pdf
Cytokine  1999 ; 11:416- 23; PMID:10346981 ; http://dx.doi.org/10.1006/ cyto.1998.0444 16.,Non-OADS,/arxiv_data1/oa_pdf/3d/00/org-10-164.PMC4154949.pdf
J Cell Biol   1984 ; 99:1706 -15; PMID:6333426 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3d/00/org-10-164.PMC4154949.pdf
Cell Transplant   2010 ; 19:369-86; PMID:20021736 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3d/00/org-10-164.PMC4154949.pdf
Circulation  2006 ;  114(Suppl ):I94-100; PMID:16820652 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3d/00/org-10-164.PMC4154949.pdf
Cell Transplant   2009 ; 18:371-80; PMID:19500466 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3d/00/org-10-164.PMC4154949.pdf
J Diabetes  Complications  2012 ; 26:29-33; PMID:22240264 ;  http://dx.doi.org/10.1016/j.jdiacomp.2011.11.007 23.,Non-OADS,/arxiv_data1/oa_pdf/3d/00/org-10-164.PMC4154949.pdf
Circ J   2007 ; 71:1199 -207; PMID:17652881 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3d/00/org-10-164.PMC4154949.pdf
Eur J Vasc Surg 1994 ;  8:351-6; PMID:8013688 ; http://dx.doi.org/10.1016/ S0950-821X(05)80155-0 25.,OADS,/arxiv_data1/oa_pdf/3d/00/org-10-164.PMC4154949.pdf
Transfus Apher Sci 2004 ; 30:163- 7; PMID:15062757 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3d/00/org-10-164.PMC4154949.pdf
PLoS One   2009 ; 4:e5643 ; PMID:19479066 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3d/00/org-10-164.PMC4154949.pdf
J Appl Physiol (1985)   2009 ; 106:212-20; PMID:19008490 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3d/00/org-10-164.PMC4154949.pdf
Circulation   1999 ; 100:547-52; PMID:10430770 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3d/00/org-10-164.PMC4154949.pdf
Cell Mol Life Sci 2008 ; 65:177- 86; PMID:17994289 ; http://dx.doi.org/10.1007/ s00018-007-7356-8 33.,OADS,/arxiv_data1/oa_pdf/3d/00/org-10-164.PMC4154949.pdf
J Control Release   2011 ; 153:217-24; PMID:21458514 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3d/00/org-10-164.PMC4154949.pdf
J Cell Biol   1981 ; 88:358-63; PMID:6259179 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3d/00/org-10-164.PMC4154949.pdf
Am J Physiol  Cell Physiol  2010 ; 298:C1527 -37; PMID:20181925 ;  http://dx.doi.org/10.1152/ajpcell.00484.2009 39.,Non-OADS,/arxiv_data1/oa_pdf/3d/00/org-10-164.PMC4154949.pdf
PLoS One  2013 ; 8:e62507 ;  PMID:23671606 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/3d/00/org-10-164.PMC4154949.pdf
J Exp Med 2000 ; 191:1789 -98; PMID:10811871 ;  http://dx.doi.org/10.1084/jem.191.10.1789 41.,Non-OADS,/arxiv_data1/oa_pdf/3d/00/org-10-164.PMC4154949.pdf
J Cereb Blood Flow Metab 2006 ; 26:1519- 26; PMID:16570076 ; http://dx.doi.org/10.1038/ sj.jcbfm.9600304 42.,Non-OADS,/arxiv_data1/oa_pdf/3d/00/org-10-164.PMC4154949.pdf
J Biol Chem 2008 ; 283:13905 - 12; PMID:18347025 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/3d/00/org-10-164.PMC4154949.pdf
Eur Surg Res 2012 ; 49:35-43; PMID:22797712 ;  http://dx.doi.org/10.1159/000339613 47.,Non-OADS,/arxiv_data1/oa_pdf/3d/00/org-10-164.PMC4154949.pdf
"However, the use of certain types of tissue scaffold such as decel - lularized matrix might provide new insights into in vivo tissue alterations, because these are transplantable with efficient vas - culature and blood flow, and therefore amenable to long-term  Correspondence to: Hiroshi Yagi; Email: h_yagi@a3.keio.jp Submitted: 06/12/2014; Accepted: 06/12/2014; Published Online: 06/24/2014http://dx.doi.org/10.4161/org.29566Special Issue “Organ Replacement Approaches” Hiroshi Yagi department of s urgery; Keio University, s chool of Medicine; t okyo, Japan",Non-OADS,/arxiv_data1/oa_pdf/93/c8/org-10-194.PMC4154953.pdf
"12 At earlier stages,  hepatoblasts are identified as Dlk-1+EpCAM+ cells.13 Expression  of Dlk-1 on hepatoblasts is observed between E10 and 16 and *Correspondence to: Naoki Tanimizu; Email: tanimizu@sapmed.ac.jp Submitted: 11/21/2013; Revised: 12/12/2013; Accepted: 12/19/2013; Published Online: 01/22/2014; http://dx.doi.org/10.4161/org.27591Re-evaluation of liver stem/progenitor cells Naoki Tanimizu* and Toshihiro Mitaka Department of Tissue Development and Regeneration; Research i nstitute for Frontier Medicine; Sapporo Medical University School of Medicine; Sapporo, Japan Keywords:  liver progenitor cell, bipotential, hepatoblast, cholangiocyte, hepatocyte, oval cell Liver stem/progenitor cells (LPCs) are defined as cells  that supply two types of liver epithelial cells, hepatocytes  and cholangiocytes, during development, cellular turnover,  and regeneration.",Non-OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Cell 2013 ; 154:274-84;  PMID:23870119 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Development   2009 ; 136:1951 -60; PMID:19429791 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
"Gastroenterology  2009 ; 137:1114 -26, e1-14 ;  PMID:19524574 ; http://dx.doi.org/10.1053/j.",Non-OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Science  1997 ; 276:60-6;  PMID:9082986 ; http://dx.doi.org/10.1126/ science.276.5309.60 6.,OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Curr Biol  2012 ; 22:1166 -75; PMID:22658593 ;  http://dx.doi.org/10.1016/j.cub.2012.05.016 7.,OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Int J Biochem Cell Biol  2011 ; 43:173-9; PMID:19788929 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Hepatology  2014 ; 59:1617-26;  PMID :24115180 ; http://dx.doi.org/10.1002/ hep.26753 9.,Non-OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Hepatology  2005 ; 41:535-44; PMID:15726663 ;  http://dx.doi.org/10.1002/hep.20600 10.,Non-OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Genes Dev  2013 ; 27:719-24; PMID:23520387 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Science  1999 ; 284:1998 - 2003 ; PMID:10373120 ; http://dx.doi.org/10.1126/ science.284.5422.1998 12.,Non-OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
J Cell Sci  2003 ; 116:1775 - 86; PMID:12665558 ; http://dx.doi.org/10.1242/ jcs.00388 13.,OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Mech Dev  2009 ; 126:665-76; PMID:19527784 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
J Cell Biol 2002 ;  156:173-84; PMID:11781341 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Exp Cell Res  2002 ; 279:330-43; PMID:12243758 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Microsc Res Tech 1997 ; 39:328-35;  PMID:9407543 ; http://dx.doi.org/10.1002/ (SICI)1097-0029(19971115)39:4<328::AID-JEMT3>3.0.CO;2-D 18.,Non-OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
J Cell Sci  2004 ; 117:3165 -74; PMID :15226394 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Development  2009 ; 136:1727 -39; PMID:19369401 ;  http://dx.doi.org/10.1242/dev.029140 22.,Non-OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Hepatology  2008 ; 48:607- 16; PMID:18666240 ; http://dx.doi.org/10.1002/ hep.22381 23.,Non-OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Gastroenterology   2009 ; 136:2325 -33; PMID:19403103 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
J Cell Sci 2013 ; 126:5239 -46;  PMID:24046446 ; http://dx.doi.org/10.1242/ jcs.133082 26.,OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Mol Biol Cell  2012 ; 23:2845 -55; PMID:22696678 ;  http://dx.doi.org/10.1091/mbc.E12-02-0097 27.,Non-OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Nat Genet  2011 ; 43:34-41; PMID:21113154 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
J Clin Invest 2011 ;  121:4850 -60; PMID:22105172 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
"Gastroenterology  2012 ; 143:1564 , e7 ;  PMID:22922013 ; http://dx.doi.org/10.1053/j.",Non-OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Lab Invest 2009 ; 89:456-69;  PMID:19204666 ; http://dx.doi.org/10.1038/ labinvest.2009.6 32.,OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Semin Liver Dis 2002 ;  22:227-40; PMID:12360417 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Liver Int  2003 ;  23:449-59; PMID:14986819 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Am J Physiol Cell Physiol 2008 ; 295:C499 -513;  PMID:18508907 ; http://dx.doi.org/10.1152/ ajpcell.00369.2007 35.,Non-OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Nat Genet 2004 ; 36:83-7;  PMID:14702043 ; http://dx.doi.org/10.1038/ng1273 36.,OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Nat Rev Gastroenterol Hepatol  2012 ; 9:231-40;  PMID:22371217 ; http://dx.doi.org/10.1038/ nrgastro.2012.23 37.,Non-OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Hepatology  1992 ; 16:440-7; PMID:1386334 ;  http://dx.doi.org/10.1002/hep.1840160224 39.,Non-OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Hepatology  1999 ; 29:111-25; PMID:9862857 ;  http://dx.doi.org/10.1002/hep.510290103,Non-OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Pathol Res Pract 1995 ; 191:513- 24; PMID:7479372 ; http://dx.doi.org/10.1016/ S0344-0338(11)80870-8 41.,Non-OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Carcinogenesis  1996 ; 17:2143 -51;  PMID:8895481 ; http://dx.doi.org/10.1093/ carcin/17.10.2143 46.,Non-OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Gene Expr Patterns 2004 ; 5:209-18;  PMID :15567716 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Hepatology  1998 ; 27:1030 -8;  PMID:9537443 ; http://dx.doi.org/10.1002/ hep.51027041950.,Non-OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Hepatology  2003 ; 37:632-40; PMID:12601361 ;  http://dx.doi.org/10.1053/jhep.2003.50104 52.,Non-OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Hepatology  2001 ; 34:519-22; PMID :11526537 ;  http://dx.doi.org/10.1053/jhep.2001.26751 53.,Non-OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Hepatology  2008 ; 48:1964 -78; PMID:18837044 ;  http://dx.doi.org/10.1002/hep.22558 54.,Non-OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Stem Cells Dev  2011 ; 20:2177 -88; PMID:21361791 ;  http://dx.doi.org/10.1089/scd.2010.0352 55.,Non-OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Nat Med   2012 ; 18:572-9; PMID:22388089 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Dev Dyn 2011 ; 240:521- 9; PMID:21312313 ; http://dx.doi.org/10.1002/ dvdy.22561 57.,OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Hepatology   2008 ; 47:1702 -13; PMID:18398918 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Am J Pathol 2005 ;  166:1077 -88; PMID:15793288 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
J Clin Invest 2012 ; 122:2911 - 5; PMID:22797301 ; http://dx.doi.org/10.1172/ JCI63212 63.,Non-OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
J Clin Invest 2012 ; 122:3914 -8;  PMID:23023701 ; http://dx.doi.org/10.1172/ JCI63065 64.,Non-OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Comp  Hepatol  2010 ; 9:9; PMID:21126359 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
J  Biol Chem  2012 ; 287:28586 -97; PMID:22761447 ;  http://dx.doi.org/10.1074/jbc.M112.350488 66.,OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
Hepatology  2012 ; 55:1215 -26; PMID:22095660 ;  http://dx.doi.org/10.1002/hep.24796,Non-OADS,/arxiv_data1/oa_pdf/08/ca/org-10-208.PMC4154955.pdf
"Conventional 3D Culturing for the Construction   of Liver Tissue Spheroid culture, based on spontaneous tissue formation It is widely recognized that culturing cells in 3D configu - rations better maintains their functions than culturing in 2D, Correspondence to: Ryo Sudo; Email: sudo@sd.keio.ac.jp Submitted: 11/11/2013; Revised: 01/20/2014; Accepted: 01/23/2014; Published Online: 02/05/2014; http://dx.doi.org/10.4161/org.27968Multiscale tissue engineering   for liver reconstruction Ryo Sudo Department of System Design e ngineering; Keio University; Yokohama, Japan Keywords:  3D culture, microfluidics, vascularization, tissue engineering Abbreviations:  2D, two-dimensional; 3D, three-dimensional; EC, endothelial cell; ECM, extracellular matrix; HSC, hepatic  stellate cell; MEMS, microelectromechanical system; PDMS, poly(dimethylsiloxane); SEC, sinusoidal endothelial cell The liver is a target of in vitro tissue engineering despite  its capability to regenerate in vivo.",Non-OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Science 1997; 276:60-6; PMID:9082986 ;  http://dx.doi.org/10.1126/science.276.5309.60 2.,Non-OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Am J Pathol 2010; 176:2-13; PMID:20019184 ;  http://dx.doi.org/10.2353/ajpath.2010.090675 3.,Non-OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Int J Exp Pathol 1998;  79:393-409;  PMID:10319020 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Nat Chem Biol 2013; 9:514-20; PMID:23728495 ;  http://dx.doi.org/10.1038/nchembio.1270 5.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Science  1993; 260:920-6;  PMID:8493529 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Science  2002; 295:1009-14;  PMID :11834815 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Sci Am 2009; 300:64-71;  PMID:19438051 ; http://dx.doi.org/10.1038/ scientificamerican0509-64 8.,Non-OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
IEEE Pulse 2011; 2:28- 34; PMID:22147066 ; http://dx.doi.org/10.1109/ MPUL.2011.942764 9.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Nat Rev Mol Cell Biol 2007; 8:839- 45; PMID:17684528 ; http://dx.doi.org/10.1038/ nrm2236 11.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
J Cell Biol  1985; 101:914-23;  PMID:2411740 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Exp Cell Res 1990; 186:227-35;  PMID:2298241 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Biomicrofluidics 2011; 5:22205;  PMID:21799712 ;  http://dx.doi.org/10.1063/1.3576905 15.,Non-OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Tissue  Eng Part A 2009; 15:2029-37; PMID:19320555 ;  http://dx.doi.org/10.1089/ten.tea.2008.040316.,Non-OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Cytotechnology 2004; 45:125-40;  PMID:19003250 ;  http://dx.doi.org/10.1007/s10616-004-7996-6 17.,Non-OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Biomaterials 2012; 33:2693-700;  PMID:22236830 ;  http://dx.doi.org/10.1016/j.biomaterials.2011.12.039 19.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Tissue Eng Part A 2012; 18:1045-56; PMID:22220631 ; http://dx.doi.org/10.1089/ten.,Non-OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
J Tissue Eng Regen Med 2012; In press; PMID:23086892 ; http://dx.doi.org/10.1002/ term.1630 .,Non-OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
J Biomed Mater Res 2002; 62:464-70; PMID:12209933 ; http://dx.doi.org/10.1002/ jbm.10228 22.,Non-OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Biomaterials 2012; 33:1406-13; PMID:22118777 ;  http://dx.doi.org/10.1016/j.biomaterials.2011.10.084 23.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Tissue Eng 2006; 12:1553-63; PMID:16846351 ;  http://dx.doi.org/10.1089/ten.2006.12.1553 24.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Tissue Eng 2004; 10:833-40; PMID :15265301 ;  http://dx.doi.org/10.1089/1076327041348301 25.,Non-OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Annu Rev Biomed Eng 2001; 3:335- 73; PMID:11447067 ; http://dx.doi.org/10.1146/ annurev.bioeng.3.1.335 26.,Non-OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Annu Rev Biomed Eng 2000; 2:227- 56; PMID :11701512 ; http://dx.doi.org/10.1146/ annurev.bioeng.2.1.227 28.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Proc Natl Acad Sci U S A 2007; 104:5722-6;  PMID:17389399 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Nat Biotechnol  2008; 26:120-6;  PMID:18026090 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Biomed Microdevices 2002; 4:167-75; http://dx.doi.org/10.1023/A:1016040212127 31.,Non-OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Nature 2006; 442:403-11;  PMID:16871208 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Bioessays 2008; 30:811-21; PMID:18693260 ;  http://dx.doi.org/10.1002/bies.20804 33.,Non-OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Int J Mol Sci 2009; 10:5411-41; PMID:20054478 ;  http://dx.doi.org/10.3390/ijms10125411 34.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Lab Chip 2007; 7:681-94;  PMID:17538709 ; http://dx.doi.org/10.1039/ b704602b 36.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Biomed Microdevices 2003; 5:109-14;  http://dx.doi.org/10.1023/A:1024583026925 37.,Non-OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Biotechnol Prog 2004; 20:750-5; PMID :15176878 ; http://dx.doi.org/10.1021/ bp0300568 38.,Non-OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Biomed Microdevices 2008; 10:795- 805; PMID:18604585 ; http://dx.doi.org/10.1007/ s10544-008-9194-3 39.,Non-OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Biotechnol Bioeng  2007; 97:1340-6;  PMID:17286266 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Biomed Microdevices 2008; 10:117-21;  PMID:17682945 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Biomicrofluidics 2011; 5:22212;  PMID:21799718 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Lab Chip 2007; 7:302- 9; PMID:17330160 ; http://dx.doi.org/10.1039/ b614872g,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Lab Chip 2009; 9:2026- 35; PMID:19568671 ; http://dx.doi.org/10.1039/ b900912d 44.,Non-OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Lab Chip 2010; 10:3380-6;  PMID:21060907 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Ann Biomed Eng 2010; 38:1164-77;  PMID:20336839 ; http://dx.doi.org/10.1007/ s10439-010-9899-3 48.,Non-OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Biomicrofluidics 2011; 5:13406; PMID :21522496 ;  http://dx.doi.org/10.1063/1.3553237 49.,Non-OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
FASEB J 2009; 23:2155-64; PMID:19246488 ;  http://dx.doi.org/10.1096/fj.08-122820 50.,Non-OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Biomaterials 2012; 33:8304- 15; PMID:22906609 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Annu Rev Biomed  Eng 2011; 13:27-53; PMID:21417722 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Biomed Mater 2013; 8:014106; PMID:23353764 ;  http://dx.doi.org/10.1088/1748-6041/8/1/014106 53.,Non-OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Surg Today  2013; 43:587-94;  PMID:23184357 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Acta Biomater 2009; 5:1-13;  PMID:18938117 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Circulation 2006;  114(Suppl):I132-7;  PMID:16820562 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Med Eng Phys  2002; 24:173-83;  PMID:12062176 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
J Thorac Cardiovasc Surg 2005; 130:1010- 5; PMID:16214512 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Biomaterials 2004; 25:2679-86;  PMID:14751754 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
FASEB J 2003; 17:2250-6; PMID:14656987 ;  http://dx.doi.org/10.1096/fj.03-0257com 61.,Non-OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Lancet 2008; 372:2023- 30; PMID:19022496 ; http://dx.doi.org/10.1016/ S0140-6736(08)61598-6 62.,Non-OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Nat Med 2008; 14:213-21;  PMID:18193059 ; http://dx.doi.org/10.1038/ nm1684 63.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Nat Med 2010; 16:927- 33; PMID:20628374 ; http://dx.doi.org/10.1038/ nm.2193 65.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Semin Cell Dev Biol  2002; 13:377-83;  PMID:12324220 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Tissue Eng 2007; 13:2301-10; PMID:17561801 ; http://dx.doi.org/10.1089/ ten.2006.0437 69.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Hepatology 2011; 53:604-17; PMID:21274881 ;  http://dx.doi.org/10.1002/hep.24067 70.,Non-OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
J Surg Res 2012; 173:e11-25; PMID:22099595 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Cell Transplant  2013; 22:231-42;  PMID:22943797 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Cell Transplant 2011; 20:753-66;  PMID:21054928 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Biotechnol Bioeng 2002a; 78:257-69;  PMID:11920442 ; http://dx.doi.org/10.1002/ bit.10143 74.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Tissue Eng 2002b; 8:499-513;  PMID:12167234 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
FASEB J  2007; 21:2564-79;  PMID:17426068 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Lab Chip 2010; 10:51- 8; PMID:20024050 ; http://dx.doi.org/10.1039/ b913221j 77.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Proc Natl Acad Sci U S A 2008; 105:9522-7;  PMID:18599452 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Nat Mater  2013; 12:584-90;  PMID:23542870 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Lab Chip 2009; 9:3185-92; PMID:19865724 ; http://dx.doi.org/10.1039/ b915147h 81.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
Trends Cell Biol  2011; 21:745-54;  PMID:22033488 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fe/d0/org-10-216.PMC4154956.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org155Paradigm Shift in the Treatment of Elderly Patients With  Unresectable Stage IV Colorectal Cancer Nam Kyu Kim Department of Surgery, Y onsei University College of Medicine, Seoul, KoreaEditorial Ann Coloproctol 2014;30(4):155-156 http://dx.doi.org/10.3393/ac.2014.30.4.155 Cancer Network (NCCN) recommend a resection of the primary  tumor only if patients are symptomatic or have metastatic sites  amenable to a potentially-curative resection.",Non-OADS,/arxiv_data1/oa_pdf/75/d6/ac-30-155.PMC4155130.pdf
"Department of Surgery, Yonsei University College of Medicine, 50 Yonsei-ro,  Seodaemun-gu, Seoul 120-749, Korea  Tel: +82-2-2228-2117, Fax: +82-2-313-8289 E-mail: namkyuk@yuhs.ac © 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/75/d6/ac-30-155.PMC4155130.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org157Prediction and Prevention of Postpolypectomy Bleeding:  Current Challenging Issues Duck-Woo Kim Department of Surgery, Seoul National University Bundang Hospital, Seongnam, KoreaEditorial Ann Coloproctol 2014;30(4):157-158 http://dx.doi.org/10.3393/ac.2014.30.4.157 whether antiplatelet agents such as aspirin increase the risk of  PPB has been debatable [4].",Non-OADS,/arxiv_data1/oa_pdf/57/42/ac-30-157.PMC4155131.pdf
"Department of Surgery, Seoul National University Bundang Hospital,   82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam 463-707, Korea Tel: +82-31-787-7101, Fax: +82-31-787-4078 E-mail: kdw@snubh.org © 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/57/42/ac-30-157.PMC4155131.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org159Epidural Injection of Extended-Release Morphine During  Colorectal Surgery Sung-Bum Kang Department of Surgery, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, KoreaEditorial Ann Coloproctol 2014;30(4):159-160 http://dx.doi.org/10.3393/ac.2014.30.4.159 series did highlight the advantages of extended-release epidural  morphine with tolerable side effects, such as transient hypotension,  respiratory compromise, pruritus, and nausea, in the context of  colorectal surgery [9].",Non-OADS,/arxiv_data1/oa_pdf/96/e2/ac-30-159.PMC4155132.pdf
"Department of Surgery, Seoul National University College of Medicine, Seoul National University Bundang Hospital, 82 Gumi-ro 173beon-gil,  Bundang-gu, Seongnam 463-707, Korea Tel: +82-31-787-7093, Fax: +82-31-787-4055 E-mail: kangsb@snubh.org © 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/96/e2/ac-30-159.PMC4155132.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org161Advancement Flap for the Treatment of a Complex Anal  Fistula Do Sun Kim Department of Surgery, Daehang Hospital, Seoul, KoreaEditorial Ann Coloproctol 2014;30(4):161-162 http://dx.doi.org/10.3393/ac.2014.30.4.161 procedures.",Non-OADS,/arxiv_data1/oa_pdf/e5/46/ac-30-161.PMC4155133.pdf
"Department of Surgery, Daehang Hospital, 2151 Nambusunhwan-ro,  Seocho-gu, Seoul 137-820, Korea Tel: +82-2-6388-8114, Fax: +82-2-6388-8673 E-mail: dskim1@daehang.com © 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/46/ac-30-161.PMC4155133.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 163Minimally Invasive Techniques for an Intersphincteric  Resection and Lateral Pelvic Lymph Node Dissection in  Rectal Cancer Jung Wook Huh Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, KoreaEditorial Ann Coloproctol 2014;30(4):163-164 http://dx.doi.org/10.3393/ac.2014.30.4.163 A proper total mesorectal excision (TME) technique is para - mount to the successful treatment of locally advanced rectal can - cer irrespective of operative method, including open and mini - mally-invasive approaches.",Non-OADS,/arxiv_data1/oa_pdf/d1/22/ac-30-163.PMC4155134.pdf
"Department of Surgery, Samsung Medical Center, Sungkyunkwan University  School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135-710, Korea Tel: +82-2-3410-1826, Fax: +82-2-3410-6980 E-mail: jungwook.huh@gmail.com © 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d1/22/ac-30-163.PMC4155134.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 165Overview of Radiation Therapy for Treating Rectal Cancer Bong-Hyeon Kye, Hyeon-Min Cho Department of Surgery, St. Vincent Hospital, The Catholic University of Korea College of Medicine, Suwon, KoreaReview Ann Coloproctol 2014;30(4):165-174 http://dx.doi.org/10.3393/ac.2014.30.4.165 A major outcome of importance for rectal cancer is local control.",Non-OADS,/arxiv_data1/oa_pdf/28/ac/ac-30-165.PMC4155135.pdf
"Department of Surgery, St. Vincent hospital, The Catholic University of Korea  College of Medicine, 93 Jungbu-daero, Paldal-gu, Suwon 442-723, Korea Tel: +82-31-249-7084, Fax: +82-31-247-5347 E-mail: hmcho@catholic.ac.kr © 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/28/ac/ac-30-165.PMC4155135.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 175Prognostic Implications of Primary Tumor Resection in  Stage IVB Colorectal Cancer in Elderly Patients Heui-June Ahn, Ho-Suk Oh, Y ongchel Ahn, Sang Jin Lee, Hyun Joong Kim, Moon Ho Kim,   Dae-Woon Eom1, Jae Y oung Kwak2, Myoung Sik Han2, Jae Seok Song3 Departments of Internal Medicine, 1Pathology, and 2Surgery, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung;  3Department of Preventive Medicine, Kwandong University College of Medicine, Gangneung, KoreaOriginal Article Ann Coloproctol 2014;30(4):175-181 http://dx.doi.org/10.3393/ac.2014.30.4.175 Purpose:  The aim of this study was to identify prognostic factors in stage IVB colorectal cancer in elderly patients, focus - ing on the influence of treatment modalities, including palliative chemotherapy and primary tumor resection.",Non-OADS,/arxiv_data1/oa_pdf/70/fb/ac-30-175.PMC4155136.pdf
"Department of Preventive Medicine, Kwandong University College of  Medicine, 24 Beomil-ro 579beon-gil, Gangneung 210-701, Korea Tel: +82-33-649-7469, Fax: +82-33-641-1074 E-mail: songjs@kd.ac © 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/70/fb/ac-30-175.PMC4155136.pdf
Available  from: http://www.cancer.go.kr.,Non-OADS,/arxiv_data1/oa_pdf/70/fb/ac-30-175.PMC4155136.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 182Only the Size of Resected Polyps Is an Independent Risk  Factor for Delayed Postpolypectomy Hemorrhage: A 10- Year Single-Center Case-Control Study Hee Seok Moon, Sun Wook Park, Dong Hwan Kim, Sun Hyung Kang, Jae Kyu Sung, Hyun Y ong Jeong Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, KoreaOriginal Article Ann Coloproctol 2014;30(4):182-185 http://dx.doi.org/10.3393/ac.2014.30.4.182 Purpose:  A colonoscopic polypectomy is an important procedure for preventing colorectal cancer, but it is not free from  complications.",Non-OADS,/arxiv_data1/oa_pdf/ab/d6/ac-30-182.PMC4155137.pdf
"Department of Internal Medicine, Chungnam National University School of  Medicine, 266 Munhwa-ro, Jung-gu, Daejeon 301-747, Korea  Tel: +82-42-280-7143, Fax: +82-42-280-4553 E-mail: jeonghy@cnuh.co.kr © 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ab/d6/ac-30-182.PMC4155137.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 186Enhancing the Enhanced Recovery Program in Colorectal  Surgery – Use of Extended-Release Epidural Morphine  (DepoDur®) Rajeev Peravali, Rachael Brock, Elizabeth Bright1, Patricia Mills1, Dawn Petty2, Justin Alberts Departments of Colorectal Surgery, 1Anaesthetics, and 2Pain Management Team, West Suffolk Hospital NHS Foundation Trust, Suffolk, UKOriginal Article Ann Coloproctol 2014;30(4):186-191 http://dx.doi.org/10.3393/ac.2014.30.4.186 Purpose:  DepoDur® is a single-dose extended-release morphine injection into the epidural space.",Non-OADS,/arxiv_data1/oa_pdf/af/f1/ac-30-186.PMC4155138.pdf
"Department of Colorectal Surgery, West Suffolk Hospital NHS Foundation  Trust, Hardwick Lane, Suffolk, UK Tel: +441284713000, Fax: +441284701993 E-mail: rajeevperavali@doctors.org.uk © 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/af/f1/ac-30-186.PMC4155138.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 192Application of Advancement Flap After Loose Seton  Placement: A Modified Two-Stage Surgical Repair of   a Transsphincteric Anal Fistula Metin Ertem1,2, Hakan Gok1, Emel Ozveri1, Volkan Ozben1 1General Surgery Clinic, Kozyatagi Acibadem Hospital, Istanbul, 2Department of General Surgery, Istanbul University, Cerrahpasa Medical  School, Istanbul, TurkeyOriginal Article Ann Coloproctol 2014;30(4):192-196 http://dx.doi.org/10.3393/ac.2014.30.4.192 Purpose:  A number of techniques have been described for the treatment of a transsphincteric anal fistula.",Non-OADS,/arxiv_data1/oa_pdf/ef/ed/ac-30-192.PMC4155139.pdf
"No: 20, Kozyatagi, 34742, Istanbul, Turkey Tel: +90-216-571-4444, Fax: +90-216-571-4000 E-mail: volkanozben@yahoo.co.uk © 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ef/ed/ac-30-192.PMC4155139.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 197Mesh-Based Transperineal Repair of a Perineal Hernia After  a Laparoscopic Abdominoperineal Resection Taek-Gu Lee, Sang-Jeon Lee Department of Surgery, Chungbuk National University College of Medicine, Cheongju, KoreaCase Report Ann Coloproctol 2014;30(4):197-200 http://dx.doi.org/10.3393/ac.2014.30.4.197 A perineal hernia (PH) is formed by a protrusion of intra-abdominal viscera through a defect in the pelvic floor.",Non-OADS,/arxiv_data1/oa_pdf/ff/15/ac-30-197.PMC4155140.pdf
"Department of Surgery, Chungbuk National University College of Medicine,  410 Sunbong-ro, Heungdeok-gu, Cheongju 361-763, Korea  Tel: +82-43-269-6360, Fax: +82-43-266-6037 E-mail: colon@chungbuk.ac.kr © 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ff/15/ac-30-197.PMC4155140.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 201Regression of Colonic Adenomas After Treatment With  Sulindac in Familial Adenomatous Polyposis: A Case With  a 2-Year Follow-up Without a Prophylactic Colectomy Kyu Y oung Kim, Seong Woo Jeon, Jung Gil Park, Chung Hoon Yu, Se Y oung Jang, Jae Kwang Lee,   Hee Y oung Hwang  Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, KoreaCase Report Ann Coloproctol 2014;30(4):201-204 http://dx.doi.org/10.3393/ac.2014.30.4.201 Familial adenomatous polyposis (FAP) is an autosomal dominant disorder characterized by hundreds of colorectal adeno - matous polyps that progress to colorectal cancer.",Non-OADS,/arxiv_data1/oa_pdf/09/56/ac-30-201.PMC4155141.pdf
"Department of Internal Medicine, Kyungpook National University Medical  Center, Kyungpook National University School of Medicine,   130 Dongdeok-ro, Jung-gu, Daegu 700-721, Korea Tel: +82-53-420-5512, Fax: +82-53-426-8773 E-mail: sw-jeon@daum.net © 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/56/ac-30-201.PMC4155141.pdf
Available from:  http://www.riskman.net.au/framework_incident.html  29.,OADS,/arxiv_data1/oa_pdf/5d/8c/pharmpract-05-010.PMC4155144.pdf
Available from : http://en.wikipedia.org/wiki/Inter-rater_reliability,OADS,/arxiv_data1/oa_pdf/5d/8c/pharmpract-05-010.PMC4155144.pdf
Bethesda: Nacional Library of Medi cine; 1966- Avaiable at:  http://www.ncbi.nlm.nih.gov/entrez/quer y.fcgi?DB=pubmed.,Non-OADS,/arxiv_data1/oa_pdf/16/9c/pharmpract-05-021.PMC4155146.pdf
Madrid: CSIC; Available at:  http://bddoc.csic.es:8080/index.jsp.,Non-OADS,/arxiv_data1/oa_pdf/16/9c/pharmpract-05-021.PMC4155146.pdf
Available at:  http://www.sefh.es/01revista_farmaci a_hospitalaria.php.,Non-OADS,/arxiv_data1/oa_pdf/16/9c/pharmpract-05-021.PMC4155146.pdf
Available at:  http://www.bugalicia.org/interface.asp?idRecurso=52.,Non-OADS,/arxiv_data1/oa_pdf/16/9c/pharmpract-05-021.PMC4155146.pdf
"http://www.cfsan.fda.gov/~dms/ds- ind.html#GMPS, (accessed 10-11-2006).",OADS,/arxiv_data1/oa_pdf/b8/f4/pharmpract-05-031.PMC4155147.pdf
URL: http://www.advis orybodies.doh.gov.uk/smac1.htm (accessed 18-02-2007)  2.,Non-OADS,/arxiv_data1/oa_pdf/14/09/pharmpract-05-036.PMC4155148.pdf
http://www.fazaclo.com/GeneralInfo.asp.,Non-OADS,/arxiv_data1/oa_pdf/e7/e4/pharmpract-05-042.PMC4155149.pdf
(revised 11-14-2003)  Available on line at:  http://www.cancer.org/docroot/PED/content/PED_10_2X_C igarette_Smoking_and_Cancer.asp.,Non-OADS,/arxiv_data1/oa_pdf/f6/c2/pharmpract-05-051.PMC4155151.pdf
"Accessed: November 28, 2006. at:  http://web.worldbank.org/WBSITE/EXTERNAL/TOPICS /EXTHEALTHNUTRITIONANDPOPULATION/EXTPHAAG/0,,co ntentMDK:20796948~menuPK:1314827~pagePK:64229817~piPK:64229743~theSitePK:672263,00.html  14.",Non-OADS,/arxiv_data1/oa_pdf/f6/c2/pharmpract-05-051.PMC4155151.pdf
Available at http://www.healthypeople.gov.,Non-OADS,/arxiv_data1/oa_pdf/f6/c2/pharmpract-05-051.PMC4155151.pdf
"Available at: URL:  http://www.fda.gov/cder/reports/prescriptionInfo/default.htm, accessed on 25/08/2005.",Non-OADS,/arxiv_data1/oa_pdf/5e/1e/pharmpract-05-089.PMC4155157.pdf
"337 http://dx.doi.org/10.3345/kjp.2014.57.8.337 Current insights into inherited bone marrow  failure syndromes Nack-Gyun Chung, MD1, Myungshin Kim, MD2,3 Departments of 1Pediatrics, 2Laboratory Medicine, and 3Catholic Genetic Laboratory Center, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of  Korea, Seoul, Korea Inherited bone marrow failure syndrome (IBMFS) encompasses a heterogeneous and complex group  of genetic disorders characterized by physical malformations, insufficient blood cell production,  and increased risk of malignancies.",Non-OADS,/arxiv_data1/oa_pdf/c2/7e/kjped-57-337.PMC4155177.pdf
"Key words:  Bone marrow failure syndromes, Fanconi anemia, Diamond-Blackfan anemia,  Shwachman-Diamond syndrome, Severe congenital neutropeniaCorresponding author:  Myungshin Kim, MD Department of Laboratory Medicine, Seoul St.  Mary’s Hospital, College of Medicine, The Catholic  University of Korea, 222 Banpo-daero, Seocho-gu,  Seoul 137-701, Korea Tel: +82-2-2258-1645 Fax: +82-2-2258-1719 E-mail: microkim@catholic.ac.kr  Received: 3 April, 2014 Accepted: 9 June, 2014 Copyright © 2014 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Review article Korean J Pediatr 2014;57(8):337-344 http://dx.doi.org/10.3345/kjp.2014.57.8.337 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction  Inherited bone marrow failure syndrome (IBMFS) encompasses a heterogeneous  and complex group of genetic disorders characterized by physical malformations and  insufficient blood cell production.",Non-OADS,/arxiv_data1/oa_pdf/c2/7e/kjped-57-337.PMC4155177.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.8.337Chung NG and Kim M  • Current insights into inherited bone marrow failure syndromes 338processes, such as DNA repair, telomere biology, and riboso - mal biogenesis, which underlie FA, DC, and DBA, respectively.",OADS,/arxiv_data1/oa_pdf/c2/7e/kjped-57-337.PMC4155177.pdf
339 http://dx.doi.org/10.3345/kjp.2014.57.8.337Korean J Pediatr 2014;57(8):337-344 test in the majority of cases.,Non-OADS,/arxiv_data1/oa_pdf/c2/7e/kjped-57-337.PMC4155177.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.8.337Chung NG and Kim M  • Current insights into inherited bone marrow failure syndromes 340hypodiploidy and loss of heterozygosity of 17p and congenital  pigmented dermofibrosarcoma protuberans were reported  in Korean FA patients19,20).",OADS,/arxiv_data1/oa_pdf/c2/7e/kjped-57-337.PMC4155177.pdf
341 http://dx.doi.org/10.3345/kjp.2014.57.8.337Korean J Pediatr 2014;57(8):337-344 a predisposition to cancer.,Non-OADS,/arxiv_data1/oa_pdf/c2/7e/kjped-57-337.PMC4155177.pdf
http://dx.doi.org/10.3345/kjp.2014.57.8.337Chung NG and Kim M  • Current insights into inherited bone marrow failure syndromes 342(c.[183_184TA>CT];[258+2T>C]) in one patient and homozygous  mutations of c.[258+2T>C];[258+2T>C] in the other patient.,OADS,/arxiv_data1/oa_pdf/c2/7e/kjped-57-337.PMC4155177.pdf
343 http://dx.doi.org/10.3345/kjp.2014.57.8.337Korean J Pediatr 2014;57(8):337-344 of Korea (A120175).,Non-OADS,/arxiv_data1/oa_pdf/c2/7e/kjped-57-337.PMC4155177.pdf
Available from: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/c2/7e/kjped-57-337.PMC4155177.pdf
http://dx.doi.org/10.3345/kjp.2014.57.8.337Chung NG and Kim M  • Current insights into inherited bone marrow failure syndromes 3442005;45:892-901.,OADS,/arxiv_data1/oa_pdf/c2/7e/kjped-57-337.PMC4155177.pdf
"345 http://dx.doi.org/10.3345/kjp.2014.57.8.345 Iron deficiency increases blood concentrations  of neurotoxic metals in children Yangho Kim, MD1, Sangkyu Park, MD2 Departments of 1Occupational and Environmental Medicine and 2Pediatrics, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea Iron deficiency affects approximately one-third of the world’s population, occurring most frequently in  children aged 6 months to 3 years.",Non-OADS,/arxiv_data1/oa_pdf/ad/76/kjped-57-345.PMC4155178.pdf
"Key words:  Iron, Deficiency, Manganese, Lead, Breast-feedingCorresponding author:  Sangkyu Park, MD Department of Pediatrics, Ulsan University Hospi - tal, University of Ulsan College of Medicine, 877  Bangeojinsunhwan-doro, Dong-gu, Ulsan 682-714,  Korea Tel: +82-52-250-7060 Fax: +82-52-250-8071 E-mail: sang@uuh.ulsan.kr Received: 3 April, 2014 Accepted: 9 June, 2014 Copyright © 2014 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Review article Korean J Pediatr 2014;57(8):345-350 http://dx.doi.org/10.3345/kjp.2014.57.8.345 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction Iron deficiency, which is the most frequent and widespread nutritional deficiency in  the world, affects approximately one-third of the world’s population1), and occurs most  frequently in rapidly growing children aged 6 months to 3 years who have an inadequate  dietary iron intake2).",Non-OADS,/arxiv_data1/oa_pdf/ad/76/kjped-57-345.PMC4155178.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.8.345Kim Y and Park S  • Neurotoxic metals in iron-deficient children 346Inhalation of metals, such as manganese, lead, and cadmium,  is the most common cause of adult toxic metal exposure in  environmental and occupational settings14), whereas food intake  is the major source of absorbed metals in neonates and infants,  who are more vulnerable than adults to metals absorbed through  the intestine15).",Non-OADS,/arxiv_data1/oa_pdf/ad/76/kjped-57-345.PMC4155178.pdf
"347 http://dx.doi.org/10.3345/kjp.2014.57.8.345Korean J Pediatr 2014;57(8):345-350 Several previous studies have assessed the temporal rela - tionship between iron deficiency and increased blood lead con - centrations13,21,51,52).",Non-OADS,/arxiv_data1/oa_pdf/ad/76/kjped-57-345.PMC4155178.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.8.345Kim Y and Park S  • Neurotoxic metals in iron-deficient children 348epidemiology of iron deficiency should be studied to assess  its role as an important susceptibility factor, especially when  carrying out environmental health risk assessments concerning  low exposure to neurotoxic metals in children.",Non-OADS,/arxiv_data1/oa_pdf/ad/76/kjped-57-345.PMC4155178.pdf
"349 http://dx.doi.org/10.3345/kjp.2014.57.8.345Korean J Pediatr 2014;57(8):345-350 Figueroa H, Hernandez-Avila M, et al.",OADS,/arxiv_data1/oa_pdf/ad/76/kjped-57-345.PMC4155178.pdf
http://dx.doi.org/10.3345/kjp.2014.57.8.345Kim Y and Park S  • Neurotoxic metals in iron-deficient children 350by iron deficiency?,Non-OADS,/arxiv_data1/oa_pdf/ad/76/kjped-57-345.PMC4155178.pdf
Available from: http://wwwn.cdc.gov/ nchs/nhanes/bibliography/key_statistics.aspx.,OADS,/arxiv_data1/oa_pdf/ad/76/kjped-57-345.PMC4155178.pdf
"351 http://dx.doi.org/10.3345/kjp.2014.57.8.351 Fecal calprotectin concentration in neonatal  necrotizing enterocolitis Jung Min Yoon, MD, Ju Yi Park, MD, Kyung Ok Ko, MD, Jae Woo Lim, MD, Eun Jeong Cheon, MD, Hyo Jeong Kim, MD  Department of Pediatrics, Konyang University College of Medicine, Daejeon, Korea Purpose: Among the many factors associated with acute intestinal mucosal infection, numerous  studies have proposed the usefulness of fecal calprotectin.",Non-OADS,/arxiv_data1/oa_pdf/2c/32/kjped-57-351.PMC4155179.pdf
"Key words:  Necrotizing enterocolitis, Premature infant, Calprotectin, Fecal calprotectinCorresponding author:  Jung Min Yoon, MD Department of Pediatrics, Konyang University Col - lege of Medicine, 158 Gwanjeodong-ro, Seo-gu,  Daejeon 302-718, Korea Tel: +82-42-600-9230 Fax: +82-42-600-9090 E-mail: jmyoon@kyuh.ac.kr Received: 29 October, 2014 Revised: 17 January, 2014 Accepted: 24 March, 2014 Copyright © 2014 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2014;57(8):351-356 http://dx.doi.org/10.3345/kjp.2014.57.8.351 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction Approximately 1%–5% of newborns in the neonatal intensive care unit suffer from  necrotizing enterocolitis (NEC).",Non-OADS,/arxiv_data1/oa_pdf/2c/32/kjped-57-351.PMC4155179.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.8.351Yoon JM, et al.",OADS,/arxiv_data1/oa_pdf/2c/32/kjped-57-351.PMC4155179.pdf
"353 http://dx.doi.org/10.3345/kjp.2014.57.8.351Korean J Pediatr 2014;57(8):351-356 weight, age of the mother, 1-minute Apgar score, 5-minute  Apgar score, corrected age, age, white blood cell count, hemo - globin level, hematocrit level, aspartate aminotransferase (AST)  level, platelet count, and metabolic acidosis.",Non-OADS,/arxiv_data1/oa_pdf/2c/32/kjped-57-351.PMC4155179.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.8.351Yoon JM, et al.",OADS,/arxiv_data1/oa_pdf/2c/32/kjped-57-351.PMC4155179.pdf
355 http://dx.doi.org/10.3345/kjp.2014.57.8.351Korean J Pediatr 2014;57(8):351-356 a clear positive linear relationship between the 2 variables  (gestational age and level of fecal calprotectin) in newborns  born at <26 weeks gestational age.,Non-OADS,/arxiv_data1/oa_pdf/2c/32/kjped-57-351.PMC4155179.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.8.351Yoon JM, et al.",OADS,/arxiv_data1/oa_pdf/2c/32/kjped-57-351.PMC4155179.pdf
"357 http://dx.doi.org/10.3345/kjp.2014.57.8.357 Clinical characteristics and serum N-terminal  pro-brain natriuretic peptide as a diagnostic  marker of Kawasaki disease in infants younger  than 3 months of age Hyun Kyung Bae, MD1, Do Kyung Lee, MD1, Jung Hyun Kwon, MD1, Hae Soon Kim, MD1, Sejung Sohn, MD1, Young Mi Hong, MD1,2 1Departments of Pediatrics, Ewha Womans University School of Medicine, 2Ewha Womans University Global Top 5 Research Program, Seoul, Korea Purpose: The incidence of Kawasaki disease (KD) is rare in young infants (less than 3 months of age),  who present with only a few symptoms that fulfill the clinical diagnostic criteria.",Non-OADS,/arxiv_data1/oa_pdf/35/64/kjped-57-357.PMC4155180.pdf
"Key words:  Kawasaki disease, Infant, Brain natriuretic peptideCorresponding author:  Young Mi Hong, MD Department of Pediatrics, Ewha Womans Univer - sity School of Medicine, 1071 Anyangcheon-ro,  Yangcheon-gu, Seoul, 158-710, Korea Tel: +82-2-2650-2841 Fax: +82-2-2653-3718 E-mail: ymhong@ewha.ac.kr Received: 25 November, 2013 Revised: 10 January, 2014 Accepted: 5 March, 2014 Copyright © 2014 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2014;57(8):357-362 http://dx.doi.org/10.3345/kjp.2014.57.8.357 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction Kawasaki disease (KD) is a multisystem vasculitis that is associated with coronary  complications.",Non-OADS,/arxiv_data1/oa_pdf/35/64/kjped-57-357.PMC4155180.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.8.357Bae HK, et al.",OADS,/arxiv_data1/oa_pdf/35/64/kjped-57-357.PMC4155180.pdf
"359 http://dx.doi.org/10.3345/kjp.2014.57.8.357Korean J Pediatr 2014;57(8):357-362 tom of the diagnostic criteria was erythema at the site of BCG  inoculation (70.8%), followed by skin rash (50.0%), changes of  oropharyngeal mucosa (29.1%) and cervical lym  phadenopathy  (20.8%) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/35/64/kjped-57-357.PMC4155180.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.8.357Bae HK, et al.",OADS,/arxiv_data1/oa_pdf/35/64/kjped-57-357.PMC4155180.pdf
361 http://dx.doi.org/10.3345/kjp.2014.57.8.357Korean J Pediatr 2014;57(8):357-362 Takahashi et al.11) found a higher prevalence of coronary artery  abnormalities in children younger than 3 months of age (39%)  compared with that of children of 1 year age (13%).,Non-OADS,/arxiv_data1/oa_pdf/35/64/kjped-57-357.PMC4155180.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.8.357Bae HK, et al.",OADS,/arxiv_data1/oa_pdf/35/64/kjped-57-357.PMC4155180.pdf
"363 http://dx.doi.org/10.3345/kjp.2014.57.8.363 Developmental profiles of preschool children  with delayed language development Jeong Ji Eun, MD, Hyung Jik Lee, MD, Jin Kyung Kim, MD, PhD Department of Pediatrics, Catholic University of Daegu School of Medicine, Daegu, Korea Purpose: This study examines changes in developmental profiles of children with language delay over  time and the clinical significance of assessment conducted at age 2–3 years.",Non-OADS,/arxiv_data1/oa_pdf/66/ec/kjped-57-363.PMC4155181.pdf
"Key words:  Language, Cognition, Intelligence, Language developmentCorresponding author:  Jin-Kyung Kim, MD, PhD Department of Pediatrics, Catholic University of  Daegu School of Medicine, 3056-6 Daemyeong  4-dong, Nam-gu, Daegu, 705-178, Korea Tel: +82-53-650-4240 Fax: +82-53-621-4106 E-mail: kimjk@cu.ac.kr Received: 13 March, 2014 Revised: 22 April, 2014 Accepted: 29 May, 2014 Copyright © 2014 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2014;57(8):363-369 http://dx.doi.org/10.3345/kjp.2014.57.8.363 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction  It is thought that all typically developing children in all cultures master the basics of  their language by 4 years of age1).",Non-OADS,/arxiv_data1/oa_pdf/66/ec/kjped-57-363.PMC4155181.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.8.363Eun JI, et al.",OADS,/arxiv_data1/oa_pdf/66/ec/kjped-57-363.PMC4155181.pdf
365 http://dx.doi.org/10.3345/kjp.2014.57.8.363Korean J Pediatr 2014;57(8):363-369 children aged 1 month through to 42 months.,Non-OADS,/arxiv_data1/oa_pdf/66/ec/kjped-57-363.PMC4155181.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.8.363Eun JI, et al.",OADS,/arxiv_data1/oa_pdf/66/ec/kjped-57-363.PMC4155181.pdf
"367 http://dx.doi.org/10.3345/kjp.2014.57.8.363Korean J Pediatr 2014;57(8):363-369 pairment, and 21.9% (7/32) had autism spectrum disorders at  follow-up assessment (Table 7).",OADS,/arxiv_data1/oa_pdf/66/ec/kjped-57-363.PMC4155181.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.8.363Eun JI, et al.",OADS,/arxiv_data1/oa_pdf/66/ec/kjped-57-363.PMC4155181.pdf
369 http://dx.doi.org/10.3345/kjp.2014.57.8.363Korean J Pediatr 2014;57(8):363-369 Conflict of interest No potential conflict of interest relevant to this article was  reported.,Non-OADS,/arxiv_data1/oa_pdf/66/ec/kjped-57-363.PMC4155181.pdf
"370 http://dx.doi.org/10.3345/kjp.2014.57.8.370 Use of intravenous immunoglobulin in a  disseminated varicella infection in an immuno­ compromised child Jae Hong Kim, MD1, Dae Hyun Kwon, MD1, E Young Bae, MD1, Seung Beom Han, MD1, Jae Wook Lee, MD2, Nack Gyun Chung, MD2,  Dae Chul Jeong, MD1, Bin Cho, MD2, Jin Han Kang, MD1, Hack Ki Kim, MD2 1Department of Pediatrics, 2The Catholic Blood and Marrow Transplantation Center, The Catholic University of Korea College of Medicine, Seoul, Korea Varicella-zoster virus infection can lead to severe illness in immunocompromised patients.",Non-OADS,/arxiv_data1/oa_pdf/0a/2b/kjped-57-370.PMC4155182.pdf
"Key words:  Varicella-zoster virus, Acyclovir, Immunoglobulin Corresponding author:  Jin Han Kang Department of Pediatrics, Seoul St. Mary's Hospital,  The Catholic University of Korea College of Medi - cine, 222 Banpo-daero, Seocho-gu, Seoul 137- 701, Korea Tel: +82-2-2258-6183 Fax: +82-2-537-4544 E-mail: kjhan@catholic.ac.kr  Received: 25 March, 2013 Revised: 29 August, 2013 Accepted: 17 October, 2013 Copyright © 2014 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Case report Korean J Pediatr 2014;57(8):370­373 http://dx.doi.org/10.3345/kjp.2014.57.8.370 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction  Varicella-zoster virus (VZV) infection is a self-limited childhood disease1,2).",Non-OADS,/arxiv_data1/oa_pdf/0a/2b/kjped-57-370.PMC4155182.pdf
"371 http://dx.doi.org/10.3345/kjp.2014.57.8.370Korean J Pediatr 2014;57(8):370-393 last chemotherapy, which included a high dose of methotraxate.",Non-OADS,/arxiv_data1/oa_pdf/0a/2b/kjped-57-370.PMC4155182.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.8.370Kim JH, et al.",OADS,/arxiv_data1/oa_pdf/0a/2b/kjped-57-370.PMC4155182.pdf
"373 http://dx.doi.org/10.3345/kjp.2014.57.8.370Korean J Pediatr 2014;57(8):370-393 immunocompromised patients4,5), because immunocompromised  children, who have lower T-cell responses, cannot control  VZV, resulting in both prolonged infection and reactivation9).",Non-OADS,/arxiv_data1/oa_pdf/0a/2b/kjped-57-370.PMC4155182.pdf
"374 http://dx.doi.org/10.3345/kjp.2014.57.8.374 A pediatric case of Brugada syndrome diag­ nosed by fever ­provoked ventricular tachycardia Geena Kim, MD1, Ye-Chan Kyung, MD2, I-Seok Kang, MD2, Jinyoung Song, MD, PhD2, June Huh, MD, PhD2, Young Keun On, MD, PhD3 1Department of Pediatrics, Pusan National University Children’s Hospital, Pusan National University School of Medicine, Yangsan, Korea, 2Division of Cardiology,  Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 3Department of Medicine, Sungkyunkwan University School  of Medicine, Seoul, Korea Brugada syndrome is a rare channelopathy associated with the  SCN5A  gene that causes fatal  ventricular arrhythmias.",Non-OADS,/arxiv_data1/oa_pdf/df/3f/kjped-57-374.PMC4155183.pdf
"Key words: Brugada syndrome, Fever, Ventricular tachycardia, Child, RetinoblastomaCorresponding author: June Huh, MD, PhD Department of Pediatrics, Samsung Medical Center, Cardiac and Vascular Center, Sungkyunkwan Uni-versity School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135-710, KoreaTel: +82-2-3410-3526Fax: +82-2-3410-0043E-mail: herzhuh@skku.edu Received: 4 July, 2013 Revised: 9 September, 2013Accepted: 13 October, 2013 Copyright © 2014 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Case report Korean J Pediatr 2014;57(8):374­378 http://dx.doi.org/10.3345/kjp.2014.57.8.374pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction Brugada syndrome (BrS) is recognized as an important cause of sudden cardiac death  (SCD) occurring in individuals at a relatively young age.",Non-OADS,/arxiv_data1/oa_pdf/df/3f/kjped-57-374.PMC4155183.pdf
"375 http://dx.doi.org/10.3345/kjp.2014.57.8.374Korean J Pediatr 2014;57(8):374-378 had a central line for chemotherapy, a catheter-related infection  was initially suspected, so blood cultures were taken and  empirical antibiotics was given.",Non-OADS,/arxiv_data1/oa_pdf/df/3f/kjped-57-374.PMC4155183.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.8.374Kim G, et al.",OADS,/arxiv_data1/oa_pdf/df/3f/kjped-57-374.PMC4155183.pdf
"377 http://dx.doi.org/10.3345/kjp.2014.57.8.374Korean J Pediatr 2014;57(8):374-378 repolarizing currents during the early repolarization phase of  the action potential, mainly demonstrated by a large transient  outward current in the epicardial cells of the right ventricle8).",OADS,/arxiv_data1/oa_pdf/df/3f/kjped-57-374.PMC4155183.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.8.374Kim G, et al.",OADS,/arxiv_data1/oa_pdf/df/3f/kjped-57-374.PMC4155183.pdf
e-mail: Mohsen.Hanifeh@helsinki.fi ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/99/c7/jvms-76-1079.PMC4155186.pdf
e-mail: thahn@chonnam.ac.kr ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/62/c0/jvms-76-1087.PMC4155187.pdf
Protein identification was performed using  MS-Fit (http://prospector.ucsf.edu).,OADS,/arxiv_data1/oa_pdf/62/c0/jvms-76-1087.PMC4155187.pdf
e-mail: etakahashi@brain.riken.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/d1/73/jvms-76-1093.PMC4155188.pdf
"Microsatellite genotyping: To examine the origin of the  Ednrb allele from genomic DNA obtained from the tails of  PROD-s/s (male, female: n=10, 10), PROD-rol/rol (male,  female: n=10, 10) and B6 (male, female: n=10, 10) mice,  microsatellite markers (D14Mit30, D14Mit193, D14Mit93,  D14Mit94, D14Mit170, D14Mit42 and D14Mit267) were  typed by PCR amplification using the Mouse Microsatellite  Data Base of Japan (MMDBJ, http://www.shigen.nig.ac.jp/ mouse/mmdbj/) and the Mouse Genome Informatics (MGI,  http://www.informatics.jax.org/).",Non-OADS,/arxiv_data1/oa_pdf/d1/73/jvms-76-1093.PMC4155188.pdf
e-mail: muehr@ncn-t.net ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/38/7f/jvms-76-1099.PMC4155189.pdf
e-mail: nagaokak@cc.tuat.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/68/82/jvms-76-1105.PMC4155190.pdf
e-mail: uchiyu@affrc.go.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/21/5d/jvms-76-1111.PMC4155191.pdf
Available from http://www.fao.org/docrep/014/i2150e/i2150e00.htm.,Non-OADS,/arxiv_data1/oa_pdf/21/5d/jvms-76-1111.PMC4155191.pdf
Available from http://www.who.int/influenza/resources/documents/vaccine_ref_viruses_reverse_genetics/en/.,Non-OADS,/arxiv_data1/oa_pdf/21/5d/jvms-76-1111.PMC4155191.pdf
Avail-able from http://www.wpro.who.int/emerging_diseases/docu-ments/docs/manualonanimalaidiagnosisandsurveillance.pdf.,Non-OADS,/arxiv_data1/oa_pdf/21/5d/jvms-76-1111.PMC4155191.pdf
Available from http://www.oie.int/fileadmin/Home/eng/Health_standards/tahm/2.03.04_AI.pdf.,Non-OADS,/arxiv_data1/oa_pdf/21/5d/jvms-76-1111.PMC4155191.pdf
Available from http://www.oie.int/animal-health-in-the-world/update-on-avian-influen-za/2013/.,Non-OADS,/arxiv_data1/oa_pdf/21/5d/jvms-76-1111.PMC4155191.pdf
e-mail: aohno@mail.ecc.u-tokyo.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/a9/03/jvms-76-1119.PMC4155192.pdf
e-mail: kwseo@cnu.ac.kr ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/32/62/jvms-76-1129.PMC4155193.pdf
"Moreover,  average temperature of the month when each calf was born  was obtained from the web site of the Japan Meteorologi-cal Agency (http://www.data.jma.go.jp/obd/stats/etrn/index.",OADS,/arxiv_data1/oa_pdf/8e/6e/jvms-76-1133.PMC4155194.pdf
e-mail: kido@hama-midorinokyokai.or.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/8e/6e/jvms-76-1133.PMC4155194.pdf
Available from http://jlia.lin.gr.jp/hi_wakaushi/pdf/all.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8e/6e/jvms-76-1133.PMC4155194.pdf
e-mail:	miurah@vmas.kitasato-u.ac.jp ©2014	The	Japanese	Society	of	 Veterinary	Science This	is	an	open-access	 article	distributed 	under	the	terms	of	the	Creative	 Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/ba/7c/jvms-76-1137.PMC4155195.pdf
e-mail: andj67@korea.kr ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/53/78/jvms-76-1141.PMC4155196.pdf
e-mail: shimamot@vmas.kitasato-u.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/44/55/jvms-76-1147.PMC4155197.pdf
"REPRESSION OF CYP2D BY BABESIA  INFECTION 1149 2D10 (70%), 2D22 (76%) and 2D26 (71%) (protein blast;  http://blast.ncbi.nlm.nih.gov/Blast.cgi).",Non-OADS,/arxiv_data1/oa_pdf/44/55/jvms-76-1147.PMC4155197.pdf
e-mail: ikazo-h@muses.tottori-u.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/08/70/jvms-76-1153.PMC4155198.pdf
e-mail: nishino@cc.kyoto-su.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/c6/9d/jvms-76-1157.PMC4155199.pdf
e-mail: kobayashi.ryousuke@mu.medience.co.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/2c/50/jvms-76-1161.PMC4155200.pdf
e-mail: ichijo@iwate-u.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Table 1.,Non-OADS,/arxiv_data1/oa_pdf/65/12/jvms-76-1165.PMC4155201.pdf
e-mail: kido@hama-midorinokyokai.or.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/99/7e/jvms-76-1169.PMC4155202.pdf
e-mail: kazu_nakagaki@hotmail.com ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/10/ca/jvms-76-1173.PMC4155203.pdf
e-mail: katsumi@nvlu.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/3c/68/jvms-76-1177.PMC4155204.pdf
e-mail: aohno@mail.ecc.u-tokyo.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/c0/14/jvms-76-1183.PMC4155205.pdf
e-mail: hnakajima@vet.osakafu-u.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/18/d4/jvms-76-1189.PMC4155206.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/31/cf/jpts-26-1139.PMC4155207.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/52/cf/jpts-26-1143.PMC4155208.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/62/32/jpts-26-1147.PMC4155209.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/f8/0a/jpts-26-1153.PMC4155210.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/b1/c4/jpts-26-1157.PMC4155211.pdf
"http://en.wikipedia.org/wiki/Scoliosis#cite_note-9 (Accessed Feb. 9, 2014) 6) Carrier J, Aubin CE, Villemure I, et al.",Non-OADS,/arxiv_data1/oa_pdf/b1/c4/jpts-26-1157.PMC4155211.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/de/93/jpts-26-1161.PMC4155212.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/80/16/jpts-26-1165.PMC4155213.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/e3/97/jpts-26-1173.PMC4155214.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/1a/85/jpts-26-1177.PMC4155215.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/c0/2e/jpts-26-1185.PMC4155216.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/9e/7f/jpts-26-1189.PMC4155217.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/3f/d4/jpts-26-1193.PMC4155218.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/7c/92/jpts-26-1199.PMC4155219.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/98/8d/jpts-26-1205.PMC4155220.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/49/8d/jpts-26-1209.PMC4155221.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/04/6c/jpts-26-1215.PMC4155222.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/99/c3/jpts-26-1219.PMC4155223.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/f5/23/jpts-26-1223.PMC4155224.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/4f/13/jpts-26-1225.PMC4155225.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/c5/23/jpts-26-1231.PMC4155226.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/e2/ae/jpts-26-1237.PMC4155227.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/da/85/jpts-26-1241.PMC4155228.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/b4/ad/jpts-26-1247.PMC4155229.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/01/95/jpts-26-1259.PMC4155230.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/07/c7/jpts-26-1263.PMC4155231.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/73/ed/jpts-26-1267.PMC4155232.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/25/70/jpts-26-1271.PMC4155233.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/f6/8c/jpts-26-1275.PMC4155234.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/0e/19/jpts-26-1277.PMC4155235.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/fc/fd/jpts-26-1279.PMC4155236.pdf
"REFERENCES 1) Ministry of Internal Affairs and Communications: http://www.stat.go.jp/ data/jinsui/tsuki/ (Accessed Sep.12, 2012) 2) Bureau of Statistics: http://www.stat.go.jp/data/nihon/02.htm (Accessed Sep.12, 2012) 3) Yeh CK, Johnson DA, Dodds MW, et al.",OADS,/arxiv_data1/oa_pdf/fc/fd/jpts-26-1279.PMC4155236.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/ac/d1/jpts-26-1283.PMC4155237.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/c0/9b/jpts-26-1287.PMC4155238.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/14/ac/jpts-26-1293.PMC4155239.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Review,Non-OADS,/arxiv_data1/oa_pdf/21/99/jpts-26-1297.PMC4155240.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Review,Non-OADS,/arxiv_data1/oa_pdf/53/54/jpts-26-1301.PMC4155241.pdf
http://www.pedro.org.au/English/% −20downloads/pedro-scale (Accessed Mar.,Non-OADS,/arxiv_data1/oa_pdf/53/54/jpts-26-1301.PMC4155241.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Case Study,Non-OADS,/arxiv_data1/oa_pdf/bf/69/jpts-26-1307.PMC4155242.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Case	Study,Non-OADS,/arxiv_data1/oa_pdf/af/9c/jpts-26-1313.PMC4155243.pdf
Availability and implementation: The CLImAT software package can be freely downloaded at http://bioinformatics.ustc.edu.cn/CLImAT/.Contact : aoli@ustc.edu.cn Supplementary information: Supplementary data are available at Bioinformatics online.,OADS,/arxiv_data1/oa_pdf/97/07/btu346.PMC4155249.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/97/07/btu346.PMC4155249.pdf
was obtained from http://hgdownload.cse.ucsc.edu/goldenPath/hg18/ encodeDCC/wgEncodeMapability/.,OADS,/arxiv_data1/oa_pdf/97/07/btu346.PMC4155249.pdf
"Software and user manual are available at http://bioinformaticstools.mayo.edu/research/patterncnv/, and R packageat https://github.com/topsoil/patternCNV/.",OADS,/arxiv_data1/oa_pdf/68/03/btu363.PMC4155258.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/68/03/btu363.PMC4155258.pdf
"Source of Support: Nil, Conflict of Interest: None declared Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.",Non-OADS,/arxiv_data1/oa_pdf/3f/18/IJA-58-410.PMC4155285.pdf
Available from: http://ispub.com/IJA/20/2/7190 [Last accessed  on 2012 Mar 20].,Non-OADS,/arxiv_data1/oa_pdf/bb/23/IJA-58-430.PMC4155288.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/01/2d/IJA-58-456.PMC4155293.pdf
Available from: http://www.venomdoc.,Non-OADS,/arxiv_data1/oa_pdf/21/55/IJA-58-458.PMC4155294.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/21/55/IJA-58-458.PMC4155294.pdf
Available from http://ispub.com/IJA/16/2/11928.,Non-OADS,/arxiv_data1/oa_pdf/42/51/IJA-58-473.PMC4155299.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/3f/95/IJA-58-506.PMC4155319.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/3f/95/IJA-58-506.PMC4155319.pdf
wrote the paper.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/21/9d/srep06293.PMC4155333.pdf
"The index contains 5629 data points from December 19, 1990 to December 31, 2013 (http://app.finance.ifeng.com/hq/stock_daily.",Non-OADS,/arxiv_data1/oa_pdf/ad/7b/srep06290.PMC4155334.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ad/7b/srep06290.PMC4155334.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6286 | DOI: 10.1038/srep06286 7",Non-OADS,/arxiv_data1/oa_pdf/aa/09/srep06286.PMC4155336.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f2/0b/srep06291.PMC4155338.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/13/09/srep06285.PMC4155340.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6285 | DOI: 10.1038/srep06285 7",Non-OADS,/arxiv_data1/oa_pdf/13/09/srep06285.PMC4155340.pdf
This includes both raw micrographs and boxcoordinates.Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/7a/5a/ncomms5808.PMC4155512.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Wang, Z. et al.",Non-OADS,/arxiv_data1/oa_pdf/7a/5a/ncomms5808.PMC4155512.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/91/18/ncomms5777.PMC4155517.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Hayes, M. et al.",Non-OADS,/arxiv_data1/oa_pdf/91/18/ncomms5777.PMC4155517.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5777 ARTICLE NATURE COMMUNICATIONS | 5:4777 | DOI: 10.1038/ncomms5777 | www.nature.com/naturecommunications 11 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/91/18/ncomms5777.PMC4155517.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/aa/b6/aps201465a.PMC4155534.pdf
Available at:  http://www.ntdaily.com/vnews/display.v/ART/200 4/02/03/40/401f3ebb7558e.,Non-OADS,/arxiv_data1/oa_pdf/2f/e5/pharmpract-04-151.PMC4155616.pdf
Available at: http://www.cens us.gov/popest/cities/SUB-EST2004- 4.html.,Non-OADS,/arxiv_data1/oa_pdf/2f/e5/pharmpract-04-151.PMC4155616.pdf
Available at:  http://www.plannedparenthood.org/pp2/portal/files/portal/m edia/factsreports/fact-050418- pharmacist-refusals.xml.,Non-OADS,/arxiv_data1/oa_pdf/2f/e5/pharmpract-04-151.PMC4155616.pdf
"Available at: http://www.guttmacher.org/statecenter /spibs/spib_RPHS.pdf (Accessed January 5, 2006).",Non-OADS,/arxiv_data1/oa_pdf/2f/e5/pharmpract-04-151.PMC4155616.pdf
http://www.polioeradication.org/history.asp (accessed 24th  July 2006).,Non-OADS,/arxiv_data1/oa_pdf/b8/9d/pharmpract-04-163.PMC4155618.pdf
"BKK Bundesverband: BKK-Umfrage zeigt: Jeder zweite Erwa chsene noch nie gegen Diphtherie geimpft, jeder fünfte  noch nie gegen Wundstarrkrampf, http://www.bkk.de/bkk/pre ssemitteilungen/powerslave,id,2,nodeid,15,ps_lo,60.html  (accessed16th October.2004).",Non-OADS,/arxiv_data1/oa_pdf/b8/9d/pharmpract-04-163.PMC4155618.pdf
http://www.iressa.jp/professional/faq/pr o_faq1.asp#01_02 (accessed 2006 August 2)  2.,Non-OADS,/arxiv_data1/oa_pdf/e1/da/pharmpract-04-168.PMC4155619.pdf
http://www.info.pmda.go.jp/shinyaku/g020706/ index.html?,Non-OADS,/arxiv_data1/oa_pdf/e1/da/pharmpract-04-168.PMC4155619.pdf
http://www.astrazeneca.co .jp/activity/other/detail/03_02_10b.html (accessed 2006 August 2)  4.,Non-OADS,/arxiv_data1/oa_pdf/e1/da/pharmpract-04-168.PMC4155619.pdf
http://www.mhlw.go.jp/shingi/2005/01/dl /s0120-4b.pdf (accessed 2006 August 2)  5.,Non-OADS,/arxiv_data1/oa_pdf/e1/da/pharmpract-04-168.PMC4155619.pdf
http://www.mhlw.go.jp/houdou/2006/04/h0426-1.html (accessed 2006  March 30)  6.,Non-OADS,/arxiv_data1/oa_pdf/e1/da/pharmpract-04-168.PMC4155619.pdf
http://www.mhlw.go.jp/shingi /2005/01/s0120-4.html (accessed 2006 March 30)  7.,Non-OADS,/arxiv_data1/oa_pdf/e1/da/pharmpract-04-168.PMC4155619.pdf
http://www.mhlw.go.j p/shingi/2005/01/dl/s0120-4d.pdf  (accessed 2006 August 2)  9.,Non-OADS,/arxiv_data1/oa_pdf/e1/da/pharmpract-04-168.PMC4155619.pdf
http://www.mhlw.go.jp/shingi/2005/03/s0324-12.html (accessed  2006 August 2)  10.,Non-OADS,/arxiv_data1/oa_pdf/e1/da/pharmpract-04-168.PMC4155619.pdf
http://www.mhlw.go.jp/shingi /2003/05/dl/s0502-1m1.pdf (accessed 2006 August 2);  http://www.mhlw.go.jp/shingi/2003/05/dl /s0502-1m2.pdf (accessed 2006 August 2)  11.,Non-OADS,/arxiv_data1/oa_pdf/e1/da/pharmpract-04-168.PMC4155619.pdf
http://www.mhlw.go.jp/shingi /2005/03/txt/s0324-6.txt (accessed 2006 August 2)  12.,Non-OADS,/arxiv_data1/oa_pdf/e1/da/pharmpract-04-168.PMC4155619.pdf
http://www.info.pmda.go.jp/kinkyu_anzen/kinkyu20021015.pdf (accessed 2006 August 2)  16.,Non-OADS,/arxiv_data1/oa_pdf/e1/da/pharmpract-04-168.PMC4155619.pdf
http://www.astrazeneca.co.jp/activity/other/detail/03_03_11.html (accessed 2006 August 2)  18.,Non-OADS,/arxiv_data1/oa_pdf/e1/da/pharmpract-04-168.PMC4155619.pdf
"May 2, 2003.  http://www.fda.gov/cder/foi/label/2003/ 021399lbl.pdf (accessed 2006 August 2)  20.",Non-OADS,/arxiv_data1/oa_pdf/e1/da/pharmpract-04-168.PMC4155619.pdf
"Febr uary 25, 2005. http://med.astrazeneca.co.jp/iressasp/index.html  (accessed 2006 August 2)  24.",OADS,/arxiv_data1/oa_pdf/e1/da/pharmpract-04-168.PMC4155619.pdf
http://www.mhlw.go.jp/shingi/2005/03/dl /s0324-11d.pdf (accessed 2006 August 2)  25.,Non-OADS,/arxiv_data1/oa_pdf/e1/da/pharmpract-04-168.PMC4155619.pdf
http://www.mhlw.go.jp/shingi/2005/03/s 0317-4.html (accessed 2006 August 2)  26.,Non-OADS,/arxiv_data1/oa_pdf/e1/da/pharmpract-04-168.PMC4155619.pdf
http://www.npojip.org/iressa/i ressa10-r1.html (accessed 2006 August 2)  46.,Non-OADS,/arxiv_data1/oa_pdf/e1/da/pharmpract-04-168.PMC4155619.pdf
"May 1, 2003. http://www.citiz en.org/publications/print_release.cfm?ID=7242 (accessed  August 2, 2006)  47.",Non-OADS,/arxiv_data1/oa_pdf/e1/da/pharmpract-04-168.PMC4155619.pdf
"September 30, 2004. http://www.vioxx.com/rofecoxi b/vioxx/consumer/index.jsp (accessed August 2, 2006)  48.",Non-OADS,/arxiv_data1/oa_pdf/e1/da/pharmpract-04-168.PMC4155619.pdf
"November 18, 2004.   http://www.nihs.go.jp/dig/ich/efficacy/e2e/e2e_041118_e.pdf (accessed August 2, 2006))  51.",OADS,/arxiv_data1/oa_pdf/e1/da/pharmpract-04-168.PMC4155619.pdf
"June  17, 2005. http://www.astrazeneca-us .com/modules/PRMS/display.asp?i d=571650 (accessed 2006 August 2)  59.",Non-OADS,/arxiv_data1/oa_pdf/e1/da/pharmpract-04-168.PMC4155619.pdf
"January 4, 2005.  http://www.astrazeneca.com/pressreleas e/4442.aspx (accessed 2006 August 2)  60.",Non-OADS,/arxiv_data1/oa_pdf/e1/da/pharmpract-04-168.PMC4155619.pdf
"April 18, 2005.  http://www.nci.nih.gov/newscenter/pressreleas es/gefitinibNSCLC (accessed 2006 August 2)  61.",Non-OADS,/arxiv_data1/oa_pdf/e1/da/pharmpract-04-168.PMC4155619.pdf
http://www.mhlw.go.jp/general/sosiki/ kanbu/050110.html (accessed 2006 August 2)  67.,Non-OADS,/arxiv_data1/oa_pdf/e1/da/pharmpract-04-168.PMC4155619.pdf
http://www.mhlw.go.jp/shingi/2005/ 03/dl/s0310-3i.pdf (accessed 2006 August 2)  71.,Non-OADS,/arxiv_data1/oa_pdf/e1/da/pharmpract-04-168.PMC4155619.pdf
http://www.mhlw.go.jp/shingi/2005/ 01/dl/s0120-4c.pdf (accessed 2006 August 2)  72.,Non-OADS,/arxiv_data1/oa_pdf/e1/da/pharmpract-04-168.PMC4155619.pdf
"October 18, 2005.  http://www.fda.gov/medwatch/safety/2005/Nov_PI/Tarceva2_PI.pdf (accessed 2006 August 2)  74.",Non-OADS,/arxiv_data1/oa_pdf/e1/da/pharmpract-04-168.PMC4155619.pdf
Available at: http://www.nof.org/prevention/risk.htm.,Non-OADS,/arxiv_data1/oa_pdf/1b/d6/pharmpract-04-179.PMC4155620.pdf
Available at: http://www.nursingworld.org/mods/arc hive/mod152/cemhb1.htm.,Non-OADS,/arxiv_data1/oa_pdf/1b/d6/pharmpract-04-179.PMC4155620.pdf
Available at: http://www.osteo.org/newfile.asp?doc=r602i&doctitle=Lat ino+Women+and+Osteoporosis& doctype=HTML+Fact+Sheet.,Non-OADS,/arxiv_data1/oa_pdf/1b/d6/pharmpract-04-179.PMC4155620.pdf
"College Vision and Mission, University of  Illinois at Chicago College of Pharmacy,  http://www.uic.edu/pharmacy/content/about/frame_vision.htm, (Accessed December 1, 2005).",Non-OADS,/arxiv_data1/oa_pdf/6d/27/pharmpract-04-191.PMC4155621.pdf
"http://uic.edu/pharmacy/depts/pmpr/missionframe.htm, (Accessed December 1, 2005).",OADS,/arxiv_data1/oa_pdf/6d/27/pharmpract-04-191.PMC4155621.pdf
"http://www.usc.edu/schools/pharmacy/about/missi on.html, (Accessed December 1, 2005).",Non-OADS,/arxiv_data1/oa_pdf/6d/27/pharmpract-04-191.PMC4155621.pdf
"http://www.pharm.ku.edu/contentm/gen/school_of_pharmacy _generated_ns_pages/Pharmacy_Practice_m62.html,  (Accessed December 1, 2005).",Non-OADS,/arxiv_data1/oa_pdf/6d/27/pharmpract-04-191.PMC4155621.pdf
"http://www.phpr.purdue.edu, (Accessed December 1, 2005).",Non-OADS,/arxiv_data1/oa_pdf/6d/27/pharmpract-04-191.PMC4155621.pdf
"Available from URL:  http://www.hcp.med.harvard.edu/hpq (Accessed 9 October, 2006)  2.",Non-OADS,/arxiv_data1/oa_pdf/81/bc/pharmpract-04-204.PMC4155623.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMarch 2014 |  85  | e51458 | Page 1 of 13Video Article Inducing Plasticity of Astrocytic Receptors by Manipulation of Neuronal Firing Rates Alison X. Xie1, Kelli Lauderdale1, Thomas Murphy1, Timothy L. Myers1, Todd A. Fiacco2,3 1Graduate Program in Neuroscience, University of California Riverside 2Department of Cell Biology and Neuroscience, University of California Riverside 3Center for Glial-Neuronal Interactions, University of California Riverside Correspondence to: Todd A. Fiacco at toddf@ucr.edu URL: http://www.jove.com/video/51458 DOI: doi:10.3791/51458 Keywords: Neuroscience, Issue 85, astrocyte, plasticity, mGluRs, neuronal Firing, electrophysiology, Gq GPCRs, Bolus-loading, calcium, microdomains, acute slices, Hippocampus, mouse Date Published: 3/20/2014 Citation: Xie, A.X., Lauderdale, K., Murphy, T., Myers, T.L., Fiacco, T.A.",Non-OADS,/arxiv_data1/oa_pdf/13/67/jove-85-51458.PMC4155624.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/51458/ Introduction Astrocytes respond within seconds to stimulation of neurons or neuronal axons with increases in cytoplasmic Ca2+ resulting almost exclusively from activation of astrocytic Gq GPCRs.,Non-OADS,/arxiv_data1/oa_pdf/13/67/jove-85-51458.PMC4155624.pdf
Available from: http://www.gfmeroch/ Medical_education_En/PGC-RH-2004/barbieri_review.htm.,Non-OADS,/arxiv_data1/oa_pdf/27/85/JRMS-19-515.PMC4155705.pdf
Tehran2013; Available from: http://www.tehrantimes.com/society/107791-2000-burn-deaths-recorded-in-iran-last-year.,Non-OADS,/arxiv_data1/oa_pdf/05/6c/JRMS-19-562.PMC4155713.pdf
"According to information published by the National Cancer Institute of the U.S. National Institute of Health, the two radioactive isotopes released in a nuclear accident that generally pose the greatest cancer risks are iodine-131 (I-131) and cesium-137(Cs-137) (http://www.cancer.gov/cancertopics/factsheet/Risk/nuclear-power-accidents#ques2).",Non-OADS,/arxiv_data1/oa_pdf/40/2f/srep06294.PMC4155733.pdf
"As a result, by the end of December 2013, over 140,000 tons of such ash was classified and treated as radioactive waste (http://shiteihaiki.env.go.jp/02/02.html#amount).",OADS,/arxiv_data1/oa_pdf/40/2f/srep06294.PMC4155733.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests Yes there is a potential Competing Interest.,Non-OADS,/arxiv_data1/oa_pdf/40/2f/srep06294.PMC4155733.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0e/20/ccid-7-231.PMC4155739.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical, Cosmetic and Investigational Dermatology 2014:7 231–241Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  231RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S5036 7Skin resurfacing procedures: new   and emerging options Mathew M Loesch1 Ally-Khan Somani1 Melanie M Kingsley1 Jeffrey B Travers1–3 Dan F Spandau1,4 1Department of Dermatology,   2Department of Pharmacology and  T oxicology, 3Department of Pediatrics,   4Department of Biochemistry and  Molecular Biology, Indiana University  School of Medicine, Indianapolis, IN,   USA Correspondence: Dan F Spandau   Indiana University School of Medicine,  975 west walnut Street, Room 349,   Indianapolis, IN 46202, USA   email dspanda@iu.ed uAbstract:  The demand for skin resurfacing and rejuvenating procedures has progressively  increased in the last decade and has sparked several advances within the skin resurfacing  field that promote faster healing while minimizing downtime and side effects for patients.",Non-OADS,/arxiv_data1/oa_pdf/0e/20/ccid-7-231.PMC4155739.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/0e/20/ccid-7-231.PMC4155739.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0e/20/ccid-7-231.PMC4155739.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cf/69/ceg-7-285.PMC4155740.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical and Experimental Gastroenterology 2014:7 285–296Clinical and Experimental Gastroenterology Dove press submit your manuscript | www.dovepress.co m Dove press  285REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEG.S4308 4Advances, problems, and complications   of polypectomy Andrea Anderloni Manol Jovani Cesare Hassan Alessandro Repici Digestive Endoscopy Unit, Division  of Gastroenterology, Humanitas  Research Hospital, Rozzano,    Milan, italy Correspondence: Alessandro Repici   Digestive Endoscopy Unit, Division of  Gastroenterology, Humanitas Research  Hospital, Rozzano, Milan, italy   Tel +39 02 8224 2579   Fax +39 02 8224 2292   Email alessandro.repici@humanitas.i tAbstract:  The major role of colonoscopy with polypectomy in reducing the incidence of and  mortality from colorectal cancer has been firmly established.",Non-OADS,/arxiv_data1/oa_pdf/cf/69/ceg-7-285.PMC4155740.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/cf/69/ceg-7-285.PMC4155740.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cf/69/ceg-7-285.PMC4155740.pdf
"Exclusion criteria were: medical history of cardiovascular disease, cancer or diabetes; metabolic syndrome as de ﬁned by the International Diabetes Federation (http://www.idf.org/metabolic-syndrome), current use of med-ications to lower BP or lipids, insulin/glucose modulating medication,serum total cholesterol 47.0 mmol/l, serum TAG 43 mmol/l or an alcohol intake exceeded 21 units/week for males and 414 units/week for females.",Non-OADS,/arxiv_data1/oa_pdf/b7/ca/ejcn2014141a.PMC4155797.pdf
The study received ethical approval and registered with the National Medical Research Register (NMRR-10-933- 7221) on 17 February 2011 and the Current Controlled Trials Database(http://www.controlled-trials.com/ISRCTN16669399) on 19 September2011.,Non-OADS,/arxiv_data1/oa_pdf/b7/ca/ejcn2014141a.PMC4155797.pdf
"The homeostatic model assessment ofinsulin resistance (HOMA2-IR) was calculated using a software implemen-tation of the HOMA2 model developed by the Diabetes Trials Unit, University of Oxford (http://www.dtu.ox.ac.uk/homacalculator/).",OADS,/arxiv_data1/oa_pdf/b7/ca/ejcn2014141a.PMC4155797.pdf
This study is registered with the Current Controlled Trial database (http://www.controlled-trials.,Non-OADS,/arxiv_data1/oa_pdf/b7/ca/ejcn2014141a.PMC4155797.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on European Journal of Clinical Nutrition website (http://www.nature.com/ejcn)Interesteri ﬁed palm olein A Filippou et al 1041 © 2014 Macmillan Publishers Limited European Journal of Clinical Nutrition (2014) 1036 –1041",Non-OADS,/arxiv_data1/oa_pdf/b7/ca/ejcn2014141a.PMC4155797.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0a/c6/ppa-8-1143.PMC4155799.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 1143–1151Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1143OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/PPA.S6671 9Patient attitudes towards a new role for pharmacists:  continued dispensing salem hasn Abukres  Kreshnik hoti Jeffery David hughes school of Pharmacy, curtin health  and innovation research institute,   curtin University, Perth, WA, Australia Background:  In Australia, “continued dispensing” (CD) is a new model for supply of pre - scription medications.",Non-OADS,/arxiv_data1/oa_pdf/0a/c6/ppa-8-1143.PMC4155799.pdf
curtin.edu.a uJournal name: Patient Preference and Adherence Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Abukres et al Running head recto: Patient attitudes towards continued dispensing DOI: http://dx.doi.org/10.2147/PPA.S66719,Non-OADS,/arxiv_data1/oa_pdf/0a/c6/ppa-8-1143.PMC4155799.pdf
Available from:  http://www.medicareaustralia.gov.au/provider/pbs/fifth-agreement/ medication-continuance.jsp .,Non-OADS,/arxiv_data1/oa_pdf/0a/c6/ppa-8-1143.PMC4155799.pdf
"Available from: http://books.google.com.au/books?hl =en&lr=&id =g0C6745CoAoC&oi =fnd&pg=PP1&dq=+General+Practice+Act ivity+in+Australia +2011-12: +Beach,+Bettering +the+Evaluation + and+Care+of+Health.+&ots=hr-veveMMB&sig =yI33Xg91MaR- fF9CYtwO8MES960#v =onepage&q =General%20Practice%20 Activity%20 in%20Australia%202011-12%3A%20Beach%2C%20 Bettering%20the%20Evaluation%20and%20Care%20of%20 Health.&f =false.",Non-OADS,/arxiv_data1/oa_pdf/0a/c6/ppa-8-1143.PMC4155799.pdf
Available from: http://www.guild.org.au/ docs/default-source/public-documents/services-and-programs/research- and-development/Third-Agreement-R-and-D/2003-017/final-report.,Non-OADS,/arxiv_data1/oa_pdf/0a/c6/ppa-8-1143.PMC4155799.pdf
Available from: http://www.medicareaustralia.gov.,Non-OADS,/arxiv_data1/oa_pdf/0a/c6/ppa-8-1143.PMC4155799.pdf
Available from: http://www.pharmacyresearchuk.org/waterway/wp- content/uploads/2012/11/Exploring_innovation_in_pharmacy_prac - tice_supplementary_prescribing.pdf .,Non-OADS,/arxiv_data1/oa_pdf/0a/c6/ppa-8-1143.PMC4155799.pdf
Available from:  http://ama.com.au/node/7453 .,OADS,/arxiv_data1/oa_pdf/0a/c6/ppa-8-1143.PMC4155799.pdf
Avail - able from: http://books.google.com.au/books?hl =en&lr=&id=x6Vp5N O93CAC&oi =fnd&pg=PP2&dq=Surveys+in+Social+Research&ots =Y MCg378Lvr&sig =Gz5zRSRpKmKc85hWuAjldphSWjA#v =onepage& q=Surveys%20in%20Social%20Research&f =false .,Non-OADS,/arxiv_data1/oa_pdf/0a/c6/ppa-8-1143.PMC4155799.pdf
Available from: http://webcache.google - usercontent.com/search?q =cache:A6E-U7hUcRAJ:www.acma.,OADS,/arxiv_data1/oa_pdf/0a/c6/ppa-8-1143.PMC4155799.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/0a/c6/ppa-8-1143.PMC4155799.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/00/28/dddt-8-1169.PMC4155800.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 1169–1173Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1169Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6855 2The efficacy of ampicillin and Lactobacillus casei  rhamnosus  in the active management of preterm  premature rupture of membranes remote   from term salih Burcin Kavak1 ebru Kavak2 rasit ilhan1 remzi atilgan1 Ozgur arat1 Ugur Deveci3 ekrem sapmaz1 1Department of Obstetrics and  gynecology, Firat Medical center,   school of Medicine, Firat University,   2Department of Obstetrics and  gynecology, special Medical Park  hospital,  3Department of Pediatrics,   Firat Medical center, school of  Medicine, Firat University, elazig,   T urkey correspondence:   salih Burcin Kavak   Firat University, school of Medicine,   Firat Medical center, Department of  Obstetrics and gynecology   23100, elazig, T urkey   T el +90 424 233 35 55  extn 2124   Fax +90 424 237 91 38   email burcinkavak@gmail.co mBackground:  We aimed to investigate the treatment efficacy of ampicillin prophylaxis  accompanied by Lactobacillus casei rhamnosus  over the latency period following preterm  premature rupture of membranes (PPROM).",Non-OADS,/arxiv_data1/oa_pdf/00/28/dddt-8-1169.PMC4155800.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/00/28/dddt-8-1169.PMC4155800.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/00/28/dddt-8-1169.PMC4155800.pdf
Available from: ftp://ftp.fao.,OADS,/arxiv_data1/oa_pdf/00/28/dddt-8-1169.PMC4155800.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bf/82/idr-7-229.PMC4155802.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInfection and Drug Resistance 2014:7 229–237Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  229RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S4922 9Peptidomimetics as a new generation   of antimicrobial agents: current progress Patricia Méndez-Samperio Department of Immunology,    National School of Biological   Sciences, National Polytechnic   Institute, Mexico City, Mexico Correspondence: Patricia Méndez- Samperio   Department of Immunology,   National School of Biological   Sciences, National Polytechnic   Institute, Prol Carpio y Plan de Ayala,   Mexico City  11340, DF, Mexico   Tel +52 55 729 6000 ext  62499  email pmendezs@encb.ipn.m xAbstract:  Antibiotic resistance is an increasing public health concern around the world.",Non-OADS,/arxiv_data1/oa_pdf/bf/82/idr-7-229.PMC4155802.pdf
Structural coordinates were obtained from the Research  Collaboratory for Structural Bioinformatics Protein Databank ( http://www.rcsb.or g).,OADS,/arxiv_data1/oa_pdf/bf/82/idr-7-229.PMC4155802.pdf
"Available from: http://files.shareholder.com/ downloads/ABEA-4ITCYZ/1997024712x0x611205/FEA66C67-D02F- 4FF2-B230-AA711F46ED7F/PMX-30063_ Antibiotic_Fact_Sheet_ Nov_2012_.pd f. Accessed February 10, 2013.",Non-OADS,/arxiv_data1/oa_pdf/bf/82/idr-7-229.PMC4155802.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/bf/82/idr-7-229.PMC4155802.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/82/idr-7-229.PMC4155802.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fe/f2/tcrm-10-701.PMC4155803.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pTherapeutics and Clinical Risk Management 2014:10 701–711Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  701Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S5761 0Avanafil for erectile dysfunction in elderly   and younger adults: differential pharmacology   and clinical utility eric G Katz1 Ronny BW Tan2 Daniel Rittenberg1 Wayne J Hellstrom3 1Tulane University School of   Medicine, New Orleans, LA, USA;    2Department of Urology, Tan Tock  Seng Hospital, Singapore;  3Section of   Andrology, Department of Urology,    T ulane University School of Medicine,   New Orleans, LA, USA Correspondence: Wayne J Hellstrom   Tulane University Health Sciences  Center, Department of Urology,   1430 Tulane Ave SL-42,   New Orleans, LA,  70112, USA   Tel +1 504 988 5372  Fax +1 504 988 5059  email whellst@tulane.ed uAbstract:  The treatment modalities of erectile dysfunction range from oral pharmacotherapy  to intracavernosal injections, intraurethral pellets, vacuum erectile devices, and the surgical  option of penile prosthesis insertion.",Non-OADS,/arxiv_data1/oa_pdf/fe/f2/tcrm-10-701.PMC4155803.pdf
"Available from: http://www.fda.gov/newsevents/newsroom/  pressannouncements/ucm302140.ht m. Accessed February  23, 2014.",Non-OADS,/arxiv_data1/oa_pdf/fe/f2/tcrm-10-701.PMC4155803.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/fe/f2/tcrm-10-701.PMC4155803.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fe/f2/tcrm-10-701.PMC4155803.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/31/a8/vhrm-10-533.PMC4155804.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpVascular Health and Risk Management 2014:10 533–538Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  533ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/VHRM.S6358 0coronary microvascular endothelial dysfunction  is an independent predictor of development   of osteoporosis in postmenopausal women Megha Prasad Martin Reriani sundeep Khosla Mario gössl Ryan lennon Rajiv gulati abhiram Prasad lilach O lerman amir lerman Division of cardiovascular Diseases,   Mayo clinic, Rochester, M n, Usa correspondence: amir lerman   Division of cardiovascular Disease,  Department of internal Medicine,   Mayo clinic, 200 First street sW,   Rochester, Mn, 55905, Usa   Tel +1 507 255 4152   Fax +1 507 255 2550   email lerman.amir@mayo.ed uBackground:  A growing body of evidence links coronary artery atherosclerosis and calcifica - tion to osteoporosis in women.",Non-OADS,/arxiv_data1/oa_pdf/31/a8/vhrm-10-533.PMC4155804.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/31/a8/vhrm-10-533.PMC4155804.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/31/a8/vhrm-10-533.PMC4155804.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/92/84/opth-8-1603.PMC4155806.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1603–1609Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1603Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OPTH.S6470 3lacrimal fossa lesions: a review of 146 cases   in egypt Mohammed a eldesouky1  Molham a elbakary1  saly sabik1 Mohamed M shareef2 1Oculoplastic Unit, Ophthalmology  Department, Faculty of Medicine,   Tanta University, 2Pathology  Department, Faculty of Medicine,   Tanta University, Tanta, egypt Correspondence: Molham a elbakary   Faculty of Medicine, Tanta University,  Postal no 31527, Tanta, egypt   T el +00 201 1482 82205   Fax +00 204 0340 7734   email melbakary75@yahoo.co mJournal name: Clinical Ophthalmology Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Eldesouky et al Running head recto: Lacrimal fossa lesions DOI: http://dx.doi.org/10.2147/OPTH.S64703 Purpose:  The incidence and clinical and imaging criteria of different pathological forms of  lacrimal fossa lesions in the Delta region of Egypt were studied.",Non-OADS,/arxiv_data1/oa_pdf/92/84/opth-8-1603.PMC4155806.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/92/84/opth-8-1603.PMC4155806.pdf
"Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1609lacrimal fossa lesions to achieve a provisional diagnosis, and is crucial when lac - rimal gland epithelial tumor is suspected.",Non-OADS,/arxiv_data1/oa_pdf/92/84/opth-8-1603.PMC4155806.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ff/07/opth-8-1611.PMC4155807.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1611–1621Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1611Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OPTH.S6089 3Clinical utilization of anti-vascular endothelial  growth-factor agents and patient monitoring in  retinal vein occlusion and diabetic macular edema szilárd Kiss1 Ying liu2 Joseph Brown3 nancy M holekamp4,5 arghavan almony6 Joanna Campbell2 Jonathan W Kowalski2 1Weill Cornell Medical College, new  Y ork, nY; 2allergan, inc., irvine, C a;   3iMs health, Woodland hills, C a;   4Pepose Vision institute, Chesterfield,   MO; 5Washington University school of  Medicine, st louis, MO; 6Carolina eye  associates, southern Pines, nC, Usa Correspondence: szilárd Kiss   Weill Cornell Medical College new Y ork  Presbyterian hospital, 1305 Y ork   avenue – 11th Floor, new Y ork,   nY 10021, Usa   T el +1 646 962 2217   Fax +1 646 962 0609   email szk7001@med.cornell.ed uPurpose:  To examine the utilization of bevacizumab and ranibizumab and disease monitoring  in patients with branch or central retinal vein occlusion (BRVO/CRVO) or diabetic macular  edema (DME) in clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/ff/07/opth-8-1611.PMC4155807.pdf
"Anti-VEGF agents, including ranibizumab (Lucentis®; Genentech, Journal name: Clinical Ophthalmology Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Kiss et al Running head recto: Anti-VEGF utilization in RVO and DME DOI: http://dx.doi.org/10.2147/OPTH.S60893",Non-OADS,/arxiv_data1/oa_pdf/ff/07/opth-8-1611.PMC4155807.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/ff/07/opth-8-1611.PMC4155807.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1621anti-VegF utilization in r VO and DMe  19.,Non-OADS,/arxiv_data1/oa_pdf/ff/07/opth-8-1611.PMC4155807.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)miR-149 targets GIT1 to suppress breast cancer metastasis S-H Chan et al 4507 © 2014 Macmillan Publishers Limited Oncogene (2014) 4496 –4507",Non-OADS,/arxiv_data1/oa_pdf/fd/bd/onc201410a.PMC4155808.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/52/9d/sccaa-7-071.PMC4155810.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pStem Cells and Cloning: Advances and Applications 2014:7 71–78Stem Cells and Cloning: Advances and Applications Dove press submit your manuscript | www.dovepress.co m Dove press  71OriginAl reSeArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/SCCAA.S6779 0Cat amniotic membrane multipotent cells   are nontumorigenic and are safe for use   in cell transplantation Atanasio S Vidane1 Aline F Souza1 rafael V Sampaio1 Fabiana F Bressan2 naira C Pieri1 Daniele S Martins2 Flavio V Meirelles2 Maria A Miglino1 Carlos e Ambrósio2 1Department of Surgery, Faculty of  Veterinary Medicine and Animal  Science, University of São Paulo,   São Paulo, Brazil;  2Department of  Veterinary Medicine, Faculty of   Animal Sciences and Food  engineering, University of   São Paulo, São Paulo, Brazil Correspondence: Carlos e Ambrosio   Department of Basic Science, Faculty of  Animal Science and Food engineering,  University of São Paulo, Av Duque de  Caxias norte  225, Pirassununga, São  Paulo, Brazil, CeP  13635-900   Tel +55 11 3565 4112  email ceambrosio@usp.b rAbstract:  Amnion-derived mesenchymal stem cells (AMSCs) are multipotent cells with  an enhanced ability to differentiate into multiple lineages.",Non-OADS,/arxiv_data1/oa_pdf/52/9d/sccaa-7-071.PMC4155810.pdf
"Stem Cells and Cloning: Advances and Applications Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/stem-cells-and-cloning-advances-and-applications-journa lStem Cells and Cloning: Advances and Applications is an international,  peer-reviewed, open access journal.",Non-OADS,/arxiv_data1/oa_pdf/52/9d/sccaa-7-071.PMC4155810.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/52/9d/sccaa-7-071.PMC4155810.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f9/a1/hiv-6-127.PMC4155831.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pHIV/AIDS – Research and Palliative Care 2014:6 127–137HIV/AIDS – Research and Palliative Care Dove press submit your manuscript | www.dovepress.co m Dove press  127ORIg InAl ReSeARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HIV.S6496 4effects of leisure activities and psychosocial support  on medication adherence and clinic attendance  among children on antiretroviral therapy emmanuel Adémólá  Anígilájé1 Othniel Joseph Dabit1 Ruth Kashimana Tyovenda2 Agnes Jane emebolu2 Augustine Aondohemba  Agbedeh2 Ayodotun Olutola3 Omolara Olufunmilayo  Anígilájé4 1Department of Paediatrics, Benue  State University, 2Department of  Paediatrics, Federal Medical Centre,   Makurdi, Benue State, 3Centre for  Clinical Care and Clinical Research,   Maitama, Abuja, 4Department of Family  Medicine, Federal Medical Centre,   Makurdi, Benue State, nigeria Correspondence: emmanuel Adémólá  Anígilájé   Department of Paediatrics, Benue State   University, Makurdi, Benue State, nigeria   Tel +234 803 383 3839   email demolaanigilaje@yahoo.co.u kBackground:  Optimal adherence to antiretroviral therapy (ART) and retention-in-care are  essential in HIV management.",Non-OADS,/arxiv_data1/oa_pdf/f9/a1/hiv-6-127.PMC4155831.pdf
"HIV/AIDS - Research and Palliative Care Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hivaids---research-and-palliative-care-journa lHIV/AIDS - Research and Palliative Care is an international, peer- reviewed open-access journal focusing on advances in research in HIV ,  its clinical progression and management options including antiviral  treatment, palliative care and public healthcare policies to control  viral spread.",Non-OADS,/arxiv_data1/oa_pdf/f9/a1/hiv-6-127.PMC4155831.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f9/a1/hiv-6-127.PMC4155831.pdf
"Available from: http://www.genecar ds.org/cgi - bin/carddisp.pl?gene=DRD2   [63] Lawford BR, Young RM, Noble EP, et al .",OADS,/arxiv_data1/oa_pdf/41/3d/CPSR-10-156.PMC4155832.pdf
2011; Available from:  http://www.genecards.org.,Non-OADS,/arxiv_data1/oa_pdf/41/3d/CPSR-10-156.PMC4155832.pdf
2011 September  23; Available from: http://www.genecards.org/cgibin/carddisp.pl?,Non-OADS,/arxiv_data1/oa_pdf/41/3d/CPSR-10-156.PMC4155832.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e6/0d/ott-7-1497.PMC4155833.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2014:7 1497–1518OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1497Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S3662 4Cytoprotection “gone astray”: Nrf2   and its role in cancer Claudia Geismann1 Alexander Arlt1 Susanne Sebens2 Heiner Schäfer1 1Laboratory of Molecular  Gastroenterology, Department of  internal Medicine i, 2inflammatory  Carcinogenesis Research Group,   institute of experimental Medicine,   Universitätsklinikum Schleswig- Holstein Campus Kiel, Kiel, Germany Correspondence: Heiner Schäfer   Laboratory of Molecular Gastroenterology,  Department of internal Medicine i,  University Hospital Schleswig Holstein  Campus Kiel,  Arnold-Heller-Strasse 3,  Building 6, D-24105 Kiel, Germany   email hschaef@1med.uni-kiel.d eAbstract:  Nrf2 has gained great attention with respect to its pivotal role in cell and tissue  protection.",Non-OADS,/arxiv_data1/oa_pdf/e6/0d/ott-7-1497.PMC4155833.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e6/0d/ott-7-1497.PMC4155833.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e6/0d/ott-7-1497.PMC4155833.pdf
"China) [b]M. A. Zie ˛tek, H. J. Russell, S. Tait, Dr. S. Hay, Prof. N. S. Scrutton Manchester Institute of Biotechnology and Faculty of Life SciencesThe University of Manchester 131 Princess Street, Manchester M1 7DN (UK) E-mail: nigel.scrutton@manchester.ac.uk [c]Dr. A. R. Jones Photon Science Institute and School of ChemistryThe University of ManchesterAlan Turing Building, Oxford Road, Manchester M13 9PL (UK) E-mail: alex.jones-2@manchester.ac.uk Supporting information for this article is available on the WWW under http://dx.doi.org/10.1002/cbic.201300420.",Non-OADS,/arxiv_data1/oa_pdf/4f/14/cbic0014-1529.PMC4155860.pdf
Find a Physio [Internet] 2012 [cited 2012 Mar 1].Available from: http://www.physiotherapy.asn.au/APAWCM/Controls/FindaPhysio.aspx 29 Continence Foundation of Australia.,Non-OADS,/arxiv_data1/oa_pdf/13/c0/bju0113-0383.PMC4155862.pdf
"Search for a service provider [Internet] 2012 [cited 2012 Mar 1].Available from: http://www.continence.org.au/service-providers.php30 Wensing M, Bosch M, Grol R. Developing and selecting interventions for translating knowledge to action.",OADS,/arxiv_data1/oa_pdf/13/c0/bju0113-0383.PMC4155862.pdf
"World cancer factsheet.Available at: http://publications.cancerresearchuk.org/downloads/product/CS_FS_WORLD_A4.pdf.Accessed September 2012 7 Miodosky M, Abdul-Hai A, Tsirigotis P etal.",Non-OADS,/arxiv_data1/oa_pdf/93/56/bju0112-0885.PMC4155867.pdf
"Common terminology criteria for adverse events,v3.0 (CTCAE), 2003.Available at: http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.pdf.Accessed June 2013 23 Hassan Z, Remberger M, Svenberg P etal.",Non-OADS,/arxiv_data1/oa_pdf/93/56/bju0112-0885.PMC4155867.pdf
"NCT01659723.Available at: http://clinicaltrials.gov/ct2/show/NCT01659723.Accessed September2012 130 Madersbacher H, van Ophoven A, van Kerrebroeck PE.",Non-OADS,/arxiv_data1/oa_pdf/93/56/bju0112-0885.PMC4155867.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0b/89/opth-8-1623.PMC4155892.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1623–1628Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1623Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OPTH.S6847 4Use of therapeutic non-refractive contact  lenses to improve visual outcome after repair  of traumatic corneal wounds Mohammad M Khater Ophthalmology Department, Tanta  University hospital, Tanta, el gharbia  governorate, egypt Background:  The purpose of this study was to evaluate the effect of use of contact lenses to  improve visual outcome after repair of traumatic corneal wounds.",Non-OADS,/arxiv_data1/oa_pdf/0b/89/opth-8-1623.PMC4155892.pdf
"Keywords:  non-refractive contact lenses, traumatic corneal wounds, repair, visual outcome  Introduction  Traumatic rupture globe injuries are sight-threatening conditions that may end  in considerable visual impairment, and even visual loss in many instances with a  severe globe insult.1,2 Traumatic corneal wounds carry a hopeful and good progno - sis especially if not associated with other ocular injuries and managed properly.3   Patients in many instances may present late, which delays management and car - ries a risk of intraocular infection, so the condition may worsen, affecting the  prognosis.4,5 Management of traumatic corneal wounds is challenging and no stan - dards are defined.6 Therapeutic contact lenses have been used in a variety of corneal  disorders to help healing of recurrent epithelial erosions, corneal dystrophy, corneal  ulcers, and corneal chemical injuries, and post photorefractive keratectomy.7 The  present study reports on the usefulness of contact lenses in decreasing the degree  of induced astigmatism and improving the visual outcome after repair of traumatic  corneal wounds.Correspondence: Mohammad M Khater Ophthalmology Department, Tanta  University hospital, Tanta, el gharbia  governorate, egypt email ophlover@yahoo.co m Journal name: Clinical Ophthalmology Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Khater Running head recto: Non-refractive contact lenses and traumatic corneal wounds DOI: http://dx.doi.org/10.2147/OPTH.S68474 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/0b/89/opth-8-1623.PMC4155892.pdf
Or use: http://dvpr.es/1qbqkX G Video abstract,Non-OADS,/arxiv_data1/oa_pdf/0b/89/opth-8-1623.PMC4155892.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/0b/89/opth-8-1623.PMC4155892.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1628Khater References  1.,Non-OADS,/arxiv_data1/oa_pdf/0b/89/opth-8-1623.PMC4155892.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/19/82/ott-7-1525.PMC4155893.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2014:7 1525–1533OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1525Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S6534 5eR-α36: a novel biomarker and potential  therapeutic target in breast cancer Xingyun Su1 Xin Xu1 Guangliang Li1,4 Bingyi Lin2 Jiang Cao3 Lisong T eng1 1Department of Surgical Oncology,   First Affiliated Hospital, College  of Medicine, Zhejiang University,   Hangzhou, Zhejiang, People’s  Republic of China; 2Key Laboratory  of Combined Multi-Organ  Transplantation, Ministry of Public  Health, Hangzhou, Zhejiang, People’s   Republic of China; 3Clinical Research   Center, The 2nd Affiliated Hospital,   College of Medicine, Zhejiang  University, Hangzhou, Zhejiang,   People’s Republic of China;   4Department of Medical Oncology,   Zhejiang Cancer Hospital, Hangzhou,   Zhejiang Province, People’s Republic  of China Correspondence: Lisong Teng   Department of Surgical Oncology,   First Affiliated Hospital, College of  Medicine, Zhejiang University, 79  Qingchun Road, Hangzhou 310003,  Zhejiang, People’s Republic of China   Tel +86 571 8706 8873   Fax +86 571 8723 6628   email lsteng@zju.edu.c n Jiang Cao   Clinical Research Center, The  2nd Affiliated Hospital, College  of Medicine, Zhejiang University,  Hangzhou, Zhejiang Province,  People’s Republic of China   Tel +86 571 8731 5201   Fax +86 571 8731 5201   email caoj@zju.edu.c nAbstract:  Estrogen receptor-alpha36 (ER- α36) is a 36-kDa variant of estrogen receptor-alpha  (ER-α) firstly identified and cloned by Wang et al in 2005.",Non-OADS,/arxiv_data1/oa_pdf/19/82/ott-7-1525.PMC4155893.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/19/82/ott-7-1525.PMC4155893.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/19/82/ott-7-1525.PMC4155893.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/56/f8/opth-8-1629.PMC4155894.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1629–1632Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1629Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/ 10.2147/OPTH.S6552 0Melina I Morkin1,2 rehan M Hussain2 ryan C Y oung2 tracy ravin2 sander r Dubovy2 eduardo C alfonso2 1Department of Ophthalmology,   shiley eye Center, University  of California – san Diego, san Diego,   Ca, 2Department of Ophthalmology,   Bascom palmer eye Institute, Miller  school of Medicine, University  of Miami, Miami, FL, UsaAbstract:  A 51-year-old male who had undergone phacoemulsification in his left eye 11 months  prior presented with complaint of sudden onset of blurred vision in the same eye.",Non-OADS,/arxiv_data1/oa_pdf/56/f8/opth-8-1629.PMC4155894.pdf
"He had undergone uncomplicated phacoemulsification (Alcon) with Correspondence: Melina I Morkin Department of Ophthalmology, shiley  eye Center, University of California – san  Diego, 9415 Campus point Drive, La Jolla,  san Diego, Ca 92093, Usa tel +1 858 246 1791 Fax +1 858 822 2245 email mmorkin@ucsd.ed u Journal name: Clinical Ophthalmology Journal Designation: Case report Y ear: 2014 Volume: 8 Running head verso: Morkin et al Running head recto: Unusually delayed Descemet’s membrane tear after cataract surgery DOI: http://dx.doi.org/10.2147/OPTH.S65520 Unusually delayed presentation of persistent  Descemet’s membrane tear and detachment  after cataract surgery",Non-OADS,/arxiv_data1/oa_pdf/56/f8/opth-8-1629.PMC4155894.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/56/f8/opth-8-1629.PMC4155894.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1632Morkin et al time of presentation.,Non-OADS,/arxiv_data1/oa_pdf/56/f8/opth-8-1629.PMC4155894.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e0/7f/ndt-10-1585.PMC4155895.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 1585–1587Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1585Case Repo RTopen access to scientific and medical research open access Full T ext article http: //dx.doi.org/ 10.2147/NDT .S6765 4Correspondence: Mong-Liang Lu   Department of psychiatry, Wan-Fang  Hospital, No 111, section 3, Hsing Long  Road, Taipei 116, Taiwan   T el +886 2 2930 7930 ext 53961   email monglianglu@gmail.co m Hepatotoxicity induced by clozapine: a case  report and review of literature ana Isabel Wu Chou1 Mong-Liang Lu1,2 Winston W shen1,2 1Department of p sychiatry, Wan-Fang  Hospital, Taipei Medical University,   2Department of psychiatry, school   of Medicine, Taipei Medical University,   Taipei, TaiwanJournal name: Neuropsychiatric Disease and Treatment Journal Designation: Case Report Y ear: 2014 Volume: 10 Running head verso: Wu Chou et al Running head recto: Hepatotoxicity induced by clozapine  DOI: http://dx.doi.org/10.2147/NDT.S67654 Abstract:  Clozapine is an effective antipsychotic drug but is associated with serious side effects.",Non-OADS,/arxiv_data1/oa_pdf/e0/7f/ndt-10-1585.PMC4155895.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/e0/7f/ndt-10-1585.PMC4155895.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.Dove pres s Neuropsychiatric Disease and Treatment 2014:10submit your manuscript | www.dovepress.co m Dove press Dove press 1587Hepatotoxicity induced by clozapine may either experience unpredictable delayed hepatitis or  become symptomatic shortly after starting the drug (within  1–2 weeks in our case).,Non-OADS,/arxiv_data1/oa_pdf/e0/7f/ndt-10-1585.PMC4155895.pdf
Available from:  http://livertox.nih.gov/Naranjoassessment.pdf.,OADS,/arxiv_data1/oa_pdf/e0/7f/ndt-10-1585.PMC4155895.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ad/3a/opth-8-1641.PMC4155896.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1641–1647Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1641Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OPTH.S6541 2Perioperative and postoperative risk factors  for corneal graft failure alice l Yu1 Michaela Kaiser1 Markus schaumberger1 elisabeth Messmer1 Daniel Kook1 Ulrich Welge-lussen2 1Department of Ophthalmology,  ludwig-Maximilians-University,  Munich, 2Department of  Ophthalmology, Friedrich-alexander- University, erlangen, germanyPurpose:  In this study, we assessed the outcome of penetrating keratoplasties using  organ-cultured corneal tissues at the University Eye Hospital, Ludwig-Maximilians-University,  Munich, Germany.",Non-OADS,/arxiv_data1/oa_pdf/ad/3a/opth-8-1641.PMC4155896.pdf
"This fact emphasizes the importance of  evaluating the risk factors for corneal transplantation in each specific setting.Correspondence: alice l Yu Department of Ophthalmology,  ludwig-Maximilians-University,  8 Mathildenstrasse, Munich 80336,  germany Tel +49 89 5160 3811 Fax +49 89 5160 3051 email alice.yu@med.uni-muenchen.d eJournal name: Clinical Ophthalmology Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Yu et al Running head recto: Risk factors for corneal graft failure DOI: http://dx.doi.org/10.2147/OPTH.S65412",Non-OADS,/arxiv_data1/oa_pdf/ad/3a/opth-8-1641.PMC4155896.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/ad/3a/opth-8-1641.PMC4155896.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1647risk factors for corneal graft failure  5.,Non-OADS,/arxiv_data1/oa_pdf/ad/3a/opth-8-1641.PMC4155896.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/37/10/ott-7-1519.PMC4155897.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 1519–1523OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1519Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S6523 8long-term outcomes from dose-escalated   image-guided intensity-modulated radiotherapy   with androgen deprivation: encouraging results   for intermediate- and high-risk prostate cancer shea W Wilcox1,4 noel J aherne2,4 linus c Benjamin1 Bosco Wu1 Thomaz de campos silva3 craig s Mclachlan4 Michael J McKay3,5 andrew J last1 Thomas P shakespeare1–4 1north coast cancer institute,   Port Macquarie, nsW, australia;   2north coast cancer institute, coffs  harbour, nsW, australia;  3north  coast cancer institute, lismore,   nsW, australia;  4The University of  new south Wales, rural clinical  school, sydney, nsW, australia;    5The University of sydney, sydney,   nsW, australia correspondence: shea W Wilcox   north coast cancer institute, Wrights rd,   Port Macquarie  2444, nsW, australia   Tel +61 422 568 663  email s hea.wilcox@gmail.co mPurpose:  Dose-escalated (DE) radiotherapy in the setting of localized prostate cancer has been  shown to improve biochemical disease-free survival (bDFS) in several studies.",Non-OADS,/arxiv_data1/oa_pdf/37/10/ott-7-1519.PMC4155897.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/37/10/ott-7-1519.PMC4155897.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/37/10/ott-7-1519.PMC4155897.pdf
http://www.ncbi.nlm.nih.gov/ pubmed/9929018.,Non-OADS,/arxiv_data1/oa_pdf/37/10/ott-7-1519.PMC4155897.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/45/92/oajsm-5-197.PMC4155898.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOpen Access Journal of Sports Medicine 2014:5 197–203Open Access Journal of Sports Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  197OriginAl reSeArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/OAJSM.S6205 0effect of tunnel placements on clinical and  magnetic resonance imaging findings  2 years   after anterior cruciate ligament reconstruction   using the double-bundle technique Piia Suomalainen1 T ommi Kiekara2 Anna-Stina Moisala1 Antti Paakkala2 Pekka Kannus3 Timo Järvelä4 1Division of Orthopaedics and  Traumatology, Department of  Trauma, Musculoskeletal Surgery and  rehabilitation, Tampere University  hospital, Tampere,  2Medical imaging  centre, Tampere University hospital,   Tampere,  3injury and Osteoporosis  research center, UKK institute,   Tampere,  4Arthroscopic and Sports  Medicine center Omasairaala,   helsinki, Finland correspondence: Piia Suomalainen   Division of Orthopaedics and  Traumatology, Department of   Trauma, Musculoskeletal Surgery   and rehabilitation, Tampere   University hospital, Teiskontie 35,    33520 Tampere, Finland   Tel +358 3 311 67773  email piia.suomalainen@uta.fiPurpose:  The purpose of the study reported here was to find out if the clinical and magnetic  resonance imaging (MRI) findings of a reconstructed anterior cruciate ligament (ACL) have an  association.",Non-OADS,/arxiv_data1/oa_pdf/45/92/oajsm-5-197.PMC4155898.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/45/92/oajsm-5-197.PMC4155898.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/45/92/oajsm-5-197.PMC4155898.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c6/f5/opth-8-1649.PMC4155899.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1649–1653Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1649Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/ 10.2147/OPTH.S6785 5endophthalmitis following pars plana vitrectomy  for vitreous floaters Christopher r Henry stephen G schwartz Harry W Flynn Jr Department of Ophthalmology,   Bascom palmer eye Institute,   University of Miami Miller school  of Medicine, Miami, FL, UsaAbstract:  A case of Staphylococcus caprae  endophthalmitis in a young patient following   pars plana vitrectomy for symptomatic vitreous floaters is reported here.",Non-OADS,/arxiv_data1/oa_pdf/c6/f5/opth-8-1649.PMC4155899.pdf
"Fluorescein angiography demonstrated areas of blockage corresponding Correspondence: Christopher r Henry Bascom palmer eye Institute, 900 NW  17th street, Miami, FL 33136, Usa tel +1 305 326 6000 email chenry2@med.miami.ed u Journal name: Clinical Ophthalmology Journal Designation: Case report Y ear: 2014 Volume: 8 Running head verso: Henry et al Running head recto: Endophthalmitis following PPV for vitreous floaters DOI: http://dx.doi.org/10.2147/OPTH.S67855",Non-OADS,/arxiv_data1/oa_pdf/c6/f5/opth-8-1649.PMC4155899.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/c6/f5/opth-8-1649.PMC4155899.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1653Endophthalmitis following PPV for vitreous floaters 13.,Non-OADS,/arxiv_data1/oa_pdf/c6/f5/opth-8-1649.PMC4155899.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9a/c6/opth-8-1633.PMC4155900.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1633–1640Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1633Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S6758 9Bacterial endogenous endophthalmitis   in Vietnam: a randomized controlled trial   comparing vitrectomy with silicone   oil versus vitrectomy alone Tan Do1 Do n hon1 Tin aung2 nguyen DTn  hien1 Claude l Cowan Jr3 1Vietnam national institute of  Ophthalmology, hanoi,   Vietnam;   2singapore national eye Center,   singapore; 3georgetown University  Medical Center,  Washington, DC, Usa Correspondence:  Tan Do   Vietnam national institute of  Ophthalmology, 85 Ba Trieu street,  hanoi,  Vietnam   T el +84 4 943 7027   Fax +84 4 943 8004   email dotan20042005@yahoo.co m Journal name: Clinical Ophthalmology Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Do et al Running head recto: Vitrectomy for bacterial endogenous endophthalmitis in Vietnam  DOI: http://dx.doi.org/10.2147/OPTH.S67589 Background/aims:  To compare treatment outcomes with and without silicone oil tamponade  in patients undergoing pars plana vitrectomy (PPV) for severe endogenous bacterial endophthal - mitis (BEE).",Non-OADS,/arxiv_data1/oa_pdf/9a/c6/opth-8-1633.PMC4155900.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/9a/c6/opth-8-1633.PMC4155900.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1640Do et al 23.,Non-OADS,/arxiv_data1/oa_pdf/9a/c6/opth-8-1633.PMC4155900.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a4/b6/opth-8-1655.PMC4155901.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1655–1660Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1655Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S6185 1Clinical characteristics of patients   with conjunctivochalasis Correspondence:  Ozlem Balci   Kolan hospitalium group,   adnan Kahveci M, Osmanli C no 17,  Beylikduzu, istabul, Turkey   Tel +90 532 463 7810   email ozlembmd@yahoo.co mOzlem Balci Ophthalmology Department, Kolan  hospitalium group, istanbul, T urkeyPurpose:  To evaluate the clinical characteristics of patients with conjunctivochalasis (CCh).",Non-OADS,/arxiv_data1/oa_pdf/a4/b6/opth-8-1655.PMC4155901.pdf
This study aimed to evaluate the clinical  characteristics of patients with CCh.Journal name: Clinical Ophthalmology Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Balci Running head recto: Clinics in conjunctivochalasis DOI: http://dx.doi.org/10.2147/OPTH.S61851,Non-OADS,/arxiv_data1/oa_pdf/a4/b6/opth-8-1655.PMC4155901.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journalClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/a4/b6/opth-8-1655.PMC4155901.pdf
Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1660Balci  17.,Non-OADS,/arxiv_data1/oa_pdf/a4/b6/opth-8-1655.PMC4155901.pdf
©2014 by Anais Brasileiros de DermatologiaCONTINUING MEDICAL EDUCATION DOI: http://dx.doi.org/10.1590/abd1806-4841.20142389 Abstract: The diagnosis of American Tegumentary Leishmaniasis is a difficult but essential task when consider- ing the high toxicity profile of the drugs available.,Non-OADS,/arxiv_data1/oa_pdf/26/fc/abd-89-05-0701.PMC4155947.pdf
"s Longitudinal evaluation of manual lymphatic drainage for the treatment of gynoid lipodystrophy* DOI: http://dx.doi.org/10.1590/abd1806-4841.20143130 Abstract: BACKGROUND : The gynoidlypodystrophy, known as cellulitis or cellulite, refers to a condition that gives the skin an undulating and uneven appearance, affecting 80-90% of women after puberty.",Non-OADS,/arxiv_data1/oa_pdf/c9/0c/abd-89-05-0712.PMC4155948.pdf
"2014;89(5):719-27. s Dermatomyositis: analysis of 109 patients surveyed at the Hospital das Clínicas  (HCFMUSP), São Paulo, Brazil* DOI: http://dx.doi.org/10.1590/abd1806-4841.20143422 Abstract: BACKGROUND : Dermatomyositis affects striated muscles, skin and other organs.",Non-OADS,/arxiv_data1/oa_pdf/80/4e/abd-89-05-0719.PMC4155949.pdf
"2014;89(5):729-34.729s Efficacy and safety of methotrexate in alopecia areata* Mariana Hammerschmidt1Fabiane Mulinari Brenner1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20142869 Abstract: BACKGROUND : Alopecia areata is a chronic disorder of the hair follicles and nails, of unknown etiology, with clear autoimmune components and genetic factors.",Non-OADS,/arxiv_data1/oa_pdf/c4/88/abd-89-05-0729.PMC4155950.pdf
Disponível em: http://www.sbd.org.br/down/censo_dermatologico2006.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c4/88/abd-89-05-0729.PMC4155950.pdf
"2014;89(5):735-44.Manifestações cutâneas em indivíduos infectados ou com doenças 735s Comorbidities and cardiovascular risk factors in patients with psoriasis* Isabela Guimarães Ribeiro Baeta1Flávia Vasques Bittencourt2 Bernardo Gontijo2Eugênio Marcos Andrade Goulart2 DOI: http://dx.doi.org/10.1590/abd1806-4841.20142874 Abstract: BACKGROUND : Psoriasis is a chronic inflammatory disease and its pathogenesis involves an interaction between genetic, environmental, and immunological factors.",Non-OADS,/arxiv_data1/oa_pdf/7a/56/abd-89-05-0735.PMC4155951.pdf
2014;89(5):745-50. s Epidemiological profile of nonmelanoma skin cancer in renal transplant recipients: experience of a referral center* Flávia Regina Ferreira1Marilia Marufuji Ogawa2 Luiz Fernando Costa Nascimento1Jane Tomimori2 DOI: http://dx.doi.org/10.1590/abd1806-4841.20142590 Abstract: BACKGROUND : Nonmelanoma skin cancer is the most common form of cancer in humans and also the malignant disease that is increasingly common among kidney transplant recipients.,Non-OADS,/arxiv_data1/oa_pdf/9e/13/abd-89-05-0745.PMC4155952.pdf
"2014;89(5):752-6. s752INVESTIGATION Prevalence of Metabolic Syndrome and its components in a Brazilian sample of pemphigus patients* Marcela Vendruscolo Ambiel1Ana Maria Roselino1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20142930 Abstract:  BACKGROUND : Pemphigus foliaceus and pemphigus vulgaris are endemic in the northeastern region of São Paulo State, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/b7/63/abd-89-05-0752.PMC4155953.pdf
Disponível em:http://bvsms.saude.gov.br/bvs/publicacoes/vigitel_2008.pdf  MAILING  ADDRESS : Ana Maria Ferreira RoselinoFMRP-USPAv.,Non-OADS,/arxiv_data1/oa_pdf/b7/63/abd-89-05-0752.PMC4155953.pdf
2014;89(5):758-62. s758INVESTIGATION Severe cutaneous reactions to drugs in the setting of  a general hospital* Luciana Rosa Grando1Tatiana Aline Berger Schmitt1Renato Marchiori Bakos1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20142997 Abstract: BACKGROUND : Cutaneous drug reactions are frequently found.,Non-OADS,/arxiv_data1/oa_pdf/d4/87/abd-89-05-0758.PMC4155954.pdf
"©2014 by Anais Brasileiros de Dermatologia sREVIEW DOI: http://dx.doi.org/10.1590/abd1806-4841.20143063 Abstract: Melasma is a chronic acquired hypermelanosis of the skin, characterized by irregular brown macules symmetrically distributed on sun-exposed areas of the body, particularly on the face.",Non-OADS,/arxiv_data1/oa_pdf/1c/73/abd-89-05-0771.PMC4155956.pdf
"sREVIEW784 Vitiligo - Part 2 - classification, histopathology and  treatment* DOI: http://dx.doi.org/10.1590/abd1806-4841.20142717 Abstract: In an unprecedented effort in the field of vitiligo, a global consensus resulted on a suggested new clas- sification protocol for the disease.",Non-OADS,/arxiv_data1/oa_pdf/33/88/abd-89-05-0784.PMC4155957.pdf
"2014;89(5):792-5. sDERMATOPATHOLOGY792 Acroangiodermatitis (pseudo-Kaposi's sarcoma) in an HIV sero- positive patient with syphilis and hepatitis C virus coinfection: clinical and dermatopathological features* Fred Bernardes Filho1Gustavo Martins2 José Augusto da Costa Nery1,3Cecília Vianna de Andrade3,4 Bernard Kawa Kac1,5 DOI: http://dx.doi.org/10.1590/abd1806-4841.20143036 Abstract: Acroangiodermatitis is an angioproliferative disease usually related to chronic venous insufficiency, and it is considered a clinical and histological simulator of Kaposi's sarcoma (KS).",Non-OADS,/arxiv_data1/oa_pdf/a8/ce/abd-89-05-0792.PMC4155958.pdf
796sCASEREPORT A rare clinical presentation of Desmoplastic Trichilemmoma mimicking Invasive Carcinoma* Daniela Tiemi Sano1Jeane Jeong Hoon Yang1 Antonio José Tebcherani1Luiz Arthur de Paula Machado Bazzo1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20143095 Abstract: Trichilemmoma is a benign neoplasm from the outer sheath of the pilosebaceous follicle.,Non-OADS,/arxiv_data1/oa_pdf/0e/35/abd-89-05-0796.PMC4155959.pdf
"2014;89(5):799-801.Fabry disease: clinical and genotypic aspects of three cases in first degree relatives  799s799CASEREPORT Alkaptonuria – Case report* Fernanda Helena Craide1Juliana Salvini Barbosa Martins da Fonseca2 Priscila Coelho Mariano1Natalia Monteiro Fernandez3 Carlos Gustavo Carneiro de Castro1Yuri de Souza Lima Mene1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20143052 Abstract: Alkaptonuria, also called endogenous ochronosis, is a rare metabolic autosomal recessive disorder.",Non-OADS,/arxiv_data1/oa_pdf/08/7f/abd-89-05-0799.PMC4155960.pdf
"2014;89(5):803-5.803sCASEREPORT Topical calcipotriol as a new therapeutic option for the treatment of clear cell acanthoma* Gaetano Scanni1Giovanni Pellacani2 DOI: http://dx.doi.org/10.1590/abd1806-4841.20143079 Abstract: Although uncommonly diagnosed, clear cell acanthoma represents an original source of speculative interest for dermatologists.",Non-OADS,/arxiv_data1/oa_pdf/06/bd/abd-89-05-0803.PMC4155961.pdf
Photographic records of all clinical and dermatoscopic inter-stages excluded from this paper due to edito rial limits are available at http://www.gaetanoscanni.it/CCA_full_storyRevista5Vol89Portugues_Layout 1  9/15/14  10:45 AM  Página 804,Non-OADS,/arxiv_data1/oa_pdf/06/bd/abd-89-05-0803.PMC4155961.pdf
"* Maíra Chiarelli Serra1,3Claudia Menicanti2,3 Elisabetta Pennacchioli1,3Giulio Tosti1,4 DOI: http://dx.doi.org/10.1590/abd1806-4841.20143058 Abstract: A 25-year-old Caucasian female with multiple genital warts involving the vulvar area was treated with imiquimod 5% cream.",Non-OADS,/arxiv_data1/oa_pdf/82/0e/abd-89-05-0806.PMC4155962.pdf
2014;89(5):808-11.808sCASEREPORT Atypical lesions in relapsed leprosy* Theisla Kely Azevedo Raiol1Solange Emanuelle Volpato1 Patrícia de Barros Guimarães1Maria Luciana Andrade de Almeida Lopes1 Daniela Mayumi Takano1Jaci Maria Santana1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20142989 Abstract: Relapsed cases of leprosy are not common in patients treated regularly with the recommended poly- chemotherapeutical schemes.,Non-OADS,/arxiv_data1/oa_pdf/1f/3e/abd-89-05-0808.PMC4155963.pdf
"Disponívelem: http://portal.saude.gov.br/portal/arquivos/pdf/portaria_n_3125_hansenia-se_2010.pdf.Teixeira LO, Silva CM, Akamatsu HT, Barreto JA, Soares CT. Neural relapse in multi- 2. bacillary leprosy 6 years after end of treatment.",Non-OADS,/arxiv_data1/oa_pdf/1f/3e/abd-89-05-0808.PMC4155963.pdf
"2014;89(5):812-15.812sCASEREPORT Pseudoxanthoma elasticum: report of two cases* Gabriela Franco Marques1Sadamitsu Nakandakari1 Ana Paula Cota Pinto Coelho1Maria Helena Mazzi Freire Nigro1 Josmar Sabage1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20143144 Abstract: Pseudoxanthoma elasticum is a rare inherited multisystem disorder that is characterized by a pathologi- cal mineralization of the elastic connective tissue, which involves predominantly the skin, eyes and cardiovascularsystem.",Non-OADS,/arxiv_data1/oa_pdf/27/0a/abd-89-05-0812.PMC4155964.pdf
"2014;89(5):816-18.816sCASEREPORT Poorly differentiated synovial sarcoma in the wrist - Case report* Daniela Cristina Caetano Maia1Carla Kellen da Silva Menezes2 Thales Costa Bastos1Luiz Carlos de Lima Ferreira2 Fabio Francesconi1,2 DOI: http://dx.doi.org/10.1590/abd1806-4841.20143015 Abstract: Synovial sarcomas are rare malignant tumors affecting mainly young adults, presenting as a slow growth mass located in deep soft tissues of extremities, near the joints.",Non-OADS,/arxiv_data1/oa_pdf/3c/f2/abd-89-05-0816.PMC4155965.pdf
"2014;89(5):819-21.819sCASEREPORT Exuberant clinical picture of Buschke-Fischer-Brauer  palmoplantar keratoderma in bedridden patient* João Roberto Antonio1,2Guilherme Bueno de Oliveira1 Natalia Cristina Pires Rossi1Laiza Gabriela Garcia Pires1 Gustavo Bueno de Oliveira3 DOI: http://dx.doi.org/10.1590/abd1806-4841.20142923 Abstract: Buschke-Fisher-Brauer keratoderma is a rare hereditary autosomal dominant disease of incomplete penetrance.",Non-OADS,/arxiv_data1/oa_pdf/0b/14/abd-89-05-0819.PMC4155966.pdf
"2014;89(5):822-4.822sCASEREPORT Livedoid vasculopathy as a marker of systemic disease:  report of two cases* Raquel Sucupira Andrade Lima1Gustavo Ávila Maquiné1 Carolina Talhari1,2,3Isabel Cristina Lima Encarnação1 Antônio Pedro Mendes Schettini1Mônica Santos1,2,3 DOI: http://dx.doi.org/10.1590/abd1806-4841.20142897 Abstract: The livedoid vasculopathy is an obstructive vascular process of etiology not yet fully known, being pos- sibly associated with several prothrombotic events.",Non-OADS,/arxiv_data1/oa_pdf/3d/f6/abd-89-05-0822.PMC4155967.pdf
"2014;89(5):825-7. s Pigmented Bowen's disease* Amanda Nascimento Cavalleiro de Macedo Mota1Juan Piñeiro-Maceira1 Maria de Fatima Guimarães Scotelaro Alves1Mónica Jidid Mateus Tarazona1 Carlos Baptista Barcaui1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20142725 Abstract: Pigmented Bowen's disease is rare, though more prevalent in men.",Non-OADS,/arxiv_data1/oa_pdf/a0/23/abd-89-05-0825.PMC4155968.pdf
"2014;89(5):828-31.High-frequency ultrasound associated with dermoscopy in pre-operative evaluation of basal cell carcinoma* Elisa de Oliveira Barcaui1Antonio Carlos Pires Carvalho1 Paulo Marcos N. Valiante1Carlos Baptista Barcaui2 DOI: http://dx.doi.org/10.1590/abd1806-4841.20143176 Abstract: The recent development of high-frequency ultrasound, associated with the improved sensitivity in color Doppler, enabled the identification of various skin structures and layers.",Non-OADS,/arxiv_data1/oa_pdf/a2/f0/abd-89-05-0828.PMC4155969.pdf
"Dermoscopy assisting the diagnosis of mycetoma:  case report and literature review* Larissa Montanheiro dos Reis1Brunno Zeni de Lima1 Fernando da Cunha Zillo2Camila Makino Rezende1 Lincoln Helder Zambaldi Fabricio1Camila Araujo Scharf Pinto1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20143008 Abstract: Mycetomas are a chronic skin infection characterized by perilesional edema, formation of sinus tracts, and discharge of purulent or seropurulent exudate containing grains.",Non-OADS,/arxiv_data1/oa_pdf/c0/a9/abd-89-05-0832.PMC4155970.pdf
"DOI: http://dx.doi.org/10.1590/abd1806-4841.20143152 FIGURE 1: Multiple normochromic hyperkeratotic, brilliant, oval papules, with approximately 1-2 mm in diameter, on the transitio-nal area between dorsal and ventral hand surfacesF IGURE 3: Verhoeff 200x.",Non-OADS,/arxiv_data1/oa_pdf/49/52/abd-89-05-0835.PMC4155971.pdf
"Serology for leishmaniasis, paracoccidioidomycosisand culture for fungi were negative.Anatomopathological examination showed: pseudoe-pitheliomatous hyperplasia, absence of granulomas,macrophages with wide vacuolated cytoplasm.Search for acid-alcohol resistant bacilli using Ziehl-Nielsen staining was positive (Figure 3).DOI: http://dx.doi.org/10.1590/abd1806-4841.20143045 FIGURE 1: Nasal leprosy.",Non-OADS,/arxiv_data1/oa_pdf/99/9c/abd-89-05-0837.PMC4155972.pdf
Disponível em: http://bvsms.saude.gov.br/bvs/publicacoes/manual_leprologia.pdfBrasil.,Non-OADS,/arxiv_data1/oa_pdf/99/9c/abd-89-05-0837.PMC4155972.pdf
"Disponível em: http://pt.scribd.com/doc/16644148/Manual-de-Prevencao-das-Incapacidades-Fisicas-em-HanseniaseNery JA, Schreuder PA, de Mattos PC, de Mendonça LV, Tardi RT, de Mello S,  et al.",Non-OADS,/arxiv_data1/oa_pdf/99/9c/abd-89-05-0837.PMC4155972.pdf
"DOI: http://dx.doi.org/10.1590/abd1806-4841.20143237 CASE REPORT A 53-year-old man presented with a 2-week old, rapidly growing, plaque on the right forearm.",Non-OADS,/arxiv_data1/oa_pdf/de/df/abd-89-05-0839.PMC4155973.pdf
"DOI: http://dx.doi.org/10.1590/abd1806-4841.20143195 FIGURE 1: Hyperkeratotic, hyperchromic plaques, with white adhe- rent scales on the fingers extending to the distal half of the righthand dorsum and metacarpophalangeal joints on the left handF IGURE 3: Acanthotic epidermis with regular elongation of interpa- pillary cones and atrophy in sections covering the dermal papillae.Focal spongiosis with intraepidermal vesicles.",Non-OADS,/arxiv_data1/oa_pdf/63/bc/abd-89-05-0841.PMC4155974.pdf
"©2014 by Anais Brasileiros de DermatologiaYinhua Wu1Jianjun Qiao1Hong Fang1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20142841 Abstract: Vulvovaginal-gingival syndrome is characterized by erosions and desquamation of the vulva, vagina, and gingiva.",Non-OADS,/arxiv_data1/oa_pdf/a3/2e/abd-89-05-0843.PMC4155975.pdf
"2014;89(5):851-3.Translation into Brazilian Portuguese and validation of the ""Quantitative Global Scarring Grading System  for Post-acne Scarring"" * Thais Hofmann Cachafeiro1Gabriela Fortes Escobar1 Gabriela Maldonado1Tania Ferreira Cestari1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20143122 Abstract: The ""Quantitative Global Scarring Grading System for Postacne Scarring"" was developed in English for acne scar grading, based on the number and severity of each type of scar.",Non-OADS,/arxiv_data1/oa_pdf/27/eb/abd-89-05-0851.PMC4155978.pdf
"Available from:http://www.who.int/substance_abuse/research_tools/translation/en/ MAILING  ADDRESS : Thais Hofmann Cachafeiro Departamento de DermatologiaRua Ramiro Barcelos, 2350 90035-903 - Porto Alegre - RSBrazilE-mail: thaishofmann@gmail.com How to cite this article: Cachafeiro TH, Escobar GF, Maldonado G, Cestari TF.",Non-OADS,/arxiv_data1/oa_pdf/27/eb/abd-89-05-0851.PMC4155978.pdf
"The phrase should read as follows: “The systemic corticoid may be associated with dapsone,1mg/kg/day, aiming at later reduction of the corticoid dose while continuing with sulfone, as described inthe reported case.”ERRATUM854NEWS DOI: http://dx.doi.org/10.1590/abd1806-4841.20142378e An Bras Dermatol.",Non-OADS,/arxiv_data1/oa_pdf/47/bc/abd-89-05-0854.PMC4155979.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMarch 2014 |  85  | e50620 | Page 1 of 7Video Article Optimized Protocols for Mycobacterium leprae  Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice Ana Paula Fávaro Trombone1, Sílvia Cristina Barbosa Pedrini2, Suzana Madeira Diório3, Andréa de Faria Fernandes Belone1, Luciana Raquel Vicenzi Fachin1, Dejair Caitano do Nascimento4, Patricia Sammarco Rosa2 1Department of Pathology, Instituto Lauro de Souza Lima (ILSL) 2Laboratory Animal House, Instituto Lauro de Souza Lima (ILSL) 3Department of Microbiology, Instituto Lauro de Souza Lima (ILSL) 4Department of Pharmacology, Instituto Lauro de Souza Lima (ILSL) Correspondence to: Patricia Sammarco Rosa at prosa@ilsl.br URL: http://www.jove.com/video/50620 DOI: doi:10.3791/50620 Keywords: Infectious Diseases, Issue 85, Mycobacterium leprae , skin diseases, bacteria, maintenance, viability, freezing, athymic nude mice Date Published: 3/23/2014 Citation: Trombone, A.P.F., Pedrini, S.C.B., Diório, S.M., Belone, A.d.F.F., Fachin, L.R.V., do Nascimento, D.C., Rosa, P.S.",Non-OADS,/arxiv_data1/oa_pdf/dd/d4/jove-85-50620.PMC4155980.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/50620/ Introduction Leprosy, a disease caused by Mycobacterium leprae,  is an important public health problem in many countries around the world1,2.",Non-OADS,/arxiv_data1/oa_pdf/dd/d4/jove-85-50620.PMC4155980.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c9/4c/dddt-8-1183.PMC4155987.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2014:8 1183–1194Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1183REVIEWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S5545 8Update on the clinical utility of once-daily  tacrolimus in the management of transplantation Maria Aurora Posadas Salas Titte R Srinivas Division of Nephrology and  Hypertension, Department of  Medicine, Medical University of South  Carolina, Charleston, SC, USA Correspondence: Maria Aurora   Posadas Salas   Division of Nephrology and Hypertension,   Department of Medicine, 96 Jonathan  Lucas St, Charleston, SC  29425, USA   Tel +1 843 792 2123  Fax +1 843 792 8399  Email posadas@musc.ed uAbstract:  Adherence to immunosuppression and minimizing variability in drug exposure are  important considerations in preventing rejection and maximizing overall transplant outcomes.",Non-OADS,/arxiv_data1/oa_pdf/c9/4c/dddt-8-1183.PMC4155987.pdf
"Available from: http://srtr.transplant.hrsa.gov/ annual_reports/2012/flash/2012_SRTR_ADR/index.htm l. Accessed  June 6, 2014.",OADS,/arxiv_data1/oa_pdf/c9/4c/dddt-8-1183.PMC4155987.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/c9/4c/dddt-8-1183.PMC4155987.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c9/4c/dddt-8-1183.PMC4155987.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0e/99/jpr-7-523.PMC4155988.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Pain Research 2014:7 523–530Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  523ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S6597 4Fasinumab (Regn475), an antinerve growth  factor monoclonal antibody, for the treatment   of acute sciatic pain: results of a proof-of-concept  study Paul J Tiseo1 haobo Ren2 scott Mellis3 1Pharmacovigilance Operations  and Risk Management, Regeneron  Pharmaceuticals, inc., Tarrytown,   nY, Usa;  2Biostatitics, Regeneron  Pharmaceuticals, inc., Basking Ridge,   nJ, Usa;  3Translational Medicine  and Predictive Medicine, Regeneron  Pharmaceuticals, inc., Tarrytown,    nY, Usa correspondence: Paul J Tiseo   Regeneron Pharmaceuticals,   inc., 777 Old saw Mill River Road,   Tarrytown, nY  10591, Usa   Tel +1 914 847 7680  Fax +1 914 860 4192  email paul.tiseo@regeneron.co mObjective:  To evaluate the efficacy and safety of subcutaneously administered fasinumab  (REGN475), a nerve growth factor-neutralizing antibody, in patients with acute sciatic pain  receiving standard of care therapy.",Non-OADS,/arxiv_data1/oa_pdf/0e/99/jpr-7-523.PMC4155988.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/0e/99/jpr-7-523.PMC4155988.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0e/99/jpr-7-523.PMC4155988.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cf/51/mder-7-299.PMC4155989.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pMedical Devices: Evidence and Research 2014:7 299–304Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  299ORiginal REsEaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/MDER.S5649 1One-year outcomes after minimally invasive  sacroiliac joint fusion with a series of triangular  implants: a multicenter, patient-level analysis Donald sachs1 Robyn capobianco2 Daniel cher2 Timothy holt3 Mukund gundanna4 Timothy graven5 a nick shamie6 John cummings Jr7 1center for spinal stenosis and  neurologic care, lakeland, Fl,   2si-BOn E, inc., san Jose, ca,   3Montgomery spine center,   Montgomery, al, 4Brazos spine,   college station, TX, 5ssM  Orthopedics, Wentzville, MO, 6Ucla   spine center, santa Monica, ca,   7community neurosurgical care,   indianapolis, in, Usa correspondence: Robyn capobianco   si-BOnE, inc., suite 2200, 3055 Olin  avenue, san Jose, ca 95124, Usa   Tel +1 650 219 8342   Fax +1 408 516 9663   Email rcapobianco@si-bone.co mBackground:  Sacroiliac joint (SI) pain is an often-overlooked cause of lower-back pain, due  in part to a lack of specific findings on radiographs and a symptom profile similar to other  back-related disorders.",Non-OADS,/arxiv_data1/oa_pdf/cf/51/mder-7-299.PMC4155989.pdf
"Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa lMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology,  research, and expert opinion supporting the use and application of  medical devices in the diagnosis, treatment and management of clini - cal conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/cf/51/mder-7-299.PMC4155989.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d3/55/oajsm-5-205.PMC4155990.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOpen Access Journal of Sports Medicine 2014:5 205–207Open Access Journal of Sports Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  205COMMent Aryopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/ 10.2147/OAJSM.S7027 8the second Summer youth Olympic Games   in nanjing, People’s republic of China: preparing   youth athletes to compete in the heat Joao Brito1 Sebastien racinais2 George P nassis1,3 1national Sports Medicine  Programme, excellence in Football  Project, Aspetar – Qatar Orthopaedic  and Sports Medicine Hospital,   Doha, Qatar; 2Athlete Health and  Performance research Centre,   Aspetar – Qatar Orthopaedic and  Sports Medicine Hospital, Doha,   Qatar; 3School of Physical education  and Sport Science, national and  Kapodistrian University of Athens,   Athens, Greece All authors contributed equally to this  manuscript Correspondence: George P nassis   Aspetar – Qatar Orthopaedic and Sports   Medicine Hospital, national Sports   Medicine Programme, excellence   in Football Project, PO Box 29222,   Doha, Qatar   tel +974 44 132 650   email george.nassis@aspetar.co mAbstract:  The second Summer Y outh Olympic Games will take place August 16–28, 2014 in  Nanjing, People’ s Republic of China during the peak of the summer.",Non-OADS,/arxiv_data1/oa_pdf/d3/55/oajsm-5-205.PMC4155990.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/d3/55/oajsm-5-205.PMC4155990.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d3/55/oajsm-5-205.PMC4155990.pdf
Available from: http://sinosphere.blogs.nytimes.,Non-OADS,/arxiv_data1/oa_pdf/d3/55/oajsm-5-205.PMC4155990.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/40/fe/vhrm-10-539.PMC4155991.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.ph pVascular Health and Risk Management 2014:10 539–548Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  539LetteRopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/VHRM.S6838 4Perindopril for improving cardiovascular events James J DiNicolantonio James H O’Keefe Department of Preventive Cardiology,   Saint Luke’s Mid America Heart  Institute, Kansas City, MO, USA Correspondence: James J DiNicolantonio   Saint Luke’s Mid America Heart Institute,  4401 Wornall Road 600   Kansas City, MO 64111, USA   tel +1 816 931 1883   email jjdinicol@gmail.co mDear editor In a recent review in V ascular Health and Risk Management  Wang et al state that  “In mainly placebo-controlled cardiovascular (CV)-outcome studies in patients with  hyperten sion, CV benefits with perindopril were associated with large reductions in  B P.”1 However, perindopril in the European Trial on Reduction of Cardiac Events With  Perindopril in S table  Coronary Artery Disease (EUROP A) study significantly reduced  major cardiovascular events despite a small reduction (approximately  4 mmHg) in  systolic blood pressure from baseline.2,3 Additionally, the average baseline blood  pressure in the EUROPA was just  137/82 mmHg, and in those without hypertension,  perindopril still provided a  20% reduction in the combined endpoint of cardiovascular  death, myocardial infarction, and cardiac arrest.4,5 In fact, patients receiving perindopril  with a baseline systolic blood pressure of ,120 mmHg had the greatest reduction in  the primary event.6 PERindopril–Thrombosis, InflammatioN, Endothelial dysfunction and   Neurohormonal activation Trial (PERTINENT), a sub study of EUROPA, also showed  that perindopril improves endothelial function, which the authors concluded may have  provided the benefit and not blood pressure reduction per se.7 Thus, the notion that  perindopril is only effective in hypertensive patients, and only when large reductions  in blood pressure occur, is not supported by the literature.",Non-OADS,/arxiv_data1/oa_pdf/40/fe/vhrm-10-539.PMC4155991.pdf
Available from: http://www.nice.org.uk/guidance/CG127/ chapter/Introduction.,Non-OADS,/arxiv_data1/oa_pdf/40/fe/vhrm-10-539.PMC4155991.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/40/fe/vhrm-10-539.PMC4155991.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/40/fe/vhrm-10-539.PMC4155991.pdf
Available from:  http://www.fda.gov/downloads/Drugs/.../Guidances/ucm075072.pdf.,Non-OADS,/arxiv_data1/oa_pdf/40/fe/vhrm-10-539.PMC4155991.pdf
Available from: http://www.ema.europa.eu/docs/en_GB/document_ library/EPAR_-_Assessment_Report_-_Variation/human/000209/ WC500073444.pdf.,Non-OADS,/arxiv_data1/oa_pdf/40/fe/vhrm-10-539.PMC4155991.pdf
Available from: http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/40/fe/vhrm-10-539.PMC4155991.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/47/71/ppa-8-1153.PMC4155992.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 1153–1160Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1153OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/PPA.S6405 1how do health services researchers understand  the concept of patient-centeredness?,Non-OADS,/arxiv_data1/oa_pdf/47/71/ppa-8-1153.PMC4155992.pdf
"In the UK, patient-centered care has been pushed forward by the Public correspondence: isabelle scholl   Department of Medical Psychology,  University Medical center hamburg- eppendorf, Martinistrasse 52, 20246  hamburg, germany   Tel +49 040 7410 57135   Fax +49 040 7410 54965   email i.scholl@uke.d eJournal name: Patient Preference and Adherence Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Scholl et al Running head recto: Understanding the concept of patient-centeredness DOI: http://dx.doi.org/10.2147/PPA.S64051",Non-OADS,/arxiv_data1/oa_pdf/47/71/ppa-8-1153.PMC4155992.pdf
Available from: http://www.gpo.gov/fdsys/ pkg/BILLS-111hr3590enr/pdf/BILLS-111hr3590enr.pdf .,Non-OADS,/arxiv_data1/oa_pdf/47/71/ppa-8-1153.PMC4155992.pdf
Available from: http://www.dh.gov.uk/prod_consum_dh/groups/ dh_digitalassets/@dh/@en/@ps/documents/digitalasset/dh_111225.,OADS,/arxiv_data1/oa_pdf/47/71/ppa-8-1153.PMC4155992.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/47/71/ppa-8-1153.PMC4155992.pdf
Available from: http://www.qualitative-research.net/ index.php/fqs/article/view/1089/2386 .,Non-OADS,/arxiv_data1/oa_pdf/47/71/ppa-8-1153.PMC4155992.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2f/c6/cpaa-6-117.PMC4155993.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Pharmacology: Advances and Applications 2014:6 117–126Clinical Pharmacology: Advances and Applications Dove press submit your manuscript | www.dovepress.co m Dove press  117Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CPAA.S4853 0Reducing medication errors in critical care:   a multimodal approach Correspondence: Asad Latif   Department of Anesthesiology and  Critical Care Medicine, Johns Hopkins  University School of Medicine,    600 North wolfe Street, Meyer  297-A,  Baltimore, MD  21287, USA   Tel +1 410 502 2714  Fax +1 410 955 8978  email alatif1@jhmi.ed uAbstract:  The Institute of Medicine has reported that medication errors are the single most  common type of error in health care, representing  19% of all adverse events, while accounting  for over  7,000 deaths annually.",Non-OADS,/arxiv_data1/oa_pdf/2f/c6/cpaa-6-117.PMC4155993.pdf
Or use: http://dvpr.es/1p5Yjt G,Non-OADS,/arxiv_data1/oa_pdf/2f/c6/cpaa-6-117.PMC4155993.pdf
Avail - able from: http://www.nap.edu/catalog.php?record_id =9728.,Non-OADS,/arxiv_data1/oa_pdf/2f/c6/cpaa-6-117.PMC4155993.pdf
"Available from: http://www.fda.gov/ downloads /Drugs/GuidanceComplianceRegulatoryInformation/ Guidances /UCM331810.pd f. Accessed February 28, 2014.",Non-OADS,/arxiv_data1/oa_pdf/2f/c6/cpaa-6-117.PMC4155993.pdf
"Available  from: https://www.ismp.org/tools/FMEA.as p. Accessed February 28,  2014.",OADS,/arxiv_data1/oa_pdf/2f/c6/cpaa-6-117.PMC4155993.pdf
"Available from: http://www.who.int/patientsafety/ solutions/ patientsafety/PS-Solution7.pd f. Accessed February 28, 2014.",OADS,/arxiv_data1/oa_pdf/2f/c6/cpaa-6-117.PMC4155993.pdf
"Clinical Pharmacology: Advances and Applications Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-pharmacology-advances-and-applications-journa lClinical Pharmacology: Advances and Applications is an international,  peer-reviewed, open access journal publishing original research, reports,  reviews and commentaries on all areas of drug experience in humans.",Non-OADS,/arxiv_data1/oa_pdf/2f/c6/cpaa-6-117.PMC4155993.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/c6/cpaa-6-117.PMC4155993.pdf
Available from: http://www.nap.edu/catalog.,Non-OADS,/arxiv_data1/oa_pdf/2f/c6/cpaa-6-117.PMC4155993.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e6/9e/jpr-7-531.PMC4155994.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2014:7 531–545Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  531Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S6592 3evidence for the endothelin system as an  emerging therapeutic target for the treatment   of chronic pain T erika P Smith1 Tami Haymond1 Sherika N Smith1 Sarah M Sweitzer1,2 1Department of Pharmacology,   Physiology and Neuroscience,   University of South Carolina,   Columbia, SC, USA;  2Department   of Pharmaceutical and Administrative  Sciences, Presbyterian College School  of Pharmacy, Clinton, SC, USA Correspondence: Terika Smith   University of South Carolina School of  Medicine, 6439 Garners Ferry Road,   Columbia, SC  29209, USA   Tel +1 803 216 3526  Fax +1 803 216 3538  email terika.smith@uscmed.sc.ed uAbstract:  Many people worldwide suffer from pain and a portion of these sufferers are  diagnosed with a chronic pain condition.",Non-OADS,/arxiv_data1/oa_pdf/e6/9e/jpr-7-531.PMC4155994.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/e6/9e/jpr-7-531.PMC4155994.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e6/9e/jpr-7-531.PMC4155994.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/09/01/ppa-8-1161.PMC4155995.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 1161–1167Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1161OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/PPA.S6691 5non-pharmaceutical factors for poor glycemic  control in 13,970 chinese women with drug- treated type 2 diabetes: a cross-sectional survey  in 77 tertiary hospitals in four chinese cities Juming lu1,* Jianping Weng2,* Weijun gu1 Xiaohui guo3 Wenying Yang4 Dajin Zou5 Zhiguang Zhou6 Dalong Zhu7 Qiuhe Ji8 linong Ji9 Xilin Yang10 1Department of endocrinology, chinese  PlA general hospital, Beijing, 2Department  of endocrinology, Third Affiliated hospital   of sun Yat-sen University, guangzhou,  3Department of  endocrinology, First hospital  of Peking University, Beijing, 4Department  of endocrinology, sino-Japan Friendship hospital,  Beijing, 5Department of endocrinology, changhai  hospital of shanghai, shanghai, 6Department  of endocrinology, The second Xiangya hospital  of central south University, changsha, 7Department  of endocrinology, n anjing Drum T ower hospital,  nanjing, Jiansu, 8Department of endocrinology,  Xijing hospital affiliated to 4th Military Medical  University, Xi’an, 9Department of endocrinology,  Peking University People’s hospital, Beijing,  10Department of epidemiology and Biostatistics,  school of Public health, Tianjin Medical University,  Tianjin, People’s republic of china *These authors contributed equally  to the manuscriptBackground:  Achieving good glycemic control improves clinical outcomes among patients  with type 2 diabetes (T2D).",Non-OADS,/arxiv_data1/oa_pdf/09/01/ppa-8-1161.PMC4155995.pdf
"The United Kingdom Prospective Diabetes Study (UKPDS) showed that maintaining  glycated hemoglobin (HbA1c) around 77  mmol/mol (7.0%) by intensive blood-glucose  control with sulfonylureas and/or insulin was able to reduce a 25% risk of microvas - cular endpoints over a 10-year period as compared with a conventional group whose  HbA1c was around 86 mmol/mol (7.9%),5 and achieved a 9% risk reduction in any  diabetes-related endpoint, 24% risk reduction in the microvascular endpoint, a 15% risk Journal name: Patient Preference and Adherence Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Lu et al Running head recto: Glycemic control in women DOI: http://dx.doi.org/10.2147/PPA.S66915 correspondence: Xilin Yang school of Public health, Tianjin Medical  University, PO Box 154, 22 Qixiangtai road,  heping District, Tianjin 300070, People’s  republic of china Tel +86 22 8333 6617 Fax +86 22 8333 6608 email yxl@hotmail.co m    linong Ji Department of endocrinology, Peking  University People’s hospital, Xicheng District,  Beijing, People’s republic of china Tel +86 10 8832 4180 Fax +86 10 8832 4180 email jiln@bjmu.edu.c n",Non-OADS,/arxiv_data1/oa_pdf/09/01/ppa-8-1161.PMC4155995.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/09/01/ppa-8-1161.PMC4155995.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1a/9d/ndt-10-1599.PMC4155996.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 1599–1604Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1599OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/NDT .S6682 8rabia Bilici1 esra Yazici2 ali evren T ufan3 elif Mutlu4 Filiz i˙zci1 Görkem Karakas Ug ˘urlu5 1erenkoy Mental health and  Neurology Training and research  hospital, Department of Psychiatry,   istanbul; 2sakarya University,   Medical Faculty, Department  of Psychiatry, sakarya, 3abant izzet  Baysal University, Medical Faculty,   Department of child and adolescent  Psychiatry, Bolu, 4Bakirköy Mental  health and Neurology Training  and research hospital, Department  of Psychiatry, istanbul, 5Yildirim  Beyazit University, Medical Faculty,   Department of Psychiatry, ankara,   T urkey correspondence:  rabia Bilici   Erenkoy Ruh ve Sinir Hastalıkları Eg ˘itim  ve Araştırma Hastanesi Psikiyatri Bölümü,  istanbul, Turkey   Tel +90 21 6302 5959   email rabiabilici@hotmail.co m Motivation for treatment in patients with  substance use disorder: personal volunteering  versus legal/familial enforcementJournal name: Neuropsychiatric Disease and Treatment Journal Designation: Original Research Y ear: 2014 Volume: 10 Running head verso: Bilici et al Running head recto: Treatment motivation in substance use DOI: http://dx.doi.org/10.2147/NDT.S66828 Background:  Motivation for treatment on the part of patients with addictive disorders is known  to affect their prognosis, and lack thereof is reported to be among the most common reasons  for failed treatment adherence and relapse after treatment.",Non-OADS,/arxiv_data1/oa_pdf/1a/9d/ndt-10-1599.PMC4155996.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/1a/9d/ndt-10-1599.PMC4155996.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.Dove pres s Neuropsychiatric Disease and Treatment 2014:10submit your manuscript | www.dovepress.co m Dove press Dove press 1604Bilici et al used for motivational interviewing may be particularly  important in patients undergoing enforced treatment.,Non-OADS,/arxiv_data1/oa_pdf/1a/9d/ndt-10-1599.PMC4155996.pdf
Available from: http://www.wma.net/en/30publications/10policies/ b3/.,Non-OADS,/arxiv_data1/oa_pdf/1a/9d/ndt-10-1599.PMC4155996.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/36/a8/clep-6-295.PMC4155997.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Epidemiology 2014:6 295–299Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  295Original rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CLEP .S6375 8acromegaly according to the Danish national   registry of Patients: how valid are iCD diagnoses   and how do patterns of registration affect   the accuracy of registry data?,Non-OADS,/arxiv_data1/oa_pdf/36/a8/clep-6-295.PMC4155997.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access  journal focusing on disease and drug epidemiology, identification of  risk factors and screening procedures to develop optimal preventative  initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/36/a8/clep-6-295.PMC4155997.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fe/fb/opth-8-1661.PMC4155998.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1661–1670Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1661Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/OPTH.S4606 8epimacular brachytherapy for wet AMD: current  perspectives Ricardo P Casaroli- Marano1,2  Socorro Alforja1  Joan Giralt1  Michel e Farah2 1instituto Clínic de Oftalmología  (Hospital Clínic de Barcelona),   University of Barcelona, Barcelona,   Spain; 2Department of Ophthalmology  and visual Sciences, Universidade  Federal de Sao Paulo, escola Paulista  de Medicina, Sao Paulo, Brazil Correspondence: Ricardo P  Casaroli-Marano   instituto Clinic de Oftalmología,  Calle Sabino de Arana 1, e-08028  Barcelona (Spain)   T el +34 93 2275667   Fax +34 93 2275662   email rcasaroli@ub.ed u Journal name: Clinical Ophthalmology Journal Designation: Review Y ear: 2014 Volume: 8 Running head verso: Casaroli-Marano et al Running head recto: Epimacular brachytherapy in AMD DOI: http://dx.doi.org/10.2147/OPTH.S46068 Abstract:  Age-related macular degeneration (AMD) is considered the most common cause  of blindness in the over-60 age group in developed countries.",Non-OADS,/arxiv_data1/oa_pdf/fe/fb/opth-8-1661.PMC4155998.pdf
http://www.clinicaltrials.gov /,Non-OADS,/arxiv_data1/oa_pdf/fe/fb/opth-8-1661.PMC4155998.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/fe/fb/opth-8-1661.PMC4155998.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1670Casaroli-Marano et al  67.,Non-OADS,/arxiv_data1/oa_pdf/fe/fb/opth-8-1661.PMC4155998.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/07/8b/ijgm-7-433.PMC4155999.pdf
"Information on how to  request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of General Medicine 2014:7 433–440International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  433RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S4631 0Prevention and treatment of venous  thromboembolism during HRT: current  perspectives Hannelore Rott Coagulation Center Rhine-Ruhr,   Duisburg, Germany Correspondence: Hannelore Rott   Coagulation Center Rhine-Ruhr,  Koenigstr 13, 47051 Duisburg, Germany   T el +49 203 3483 360   Fax +49 203 3483 3636   email hannelore.rott@gzrr.d eAbstract:  Many large trials in the past 15 years have proven an increased risk of vascular  complications in women using oral, mostly non-bioidentical, hormone therapy.",Non-OADS,/arxiv_data1/oa_pdf/07/8b/ijgm-7-433.PMC4155999.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/07/8b/ijgm-7-433.PMC4155999.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/07/8b/ijgm-7-433.PMC4155999.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d9/6f/prom-5-071.PMC4156000.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPatient Related Outcome Measures 2014:5 71–85Patient Related Outcome Measures Dove press submit your manuscript | www.dovepress.co m Dove press  71Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PROM.S4958 6Follow-up care for breast cancer survivors:  improving patient outcomes ishveen Chopra1 Avijeet Chopra2 1Department of Pharmacy  Administration, Duquesne University,   Pittsburgh, PA, USA;  2Department of  Molecular and Cell Biology, University  of Connecticut, Storrs, CT, USA Correspondence: ishveen Chopra   Department of Pharmacy Administration,  Duquesne University,  600 Forbes  Avenue, Pittsburgh, PA,  15282, USA   Tel +1 412 427 5609  Fax +1 412 396 5130  email ishveenkc@gmail.co mBackground:  Appropriate follow-up care is important for improving health outcomes in breast  cancer survivors (BCSs) and requires determination of the optimum intensity of clinical exami - nation and surveillance, assessment of models of follow-up care such as primary care-based  follow-up, an understanding of the goals of follow-up care, and unique psychosocial aspects  of care for these patients.",Non-OADS,/arxiv_data1/oa_pdf/d9/6f/prom-5-071.PMC4156000.pdf
Available from: http://www.wcrf.,Non-OADS,/arxiv_data1/oa_pdf/d9/6f/prom-5-071.PMC4156000.pdf
Available from: http://www.seer.,Non-OADS,/arxiv_data1/oa_pdf/d9/6f/prom-5-071.PMC4156000.pdf
"Available from: http://guidelines.canceraustralia.gov.au/ guidelines/early_breast_cancer/ch01.ph p. Accessed May  26, 2014.",Non-OADS,/arxiv_data1/oa_pdf/d9/6f/prom-5-071.PMC4156000.pdf
Available from: http://www.prisma-statement.org /.,Non-OADS,/arxiv_data1/oa_pdf/d9/6f/prom-5-071.PMC4156000.pdf
"Patient Related Outcome Measures Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-related-outcome-measures-journa lPatient Related Outcome Measures is an international, peer-reviewed,  open access journal focusing on treatment outcomes specifically  relevant to patients.",Non-OADS,/arxiv_data1/oa_pdf/d9/6f/prom-5-071.PMC4156000.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/d9/6f/prom-5-071.PMC4156000.pdf
"Available  from: http://www.iarc.fr/en/media-centre/pr/2013/pdfs/pr223_E.pd f.  Accessed August  7, 2014.",Non-OADS,/arxiv_data1/oa_pdf/d9/6f/prom-5-071.PMC4156000.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7f/c1/ijwh-6-829.PMC4156001.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Women’s Health 2014:6 829–838International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  829RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S5538 3Prevention and management of postoperative  urinary retention after urogynecologic surgery elizabeth J Geller Division of Female Pelvic Medicine  and Reconstructive Surgery,   Department of Obstetrics and  Gynecology, University of North  Carolina at Chapel Hill, Chapel Hill,   NC, USA Correspondence: elizabeth J Geller   Division of Female Pelvic Medicine and  Reconstructive Surgery, Department   of Obstetrics and Gynecology,   CB 7570 Old Clinic, University   of North Carolina at Chapel Hill,   Chapel Hill, NC  27599-7570, USA   Tel +1 919 966 4717  email egeller@med.unc.ed uAbstract:  Postoperative urinary retention (POUR) is a frequent consequence of gynecologic  surgery, especially with surgical correction of urinary incontinence and pelvic organ prolapse.",Non-OADS,/arxiv_data1/oa_pdf/7f/c1/ijwh-6-829.PMC4156001.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/7f/c1/ijwh-6-829.PMC4156001.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7f/c1/ijwh-6-829.PMC4156001.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9a/82/ndt-10-1629.PMC4156002.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 1629–1634Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1629Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S6760 7Chuan-Hsun Yu1 Ryouhei ishii2 Shun-Chieh Yu1 Masatoshi Takeda2 1Yuli Hospital, Department   of Health, Hualien, Taiwan;   2Department of Psychiatry,   Osaka University Graduate  School of Medicine, Osaka, Japan Correspondence: Ryouhei ishii Department of Psychiatry, Osaka  University Graduate School of Medicine 2-2 D3, Yamadaoka, Suita City,   Osaka, Japan 565-0871 T el +816 6879 3051 Fax +816 6879 3059 email ishii@psy.med.osaka-u.ac.j pY okukansan and its ingredients as possible  treatment options for schizophreniaJournal name: Neuropsychiatric Disease and Treatment Journal Designation: Review Y ear: 2014 Volume: 10 Running head verso: Yu et al Running head recto: Y okukansan for the treatment of schizophrenia DOI: http://dx.doi.org/10.2147/NDT.S67607 Abstract:  Schizophrenia is a debilitating psychotic mental disorder that affects almost the entire  range of human mental function.",Non-OADS,/arxiv_data1/oa_pdf/9a/82/ndt-10-1629.PMC4156002.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/9a/82/ndt-10-1629.PMC4156002.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.Dove pres s Neuropsychiatric Disease and Treatment 2014:10submit your manuscript | www.dovepress.co m Dove press Dove press 1634Yu et al  38.,Non-OADS,/arxiv_data1/oa_pdf/9a/82/ndt-10-1629.PMC4156002.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/46/e8/opth-8-1671.PMC4156003.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1671–1673Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1671Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/ 10.2147/OPTH.S6529 8Chemical injury treated with autologous  limbal epithelial stem cell transplantation  and subconjunctival bevacizumab Gian Maria Cavallini1 Graziella pellegrini2 Veronica Volante1 pietro Ducange1 Michele De Maria1 Giulio torlai1 Caterina Benatti1 Matteo Forlini1 1Institute of Ophthalmology, 2Centre  for regenerative Medicine “ stefano  Ferrari”, University of Modena e  reggio emilia, Modena, ItalyBackground:  Limbal stem cell (LSC) deficiency leads to corneal opacity due to a conjunc - tivalization of the corneal surface.",Non-OADS,/arxiv_data1/oa_pdf/46/e8/opth-8-1671.PMC4156003.pdf
"Numerous trials have been published on the off-label intravitreal injection of beva - cizumab in ophthalmology, especially for the treatment of neovascular age-related  macular degeneration, proliferative diabetic retinopathy, macular edema from central  retinal vein occlusion, and refractory pseudophakic cystoid macular edema.5Correspondence: Gian Maria Cavallini struttura Complessa di Oftalmologia,  azienda Ospedaliero-Universitaria di  Modena policlinico, Via del pozzo 71,  41100, Modena, Italy tel +39 059 360 309 Fax +39 059 371 532 email cavallini.gianmaria@unimore.i t Journal name: Clinical Ophthalmology Journal Designation: Case report Y ear: 2014 Volume: 8 Running head verso: Cavallini et al Running head recto: Chemical injury treated with epithelial stem cells DOI: http://dx.doi.org/10.2147/OPTH.S65298",Non-OADS,/arxiv_data1/oa_pdf/46/e8/opth-8-1671.PMC4156003.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/46/e8/opth-8-1671.PMC4156003.pdf
"Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1673Chemical injury treated with epithelial stem cells injection was performed, the patient’s CDVA was 1/10.",Non-OADS,/arxiv_data1/oa_pdf/46/e8/opth-8-1671.PMC4156003.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/30/87/ndt-10-1621.PMC4156004.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 1621–1627Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1621OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/NDT .S6720 5Koji Tsuruga1 Norio sugawara1 Norio Yasui-Furukori1 ippei Takahashi2 shoko Tsuchimine1 ayako Kaneda1 shigeyuki Nakaji 2 Kazuhiko Nakamura1 1Department of Neuropsychiatry,   2Department of social Medicine,   hirosaki University school  of Medicine, hirosaki, Japan  correspondence: Norio sugawara Department of Neuropsychiatry,   hirosaki University school of Medicine,   5 Zaifu-cho, hirosaki city, aomori 036-8562, Japan  Tel +81 172 39 5066 Fax +81 172 34 5067 email nsuga3@yahoo.co.j p a positive correlation between serum amyloid  β levels and depressive symptoms among  community-dwelling elderly individuals in Japan Background:  Amyloid beta (A β) levels have been associated with an increased risk of  Alzheimer’s disease (AD).",Non-OADS,/arxiv_data1/oa_pdf/30/87/ndt-10-1621.PMC4156004.pdf
"Keywords:  Alzheimer’s disease, depression, dementia, Japanese Introduction Depression is a serious affective illness with heterogeneous etiologies and underlying  pathologies.1–3 The unsatisfactory results of antidepressant medication and the high  prevalence of somatic symptoms and physical illness in patients with depression  imply that the serotonin hypothesis cannot fully explain the etiology of depression.4 In  particular, late-onset depression is heterogeneous and requires various interventions,5  and different pathogenic processes are thought to occur between younger elderly and  older elderly individuals with depression.6,7 Recently, an association between depression and cognitive impairment or dementia  has been recognized.8,9 Although the mechanisms are not fully understood, a meta- analysis of studies concerning the association between depression and dementia showed  that a history of depression significantly increased the risk of Alzheimer’s disease Journal name: Neuropsychiatric Disease and Treatment Journal Designation: Original Research Y ear: 2014 Volume: 10 Running head verso: Tsuruga et al Running head recto: Correlation between serum amyloid β levels and depressive symptoms DOI: http://dx.doi.org/10.2147/NDT.S67205",Non-OADS,/arxiv_data1/oa_pdf/30/87/ndt-10-1621.PMC4156004.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/30/87/ndt-10-1621.PMC4156004.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.Dove pres s Neuropsychiatric Disease and Treatment 2014:10submit your manuscript | www.dovepress.co m Dove press Dove press 1627correlation between serum amyloid β levels and depressive symptoms  5.,Non-OADS,/arxiv_data1/oa_pdf/30/87/ndt-10-1621.PMC4156004.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a5/83/ndt-10-1605.PMC4156005.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 1605–1611Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1605Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/NDT .S5248 6Correspondence: Chi-Un Pae   Department of Psychiatry, Bucheon  St Mary’s Hospital, The Catholic  University of Korea College of Medicine,  2 Sosa-Dong, wonmi-Gu, Bucheon  420-717, Gyeonggi-Do, Republic of Korea   Tel +823 2340 7067   Fax +823 2340 2255   email pae@catholic.ac.k rSchizophrenia relapse and the clinical usefulness  of once-monthly aripiprazole depot injection Sheng-Min wang1 Changsu Han2 Soo-Jung Lee5 Ashwin A Patkar3 Prakash S Masand4 Chi-Un Pae3,5 1international Health Care Center,   Seoul St Mary’s Hospital, The Catholic  University of Korea, College   of Medicine, Seoul, Republic of Korea;   2Department of Psychiatry, College  of Medicine, Korea University, Seoul,   Republic of Korea; 3Department   of Psychiatry and Behavioral Sciences,   Duke University Medical Center,   Durham, NC, 4Global Medical  education, New Y ork, NY, USA;   5Department of Psychiatry, Bucheon  St Mary’s Hospital, The Catholic  University of Korea, College of  Medicine, Seoul, Republic of KoreaJournal name: Neuropsychiatric Disease and Treatment Journal Designation: Review Y ear: 2014 Volume: 10 Running head verso: Wang et al Running head recto: Schizophrenia relapse and once-monthly aripiprazole injection DOI: http://dx.doi.org/10.2147/NDT.S52486 Abstract:  Improving medication adherence is critical to improving outcomes in patients  with schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/a5/83/ndt-10-1605.PMC4156005.pdf
"To supplement  these six studies, data obtained from the package informa - tion by Otsuka Pharmaceuticals were extracted online from  http://www.fda.gov .",OADS,/arxiv_data1/oa_pdf/a5/83/ndt-10-1605.PMC4156005.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/a5/83/ndt-10-1605.PMC4156005.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.Dove pres s Neuropsychiatric Disease and Treatment 2014:10submit your manuscript | www.dovepress.co m Dove press Dove press 1611Schizophrenia relapse and once-monthly aripiprazole injection 15.,Non-OADS,/arxiv_data1/oa_pdf/a5/83/ndt-10-1605.PMC4156005.pdf
Available from: http://www.otsuka-us.,Non-OADS,/arxiv_data1/oa_pdf/a5/83/ndt-10-1605.PMC4156005.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/47/1a/ndt-10-1589.PMC4156006.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 1589–1597Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1589OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/NDT .S6895 1correspondence: robert l Findling  Department of Psychiatry   and Behavioral sciences, The Johns  hopkins hospital, Bloomberg children’s  center, 1800 Orleans street/suite  12344a, Baltimore, Maryland 21287 Usa Tel +1 410 614 3225 Fax +1 410 955 8691 email rfindli1@jhmi.ed uThe safety and effectiveness of open-label  extended-release carbamazepine in the treatment  of children and adolescents with bipolar i  disorder suffering from a manic or mixed episode robert l Findling1,2 lawrence D ginsberg3 1Division of child and adolescent  Psychiatry, Department of Psychiatry  and Behavioral sciences, Johns  hopkins University, 2Kennedy Krieger  institute, Baltimore, MD, Usa; 3red  Oak Psychiatry associates, P a,   houston, TX, UsaObjective:  To assess the safety and effectiveness of open-label treatment with extended-release  carbamazepine (ERC) in pediatric subjects suffering from bipolar I disorder.",Non-OADS,/arxiv_data1/oa_pdf/47/1a/ndt-10-1589.PMC4156006.pdf
Journal name: Neuropsychiatric Disease and Treatment Journal Designation: Original Research Y ear: 2014 Volume: 10 Running head verso: Findling and Ginsberg Running head recto: Carbamazepine in children and adolescents with bipolar I disorder DOI: http://dx.doi.org/10.2147/NDT.S68951,Non-OADS,/arxiv_data1/oa_pdf/47/1a/ndt-10-1589.PMC4156006.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/47/1a/ndt-10-1589.PMC4156006.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.Dove pres s Neuropsychiatric Disease and Treatment 2014:10submit your manuscript | www.dovepress.co m Dove press Dove press 1597carbamazepine in children and adolescents with bipolar i disorder  3.,Non-OADS,/arxiv_data1/oa_pdf/47/1a/ndt-10-1589.PMC4156006.pdf
SUPPLEMENTARY MATERIAL is linked to the online version of the paper at http://www.nature.com/mi ACKNOWLEDGMENTS We would like to thank Leo LeFrancois for the kind gift of IFABP-tOVA 232-4mice.,Non-OADS,/arxiv_data1/oa_pdf/a7/77/mi201440a.PMC4156465.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLES 48 VOLUME 8 NUMBER 1 |JANUARY 2015 |www.nature.com/mi",Non-OADS,/arxiv_data1/oa_pdf/a7/77/mi201440a.PMC4156465.pdf
"Cellular Logistics 2014; 4:e28461; http://dx.doi.org/10.4161/cl.28461Altered trafficking of mutated growth factor  receptors and their associated molecules Implication for human cancers Shunsuke Kon1, Nobuhide Kobayashi1 and Masanobu Satake1,* 1institute of Development, Aging and Cancer, Tohoku University; Sendai, Japan Keywords:  endocytosis, endosomes, lysosomes, membrane vesicles, oncogenesis, receptor tyrosine kinase, signal transduction,  ubiquitination Abbreviations:  AML, acute myeloid leukemia; CMML, chronic myelomonocytic leukemia; EE, early endosomes; EGFR,  epidermal growth factor receptor; ER, endoplasmic reticulum; FLT3, fms-like tyrosine kinase 3; HGF, hepatocyte growth factor;  ITD, internal tandem duplication; KIT, tyrosine-protein kinase; LE, late endosomes; MDS, myelodysplastic syndrome; MET,  mesenchymal epithelial transition factor; MVB, multivesicular bodies; RE, recycling endosomes; RTK, receptor tyrosine kinase;  T-ALL, T cell acute lymphoblastic lymphoma Ligand-stimulated receptor tyrosine kinases (RTKs) are  phosphorylated/ubiquitinated, endocytosed and transported  to the lysosomes via endosomes/multivesicular bodies, result - ing in the attenuation of signal transmission.",OADS,/arxiv_data1/oa_pdf/bf/95/cl-4-e28461.PMC4156482.pdf
Nature 2001; 411:355-65; PMID:11357143 ;  http://dx.doi.org/10.1038/35077225 2.,Non-OADS,/arxiv_data1/oa_pdf/bf/95/cl-4-e28461.PMC4156482.pdf
Curr Opin Cell Biol 2003; 15:128-35;  PMID:12648667 ; http://dx.doi.org/10.1016/ S0955-0674(03)00004-8 3.,OADS,/arxiv_data1/oa_pdf/bf/95/cl-4-e28461.PMC4156482.pdf
Cancer Cell  2003; 3:519-23;  PMID:12842080 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bf/95/cl-4-e28461.PMC4156482.pdf
FEBS Lett 2001; 490:142- 52; PMID:11223029 ; http://dx.doi.org/10.1016/ S0014-5793(01)02117-25.,OADS,/arxiv_data1/oa_pdf/bf/95/cl-4-e28461.PMC4156482.pdf
N Engl J Med 2004; 350:2129- 39; PMID :15118073 ; http://dx.doi.org/10.1056/ NEJMoa040938 6.,OADS,/arxiv_data1/oa_pdf/bf/95/cl-4-e28461.PMC4156482.pdf
Proc Natl Acad Sci U S A 2004; 101:13306- 11; PMID :15329413 ; http://dx.doi.org/10.1073/ pnas.04052201018.,OADS,/arxiv_data1/oa_pdf/bf/95/cl-4-e28461.PMC4156482.pdf
Oncogene  2007; 26:6968-78;  PMID:17486068 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/95/cl-4-e28461.PMC4156482.pdf
Cancer Sci 2003; 94:50-6; PMID:12708474 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bf/95/cl-4-e28461.PMC4156482.pdf
Carcinogenesis 2007; 28:1408-17; PMID:17372273 ; http://dx.doi.org/10.1093/ carcin/bgm058 14.,Non-OADS,/arxiv_data1/oa_pdf/bf/95/cl-4-e28461.PMC4156482.pdf
Nat Genet 1997; 16:68- 73; PMID:9140397 ; http://dx.doi.org/10.1038/ ng0597-68 16.,Non-OADS,/arxiv_data1/oa_pdf/bf/95/cl-4-e28461.PMC4156482.pdf
Nat Cell Biol 2011; 13:827-37;   PMID:21642981 ; http://dx.doi.org/10.1038/ncb2257 17.,OADS,/arxiv_data1/oa_pdf/bf/95/cl-4-e28461.PMC4156482.pdf
Mol Cell Biol 2007; 27:267-82; PMID:17060458 ; http://dx.doi.org/10.1128/ MCB.01153-06 20.,Non-OADS,/arxiv_data1/oa_pdf/bf/95/cl-4-e28461.PMC4156482.pdf
Blood 2002; 100:1532- 42; PMID:12176867 ; http://dx.doi.org/10.1182/ blood-2002-02-0492 21.,Non-OADS,/arxiv_data1/oa_pdf/bf/95/cl-4-e28461.PMC4156482.pdf
Nat Rev Cancer 2003; 3:650-65; PMID :12951584 ; http://dx.doi.org/10.1038/ nrc1169 22.,Non-OADS,/arxiv_data1/oa_pdf/bf/95/cl-4-e28461.PMC4156482.pdf
Mol Cell 2009; 36:326-39; PMID:19854140 ;  http://dx.doi.org/10.1016/j.molcel.2009.09.019 23.,OADS,/arxiv_data1/oa_pdf/bf/95/cl-4-e28461.PMC4156482.pdf
Nature 2009; 460:904-8; PMID:19620960 ;  http://dx.doi.org/10.1038/nature0824026.,Non-OADS,/arxiv_data1/oa_pdf/bf/95/cl-4-e28461.PMC4156482.pdf
J Biol Chem 2008; 283:34365-73; PMID:18819912 ;  http://dx.doi.org/10.1074/jbc.M804587200 29.,OADS,/arxiv_data1/oa_pdf/bf/95/cl-4-e28461.PMC4156482.pdf
Science 2004; 306:269-71; PMID:15472075 ;  http://dx.doi.org/10.1126/science.1102160 30.,Non-OADS,/arxiv_data1/oa_pdf/bf/95/cl-4-e28461.PMC4156482.pdf
J Clin Invest  2010; 120:2537-48;  PMID:20516639 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/95/cl-4-e28461.PMC4156482.pdf
Oncogene 2013; http://dx.doi.org/10.1038/onc.2013.211 ; PMID:23752192 34.,OADS,/arxiv_data1/oa_pdf/bf/95/cl-4-e28461.PMC4156482.pdf
J Clin Invest 2013; 123:1123-37; PMID:23434593 ;  http://dx.doi.org/10.1172/JCI63711 35.,Non-OADS,/arxiv_data1/oa_pdf/bf/95/cl-4-e28461.PMC4156482.pdf
J Biol Chem  2001; 276:39271-6;  PMID:11517213 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/95/cl-4-e28461.PMC4156482.pdf
J Biol Chem 2001; 276:46230- 6; PMID:11577110 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/bf/95/cl-4-e28461.PMC4156482.pdf
Mol Cell Biol 2001; 21:7796-806;  PMID:11604514 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/95/cl-4-e28461.PMC4156482.pdf
Cancer Cell 2003; 3:471- 82; PMID:12781365 ; http://dx.doi.org/10.1016/ S1535-6108(03)00107-7 42.,Non-OADS,/arxiv_data1/oa_pdf/bf/95/cl-4-e28461.PMC4156482.pdf
Biochem J 2004; 382:13-25; PMID :15186216 ;  http://dx.doi.org/10.1042/BJ20040737 43.,Non-OADS,/arxiv_data1/oa_pdf/bf/95/cl-4-e28461.PMC4156482.pdf
Oncogene 1997; 15:1617-23; PMID:9380415 ;  http://dx.doi.org/10.1038/sj.onc.1201311 44.,Non-OADS,/arxiv_data1/oa_pdf/bf/95/cl-4-e28461.PMC4156482.pdf
EMBO J 2004; 23:2707-12; PMID:15229652 ;  http://dx.doi.org/10.1038/sj.emboj.7600292 47.,Non-OADS,/arxiv_data1/oa_pdf/bf/95/cl-4-e28461.PMC4156482.pdf
FEBS Lett 2005; 579:3231-8;  PMID :15943966 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/95/cl-4-e28461.PMC4156482.pdf
Traffic  2008; 9:2011-21;  PMID:18785924 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/95/cl-4-e28461.PMC4156482.pdf
Nat Rev Cancer  2008; 8:835-50;  PMID:18948996 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bf/95/cl-4-e28461.PMC4156482.pdf
Nat Rev Mol Cell Biol 2011; 12:517- 33; PMID:21779028 ; http://dx.doi.org/10.1038/ nrm3151 51.,OADS,/arxiv_data1/oa_pdf/bf/95/cl-4-e28461.PMC4156482.pdf
Dev Cell 2008; 15:209- 19; PMID:18694561 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/bf/95/cl-4-e28461.PMC4156482.pdf
Oncogene 2002; 21:4830-7; PMID:12101421 ; http://dx.doi.org/10.1038/ sj.onc.1205612 53.,OADS,/arxiv_data1/oa_pdf/bf/95/cl-4-e28461.PMC4156482.pdf
Cell 1997; 88:143-54;  PMID:9019400 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/95/cl-4-e28461.PMC4156482.pdf
"Cellular Logistics 2014; 4:e29191; http://dx.doi.org/10.4161/cl.29191Tracking of the dynamic localization of the Rab- specific HOPS subunits reveal their distinct  interaction with Ypt7 and vacuoles Kathrin a uffarth, h enning a rlt, Jens Lachmann, Margarita c abrera and c hristian Ungermann* Biochemistry section; Department of Biology/ chemistry; University of Osnabrück; Osnabrück, Germany Keywords:  HOPS, tethering complex, Vps39, Vps41, endosome, vacuole endosomal and vacuole fusion depends on the two homologous tethering complexes c ORV eT and h OPs.",OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
EMBO J 2011; 30:3481-500;  PMID:21878991 ;  http://dx.doi.org/10.1038/emboj.2011.286 3.,Non-OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
Proc Natl Acad Sci U S A  2012; 109:1991-6;  PMID:22308417 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
Curr  Opin Cell Biol 2010; 22:461-70;  PMID:20466531 ;  http://dx.doi.org/10.1016/j.ceb.2010.04.007 6.,OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
Physiol Rev  2011; 91:119-49;  PMID:21248164 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
Cell 2005; 122:735-49;   PMID:16143105 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
Trends Cell Biol  2006; 16:27-35;  PMID:16330212 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
Curr Biol 2010; 20:1654- 9; PMID:20797862 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
Curr Biol 2012; 22:2135-9;  PMID:23084991 ;  http://dx.doi.org/10.1016/j.cub.2012.09.020 12.,OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
J Cell Biol 2000; 151:551- 62; PMID:11062257 ; http://dx.doi.org/10.1083/ jcb.151.3.551 13.,OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
Proc Natl Acad Sci U S A 2000; 97:9402- 7; PMID:10944212 ; http://dx.doi.org/10.1073/ pnas.97.17.9402 14.,OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
Dev Cell  2007; 12:739-50;  PMID:17488625 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
Mol Biol Cell  2012; 23:1889-901;  PMID:22456509 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
Mol Biol Cell 2010;  21:2297-305;  PMID:20462954 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
Mol Biol Cell 2012; 23:3429-37;   PMID:22787280 ; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
Proc Natl Acad Sci U S A  2013; 110:3823-8;  PMID:23417307 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
J Cell Sci 2013; 126:1307- 16; PMID:23645161 ; http://dx.doi.org/10.1242/ jcs.107805 21.,OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
Nat Cell Biol 1999; 1:346-53;   PMID:10559961 ; http://dx.doi.org/10.1038/14037 22.,OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
Mol Biol  Cell 2001; 12:37-51;  PMID:11160821 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
Mol Biol Cell  2009; 20:4563-74;  PMID:19741093 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
Mol Cell 2008; 31:925- 32; PMID:18922474 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
Yeast 2008; 25:577- 94; PMID:18668531 ; http://dx.doi.org/10.1002/ yea.1610 27.,OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
Dev Cell 2010; 18:324- 31; PMID :20159602 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
J Cell Biol 2013; 200:287-300;  PMID:23382462 ;  http://dx.doi.org/10.1083/jcb.201209113,OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
Nature  2003; 425:737-41;  PMID:14562106 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
EMBO J 2007; 26:1- 8; PMID:17170709 ; http://dx.doi.org/10.1038/ sj.emboj.7601466 31.,Non-OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
J  Biol Chem 2013; 288:28704-12;  PMID:23979137 ;  http://dx.doi.org/10.1074/jbc.M113.488213 32.,OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
PLoS One 2013; 8:e67307;  PMID:23840658 ;  http://dx.doi.org/10.1371/journal.pone.0067307 33.,Non-OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
Traffic  2010; 11:1334-46;  PMID:20604902 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
Yeast 2007; 24:767-75;  PMID:17534848 ;  http://dx.doi.org/10.1002/yea.1504 35.,Non-OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
Mol Biol Cell 2009; 20:5276-89;   PMID:19828734 ; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
J Cell Biol  2000; 148:1223-9;  PMID:10725335 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
J Cell Biol  2002; 157:79-89;  PMID:11916982 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
Proc Natl Acad Sci U S A  2000; 97:8889-91;  PMID:10908678 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
J Cell Biol  2005; 168:401-14;  PMID:15684030 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
EMBO J 2004; 23:2765-76;  PMID :15241469 ;  http://dx.doi.org/10.1038/sj.emboj.7600286 41.,OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
Cell 2010; 141:497-508;   PMID:20434987 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
J Cell Sci 2014; 127:1043-51;   PMID:24413168 ; http://dx.doi.org/10.1242/ jcs.14092143.,OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
Curr Biol 2008;  18:1072-7;  PMID:18619842 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
Yeast 2004; 21:947-62;  PMID:15334558 ;  http://dx.doi.org/10.1002/yea.1142 46.,OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
Yeast 1998; 14:953- 61; PMID:9717241 ; http://dx.doi.org/10.1002/ (SICI)1097-0061(199807)14:10<953::AID- YEA293>3.0.CO;2-U,OADS,/arxiv_data1/oa_pdf/99/21/cl-4-e29191.PMC4156483.pdf
"Cellular Logistics 2014; 4:e28680; http://dx.doi.org/10.4161/cl.28680Distinct patterns of phosphatidylserine  localization within the Rab11a-containing  recycling system Nicholas W Baetz1 and James R Goldenring1,2,3,4,* 1section of s urgical s ciences and the e pithelial Biology c enter; Vanderbilt University Medical c enter; Nashville, TN U sa; 2Department of c ell & Developmental Biology;  Vanderbilt University s chool of Medicine; Nashville, TN U sa; 3Vanderbilt-Ingram cancer c enter; Vanderbilt University Medical c enter; Nashville, TN U sa; 4Nashville Veterans  affairs Medical c enter; Nashville, TN U sa Keywords:  Rab11-FIP, Rab11a, Rab5, Rab7, Rab8a, live cell microscopy, phophatidylserine, structured illumination The Rab11 GTPases and Rab11 family-interacting proteins (Rab11-FIPs) define integrated yet distinct compartments  within the slow recycling pathway.",Non-OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
Cell 1990; 62:317-29; PMID:2115402 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
Annu Rev Biochem 2012; 81:637-59;  PMID:22463690 ; http://dx.doi.org/10.1146/ annurev-biochem-052810-093700 3.,Non-OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
J Cell Biol  2000; 149:901-14;  PMID:10811830 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
Cell 2005; 122:735-49;  PMID:16143105 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
Nature  2006; 443:651-7;  PMID:17035995 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
Traffic 2009; 10:1377-89; PMID:19522756 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
J Cell Biol 1996; 135:913-24; PMID:8922376 ; http://dx.doi.org/10.1083/ jcb.135.4.913 8.,Non-OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
Mol Cell  2000; 6:1437-48;  PMID:11163216 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
Biochem Biophys Res Commun 2002; 299:770- 9; PMID:12470645 ; http://dx.doi.org/10.1016/ S0006-291X(02)02720-1 10.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
J Cell Sci 2008; 121:3824-33; PMID:18957512 ; http://dx.doi.org/10.1242/ jcs.032441 11.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
J Biol Chem 2002; 277:27193-9; PMID:11994279 ;  http://dx.doi.org/10.1074/jbc.M200757200 12.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
J  Biol Chem 2002; 277:50415-21; PMID:12393859 ;  http://dx.doi.org/10.1074/jbc.M20927020013.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
J Biol Chem 2001; 276:39067-75; PMID:11495908 ;  http://dx.doi.org/10.1074/jbc.M104831200 14.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
J Biol Chem 2001; 276:32407-10; PMID:11432875 ;  http://dx.doi.org/10.1074/jbc.R100007200 16.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
J Cell Sci  2004; 117:4365-75;  PMID:15304524 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
J Cell Biol 2012; 196:277-95; PMID:22270919 ; http://dx.doi.org/10.1083/ jcb.201109112 19.,Non-OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
J Lipid Res 2008; 49:1377-87;  PMID:18204094 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
Prog Lipid Res 2005; 44:207- 34; PMID :15979148 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
Physiol Rev 2013; 93:69-106; PMID:23303906 ;  http://dx.doi.org/10.1152/physrev.00002.2012 22.,Non-OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
Future Med Chem 2013; 5:947- 59; PMID:23682570 ; http://dx.doi.org/10.4155/ fmc.13.66 23.,Non-OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
Science 2008; 319:210-3;  PMID:18187657 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
Nat Rev Mol Cell Biol 2012; 13:463-70; PMID:22722608 ; http://dx.doi.org/10.1038/ nrm3379 25.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
Mol Biol Cell 2013; 24:643-58;  PMID:23283983 ; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
J Cell Biol  2011; 194:257-75;  PMID:21788369 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
Biochem Biophys Res Commun 2002 ; 292:909-15;  PMID:11944901 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
J Biol Chem 2002; 277:49003-10;  PMID:12376546 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
J Biol Chem 2002; 277:12190-9;  PMID:11786538 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
Biol Cell  2010; 102:51-62;  PMID:19702578 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
PLoS Pathog  2013; 9:e1003278;  PMID:23592992 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
Biochem Soc Trans 2005; 33:1276-8; PMID:16246097 ; http://dx.doi.org/10.1042/ BST20051276 34.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
J Biol Chem 1999;  274:36609-15;  PMID:10593962 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
Nat Rev  Mol Cell Biol 2008; 9:833-45; PMID:18946473 ;  http://dx.doi.org/10.1038/nrm2525 36.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
Nat Rev Mol Cell Biol 2001;  2:721-30;  PMID :11584299 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
J Cell Biol  2013; 202:191-9;  PMID:23878272 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
Mol Biol Cell 2012; 23:2198-212; PMID:22496416 ;  http://dx.doi.org/10.1091/mbc.E11-11-0936 39.,Non-OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
Nat Rev Mol Cell Biol  2008; 9:99-111;  PMID:18216767 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
Nat Struct Mol Biol  2006; 13:209-17;  PMID:16491093 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
EMBO J 2011; 30:3481-500; PMID:21878991 ;  http://dx.doi.org/10.1038/emboj.2011.286 43.,Non-OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
EMBO J 2000; 19:4577- 88; PMID:10970851 ; http://dx.doi.org/10.1093/ emboj/19.17.4577 44.,Non-OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
Proc Natl Acad Sci U S A 2013; 110:21165-70;  PMID:24324172 ; http://dx.doi.org/10.1073/ pnas.131186411045.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
Methods Cell Biol 2012; 108:367-93;  PMID:22325611 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
Mol Biol Cell 2007; 18:2828-37; PMID:17507647 ;  http://dx.doi.org/10.1091/mbc.E07-02-0169 48.,Non-OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
J Biol Chem 2009; 284:1213-23;  PMID:19008234 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
Nat Biotechnol 2004; 22:445-9; PMID:14990965 ; http://dx.doi.org/10.1038/nbt945 51.,Non-OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
J Microsc 2000;  198:82-7;  PMID:10810003 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
J Microsc 1993; 169:375-82; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
Mol Cell Proteomics  2008; 7:282-9;  PMID:17951627 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
Nature  1970; 227:680-5;  PMID:5432063 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/52/8e/cl-4-e28680.PMC4156484.pdf
"Cellular Logistics 2014; 4:e29087; http://dx.doi.org/10.4161/cl.29087An investigation of the effect of membrane  curvature on transmembrane-domain dependent  protein sorting in lipid bilayers Matteo Fossati1,†, Bruno Goud2, Nica Borgese1,3,* and Jean-Baptiste Manneville2,* 1CNR Institute of Neuroscience and Department of Biotechnology and Translational Medicine; University of Milano; Milano, Italy; 2CNR s-Institut Curie; UMR144; Paris, France;  3Department of h ealth s cience; University of Catanzaro “Magna Graecia”; Catanzaro, Italy; †Current affiliation: Institute of Biology at the École Normale s upérieure (IB eNs);  Paris, France Keywords:  endoplasmic reticulum, giant unilamellar vesicles, hydrophobic mismatch, nanotubes, tail-anchored proteins, optical  tweezers, bending rigidity Abbreviations:  ER, endoplasmic reticulum; ERES, ER exit sites; FP, fluorescent protein; FRAP, Fluorescence recovery after  photobleaching; GUV, giant unilamellar vesicle; LUV, large unilamellar vesicle; OG, N-octyl glucoside; PK, Protease K; POPC,  palmitoyl oleyl phosphatidylcholine; TA, tail-anchored; TMD, transmembrane domain sorting of membrane proteins within the secretory pathway of eukaryotic cells is a complex process involving  discrete sorting signals as well as physico-chemical properties of the transmembrane domain (TMD).",Non-OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
Nature 2005; 438:590-6; http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=16319878 ;  PMID:16319878 ; http://dx.doi.org/10.1038/ nature04396 .,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
Cell 2010 ; 142:507-10; http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
nih.gov/entrez/query.fcgi?cmd=Retrieve&db=P ubMed&dopt=Citation&list_uids=20723749 ;  PMID:20723749 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
Nat Cell Biol  2013 ; 15:1019 - 27; http://www.ncbi.nlm.nih.gov/entrez/query.fcg i?cmd=Retrieve&db=PubMed&dopt=Citation&l ist_uids=23999615 ; PMID:23999615 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
Cell 2006 ; 124:573-86;  http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?c md=Retrieve&db=PubMed&dopt=Citation&list_ uids=16469703 ; PMID:16469703 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
EMBO  J 2005 ; 24:1537 -45; http://www.ncbi.nlm.nih.gov/ entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=15791208 ; PMID:15791208 ;  http://dx.doi.org/10.1038/sj.emboj.7600631 .,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
Proc Natl Acad Sci U S  A 2009 ; 106:5622 -6; http://www.ncbi.nlm.nih.gov/ entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=19304798 ; PMID:19304798 ;  http://dx.doi.org/10.1073/pnas.0811243106 .7.,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
Biophys J  2013 ; 104:575-84;  http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?c md=Retrieve&db=PubMed&dopt=Citation&list_ uids=23442908 ; PMID:23442908 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
Cell 2003 ; 114:497-509; PMID:12941277 ;  http://dx.doi.org/10.1016/S0092-8674(03)00609-3 9.,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
Cell 2004 ; 116:153-66; http:// www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd= Retrieve&db=PubMed&dopt=Citation&list_ uids=14744428 ; PMID:14744428 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
Cell 2010 ; 142:158-69;  http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?c md=Retrieve&db=PubMed&dopt=Citation&list_ uids=20603021 ; PMID:20603021 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
J Cell Biol  2008 ; 181:105-18; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
J Cell Sci   2009 ; 122:1759 -67; http://www.ncbi.nlm.nih.gov/ entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=19435807 ; PMID:19435807 ;  http://dx.doi.org/10.1242/jcs.039339 .,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
J Cell Sci  2010 ; 123:3329 -35; http://www.ncbi.,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db =PubMed&dopt=Citation&list_uids=20826467 ;  PMID:20826467 ; http://dx.doi.org/10.1242/ jcs.073031 .,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
EMBO J  1995 ; 14:4695 -704; http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
Biophys Chem  2010 ; 151:34- 8; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?c md=Retrieve&db=PubMed&dopt=Citation&list_ uids=20537786 ; PMID:20537786 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
PLoS Biol  2012 ;  10:e1001329 ; http://www.ncbi.nlm.nih.gov/entrez/ query.fcgi?cmd=Retrieve&db=PubMed&dopt=C itation&list_uids=22629230 ; PMID:22629230 ;  http://dx.doi.org/10.1371/journal.pbio.1001329 .,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve& db=PubMed&dopt=Citation&list_uids=17629691 ;  PMID:17629691 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
Proc Natl Acad Sci U S A  2002 ; 99:5394 -9; http:// www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd= Retrieve&db=PubMed&dopt=Citation&list_ uids=11959994 ; PMID:11959994 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve& db=PubMed&dopt=Citation&list_uids=15569933 ;  PMID:15569933 ; http://dx.doi.org/10.1073/ pnas.0406598101 .,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
Cold Spring  Harb Perspect Biol  2011 ; 3:•••; http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db =PubMed&dopt=Citation&list_uids=21421916 ;  PMID:21421916 ; http://dx.doi.org/10.1101/ cshperspect.a004648 .,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
Methods Cell  Biol 2012 ; 108:47-71; http://www.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=22325597 ;  PMID:22325597 ; http://dx.doi.org/10.1016/ B978-0-12-386487-1.00003-1 .,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
Chemphyschem   2009 ; 10:1369 -79; http://www.ncbi.nlm.nih.gov/ entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=19229892 ; PMID:19229892 ;  http://dx.doi.org/10.1002/cphc.200800839 .,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
Proc Natl Acad Sci U S A  2011 ; 108:12605 -10;  http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
cmd=Retrieve&db=PubMed&dopt=Citation&l ist_uids=21768336 ; PMID:21768336 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve& db=PubMed&dopt=Citation&list_uids=21806937 ;  PMID:21806937 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
Biophys J  2006 ; 91:4464 -77; http:// www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd= Retrieve&db=PubMed&dopt=Citation&list_ uids=17012328 ; PMID:17012328 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
Curr Opin Cell Biol  2004 ; 16:373- 8; http://www.ncbi.nlm.nih.gov/entrez/query.fcg i?cmd=Retrieve&db=PubMed&dopt=Citation&l ist_uids =15261669 ; PMID :15261669 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
Biochem Biophys Res  Commun  2012 ; 426:585-9; http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
nih.gov/entrez/query.fcgi?cmd=Retrieve&db=P ubMed&dopt=Citation&list_uids=22974979 ;  PMID:22974979 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
Biophys J  2010 ; 99:1539 -45;  http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?c md=Retrieve&db=PubMed&dopt=Citation&list_ uids=20816066 ; PMID:20816066 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
Mol Membr Biol  2003 ; 20:271-84; PMID:14578043 ;  http://dx.doi.org/10.1080/09687680310001605352 34.,Non-OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
Biophys J  2010 ; 99:175-83;  http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
cmd=Retrieve&db=PubMed&dopt=Citation&l ist_uids=20655845 ; PMID:20655845 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
Dev  Cell 2014 ; 28:212-8; http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
Biochim Biophys Acta 2013; 1833 :  2464-72; http://www.ncbi.nlm.nih.gov/entrez/ query.fcgi?cmd=Retrieve&db=PubMed&dopt=Cita tion&list_uids=23419775 37.,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
J Cell Sci  2006 ; 119:3149 - 60; http://www.ncbi.nlm.nih.gov/entrez/query.fcg i?cmd=Retrieve&db=PubMed&dopt=Citation&l ist_uids=16835267 ; PMID:16835267 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
J Cell Sci  2006 ; 119:433- 42; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
cmd=Retrieve&db=PubMed&dopt=Citation&list_ uids=16443748 ; PMID:16443748 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
Mol Biol Cell  2006 ;  17:1375 -87; http://www.ncbi.nlm.nih.gov/entrez/ query.fcgi?cmd=Retrieve&db=PubMed&dopt=Cita tion&list_uids=16381816 ; PMID:16381816 ; http:// dx.doi.org/10.1091/mbc.E05-11-1035 .,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
"Runz  H, Miura  K, Weiss  M, Pepperkok  R. Sterols  regulate ER-export dynamics of secretory cargo  protein ts-O45-G.  EMBO J  2006 ; 25:2953 -65;  http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?",OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
cmd=Retrieve&db=PubMed&dopt=Citation&l ist_uids=16794576 ; PMID:16794576 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
Plant Physiol  1999 ; 120:245-56;  PMID:10318702 ; http://dx.doi.org/10.1104/ pp.120.1.245,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
J Cell Sci  2010 ;  123:1705 -15; http://www.ncbi.nlm.nih.gov/entrez/ query.fcgi?cmd=Retrieve&db=PubMed&dopt=Cita tion&list_uids=20427317 ; PMID:20427317 ; http:// dx.doi.org/10.1242/jcs.062950 .,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
Biophys J  2004 ; 87:2107 -15; http://www.ncbi.,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db =PubMed&dopt=Citation&list_uids=15454415 ;  PMID :15454415 ; http://dx.doi.org/10.1529/ biophysj.104.040311 .,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
Biochim Biophys Acta 2012;  1818 : 984-94; http://www.ncbi.nlm.nih.gov/entrez/ query.fcgi?cmd=Retrieve&db=PubMed&dopt=Cita tion&list_uids=21884678 45.,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
J Phys  Chem B  2010 ; 114:8076 -80; http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db =PubMed&dopt=Citation&list_uids=20509701 ;  PMID:20509701 ; http://dx.doi.org/10.1021/ jp100931h .46.,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
Proc Natl Acad Sci U S A  2005 ; 102:16269 - 74; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
cmd=Retrieve&db=PubMed&dopt=Citation&list_ uids=16258060 ; PMID:16258060 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
Methods Enzymol  1983 ; 96:84-93; PMID:6656655 ;  http://dx.doi.org/10.1016/S0076-6879(83)96010-X 48.,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
J Biol Chem  1957 ; 226:497-509;  http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?c md=Retrieve&db=PubMed&dopt=Citation&list_ uids=13428781 ; PMID:13428781 .,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
Proc Natl Acad Sci U S A  1998 ; 95:4293 - 8; http://www.ncbi.nlm.nih.gov/entrez/query.fcg i?cmd=Retrieve&db=PubMed&dopt=Citation&l ist_uids=9539730 ; PMID:9539730 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
Biophys J  1981 ; 35:637-52;  http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
cmd=Retrieve&db=PubMed&dopt=Citation&l ist_uids=7272454 ; PMID:7272454 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/62/cl-4-e29087.PMC4156485.pdf
Available from:  http://www.nature.com/news/fishy-business- 1.15627?W t.ec_id=NA tURe-20140731  AquaBounty t echnologies [ internet].,Non-OADS,/arxiv_data1/oa_pdf/a2/6f/bbug-5-283.PMC4156487.pdf
"Available from:  http://www.the-scientist.com//?articles.view/ articleNo/40711/title/Light- tolerant- tomatoes/ Ebola outbreak: WHO agrees to unproven interventions According to the World Health  organization (WH o), West Africa is experienc - ing the largest, most severe, and complex out - break of e bola virus disease in history.",Non-OADS,/arxiv_data1/oa_pdf/a2/6f/bbug-5-283.PMC4156487.pdf
Available  from: http://www.who.int/mediacentre/news/ statements/2014/ebola-ethical-review-summary/ en,Non-OADS,/arxiv_data1/oa_pdf/a2/6f/bbug-5-283.PMC4156487.pdf
"1A).4,8-11 The majority of these aptamers had the  potential to form G-quadruplex structures, and further analysis  Correspondence to: Edward A Curtis; Email: curtis@uochb.cas.cz; and David R Liu; Email: drliu@fas.harvard.edu Submitted: 10/27/2013; Revised: 04/02/2014; Accepted: 04/06/2014; Published Online: 04/24/2014http://dx.doi.org/10.4161/rna.28798A naturally occurring, noncanonical GTP aptamer  made of simple tandem repeats edward A curti s and David R Liu Department of chemi stry and chemi cal Biology and howar d hughe s Medical Institute; harva rd University; cambr idge, MA U sA Keywords:  naturally occurring aptamer, tandem repeats, in vitro selection, GTP, RNA, microsatellite Recently, we used in vitro selection to identify a new class of naturally occurring GTP aptamer called the G motif.",Non-OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Methods Mol Biol 2009; 575:47-92; PMID:19727611 ;  http://dx.doi.org/10.1007/978-1-60761-274-2_3 4.,Non-OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Nat Struct Biol   2003 ; 10:33-7; PMID:12447348 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Annu Rev Genet  2010 ; 44:445-77; PMID:20809801 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Biol Chem  2012 ; 393:1299 - 315; PMID:23052488 ; http://dx.doi.org/10.1515/ hsz-2012-0218 8.,Non-OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Science  2006 ; 313:1788 -92; PMID:16990549 ;  http://dx.doi.org/10.1126/science.1129308 10.,Non-OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Methods  2010 ; 52:125-32;  PMI D:20541015 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Chem Biol   2012 ; 19:1247 -54; PMID:23102219 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Biochemistry  1993 ; 32:5497 -502; PMID:8504070 ;  http://dx.doi.org/10.1021/bi00072a002 14.,Non-OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Chem Biol  1997 ; 4:767-74; PMID:9375255 ;  http://dx.doi.org/10.1016/S1074-5521(97)90315-X 15.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Nucleic Acids Res 2002 ;  30:3497 -531; PMID:12177293 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Methods Enzymol  1992 ; 211:199- 220; PMID:1383673 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Proc Natl Acad Sci U S A 1962 ;  48:2013 -8; PMID:13947099 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Angew Chem Int Ed Engl 2004 ; 43:668-98;  PMID:14755695 ; http://dx.doi.org/10.1002/ anie.200300589 19.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Nucleic Acids Res 2009 ;  37:1713 -25; PMID:19190094 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Nucleic Acids Res 2008 ; 36:5123 -38;  PMID:18676453 ; http://dx.doi.org/10.1093/nar/ gkn493 21.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Nucleic Acids  Res 1979 ; 6:3073 -91; PMID:40208 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
J Mol Biol  1990 ; 213:833-43;  PMID:2359124 ; http://dx.doi.org/10.1016/ S0022-2836(05)80267-0 23.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Methods Enzymol   1995 ; 246:19-34; PMID:7538624 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Nucleic Acids Res 2002 ;  30:207-10; PMID:11752295 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Gene  1993 ;  135:99-109; PMID:8276285 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Curr  Opin Struct Biol  1996 ; 6:299-304; PMID:8804832 ;  http://dx.doi.org/10.1016/S0959-440X(96)80047-9 28.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Science  2000 ; 289:905- 20; PMID:10937989 ; http://dx.doi.org/10.1126/ science.289.5481.905 29.,Non-OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Nature   1979 ; 282:680-6  ; PMID:514347 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Biochim  Biophys Acta  1957 ; 26:457-68; PMID:13499402 ;  http://dx.doi.org/10.1016/0006-3002(57)90091-4 31.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Nature  1993 ; 363:561-5; PMID:8389423 ;  http://dx.doi.org/10.1038/363561a032.,Non-OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Gene   1987 ; 60:217-25; PMID:2832252 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Nucleic Acids Res  1992 ; 20:4631 -8; PMID:1408765 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Biochem Biophys Res Commun  2007 ; 358:368- 72; PMID:17482561 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Biochem Biophys Res Commun   2011 ; 404:250-3; PMID:21114960 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Biochem Biophys Res Commun  2009 ; 388:127- 30; PMID:19646956 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Proc Natl Acad Sci U S A  1980 ; 77:1852 -6; PMID:6929524 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Trends Cell Biol 1999 ; 9:M9-13; PMID:10611672 ;  http://dx.doi.org/10.1016/S0962-8924(99)01669-4 40.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Science   1994 ; 264:1137 -41; PMID:7513905 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Proc Natl Acad Sci U S A 2002 ; 99:11616 - 21; PMID:12185247 ; http://dx.doi.org/10.1073/ pnas.182095699 42.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
RNA  2003 ; 9:1456 -63;  PMID:14624002 ; http://dx.doi.org/10.1261/ rna.5990203 43.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
J Am Chem Soc 2004 ; 126:5130 - 7; PMID:15099096 ; http://dx.doi.org/10.1021/ ja031504a 44.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
J Am Chem Soc 2006 ;  128:7929 -37; PMID :16771507 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
RNA  2006 ;  12:567-79; PMID:16510427 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
J Org Chem 2011 ;  76:2933 -6; PMID:21413744 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Chemistry   2013 ; 19:15879 -87; PMID:24194407 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Curr Opin Struct Biol  2005 ; 15:342-8; PMID:15919195 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Nature  2007 ;  447:497-500; PMID:17468745 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
J Agric Food Chem 2007 ; 55:3788 - 97; PMID:17455948 ; http://dx.doi.org/10.1021/ jf063286l 52.,Non-OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Genome Res 2002 ; 12:656-64; PMID:11932250 ;  http://dx.doi.org/10.1101/gr.229202.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Nucleic  Acids Res 2012 ; 40:D26-32; PMID:22110030 ;  http://dx.doi.org/10.1093/nar/gkr947 54.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Nucleic Acids Res 2014 ; 42:D699 - 704; PMID:24297253 ; http://dx.doi.org/10.1093/ nar/gkt1183 55.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Nucleic Acids Res 2014 ; 42:D7-17; PMID:24259429 ;  http://dx.doi.org/10.1093/nar/gkt1146 57.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
Genome Res 2002 ; 12:996- 1006 ; PMID:12045153 ; http://dx.doi.org/10.1101/ gr.229102.,OADS,/arxiv_data1/oa_pdf/74/68/rna-11-682.PMC4156500.pdf
"2–5  Loss of MBNL1 and a gain of CUGBP1 function result in a misregulated splicing pattern of several pre-mRNAs, including  *Correspondence to: Marzena Wojciechowska; Email: mwojska@gmail.com; Wlodzimierz Krzyzosiak; Email: wlodkrzy@ibch.poznan.pl Submitted: 11/22/2013; Revised: 03/20/2014; Accepted: 04/06/2014; Published Online: 04/24/2014http://dx.doi.org/10.4161/rna.28799Small molecule kinase inhibitors alleviate different  molecular features of myotonic dystrophy type 1 Marzena Wojciechowska1,*, Katarzyna Taylor2, Krzysztof sobcz ak2, Marek Napierala3, and Wlodzimierz J Krzyzosiak1,* 1Department of Molecular Biomedicine; Institute of Bioorganic chemi stry; Polish Academy of scien ces; Noskowskiego; Poznan, Poland; 2Department of Gene expre ssion;  Institute of Molecular Biology and Biotechnology; Adam Mickiewicz University; Umultowska 89; Poznan, Poland; 3Department of Biochemistry and Molecular Genetics and  UAB stem cell In stitute; University of Alabama at Birmingham; Birmingham, AL U sA Keywords:  myotonic dystrophy, RNA-binding proteins, RNA splicing, protein kinases, protein phosphorylation, CUG Foci,  MBNL1 protein, CUGBP1 protein Abbreviations: DM1, myotonic dystrophy type 1; DMPK, dystrophia myotonica protein kinase; FISH, fluorescence in situ  hybridization; IF, immunofluorescence; CUGBP1, CUG repeat-binding protein; ATP, Adenosine-5'-triphosphate; PKR, protein  kinase R; DMSO, dimethyl sulfoxide; SERCA1 (ATP2A1), sarcoplasmic/endoplasmic reticulum calcium ATPase 1; MBNL1,  muscleblind-like 1 protein; CUGexp RNA, mutant CUG repeat transcript; GAPDH, glyceraldehyde 3-phosphate dehydrogenase;  qRT-PCR, quantitative real time RT-PCR; LNA, locked nucleic acids; LDB3, LIM domain-binding protein 3; DMD, dystrophin;  ITGA6, Integrin alpha-6; MTMR3, myotubularin-related protein 3; CAPZB, capping protein (actin filament) muscle Z-Line,  beta; SORBS1, sorbin and SH3 domain containing 1; ATP2B1, ATPase, Ca++ Transporting, Plasma Membrane 1; ABLIM1,  actin binding LIM protein 1; ERBB2IP, erbb2 interacting protein; SGT2, small glutamine-rich tetratricopeptide repeat (TPR)- containing, beta; KIDINS220, kinase D-interacting substrate, 220 kDa; R3HDM2, R3H domain containing 2; CTAGE5,  CTAGE family, member 5; MAP4K4, mitogen-activated protein kinase kinase kinase kinase 4; APLP2, amyloid beta (A4)  precursor-like protein 2; HMGCS1, 3-hydroxy-3-methylglutaryl-CoA synthase 1; 38 PPP3CB, protein phosphatase 3, catalytic  subunit, beta isozyme; CAPN3, calpain 3, (p94); ECT2, epithelial cell transforming sequence 2 oncogene; TSC2, tuberous  sclerosis 2 expandable ( cTG)n r epeats in the 3′ UTR of the DMPK  gene are a cause of myotonic dystrophy type 1 (DM1), which  leads to a toxic RNA gain-of-function disease.",Non-OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
J Biol Chem 2001; 276:7820-6; PMID:11124939 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Circ Res 2005; 97:1152-5; PMID:16254211 ; http://dx.doi.org/10.1161/01.,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Ann Neurol 2003; 54:760-8; PMID:14681885 ;  http://dx.doi.org/10.1002/ana.10763 6.,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Science 1998; 280:737-41; PMID:9563950 ; http://dx.doi.org/10.1126/ science.280.5364.737 8.,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Hum Mol Genet 2004; 13:3079-88; PMID :15496431 ; http://dx.doi.org/10.1093/ hmg/ddh3279.,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Hum Mol Genet 2007; 16:2834-43; PMID:17728322 ; http://dx.doi.org/10.1093/ hmg/ddm239 10.,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
J Biol Chem 2005; 280:20549-57; PMID:15788409 ;  http://dx.doi.org/10.1074/jbc.M409563200 11.,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
J Biol Chem 2006; 281:32806-19; PMID :16931514 ;  http://dx.doi.org/10.1074/jbc.M605701200,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Cell 2012; 150:710-24;   PMID:22901804 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Nat Struct Mol Biol 2011; 18:840-5;   PMID:21685920 ; http://dx.doi.org/10.1038/ nsmb.2067 14.,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Hum Mol Genet 2013; 22:704-16;  PMID:23139243 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Cell Cycle 2009; 8:2356-9; PMID:19571675 ;  http://dx.doi.org/10.4161/cc.8.15.9248 16.,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Exp Cell Res 2008; 314:2266-78; PMID:18570922 ;  http://dx.doi.org/10.1016/j.yexcr.2008.04.018 18.,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Mol Cell 2007; 28:68-78;   PMID:17936705 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Cell Death Dis 2013; 4:e770; PMID:23949219 ;  http://dx.doi.org/10.1038/cddis.2013.291 21.,Non-OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Nucleic Acids Res 2012; 40:11-26; PMID:21908410 ; http://dx.doi.org/10.1093/ nar/gkr729 22.,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Science 2009; 325:336-9; PMID:19608921 ; http://dx.doi.org/10.1126/ science.1173110 23.,Non-OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Nature 2012; 488:111-5;  PMID:22859208 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Mol Ther Nucleic Acids 2013; 2:e81; PMID:23511335 ;  http://dx.doi.org/10.1038/mtna.2013.9 26.,Non-OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Mol Ther 2013; 21:380-7;  PMID:23183533 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Nat Struct Mol Biol 2011; 18:85-7; PMID:21186365 ; http://dx.doi.org/10.1038/ nsmb.1958 28.,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
J Am Chem Soc 2009; 131:9767-79;  PMID:19552411 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Proc Natl Acad Sci U S A 2009; 106:16068-73;  PMID:19805260 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
ACS Chem Biol 2012; 7:856-62; PMID:22332923 ;  http://dx.doi.org/10.1021/cb200408a 31.,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
ACS Chem Biol 2013; 8:1037-43; PMID:23480597 ; http://dx.doi.org/10.1021/ cb400046u 32.,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Nucleic Acids Res 2013; 41:6687-97; http://dx.doi.org/10.1093/nar/gkt330 33.,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Proc Natl Acad Sci U S A 2009; 106:18551-6;   PMID:19822739 ; http://dx.doi.org/10.1073/ pnas.0903234106 34.,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Hum Mol Genet 2013; 23:1551-62;   PMID:24179176 ; http://dx.doi.org/10.1093/hmg/ ddt542 35.,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Biochem Biophys Res Commun 2003; 308:50-7; PMID:12890478 ; http://dx.doi.org/10.1016/ S0006-291X(03)01318-436.,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Bioorg Med Chem Lett 2011; 21:4108-14;   PMID:21632247 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Eur J Neurosci 2008;  28:2003-16; PMID:19046382 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Cell 2011;  147:1384-96;  PMID:22153080 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Neurosci Lett 2006; 409:192-5;  PMID:17055645 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Invest Ophthalmol Vis Sci 2007; 48:3729-36; PMID:17652745 ; http://dx.doi.org/10.1167/ iovs.06-1122 41.,Non-OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Neuroscience 2006; 139:1343-54;  PMID:16581193 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Hum Mol Genet 2005; 14:1539-47;   PMID:15843400 ; http://dx.doi.org/10.1093/hmg/ ddi162 43.,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Mol Cell Biol 2009; 29:871- 80; PMID:19047369; http://dx.doi.org/10.1128/ MCB.01709-08 46.,Non-OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Hum Mol Genet 2011; 20:3811-21; PMID:21729883 ;  http://dx.doi.org/10.1093/hmg/ddr299 47.,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Hum Mol Genet 2001; 10:2165-70; PMID:11590133 ; http://dx.doi.org/10.1093/ hmg/10.19.2165,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Hum Mol Genet 2006; 15:2087-97;  PMID:16717059 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Nat Struct Mol Biol 2009; 16:130-7; PMID:19136955 ; http://dx.doi.org/10.1038/ nsmb.154550.,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Genes Dev 2012; 26:1626-42;  PMID:22802532 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Neurobiol Dis 2009; 36:181- 90; PMID:19632331 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
Nucleic Acids Res 2011; 39:3852-63;   PMID:21247881 ; http://dx.doi.org/10.1093/nar/ gkq1323,OADS,/arxiv_data1/oa_pdf/5a/41/rna-11-742.PMC4156505.pdf
"RNA Biol  2013; 10:924-33; PMID:23696037; http://dx.doi.org/10.4161/rna.24604  Cia frè SA, Galardi S. microRNAs and RNA-binding proteins: a complex network  of interactions and reciprocal regulations in cancer.",OADS,/arxiv_data1/oa_pdf/5f/50/rna-11-789.PMC4156510.pdf
"RNA Biol 2013; 10:934-42;  PMID:23696003; http://dx.doi.org/10.4161/rna.24641  Kom arova AV, Combredet C, Sismeiro O, Dillies MA, Jagla B, Sanchez David RY,  Vabret N, Coppée JY, Vidalain PO, Tangy F. Identification of RNA partners of viral proteins in infected cells.",OADS,/arxiv_data1/oa_pdf/5f/50/rna-11-789.PMC4156510.pdf
"RNA Biol 2013; 10:943-56; PMID:23595062; http://dx.doi.org/10.4161/rna.24453  Yua n C, Liu Y, Yang M, Liao DJ.",OADS,/arxiv_data1/oa_pdf/5f/50/rna-11-789.PMC4156510.pdf
"RNA Biol 2013; 10:957-67; PMID:23618925; http://dx.doi.org/10.4161/rna.24570  Mat eus DD, Paredes JA, Español Y, Ribas de Pouplana L, Moura GR, Santos MA.",OADS,/arxiv_data1/oa_pdf/5f/50/rna-11-789.PMC4156510.pdf
"RNA Biol 2013; 10:968-80; PMID:23619021; http://dx.doi.org/10.4161/rna.24683  Kli gun E, Mandel-Gutfreund Y. Conformational readout of RNA by small ligands.",OADS,/arxiv_data1/oa_pdf/5f/50/rna-11-789.PMC4156510.pdf
"RNA Biol 2013; 10:981-9; PMID:23618839; http://dx.doi.org/10.4161/rna.24682 Yi F, Y ang F, Liu X, Chen H, Ji T, Jiang L, Wang X, Yang Z, Zhang LH, Ding X,  et al.",OADS,/arxiv_data1/oa_pdf/5f/50/rna-11-789.PMC4156510.pdf
"RNA Biol 2013; 10:990-1001; PMID:23603976; http://dx.doi.org/10.4161/rna.24644  Amo rt T, Soulière MF, Wille A, Jia XY, Fiegl H, Wörle H, Micura R, Lusser A.",OADS,/arxiv_data1/oa_pdf/5f/50/rna-11-789.PMC4156510.pdf
"RNA Biol 2013; 10:1002-8; PMID:23595112; http://dx.doi.org/10.4161/rna.24454  Sar agliadis A, Krajewski SS, Rehm C, Narberhaus F, Hartig JS.",OADS,/arxiv_data1/oa_pdf/5f/50/rna-11-789.PMC4156510.pdf
"RNA Biol 2013; 10:1009-16; PMID:23595083; http://dx.doi.org/10.4161/rna.24482  Mei er J, Hovestadt V, Zapatka M, Pscherer A, Lichter P, Seiffert M. Genome-wide  identification of translationally inhibited and degraded miR-155 targets using RNA-interacting protein-IP.",OADS,/arxiv_data1/oa_pdf/5f/50/rna-11-789.PMC4156510.pdf
"RNA Biol 2013; 10:1017-29; PMID:23673373; http://dx.doi.org/10.4161/rna.24553  Lap ouge K, Perozzo R, Iwaszkiewicz J, Bertelli C, Zoete V, Michielin O, Scapozza L,  Haas D. RNA pentaloop structures as effective targets of regulators belonging to the RsmA/CsrA protein family.",OADS,/arxiv_data1/oa_pdf/5f/50/rna-11-789.PMC4156510.pdf
RNA Biol 2013; 10:1030-41; PMID:23635605; http://dx.doi.org/10.4161/rna.24771,OADS,/arxiv_data1/oa_pdf/5f/50/rna-11-789.PMC4156510.pdf
Editor: Joseph Mindell./C2112014 The Authors 0006-3495/14/09/1105/12 $2.00 http://dx.doi.org/10.1016/j.bpj.2014.07.040 Biophysical Journal Volume 107 September 2014 1105–1116 1105,Non-OADS,/arxiv_data1/oa_pdf/0b/12/main.PMC4156679.pdf
"Two electrode voltage-clamp was performed with a Turbo- tec 03 ampliﬁer (npi, Tamm, npi electronic, Germany) and the custom acquisition program GePulse (freely available at http://users.ge.ibf.cnr.it/ pusch/programs-mik.htm ).",OADS,/arxiv_data1/oa_pdf/0b/12/main.PMC4156679.pdf
"Raw data were analyzed using a custom analysis program (Ana; freely available at http://users.ge.ibf.cnr.it/pusch/programs-mik.htm ), Excel (Microsoft Corp., Redmond, WA), and Sigma Plot (Systat Software, Inc., San Jose, CA).",OADS,/arxiv_data1/oa_pdf/0b/12/main.PMC4156679.pdf
http://www.info.,Non-OADS,/arxiv_data1/oa_pdf/94/3a/40262_2014_Article_165.PMC4156782.pdf
Jan- uary 2001. http://www.fda.gov/downloads/Drugs/Guidances/ ucm070244.pdf .,Non-OADS,/arxiv_data1/oa_pdf/94/3a/40262_2014_Article_165.PMC4156782.pdf
20 January 2010. http://www.emea.,Non-OADS,/arxiv_data1/oa_pdf/94/3a/40262_2014_Article_165.PMC4156782.pdf
http://clinicaltrials.gov .,Non-OADS,/arxiv_data1/oa_pdf/94/3a/40262_2014_Article_165.PMC4156782.pdf
http://clinicaltrials.gov .,Non-OADS,/arxiv_data1/oa_pdf/94/3a/40262_2014_Article_165.PMC4156782.pdf
"Methods This study had the approval of the Institutional Review Board (provided ID number: 24089) on the basis of the EthicalGuidelines for Clinical Research of the Ministry of Health, Labour and Welfare in Japan ( http://www.mhlw.go.jp/seisakunitsuite/bunya/hokabunya/kenkyujigyou/i-kenkyu/ index.html ).",Non-OADS,/arxiv_data1/oa_pdf/f6/89/535_2013_Article_895.PMC4156784.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-006175).,Non-OADS,/arxiv_data1/oa_pdf/0f/6d/bmjopen-2014-006175.PMC4156794.pdf
http://dx.doi.org/10.423T6/sn.2012.,Non-OADS,/arxiv_data1/oa_pdf/0f/6d/bmjopen-2014-006175.PMC4156794.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-005683).,Non-OADS,/arxiv_data1/oa_pdf/4c/88/bmjopen-2014-005683.PMC4156795.pdf
http://www.ons.gov.uk/ons/guide-method/classifications/ current-standard-classifications/soc2010/soc2010-volume-3-ns-sec-- rebased-on-soc2010--user-manual/index.html 40.,Non-OADS,/arxiv_data1/oa_pdf/4c/88/bmjopen-2014-005683.PMC4156795.pdf
http://www.mrc-hnr.cam.ac.uk/research/current-projects/ national-diet-and-nutrition-survey 41.,Non-OADS,/arxiv_data1/oa_pdf/4c/88/bmjopen-2014-005683.PMC4156795.pdf
http://www.ons.gov.uk/ons/guide-method/geography/ beginner-s-guide/administrative/england/government-office-regions/index.html 42.,Non-OADS,/arxiv_data1/oa_pdf/4c/88/bmjopen-2014-005683.PMC4156795.pdf
We are unable to share the study database but information related to it is available at: https://www.dur.ac.uk/wolfson.institute/geohealth/.,Non-OADS,/arxiv_data1/oa_pdf/ad/1b/bmjopen-2014-005764.PMC4156797.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.New tool to enhance role of pharmacists in health care .,Non-OADS,/arxiv_data1/oa_pdf/ad/1b/bmjopen-2014-005764.PMC4156797.pdf
"Department of Health, 2008. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/228858/7341.pdf (accessed 18 May 2014).",Non-OADS,/arxiv_data1/oa_pdf/ad/1b/bmjopen-2014-005764.PMC4156797.pdf
"Pharmaceutical Services Negotiating Committee (PSNC), 2014. http://psnc.org.uk/contract-it/the-pharmacy-contract/ (accessed 26 Jun 2014).",Non-OADS,/arxiv_data1/oa_pdf/ad/1b/bmjopen-2014-005764.PMC4156797.pdf
"Pharmaceutical Services Negotiating Committee (PSNC), 2014. http://psnc.org.uk/services-commissioning/locally-commissioned-services/ (accessed 18 May 2014).",Non-OADS,/arxiv_data1/oa_pdf/ad/1b/bmjopen-2014-005764.PMC4156797.pdf
"London: UCL, 2010. http://www.instituteofhealthequity.org/projects/ fair-society-healthy-lives-the-marmot-review (accessed 18 May 2014).",Non-OADS,/arxiv_data1/oa_pdf/ad/1b/bmjopen-2014-005764.PMC4156797.pdf
http://www.instituteofhealthequity.org/projects/priority-public-health-conditions-task-group-report (accessed 18 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/ad/1b/bmjopen-2014-005764.PMC4156797.pdf
http://www.ons.gov.uk/ons/dcp171778_254061.pdf (accessed 18 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/ad/1b/bmjopen-2014-005764.PMC4156797.pdf
http://www.ic.nhs.uk/pubs/smoking11(accessed 18 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/ad/1b/bmjopen-2014-005764.PMC4156797.pdf
"Department of Health, 2008. http://image.guardian.",Non-OADS,/arxiv_data1/oa_pdf/ad/1b/bmjopen-2014-005764.PMC4156797.pdf
2010. http://age-equality.southwest.nhs.uk/downloads/guides/age-equality-nhs-practice-guide-ALL-chapters.pdf (accessed 18 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/ad/1b/bmjopen-2014-005764.PMC4156797.pdf
2008. http://www.scotland.gov.uk/Resource/Doc/210642/0055693.pdf (accessed 18 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/ad/1b/bmjopen-2014-005764.PMC4156797.pdf
http://www.ons.gov.uk/ons/guide-method/geography/products/area-classifications/rural-urban-definition-and-la/rural-urban-definition—england-and-wales-/index.html (accessed 18 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/ad/1b/bmjopen-2014-005764.PMC4156797.pdf
http://www.pharmacyregulation.org/ (accessed 19 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/ad/1b/bmjopen-2014-005764.PMC4156797.pdf
https://www.gov.uk/government/publications/english-indices-of-deprivation-2010 (accessed 18 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/ad/1b/bmjopen-2014-005764.PMC4156797.pdf
"Pharmaceutical Services Negotiating Committee (PSNC), 2014. http://psnc.org.uk/contract-it/market-entry-regulations/ (accessed 26 Jun 2014).",Non-OADS,/arxiv_data1/oa_pdf/ad/1b/bmjopen-2014-005764.PMC4156797.pdf
December 2013. http://www.england.nhs.uk/wp-content/uploads/2013/12/community-pharmacy-cta.pdf (accessed 18 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/ad/1b/bmjopen-2014-005764.PMC4156797.pdf
Secondary The top 10 causes of death 2011 2013. http://who.int/mediacentre/factsheets/fs310/en/ (access 16 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/85/00/bmjopen-2014-005715.PMC4156798.pdf
The causes of death 2012. https://tilastokeskus.fi/til/ksyyt/2012/ksyyt_2012_2013-12-30_tie_001_fi.html (access 16 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/85/00/bmjopen-2014-005715.PMC4156798.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-005837).,Non-OADS,/arxiv_data1/oa_pdf/21/ad/bmjopen-2014-005837.PMC4156799.pdf
http://apps.who.int/202A1F3B-6F1E-4162 –96E2 –979BCB3B5F15/FinalDownload/ DownloadId-BD5DACF211A245F200FD6C52B616EE29/202A1F3B-6F1E-4162 –96E2 –979BCB3B5F15/iris/bitstream/10665/ 85380/1/9789241505871_eng.pdf (accessed 10 Dec 2013).,Non-OADS,/arxiv_data1/oa_pdf/21/ad/bmjopen-2014-005837.PMC4156799.pdf
http://esa.un.org/unpd/wpp/unpp/p2k0data.asp(assessed 6 Jul 2014).,Non-OADS,/arxiv_data1/oa_pdf/21/ad/bmjopen-2014-005837.PMC4156799.pdf
http://datatopics.worldbank.org/hnp/popestimates (accessed 23 Jun 2014).,Non-OADS,/arxiv_data1/oa_pdf/21/ad/bmjopen-2014-005837.PMC4156799.pdf
http://apps.nccd.cdc.gov/gtssdata/Ancillary/DataReports.aspx?CAID=1 (accessed 5 Jul 2014).,OADS,/arxiv_data1/oa_pdf/21/ad/bmjopen-2014-005837.PMC4156799.pdf
http://unstats.un.org/unsd/methods/m49/m49regin.htm (accessed 6 Jul 2014).,OADS,/arxiv_data1/oa_pdf/21/ad/bmjopen-2014-005837.PMC4156799.pdf
http://www.fctc.org/ fca-news/packaging-and-labelling/251-mauritius-leads-africa-with-cigarette-pack-warnings (accessed 5 Jun 2014).,Non-OADS,/arxiv_data1/oa_pdf/21/ad/bmjopen-2014-005837.PMC4156799.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 005799).,Non-OADS,/arxiv_data1/oa_pdf/5c/4a/bmjopen-2014-005799.PMC4156800.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005372).,Non-OADS,/arxiv_data1/oa_pdf/9a/14/bmjopen-2014-005372.PMC4156801.pdf
http://www.rijksoverheid.nl/onderwerpen/zorgverzekering/ aanvullende-verzekering 6.,Non-OADS,/arxiv_data1/oa_pdf/e2/c5/bmjopen-2014-005332.PMC4156802.pdf
"Manheimer B, Berman B. Cochrane complementary medicine field, about the Cochrane Collaboration (Fields) 2008, Issue 2. http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/CE000052/frame.html 9.",OADS,/arxiv_data1/oa_pdf/e2/c5/bmjopen-2014-005332.PMC4156802.pdf
http://www.imconsortium.org/about/ 10.,Non-OADS,/arxiv_data1/oa_pdf/e2/c5/bmjopen-2014-005332.PMC4156802.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005508).,Non-OADS,/arxiv_data1/oa_pdf/53/f7/bmjopen-2014-005508.PMC4156803.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/53/f7/bmjopen-2014-005508.PMC4156803.pdf
"Three on-line clinical trial registries were searched: Cochrane Central Register of Controlled trials (http://www.cochrane.org), MetaRegister of Controlled Trials (http:www.controlled-trials.com/mrct) and NationalInstitutes of Health (http://www.clinicaltrials.gov).",OADS,/arxiv_data1/oa_pdf/9b/a8/bmjopen-2014-005047.PMC4156804.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/9b/a8/bmjopen-2014-005047.PMC4156804.pdf
2008. http://www.fda/gov/food/guidanceregulation/guidancedocumentsregulatoryinformation/ dietarysupplements/default.htm (accessed 29 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/9b/a8/bmjopen-2014-005047.PMC4156804.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/5e/73/bmjopen-2014-005873.PMC4156805.pdf
2011. http://www.comlaw.gov.au/ Details/C2011A00148 2.,Non-OADS,/arxiv_data1/oa_pdf/5e/73/bmjopen-2014-005873.PMC4156805.pdf
2011. http://www.comlaw.,Non-OADS,/arxiv_data1/oa_pdf/5e/73/bmjopen-2014-005873.PMC4156805.pdf
2011. http://www.comlaw.gov.au/Details/F2011L02766 4.,Non-OADS,/arxiv_data1/oa_pdf/5e/73/bmjopen-2014-005873.PMC4156805.pdf
2014. http://www.parliament.nz/en-nz/pb/legislation/bills/00DBHOH_BILL12969_1/smoke-free-environments-tobacco-plain-packaging-amendment (accessed Mar2014).,Non-OADS,/arxiv_data1/oa_pdf/5e/73/bmjopen-2014-005873.PMC4156805.pdf
"London: Kings College London, 2014. http://www.kcl.ac.uk/ health/packaging-review.aspx (accessed May 2014).",Non-OADS,/arxiv_data1/oa_pdf/5e/73/bmjopen-2014-005873.PMC4156805.pdf
2011.http://www.yourhealth.gov.au/internet/yourhealth/publishing.nsf/Content/plainpack-tobacco-subs-a#.UOzuWKxqF9M (accessedMay 2014).,Non-OADS,/arxiv_data1/oa_pdf/5e/73/bmjopen-2014-005873.PMC4156805.pdf
2011. https://www.australianretailers.,Non-OADS,/arxiv_data1/oa_pdf/5e/73/bmjopen-2014-005873.PMC4156805.pdf
"Department of Health and Ageing Consultation website Canberra, 2011. http://www.yourhealth.gov.au/internet/yourhealth/publishing.nsf/Content/plainpack-tobacco-subs-b#.UOzuWKxqF9M (accessed 2 Jun 2014).",Non-OADS,/arxiv_data1/oa_pdf/5e/73/bmjopen-2014-005873.PMC4156805.pdf
"Alliance of Australian RetailersSydney, 2011. https://www.australianretailers.com.au/downloads/pdf/deloitte/2011_01_31_AAR_Plain_Packaging2.pdf (accessed Mar2013).",Non-OADS,/arxiv_data1/oa_pdf/5e/73/bmjopen-2014-005873.PMC4156805.pdf
"Alliance of Australian Retailers Sydney, 2011. https://www.australianretailers.com.au/downloads/pdf/deloitte/Potential_impact_of_channel_shift.pdf (accessed Mar 2013).",Non-OADS,/arxiv_data1/oa_pdf/5e/73/bmjopen-2014-005873.PMC4156805.pdf
"LECG Consulting Belgium Brussels, 2010. http://www.yourhealth.",Non-OADS,/arxiv_data1/oa_pdf/5e/73/bmjopen-2014-005873.PMC4156805.pdf
2011. http://www.bata.com.au/group/sites/bat_7wykg8.nsf/vwPagesWebLive/DO7WZEX6/$FILE/medMD8GX5XH.pdf?openelement (accessed May 17).,Non-OADS,/arxiv_data1/oa_pdf/5e/73/bmjopen-2014-005873.PMC4156805.pdf
"BATA Sydney, 2013.http://www.bata.com.au/group/sites/BAT_7WYKG8.nsf/vwPagesWebLive/DO9879X3?opendocument&SKN=1 (accessedMay 2014).",Non-OADS,/arxiv_data1/oa_pdf/5e/73/bmjopen-2014-005873.PMC4156805.pdf
2012. http://www.bat.com/group/sites/uk__3mnfen.nsf/ vwPagesWebLive/DO8WZC5E/$FILE/medMD8WZC6J.pdf?openelement (accessed May 2014).,Non-OADS,/arxiv_data1/oa_pdf/5e/73/bmjopen-2014-005873.PMC4156805.pdf
2012. http://www.bat.com/group/sites/uk__3mnfen.nsf/vwPagesWebLive/DO8WZC5E/$FILE/medMD8WZC6J.pdf?openelement (accessed May 2014).,Non-OADS,/arxiv_data1/oa_pdf/5e/73/bmjopen-2014-005873.PMC4156805.pdf
2012. http://www.bat.com/group/sites/uk__3mnfen.nsf/vwPagesWebLive/DO8WZC5E/$FILE/medMD8WZC6J.pdf?openelement (accessed May 2014).,Non-OADS,/arxiv_data1/oa_pdf/5e/73/bmjopen-2014-005873.PMC4156805.pdf
2012. http://www.jti.com/how-we-do-business/key-regulatory-submissions/ (accessed May 2014).,Non-OADS,/arxiv_data1/oa_pdf/5e/73/bmjopen-2014-005873.PMC4156805.pdf
2011. http://www.theaustralian.com.au/national-affairs/tobacco-firms-say-itll-take-two-years-to-meet-pack-deadline/story-fn59niix-1226108594740 27.,Non-OADS,/arxiv_data1/oa_pdf/5e/73/bmjopen-2014-005873.PMC4156805.pdf
Secondary ExplanatoryMemorandum to Excise Tariff Amendment (Tobacco) Bill 2014.2014. http://parlinfo.aph.gov.au/parlInfo/search/display/display.w3p;query=Id%3A%22legislation%2Fems%2Fr5172_ems_78ed6212-03a3-4669-9947-c3fc17c8b5e0%22 (accessed Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/5e/73/bmjopen-2014-005873.PMC4156805.pdf
"Sydney, 2013. http://www.bata.com.au/group/sites/BAT_7WYKG8.nsf/vwPagesWebLive/DO9879X3?opendocument&SKN=1 (accessedNov 2013).",Non-OADS,/arxiv_data1/oa_pdf/5e/73/bmjopen-2014-005873.PMC4156805.pdf
"Australia: Cancer Council Victoria Melbourne, 2013. http://www.cancervic.org.au/plainfacts/browse.asp?",Non-OADS,/arxiv_data1/oa_pdf/5e/73/bmjopen-2014-005873.PMC4156805.pdf
"Canberra, Australian Capital Territory: ABS, 2013. http://www.abs.",Non-OADS,/arxiv_data1/oa_pdf/5e/73/bmjopen-2014-005873.PMC4156805.pdf
http://www.abs.gov.au/AUSSTATS/abs@.nsf/ allprimarymainfeatures/6D29D79856AA107ECA257BD60010DD6C?opendocument (accessed Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/5e/73/bmjopen-2014-005873.PMC4156805.pdf
2011.http://www.ada.edu.au/social-science/browse/alcohol –tobacco-and- other-drugs/national-drug-strategy-household-survey (accessed Jun 2013).,OADS,/arxiv_data1/oa_pdf/5e/73/bmjopen-2014-005873.PMC4156805.pdf
No longer on line at http://www.illegaltobacco.com.au/ 47.,Non-OADS,/arxiv_data1/oa_pdf/5e/73/bmjopen-2014-005873.PMC4156805.pdf
"Philip Morris International, 2013. http://www.pmi.com/eng/ tobacco_regulation/illicit_trade/pages/illicit_trade.aspx (accessed 16Apr 2013).",Non-OADS,/arxiv_data1/oa_pdf/5e/73/bmjopen-2014-005873.PMC4156805.pdf
"IDRC Working Paper Series, 2007. http://web.idrc.ca/fr/ev-119595-201-1-DO _TOPIC.html (accessed Nov 2013).",OADS,/arxiv_data1/oa_pdf/5e/73/bmjopen-2014-005873.PMC4156805.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005577).,Non-OADS,/arxiv_data1/oa_pdf/9c/85/bmjopen-2014-005577.PMC4156806.pdf
"Stata/IC V.12.0 (Stata Corp. LP , College Station, T exas, USA) and RV.3.0.1 (available at http://www.r-project.org/) will be used for the conduct of all statistical analyses.",OADS,/arxiv_data1/oa_pdf/9c/85/bmjopen-2014-005577.PMC4156806.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/9c/85/bmjopen-2014-005577.PMC4156806.pdf
http://www.cdc.gov/ hai/pdfs/hai/scott_costpaper.pdf 8.,OADS,/arxiv_data1/oa_pdf/9c/85/bmjopen-2014-005577.PMC4156806.pdf
April 2013. http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/9c/85/bmjopen-2014-005577.PMC4156806.pdf
"The algorithms predict outcomes such as cardiovascu- lar disease (http://www.qrisk.org),1stroke (http://www.",Non-OADS,/arxiv_data1/oa_pdf/03/77/bmjopen-2014-005809.PMC4156807.pdf
"qstroke.org),2type 2 diabetes (http://www.qdiabetes.",Non-OADS,/arxiv_data1/oa_pdf/03/77/bmjopen-2014-005809.PMC4156807.pdf
"org),3osteoporotic fracture (http://www.qfracture.org),4 moderate or severe kidney disease (http://www.qkidney.",Non-OADS,/arxiv_data1/oa_pdf/03/77/bmjopen-2014-005809.PMC4156807.pdf
"qthrombosis.org)6and emergency hospital admission (http://www.qadmissions.org).7Generally, the ‘QPrediction ’algorithms have been designed to system- atically identify patients in primary care at high risk of a serious clinical outcome for whom further interventionto lower risk of that outcome might be possible.",Non-OADS,/arxiv_data1/oa_pdf/03/77/bmjopen-2014-005809.PMC4156807.pdf
"qdiabetes.org10-year risk of type 2 diabetes † In men and women : age, sex, ethnicity, deprivation, smoking, family history of diabetes,cardiovascular disease, treated hypertension,steroid tables, body mass index QRISK2 28http://www.qrisk.org10-year risk of CVD ‡ In men and women : age, smoking status ethnic group (nine categories), systolic blood pressure, cholesterol/HDL ratio, body mass index, familyhistory of cardiovascular disease in first degreerelative under 60 years, Townsend deprivationscore, treated hypertension, rheumatoid arthritis,chronic renal disease, type 2 diabetes, atrialfibrillation QStroke 2http://www.qstroke.org10-year risk of ischaemic stroke or TIA†In men and women : age, smoking status ethnic group (nine categories), systolic blood pressure, cholesterol/HDL ratio, body mass index, family history of cardiovascular disease in first degree relative under 60 years, Townsend deprivationscore, treated hypertension, rheumatoid arthritis,chronic renal disease, type 2 diabetes, atrialfibrillation, congestive cardiac failure, valvular heartdisease QKidney 5http://www.qkidney.org5-year risk of moderate or severe kidney failure§In men and women : age, smoking status ethnic group (nine categories), systolic blood pressure, body mass index, family history of kidney disease,Townsend deprivation score, treated hypertension,rheumatoid arthritis, chronic renal disease, type 2diabetes, atrial fibrillation, SLE, peripheral vasculardisease, kidney stones, NSAIDs QThrombosis http://www.",Non-OADS,/arxiv_data1/oa_pdf/03/77/bmjopen-2014-005809.PMC4156807.pdf
"qthrombosis.org5-year risk of venous thromboembolism †In men and women : age, body mass index, smoking status, varicose veins, congestive cardiacfailure, chronic renal disease, cancer, chronicobstructive pulmonary disease, inflammatory boweldisease, hospital admission in past 6 months andcurrent prescriptions for antipsychotic drugs.Additionally in women: combined oralcontraceptives, tamoxifen and hormonereplacement therapy QBleed 13http://www.qbleed.org5-year risk of upper gastrointestinal bleed in patient starting anticoagulantsversus others¶In men and women : age; body mass index; Townsend score; smoking status; ethnicity; alcoholintake; prior bleed; oesophageal varices; chronicliver disease or pancreatitis; atrial fibrillation;venous thromboembolism; congestive cardiacfailure; treated hypertension; cancer; recentabnormal platelets (<150 or >480 μL); new use of anticoagulants; current prescriptions forantiplatelets; NSAIDs; corticosteroids;antidepressants; anticonvulsants (phenytoin orcarbamazepine) QBleed 13http://www.",Non-OADS,/arxiv_data1/oa_pdf/03/77/bmjopen-2014-005809.PMC4156807.pdf
"http://qdiabetes.org/QDiabetes-2013-Annual-Update-Information.pdf Hippisley-Cox J, et al.BMJ Open 2014; 4:e005809.",OADS,/arxiv_data1/oa_pdf/03/77/bmjopen-2014-005809.PMC4156807.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-005131).,Non-OADS,/arxiv_data1/oa_pdf/8c/9d/bmjopen-2014-005131.PMC4156808.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/8c/9d/bmjopen-2014-005131.PMC4156808.pdf
http://www.kff.org/insurance/upload/Medical-Malpractice-Law-in-the-United-States-Report.pdf (accessed 31 Aug2012).,Non-OADS,/arxiv_data1/oa_pdf/8c/9d/bmjopen-2014-005131.PMC4156808.pdf
http://www.dh.gov.uk/health/contact-dh/complaints/ (accessed31 Aug 2012).,Non-OADS,/arxiv_data1/oa_pdf/8c/9d/bmjopen-2014-005131.PMC4156808.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005254).,Non-OADS,/arxiv_data1/oa_pdf/f8/5c/bmjopen-2014-005254.PMC4156809.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/f8/5c/bmjopen-2014-005254.PMC4156809.pdf
doi:10.1136/bmjopen-2014- 006264 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-006264).,Non-OADS,/arxiv_data1/oa_pdf/eb/fc/bmjopen-2014-006264.PMC4156812.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 005281).,Non-OADS,/arxiv_data1/oa_pdf/f2/1e/bmjopen-2014-005281.PMC4156814.pdf
"nl, http://www.daniel-kotz.deABSTRACT Introduction: Cigarette smoking continues to be the leading cause of preventable death and is the main riskfactor of major diseases such as chronic obstructivepulmonary disease (COPD).",Non-OADS,/arxiv_data1/oa_pdf/f2/1e/bmjopen-2014-005281.PMC4156814.pdf
"QResearch is a very large, validated electronic GP database; it includes data from the anon- ymised health records of over 13 million patients from753 general practices from across England that use the EMIS software system (http://www.qresearch.org).",OADS,/arxiv_data1/oa_pdf/f2/1e/bmjopen-2014-005281.PMC4156814.pdf
"QResearch has been used for various research studies,including studies of the incidence and risk neuropsychi- atric and cardiovascular events 37–41(for a complete and up-to-date list of studies visit: http://www.qresearch.org/SitePages/publications.aspx).",OADS,/arxiv_data1/oa_pdf/f2/1e/bmjopen-2014-005281.PMC4156814.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/f2/1e/bmjopen-2014-005281.PMC4156814.pdf
http://www.who.int/mediacentre/factsheets/fs310/en/index.html (accessed24 Apr 2012).,OADS,/arxiv_data1/oa_pdf/f2/1e/bmjopen-2014-005281.PMC4156814.pdf
Revised 2011. http://www.goldcopd.com (accessed 24 Apr 2012).,Non-OADS,/arxiv_data1/oa_pdf/f2/1e/bmjopen-2014-005281.PMC4156814.pdf
Revised 2011. http://www.goldcopd.com (accessed24 Apr 2012).,Non-OADS,/arxiv_data1/oa_pdf/f2/1e/bmjopen-2014-005281.PMC4156814.pdf
"METHODS The Determinants of Cotinine phase 3 project (dCOT3,website: http://bioinfo.iconcologia.net/es/content/ estudio-dcot3) is a longitudinal study of a representative sample of the adult ( ≥16 years old) non-institutionalised population of the city of Barcelona (Spain; n=1245, 694 women and 551 men).",Non-OADS,/arxiv_data1/oa_pdf/97/ed/bmjopen-2014-005894.PMC4156815.pdf
http://ec.europa.eu/health/tobacco/eurobarometers/index_en.htm (accessed 20 May 2014) 9.,Non-OADS,/arxiv_data1/oa_pdf/97/ed/bmjopen-2014-005894.PMC4156815.pdf
"Barcelona, 30Jul 2013. http://tobaccorelated.files.wordpress.com/2013/08/statement_ecigs.pdf (accessed 28 Jul 2014) 11.",Non-OADS,/arxiv_data1/oa_pdf/97/ed/bmjopen-2014-005894.PMC4156815.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005528).,Non-OADS,/arxiv_data1/oa_pdf/0f/ce/bmjopen-2014-005528.PMC4156816.pdf
Data sharing statement The R code that was used to perform the simulations is available on figshare at: http://www.dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/74/d4/bmjopen-2014-004831.PMC4156818.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/74/d4/bmjopen-2014-004831.PMC4156818.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005456).,Non-OADS,/arxiv_data1/oa_pdf/c3/3d/bmjopen-2014-005456.PMC4156819.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/c3/3d/bmjopen-2014-005456.PMC4156819.pdf
doi:10.1136/bmjopen-2014- 005329 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005329).,Non-OADS,/arxiv_data1/oa_pdf/b2/31/bmjopen-2014-005329.PMC4156820.pdf
"The article with the headline “Medical Council of India  (MCI)  likely to ban animal dissection at post -grad level too”  in the Pioneer, a New Delhi based daily came as a rude  shock to some of us (http://www.dailypioneer.com/nation/ mci-likely-to-ban-animal-dissection-at-post-grad-level-too.",Non-OADS,/arxiv_data1/oa_pdf/27/bb/JPP-5-179.PMC4156827.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/0d/17/JPP-5-181.PMC4156828.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/0d/17/JPP-5-181.PMC4156828.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/af/5c/JPP-5-186.PMC4156829.pdf
Available	 from:	http://www.us.zometa.com.,Non-OADS,/arxiv_data1/oa_pdf/51/e5/JPP-5-217.PMC4156837.pdf
Available	from:	http://www.pharma.,Non-OADS,/arxiv_data1/oa_pdf/51/e5/JPP-5-217.PMC4156837.pdf
Available from: http://www.iasociety.org/ Abstracts/A200747433.aspx.,Non-OADS,/arxiv_data1/oa_pdf/d6/9f/JPP-5-222.PMC4156838.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/d6/9f/JPP-5-222.PMC4156838.pdf
"Available at:  http://www.update-software.com  4 Lahdensuo A, Haahtela T, Herrala J, Kava T, Kiviranta K, Kuusisto P, et al.. Randomised comparison of guided self  management and traditional treatment of asthma over one year.",OADS,/arxiv_data1/oa_pdf/10/1c/pharmpract-04-139.PMC4156847.pdf
"Available at:  http://www.portalfarma.com/pfarma/taxonomia/general /gp000016.nsf/voDocumentos/A4C2DD45FCF8B8BCC1256DEF0 059477B/$File/004.pdf (accessed 4 sept 2006)  10 Dualde E, Mañes J, Román B, Font G. Evaluación de c onocimientos adquiridos en el cu rso de libre opción de Atención  Farmacéutica de la Facultad de Farmacia de Valencia.",OADS,/arxiv_data1/oa_pdf/10/1c/pharmpract-04-139.PMC4156847.pdf
"http://www.pcne.org/dokumenter/PCNE%20classifi cation%20V5.00.pdf (accessed April 19, 2006).",OADS,/arxiv_data1/oa_pdf/99/3c/pharmpract-04-143.PMC4156848.pdf
"ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommonsAttributionNon-CommercialLicense(http://creativecommons.org/licenses/by-nc/.0/),which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ae/e4/ehu189.PMC4156973.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Food & Nutrition Research 2014, 58: 24024 - http://dx.doi.org/10.3402/fnr.v58.24024 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/e7/4a/FNR-58-24024.PMC4157137.pdf
"2 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 24024 - http://dx.doi.org/10.3402/fnr.v58.24024",Non-OADS,/arxiv_data1/oa_pdf/e7/4a/FNR-58-24024.PMC4157137.pdf
"Factors representing a healthier lifestyle were self-reportedBread consumption patterns in Sweden Citation: Food & Nutrition Research 2014, 58: 24024 - http://dx.doi.org/10.3402/fnr.v58.24024 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/e7/4a/FNR-58-24024.PMC4157137.pdf
"4 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 24024 - http://dx.doi.org/10.3402/fnr.v58.24024",Non-OADS,/arxiv_data1/oa_pdf/e7/4a/FNR-58-24024.PMC4157137.pdf
"Mean reported intake of bread (g/day) among low and high bread consumers and main consumers of white bread, bread with B25% whole grain, whole-grain bread and dry crisp bread T otal mean intake, all respondentsLow and high total bread consumers Main consumers of different types of bread (n/C301,435)Low (n/C30717)High (n/C30718)White bread (n/C30514)Bread with B25% whole grain (n/C30355)Whole-grain bread ( n/C30526)Dry crisp bread (n/C30358) g (SD) g (SD) g (SD) g (SD) g (SD) g (SD) g (SD) T otal bread 86 (49) 56 (31) 115 (45) 92 (50) 89 (43) 92 (46) 68 (40) White bread 31 (38) 21 (25) 42 (45) 66 (41) 18 (24) 13 (18) 16 (21)Bread with B25% whole grain 11 (22) 8 (16) 15 (26) 7 (13) 35 (31) 5 (10) 6 (14) Whole-grain bread 34 (38) 21 (24) 47 (44) 12 (18) 28 (30) 67 (37) 21 (25) Dry crisp bread 9 (12) 7 (9) 11 (14) 7 (10) 8 (12) 8 (10) 24 (14) SD: standard deviation.Bread consumption patterns in Sweden Citation: Food & Nutrition Research 2014, 58: 24024 - http://dx.doi.org/10.3402/fnr.v58.24024 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/e7/4a/FNR-58-24024.PMC4157137.pdf
"6 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 24024 - http://dx.doi.org/10.3402/fnr.v58.24024",Non-OADS,/arxiv_data1/oa_pdf/e7/4a/FNR-58-24024.PMC4157137.pdf
"WG: whole grain.Bread consumption patterns in Sweden Citation: Food & Nutrition Research 2014, 58: 24024 - http://dx.doi.org/10.3402/fnr.v58.24024 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/e7/4a/FNR-58-24024.PMC4157137.pdf
"8 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 24024 - http://dx.doi.org/10.3402/fnr.v58.24024",Non-OADS,/arxiv_data1/oa_pdf/e7/4a/FNR-58-24024.PMC4157137.pdf
"Socio-demographic, geographic, and lifestyle-related fac-tors are associated with what type of bread is consumed.Older age groups more often reported eating traditionalBread consumption patterns in Sweden Citation: Food & Nutrition Research 2014, 58: 24024 - http://dx.doi.org/10.3402/fnr.v58.24024 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/e7/4a/FNR-58-24024.PMC4157137.pdf
"10 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 24024 - http://dx.doi.org/10.3402/fnr.v58.24024",Non-OADS,/arxiv_data1/oa_pdf/e7/4a/FNR-58-24024.PMC4157137.pdf
"*Pernilla Sandvik Department of Food, Nutrition and DieteticsUppsala UniversitySE-751 05 Uppsala, Sweden Email: pernilla.sandvik@ikv.uu.seBread consumption patterns in Sweden Citation: Food & Nutrition Research 2014, 58: 24024 - http://dx.doi.org/10.3402/fnr.v58.24024 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/e7/4a/FNR-58-24024.PMC4157137.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, dist ribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Oral Microbiology 2014, 6: 24878 - http://dx.doi.org/10.3402/jom.v6.24878 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/8d/ff/JOM-6-24878.PMC4157138.pdf
"2 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2014, 6: 24878 - http://dx.doi.org/10.3402/jom.v6.24878",Non-OADS,/arxiv_data1/oa_pdf/8d/ff/JOM-6-24878.PMC4157138.pdf
"Overall, PTS porters monitor the type and levels of carbohydrates present in the oral cavity, while theoverall supply of carbohydrate in relation to cellular energy demands is monitored by the activity of HPr and CcpA.Sugar metabolism and virulence Citation: Journal of Oral Microbiology 2014, 6: 24878 - http://dx.doi.org/10.3402/jom.v6.24878 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/8d/ff/JOM-6-24878.PMC4157138.pdf
"4 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2014, 6: 24878 - http://dx.doi.org/10.3402/jom.v6.24878",Non-OADS,/arxiv_data1/oa_pdf/8d/ff/JOM-6-24878.PMC4157138.pdf
"It is howeversometimes necessary to utilize rich and defined mediaSugar metabolism and virulence Citation: Journal of Oral Microbiology 2014, 6: 24878 - http://dx.doi.org/10.3402/jom.v6.24878 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/8d/ff/JOM-6-24878.PMC4157138.pdf
"6 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2014, 6: 24878 - http://dx.doi.org/10.3402/jom.v6.24878",Non-OADS,/arxiv_data1/oa_pdf/8d/ff/JOM-6-24878.PMC4157138.pdf
"Found in biological structures as diverse as the shells of arthropods to the cell walls of fungi and bacteria, these amino sugarsSugar metabolism and virulence Citation: Journal of Oral Microbiology 2014, 6: 24878 - http://dx.doi.org/10.3402/jom.v6.24878 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/8d/ff/JOM-6-24878.PMC4157138.pdf
"8 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2014, 6: 24878 - http://dx.doi.org/10.3402/jom.v6.24878",Non-OADS,/arxiv_data1/oa_pdf/8d/ff/JOM-6-24878.PMC4157138.pdf
"This observation with MtlR could provide a possible explanation for the behavior of S. mutans UA159 lacking EIIB Cel, whereby phosphorylation by EIIBCelserves to inactivate CelR, and dephosphory- lated EIIBCelserves as a tether to keep CelR associated with the membrane and facilitates celoperon activation.Sugar metabolism and virulence Citation: Journal of Oral Microbiology 2014, 6: 24878 - http://dx.doi.org/10.3402/jom.v6.24878 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/8d/ff/JOM-6-24878.PMC4157138.pdf
"10 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2014, 6: 24878 - http://dx.doi.org/10.3402/jom.v6.24878",Non-OADS,/arxiv_data1/oa_pdf/8d/ff/JOM-6-24878.PMC4157138.pdf
"Illustration of the response of S. mutans and non-cariogenic ﬂora to carbohydrates introduced to the oral cavity.Sugar metabolism and virulence Citation: Journal of Oral Microbiology 2014, 6: 24878 - http://dx.doi.org/10.3402/jom.v6.24878 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/8d/ff/JOM-6-24878.PMC4157138.pdf
